Sentence,class,file
World J Psychiatr  2016; 6(3):  322-328  Available from: URL:  http://www.wjgnet.com/2220-3206/ full/v6/i3/ 322.htm  DOI: http://dx.doi.org/10.5498/wjp.v6.i3.,Non-OADS,/arxiv_data1/oa_pdf/76/48/WJP-6-322.PMC5031932.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/76/48/WJP-6-322.PMC5031932.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript  source:  Invited  manuscript Correspondence to: Antonio Bruno, MD, PhD,  Psychiatric  Unit, Department of Biomedical, Dental Sciences and Morpho- functional Imaging, University of Messina, Via Consolare Valeria  n. 1, 98125 Messina, Italy.",Non-OADS,/arxiv_data1/oa_pdf/8e/f5/WJP-6-329.PMC5031933.pdf
"To evaluate the effect  of gender, Pearson correlations were re-computed ORIGINAL ARTICLE 329 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.329World J Psychiatr  2016 September 22; 6(3): 329-338 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Case Control Study",Non-OADS,/arxiv_data1/oa_pdf/8e/f5/WJP-6-329.PMC5031933.pdf
World J Psychiatr  2016; 6(3): 329-338  Available from:  URL:  http://www.wjgnet.com/2220-3206/full/v6/i3/ 329.htm   DOI: http://dx.doi.org/10.5498/wjp.v6.i3.,Non-OADS,/arxiv_data1/oa_pdf/8e/f5/WJP-6-329.PMC5031933.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8e/f5/WJP-6-329.PMC5031933.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Flávia L Osório, Professor ,  Medical School  of Ribeirão Preto, São Paulo University, Avenida dos Bandeirantes  3900, Ribeirão Preto 14048-900, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/WJP-6-339.PMC5031934.pdf
"The CPP was associated ORIGINAL ARTICLE 339 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.339World J Psychiatr  2016 September 22; 6(3): 339-344 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Case Control Study",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/WJP-6-339.PMC5031934.pdf
wjgnet.com/2220-3206/full/v6/i3/ 339.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/7a/WJP-6-339.PMC5031934.pdf
"Available from: URL: https://www.researchgate.net/publication/27  3143169_Calcular_e_apresentar_tamanhos_do_efeito_em_trabalhos_c ientificos_1_As_limitacoes_do_p_005_na_analise_de_diferencas_de_medias_de_dois_grupos_Calculating_and_reporting_effect_sizes_on_s cientific_papers 15 Lima MP , Longatto-Filho A, Osório FL.",OADS,/arxiv_data1/oa_pdf/cf/7a/WJP-6-339.PMC5031934.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/WJP-6-339.PMC5031934.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: David Jonathan Castle, MD, Professor   of Psychiatry, Department of Psychiatry, St Vincent’s Hospital,  Level 2, 46 Nicholson St, Fitzroy, 3065 VIC,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/96/f3/WJP-6-345.PMC5031935.pdf
"david.castle@svha.org.a u Telephone: +61-3-92314751 Fax: +61-3-92314802 Received: April 19, 2016 Peer-review started:  April 20, 2016 First decision: June 20, 2016 Revised:  July 12, 2016 Accepted:  August 11, 2016 Article in press:  August 11, 2016 Published online:  September 22, 2016ORIGINAL ARTICLE 345 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.345World J Psychiatr  2016 September 22; 6(3): 345-350 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Case Control Study",Non-OADS,/arxiv_data1/oa_pdf/96/f3/WJP-6-345.PMC5031935.pdf
World J Psychiatr  2016; 6(3): 345-350  Available from:  URL:  http://www.wjgnet.com/2220-3206/full/v6/i3/ 345.htm   DOI: http://dx.doi.org/10.5498/wjp.v6.i3.,OADS,/arxiv_data1/oa_pdf/96/f3/WJP-6-345.PMC5031935.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/96/f3/WJP-6-345.PMC5031935.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscriptCorrespondence to: Dr. Susanne Knappe, PD, Dipl, Psych,  Institute of Clinical Psychology and Psychotherapy, Technische  Universität Dresden, Chemnitzer Str.",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
"Compared to written TA, trigger ORIGINAL ARTICLE 351 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.351World J Psychiatr  2016 September 22; 6(3): 351-357 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Retrospective Study",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
World J Psychiatr   2016; 6(3): 351-357  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
com/2220-3206/full/v6/i3/ 351.htm  DOI: http://dx.doi.org/10.5498/ wjp.v6.i3.,Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
"Available from: URL: http://psych.unl.edu/ psycrs/statpage/biv_corr_comp_eg.pdf 18 PASW Statistics for Windows, V ersion 18.0.",OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2b/f5/WJP-6-351.PMC5031936.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to:  Dimitrios Adamis, Consultant Psychiatrist, Sligo/Leitrim Mental Health Services, Clarion Rd Sligo, F91 CD34  Sligo, Ireland.",Non-OADS,/arxiv_data1/oa_pdf/be/06/WJP-6-358.PMC5031937.pdf
"In the second  sample MoCA scores were converted to MMSE scores  according to a conversion rule from the first sample  which achieved agreement with the original MMSE scores ORIGINAL ARTICLE 358 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.358World J Psychiatr  2016 September 22; 6(3): 358-364 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Prospective Study",Non-OADS,/arxiv_data1/oa_pdf/be/06/WJP-6-358.PMC5031937.pdf
wjgnet.com/2220-3206/full/v6/i3/ 358.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/06/WJP-6-358.PMC5031937.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/be/06/WJP-6-358.PMC5031937.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to:  Dr. Sandeep Grover, MD, Additional  Professor, Department of Psychiatry, Postgraduate Institute of  Medical Education and Research, Cobalt Block, Nehru Hospital,  Chandigarh 160012, India.",Non-OADS,/arxiv_data1/oa_pdf/f8/16/WJP-6-365.PMC5031938.pdf
"By 6th day, 12  (37.5%) patients in haloperidol group  and 9 (29.03%) patients in the quetiapine group had ORIGINAL ARTICLE 365 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.365World J Psychiatr  2016 September 22; 6(3): 365-371 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP Randomized Controlled Trial",Non-OADS,/arxiv_data1/oa_pdf/f8/16/WJP-6-365.PMC5031938.pdf
World J Psychiatr  2016; 6(3):  365-371  Available from: URL:  http://www.wjgnet.com/2220-3206/ full/v6/i3/ 365.htm  DOI: http://dx.doi.org/10.5498/wjp.v6.i3.,OADS,/arxiv_data1/oa_pdf/f8/16/WJP-6-365.PMC5031938.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/f8/16/WJP-6-365.PMC5031938.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript   source:   Invited   manuscript Correspondence to: Dr. Maria Pontillo, PhD, Child and  Adolescence Neuropsychiatry Unit, Department of Neuroscience,  Children Hospital Bambino Gesù, Piazza Sant’Onofrio 4, 00165  Rome, Italy.",Non-OADS,/arxiv_data1/oa_pdf/b4/2c/WJP-6-372.PMC5031939.pdf
"In  terms of predictive variables, SYSTEMATIC REVIEWS 372 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.372World J Psychiatr  2016 September 22; 6(3): 372-380 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP",Non-OADS,/arxiv_data1/oa_pdf/b4/2c/WJP-6-372.PMC5031939.pdf
wjgnet.com/2220-3206/full/v6/i3/ 372.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/2c/WJP-6-372.PMC5031939.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/b4/2c/WJP-6-372.PMC5031939.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Helena García-Mieres, MD, Department  of Personality, Assessment and Psychological Treatments, Faculty  of Psychology, University of Barcelona, Passeig de Valld’Hebrón 171, 08035 Barcelona, Spain.",Non-OADS,/arxiv_data1/oa_pdf/88/b2/WJP-6-381.PMC5031940.pdf
"Furthermore, constructs related CASE REPORT 381 September 22, 2016 |Volume 6 |Issue 3| WJP|www.wjgnet.comSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5498/wjp.v6.i3.381World J Psychiatr  2016 September 22; 6(3): 381-390 ISSN 2220-3206 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.World Journal of  Psychiatry WJP",Non-OADS,/arxiv_data1/oa_pdf/88/b2/WJP-6-381.PMC5031940.pdf
wjgnet.com/2220-3206/full/v6/i3/ 381.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/88/b2/WJP-6-381.PMC5031940.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/88/b2/WJP-6-381.PMC5031940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/5b/cvw111.PMC5031949.pdf
"Stem Cell Reports Resource A Cas9 Variant for Efﬁcient Generation of Indel-Free Knockin or Gene- Corrected Human Pluripotent Stem Cells Sara E. Howden,1,2,*Bradley McColl,1Astrid Glaser,1,2Jim Vadolas,1,2Steven Petrou,3Melissa H. Little,1,2 Andrew G. Elefanty,1,2,4and Edouard G. Stanley1,2,4 1Murdoch Childrens Research Institute, The Royal Children’s Hospital, Flemington Road, Parkville, VIC 3052, Australia 2Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences 3The Florey Institute for Neuroscience and Mental Health University of Melbourne, Parkville, VIC 3052, Australia 4Department of Anatomy and Developmental Biology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC 3800, Australi a *Correspondence: sara.howden@mcri.edu.au http://dx.doi.org/10.1016/j.stemcr.2016.07.001 SUMMARY While Cas9 nucleases permit rapid and efﬁcient generation of gene-edited cell lines, the CRISPR-Cas9 system can introduce undesirable ‘‘on-target’’ mutations within the second allele of successfully modiﬁed cells via non-homologous end joining (NHEJ).",Non-OADS,/arxiv_data1/oa_pdf/6b/a7/main.PMC5031952.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6b/a7/main.PMC5031952.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Sequencing Data, three ﬁgures, and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.001 .",OADS,/arxiv_data1/oa_pdf/6b/a7/main.PMC5031952.pdf
http://dx.doi.org/10.7554/eLife.00471 .,Non-OADS,/arxiv_data1/oa_pdf/6b/a7/main.PMC5031952.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6b/a7/main.PMC5031952.pdf
"Stem Cell Reports Resource Haemopedia: An Expression Atlas of Murine Hematopoietic Cells Carolyn A. de Graaf,1,5,*Jarny Choi,1,5Tracey M. Baldwin,1Jessica E. Bolden,1,5Kirsten A. Fairfax,1,5 Aaron J. Robinson,1,5Christine Biben,1,5Clare Morgan,1,5Kerry Ramsay,1Ashley P. Ng,2,5Maria Kauppi,2,5 Elizabeth A. Kruse,1,5Tobias J. Sargeant,1,5Nick Seidenman,1Angela D’Amico,3Marthe C. D’Ombrain,1,7 Erin C. Lucas,1Sandra Koernig,7Adriana Baz Morelli,7Michael J. Wilson,7Steven K. Dower,7 Brenda Williams,8,9Shen Y. Heazlewood,8,9Yifang Hu,4Susan K. Nilsson,8,9Li Wu,3,10Gordon K. Smyth,4,6 Warren S. Alexander,2,5and Douglas J. Hilton1,5 1Molecular Medicine Division 2Cancer and Haematology Division 3Molecular Immunology Division The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia 4Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3010, Australia 5Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia 6Department of Mathematics and Statistics, University of Melbourne, Parkville, VIC 3052, Australia 7CSL Limited, Parkville, VIC 3052, Australia 8Biomedical Manufacturing, CSIRO Manufacturing, Clayton, VIC 3169, Australia 9Australian Regenerative Medicine Institute, Monash University, Clayton, VIC 3800, Australia 10Tsinghua University School of Medicine, Beijing 100084, China *Correspondence: degraaf@wehi.edu.au http://dx.doi.org/10.1016/j.stemcr.2016.07.007 SUMMARY Hematopoiesis is a multistage process involving the differentiation of stem and progenitor cells into distinct mature cell lineages.",Non-OADS,/arxiv_data1/oa_pdf/78/96/main.PMC5031953.pdf
571 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/96/main.PMC5031953.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, six ﬁgures, and eight tables and can be found withthis article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.",OADS,/arxiv_data1/oa_pdf/78/96/main.PMC5031953.pdf
R Pack-age Version 2.3-1. http://CRAN.R-Project.org/package=vegan .,Non-OADS,/arxiv_data1/oa_pdf/78/96/main.PMC5031953.pdf
"Guy Lyons,4Nick Di Girolamo,3 and James V. Jester1,* 1The Gavin Herbert Eye Institute, University of California Irvine, 843 Health Sciences Road, Irvine, CA 92697-4390, USA 2The School of Optometry & Vision Sciences, Cardiff University, Maindy Road, Cardiff CF24 4HQ, UK 3School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia 4Centenary Institute and Discipline of Dermatology, Bosch Institute, Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia *Correspondence: jjester@uci.edu http://dx.doi.org/10.1016/j.stemcr.2016.07.010 SUMMARY The meibomian and sebaceous glands secrete lipids to prevent desiccation of the ocular surface and skin, respectively.",Non-OADS,/arxiv_data1/oa_pdf/29/43/main.PMC5031954.pdf
399 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/29/43/main.PMC5031954.pdf
"Stem Cell Reports Article Enhanced Reconstitution of Human Erythropoiesis and Thrombopoiesis in an Immunodeﬁcient Mouse Model with KitWvMutations Ayano Yurino,1Katsuto Takenaka,2Takuji Yamauchi,1Takuya Nunomura,1Yasufumi Uehara,1 Fumiaki Jinnouchi,1Kohta Miyawaki,1Yoshikane Kikushige,1Koji Kato,1Toshihiro Miyamoto,1 Hiromi Iwasaki,2Yuya Kunisaki,2and Koichi Akashi1,2,* 1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan 2Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka 812-8582, Japan *Correspondence: akashi@med.kyushu-u.ac.jp http://dx.doi.org/10.1016/j.stemcr.2016.07.002 SUMMARY In human-to-mouse xenograft models, reconstitution of human hematopoiesis is usually B-lymphoid dominant.",OADS,/arxiv_data1/oa_pdf/0c/b9/main.PMC5031955.pdf
425 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0c/b9/main.PMC5031955.pdf
We used the Molec-ular Signatures Database v5.1 ( http://www.broadinstitute.,OADS,/arxiv_data1/oa_pdf/0c/b9/main.PMC5031955.pdf
"Primer sequences aredescribed in our previous report ( Yamauchi et al., 2013 ) and the JAX website ( http://jaxmice.jax.org/strain/000049.html ).",OADS,/arxiv_data1/oa_pdf/0c/b9/main.PMC5031955.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article on- line at http://dx.doi.org/10.1016/j.stemcr.2016.07.002 .,Non-OADS,/arxiv_data1/oa_pdf/0c/b9/main.PMC5031955.pdf
"Stem Cell Reports Article L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells Zhongqi Li,1Diana Oganesyan,1Rachael Mooney,1Xianfang Rong,5Matthew J. Christensen,1 David Shahmanyan,1Patrick M. Perrigue,3Joseph Benetatos,5Lusine Tsaturyan,1Soraya Aramburo,1 Alexander J. Annala,1Yang Lu,2Joseph Najbauer,4Xiwei Wu,2Michael E. Barish,1David L. Brody,5 Karen S. Aboody,1and Margarita Gutova1,* 1Department of Developmental and Stem Cell Biology, City of Hope National Medical Center and Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA 2Integrative Genomics Core, City of Hope National Medical Center and Beckman Research Institute of City of Hope, Duarte, CA 91010, USA 3Department of Epigenetics, Institute of Bioorganic Chemistry of the Polish Academy of Sciences, 61-704 Poznan, Poland 4Department of Immunology and Biotechnology, University of Pe ´cs Medical School, Pe ´cs 7624, Hungary 5Department of Neurology, Hope Center for Neurological Disorders, Washington University, St. Louis, MO 63110, USA *Correspondence: mgutova@coh.org http://dx.doi.org/10.1016/j.stemcr.2016.07.013 SUMMARY Pre-clinical studies indicate that neural stem cells (NSCs) can limit or reverse CNS damage through direct cell replacement, promotion of regeneration, or delivery of therapeutic agents.",Non-OADS,/arxiv_data1/oa_pdf/53/3b/main.PMC5031988.pdf
483 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/3b/main.PMC5031988.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, ﬁve ﬁgures, and ﬁve tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.013 .",OADS,/arxiv_data1/oa_pdf/53/3b/main.PMC5031988.pdf
"Stem Cell Reports Article Modeling Dengue Virus-Hepatic Cell Interactions Using Human Pluripotent Stem Cell-Derived Hepatocyte-like Cells Jianshe Lang,1Daniel Vera,2Yichen Cheng,1and Hengli Tang1,* 1Department of Biological Science, Florida State University, 319 Stadium Drive, Tallahassee, FL 32306-4295, USA 2Center for Genomics and Personalized Medicine, Florida State University, Tallahassee, FL 32306, USA *Correspondence: tang@bio.fsu.edu http://dx.doi.org/10.1016/j.stemcr.2016.07.012 SUMMARY The development of dengue antivirals and vaccine has been hampered by the incomplete understanding of molecular mechanisms of dengue virus (DENV) infection and pathology, partly due to the limited suitable cell culture or animal models that can capture thecomprehensive cellular changes induced by DENV.",Non-OADS,/arxiv_data1/oa_pdf/19/8d/main.PMC5031989.pdf
341 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/8d/main.PMC5031989.pdf
Bar plot of log 2(DENV2-treated/untreated) ratios of RNA-seq expression values for cytokines and chemokines targeted by NF- kB signaling ( http://www.bu.edu/nf-kb/gene-resources/ target-genes/ ).,OADS,/arxiv_data1/oa_pdf/19/8d/main.PMC5031989.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes ﬁve ﬁgures and ﬁve tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.07.012 .,Non-OADS,/arxiv_data1/oa_pdf/19/8d/main.PMC5031989.pdf
"Stem Cell Reports Article Immune Regulator MCPIP1 Modulates TET Expression during Early Neocortical Development Huihui Jiang,1,3Xiaohui Lv,1,3Xuepei Lei,1,3Ying Yang,2Xin Yang,2and Jianwei Jiao1,* 1State Key Laboratory of Stem Cells and Reproductive Biology, Institute of Zoology 2Key Laboratory of Genomics and Precision Medicine, Beijing Institute of Genomics Chinese Academy of Sciences, Beijing 100101, China 3Co-ﬁrst author *Correspondence: jwjiao@ioz.ac.cn http://dx.doi.org/10.1016/j.stemcr.2016.07.011 SUMMARY MCPIP1 is a recently identiﬁed immune regulator that plays critical roles in preventing immune disorders, and is also present in the brain.",Non-OADS,/arxiv_data1/oa_pdf/79/e8/main.PMC5031990.pdf
439 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/79/e8/main.PMC5031990.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.07.011 .",OADS,/arxiv_data1/oa_pdf/79/e8/main.PMC5031990.pdf
"E-mail: ydchung@uos.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.7.099Received 14 June 2016Keywords: Drosophila , Dual-strand piRNA cluster, piRNA, RDC  (Rhino-Deadlock-Cutoff) complex, THO/TREX Abbreviations:  Cuff, Cutoff; piRNA, Piwi-interacting RNA; RDC,  Rhino-Deadlock-Cutoff; Rhi, Rhino; TE, Transposable element;  THO, Suppressors of the transcriptional defects of hpr1D by over- expression; TREX, Transcription Export Perspective to:  Hur et al.",OADS,/arxiv_data1/oa_pdf/90/4c/BMB-49-355.PMC5032001.pdf
A novel model of THO/TREX loading onto target RNAs in metazoan gene expression Junho K. Hur and Yun Doo Chung 356 BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/90/4c/BMB-49-355.PMC5032001.pdf
"E-mail: ej70@uos.ac.kr http://dx.doi.org/10.5483/BMBRep.2016.49.7.104Received 24 June 2016Keywords: LRP6, Merlin, NF2, PAK, Wnt/ -catenin Abbreviations:  dnPAK1, dominant-negative form of PAK1; NF2,  Neurofibromatosis type II; PAK, p21 activated kinase; PIP 2, phos- phatidylinositol 4,5 bisphosphate; Wnt-CM, Wnt3a-conditionedmedia Perspective to:  Kim et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/c3/BMB-49-357.PMC5032002.pdf
"Merlin, a regulator of Hippo signaling, regulates Wnt/ -catenin signaling Soyoung Kim and Eek-hoon Jho 358 BMB Reports http://bmbreports.org Fig.",Non-OADS,/arxiv_data1/oa_pdf/f4/c3/BMB-49-357.PMC5032002.pdf
"Tel: +82-2-2228-2482; Fax: +82-2-362-  0860; E-mail: hylee192@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2016.49.7.070Received 20 April 2016Keywords: Age prediction, Body fluid identification, DNA methyl- ation, Forensic genetics, Investigative lead ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Forensic DNA methylation profiling from evidence material for  investigative leads Hwan Young Lee1,*, Soong Deok Lee2 & Kyoung-Jin Shin1 1Department of Forensic Medicine, Yonsei University College of Medicine, Seoul 03722, 2Department of Forensic Medicine, Seoul National  University College of Medicine, Seoul 03080, Korea DNA methylation is emerging as an attractive marker  providing investigative leads to solve crimes in forensic genetics.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
360 BMB Reports http://bmbreports.orgdealt with by the court.,OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
"361 http://bmbreports.org BMB Reportscommon across individuals and sometimes even tissues (11,  12).",Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
362 BMB Reports http://bmbreports.orgModels Age signaturesa Gene Tissue Analysis platform Accuracyb Bocklandt et al.,OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
363 http://bmbreports.org BMB Reportsand gradual loss in later life across the genome (46).,OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
"364 BMB Reports http://bmbreports.orginduce less extensive, tissue-specific modifications of DNA  methylation (25).",Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
"365 http://bmbreports.org BMB Reports58.5 ± 13.2, habitual alcohol drinkers: 48.1 ± 9.1).",Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
366 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
367 http://bmbreports.org BMB Reports5.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
368 BMB Reports http://bmbreports.orgbisulfite modification and pyrosequencing.,OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
369 http://bmbreports.org BMB ReportsAlcohol abuse and cigarette smoking are associated with  global DNA hypermethylation: Results from the german investigation on neurobiology in alcoholism (GINA).,Non-OADS,/arxiv_data1/oa_pdf/b2/96/BMB-49-359.PMC5032003.pdf
"Tel: +82-43-840-3903; Fax: +82-43-852-  3616; E-mail: bahk12@empal.com http://dx.doi.org/10.5483/BMBRep.2016.49.7.256Received 3 December 2015, Revised 4 January 2016, Accepted 25  January 2016 Keywords: Effector mutants, Mitogen-activated protein kinase, Mito- gen-activated protein kinase phosphatase 3, Oncogenic Ras, Onco-genic Ras inducible NIH/3T3 cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Induction of MAP kinase phosphatase 3 through Erk/MAP  kinase activation in three oncogenic Ras (H-, K- and N-Ras)-expressing NIH/3T3 mouse embryonic fibroblast cell lines JaeHyung Koo1, Sen Wang2, NaNa Kang1, Sun Jin Hur3 & Young Yil Bahk4,* 1Department of Brain & Cognitive Sciences, DGIST, Daegu 42988, Korea, 2Qiqihar Medical University, Qiqihar City, Heilongjiang Province,  161006, China, 3Department of Animal Science and Technology, Chung-Ang University, Anseong 17546, Korea, 4Department of  Biotechnology, Konkuk University, Chungju 27478, Korea Ras oncoproteins are small molecular weight GTPases known  for their involvement in oncogenesis, which operate in a com-plex signaling network with multiple effectors.",Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
371 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
372 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
373 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
374 BMB Reports http://bmbreports.orgMKP3.,Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
"375 http://bmbreports.org BMB ReportsBiophys Acta 1773, 1177-1195 4.",Non-OADS,/arxiv_data1/oa_pdf/22/04/BMB-49-370.PMC5032004.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.7.246Received 26 November 2015, Revised 14 December 2015,  Accepted 3 February 2016 Keywords: Alzheimer’s disease, APP , JNK, Okadaic acid, PP2A ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.c-Jun N-terminal Kinase (JNK) induces phosphorylation of  amyloid precursor protein (APP) at Thr668, in okadaic acid-induced neurodegeneration Ji-Hwan Ahn1,2,3,4,#, Sang-Pil So1,2,3,4,#, Na-Young Kim1,2,3,4,#, Hyun-Ju Kim1,2,3,4, Seung-Yong Yoon1,2,3,4,*  & Dong-Hou Kim1,2,3,4,* 1Alzheimer’s Disease Experts Lab (ADEL), Asan Medical Center, University of Ulsan College of Medicine, 2Department of Brain Science,  3Bio-Medical Institute of Technology (BMIT), 4Cell Dysfunction Research Center (CDRC), University of Ulsan College of Medicine, Seoul  05505, Korea Several lines of evidence have revealed that phosphorylation  of amyloid precursor protein (APP) at Thr668 is involved in the pathogenesis of Alzheimer’s disease (AD).",Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
377 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
378 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
"379 http://bmbreports.org BMB ReportsAPP) localizes to the late protein secretory pathway, in which  mature APP is cleaved by secretases (23).",Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
380 BMB Reports http://bmbreports.orgwell.,Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
381 http://bmbreports.org BMB Reportsdisease pathology.,Non-OADS,/arxiv_data1/oa_pdf/1c/13/BMB-49-376.PMC5032005.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.7.048Received 8 March 2016, Revised 28 March 2016, Accepted 4 April  2016 Keywords: Apoptotic signals, Ischemia, Oxidative stress, PEP-1-  GSTpi, Protein therapy ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.PEP-1-GSTpi protein enhanced hippocampal neuronal cell  survival after oxidative damage Eun Jeong Sohn1,#, Min Jea Shin1,#, Dae Won Kim2,#, Ora Son1, Hyo Sang Jo1, Su Bin Cho1, Jung Hwan Park1,  Chi Hern Lee1, Eun Ji Yeo1, Yeon Joo Choi1, Yeon Hee Yu3, Duk-Soo Kim3, Sung-Woo Cho4, Oh Shin Kwon5,  Yong-Jun Cho6, Jinseu Park1, Won Sik Eum1,* & Soo Young Choi1,* 1Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chunchon 24252,  2Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangnung-Wonju Nat ional  University, Gangneung 25457, 3Department of Anatomy, College of Medicine, Soonchunhyang University, Cheonan 31538, 4Department of  Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 05505, 5School of Life Sciences, College of Natural  Sciences, Kyungpook National University, Daegu 41566, 6Department of Neurosurgery, Hallym University Medical Center, Chuncheon  24253, Korea Reactive oxygen species generated under oxidative stress are  involved in neuronal diseases, including ischemia.",Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
383 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
384 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
385 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
386 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
387 http://bmbreports.org BMB ReportsMitochondrial respiratory chain and free radical  generation in stroke.,Non-OADS,/arxiv_data1/oa_pdf/eb/8c/BMB-49-382.PMC5032006.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.7.062Received 22 March 2016, Revised 30 March 2016,  Accepted 2 May 2016 Keywords: Brown adipocytes, Demethylase, Methyltransferase, Obesity, SUV420H2 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Methyltransferase and demethyl ase profiling studies during  brown adipocyte differentiation Min Jeong Son1,#, Won Kon Kim1,2,#, Kyoung-Jin Oh1, Anna Park1, Da Som Lee1, Baek Soo Han1,2, Sang Chul Lee1,2,*  & Kwang-Hee Bae1,2,* 1Metabolic Regulation Research Center, KRIBB, 2Department of Functional Genomics, University of Science and Technology (UST),  Daejeon 34141, Korea Although brown adipose tissue is important with regard to  energy balance, the molecular mechanism of brown adipocyte differentiation has not been extensively studied.",Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
389 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
390 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
391 http://bmbreports.org BMB Reportsbrown adipocyte differentiation.,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
"392 BMB Reports http://bmbreports.orgQuantification of KMTs and KDMs during brown adipocyte  differentiation Total RNA was prepared by extraction from cultured cells  using the QIAzol lysis reagent (Qiagen, Hilden, Germany),  according to the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
393 http://bmbreports.org BMB Reports154-165 18.,Non-OADS,/arxiv_data1/oa_pdf/4e/a5/BMB-49-388.PMC5032007.pdf
"http://dx.doi.org/10.5483/BMBRep.2016.49.7.011Received 18 January 2016, Revised 16 February 2016,  Accepted 26 April 2016 Keywords: Invasion, Migration, U251, U87 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2016 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Glioma-Associated Oncogene Homolog1 (Gli1)-Aquaporin1  pathway promotes glioma cell metastasis  Zheng-qiang Liao1,#, Ming Ye2,#, Pei-gen Yu1, Chun Xiao1 & Feng-yun Lin3,* 1Department of Neurosurgery, The Nine People’s Hospital of Chongqing, Chongqing, 2Department of Neurosurgery, The First Affiliated  Hospital of Suzhou University, Suzhou, 3Department of Pharmaceutics, Chongqing Medical and Pharmaceutical College, Chongqing, China Glioma-Associated Oncogene Homolog1 (Gli1) is known to  be activated in malignant glioma; however, its downstream pathway has not been fully explained.",Non-OADS,/arxiv_data1/oa_pdf/21/e4/BMB-49-394.PMC5032008.pdf
395 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/BMB-49-394.PMC5032008.pdf
396 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/e4/BMB-49-394.PMC5032008.pdf
"397 http://bmbreports.org BMB ReportsGli1, a full-length transcriptional activator, belongs to the  Gli family of Zinc-finger transcription factors and has been shown to be involved in the intracellular signal transduction  controlled by the Hedgehog signaling pathway.",Non-OADS,/arxiv_data1/oa_pdf/21/e4/BMB-49-394.PMC5032008.pdf
399 http://bmbreports.org BMB ReportsStatistical analysis  All data are expressed as mean ± standard deviation (SD).,OADS,/arxiv_data1/oa_pdf/21/e4/BMB-49-394.PMC5032008.pdf
"Stem Cell Reports Resource Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications Dana M. Cairns,1Karolina Chwalek,1Yvonne E. Moore,2Matt R. Kelley,2Rosalyn D. Abbott,1Stephen Moss,2 and David L. Kaplan1,* 1Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA 2Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, USA *Correspondence: david.kaplan@tufts.edu http://dx.doi.org/10.1016/j.stemcr.2016.07.017 SUMMARY Limited availability of human neurons poses a signiﬁcant barrier to progress in biological and preclinical studies of the human nervous system.",OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC5032182.pdf
557 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC5032182.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, two tables, and one movie and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",Non-OADS,/arxiv_data1/oa_pdf/a9/37/main.PMC5032182.pdf
"Stem Cell Reports Article Autonomous and Non-autonomous Defects Underlie Hypertrophic Cardiomyopathy in BRAF-Mutant hiPSC-Derived Cardiomyocytes Rebecca Josowitz,1Sonia Mulero-Navarro,1Nelson A. Rodriguez,1Christine Falce,2Ninette Cohen,3 Erik M. Ullian,5,6Lauren A. Weiss,7Katherine A. Rauen,8Eric A. Sobie,2and Bruce D. Gelb1,3,4,* 1The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 2Department of Pharmacology and Systems Therapeutics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 3Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 4Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA 5Department of Ophthalmology, University of California, San Francisco, San Francisco, CA 94143, USA 6Department of Physiology, University of California, San Francisco, San Francisco, CA 94143, USA 7Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94143, USA 8Department of Pediatrics, University of California, Davis, Davis, CA 95616, USA *Correspondence: bruce.gelb@mssm.edu http://dx.doi.org/10.1016/j.stemcr.2016.07.018 SUMMARY Germline mutations in BRAF cause cardio-facio-cutaneous syndrome (CFCS), whereby 40% of patients develop hypertrophic cardio- myopathy (HCM).",Non-OADS,/arxiv_data1/oa_pdf/5a/55/main.PMC5032183.pdf
355 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/55/main.PMC5032183.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/5a/55/main.PMC5032183.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.07.021 SUMMARY Loss-of-function studies in human pluripotent stem cells (hPSCs) require efﬁcient methodologies for lesion of genes of interest.,Non-OADS,/arxiv_data1/oa_pdf/8a/ba/main.PMC5032288.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8a/ba/main.PMC5032288.pdf
We thereforeanalyzed the integrity of the potential off-target sites pre- dicted by the online program designed by Zhang’s labora-tory ( http://crispr.mit.edu/ ) through Sanger sequencing.,OADS,/arxiv_data1/oa_pdf/8a/ba/main.PMC5032288.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/8a/ba/main.PMC5032288.pdf
http://dx.doi.org/10.1093/cercor/ bhw152 .,Non-OADS,/arxiv_data1/oa_pdf/8a/ba/main.PMC5032288.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.07.020 SUMMARY A cardiomyocyte differentiation in vitro system from zebraﬁsh embryos remains to be established.,Non-OADS,/arxiv_data1/oa_pdf/fc/e6/main.PMC5032289.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/e6/main.PMC5032289.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, one table, and one movie and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.07.020 .",Non-OADS,/arxiv_data1/oa_pdf/fc/e6/main.PMC5032289.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.07.019 SUMMARY Controlled differentiation of human embryonic stem cells (hESCs) can be utilized for precise analysis of cell type identities during early development.,OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"7 j527–542 jSeptember 13, 2016 j527 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"The number of non-redundant phosphorylation sites is presented in Table S1, whereas Tables S2–S16 are available at http://dx.doi.org/ 10.17632/v7nt3wm8rk.1 .",OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"Bio- logical data annotation is available at a searchable website,http://pluriprot.org .Figure S5 A illustrates how to access in- formation on (phospho)proteins from our dataset.",OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"Supplemental Material Table S1 is included in the Supplemental Information , and Tables S2–S16 can be downloaded at http://dx.doi.org/10.17632/ v7nt3wm8rk.1 .",Non-OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
Interactive analysis of the proteomic dataset can be performed by searching for speciﬁc proteins of interest (enter protein name on Homepage) and accessing Network diagrams(Networks): http://pluriprot.org .,OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
Source Data Tables S2–S16 :http://dx.doi.org/10.17632/v7nt3wm8rk.1 .,OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"ACCESSION NUMBERS The (phospho)proteome data can be accessed on the websites speciﬁed above, and all raw data are deposited in the Peptide Atlas(accession number PASS00233; https://db.systemsbiology.net/ sbeams/cgi/PeptideAtlas/PASS_View?identiﬁer=PASS00233 ; Insti- tute for Systems Biology).",OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, seven ﬁgures, and 16 tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.",OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
4.http://dx.doi.org/10.1101/cshper- spect.a008177 .,Non-OADS,/arxiv_data1/oa_pdf/1a/d3/main.PMC5032292.pdf
"Stem Cell Reports Article Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma Mahua Dey,1Dou Yu,1,4Deepak Kanojia,1,4Gina Li,1Madina Sukhanova,2Drew A. Spencer,1,4 Katatzyna C. Pituch,1,4Lingjiao Zhang,1Yu Han,1,4Atique U. Ahmed,1,4Karen S. Aboody,3 Maciej S. Lesniak,1,4and Irina V. Balyasnikova1,4,* 1The Brain Tumor Center 2Department of Medicine The University of Chicago, Chicago, IL 60637, USA 3Division of Neurosurgery, Department of Neurosciences, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA 4Department of Neurological Surgery, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA *Correspondence: irinabal@northwestern.edu http://dx.doi.org/10.1016/j.stemcr.2016.07.024 SUMMARY The challenges to effective drug delivery to brain tumors are twofold: (1) there is a lack of non-invasive methods of local delivery and (2) the blood-brain barrier limits systemic delivery.",Non-OADS,/arxiv_data1/oa_pdf/a5/04/main.PMC5032402.pdf
471 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/04/main.PMC5032402.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and two tables and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/a5/04/main.PMC5032402.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.07.022 SUMMARY Conventional rabbit embryonic stem cell (ESC) lines are derived from the inner cell mass (ICM) of pre-implantation embryos using methods and culture conditions that are established for primate ESCs.,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/main.PMC5032405.pdf
383 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/7c/main.PMC5032405.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven ﬁgures, and one table and can be foundwith this article online at http://dx.doi.org/10.1016/j.stemcr.",OADS,/arxiv_data1/oa_pdf/0d/7c/main.PMC5032405.pdf
"Kirby Neurobiology Center, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USA 3Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA 4Departments of Neurology and Pathology, Gladstone Institute of Neurological Disease, University of California, San Francisco, CA 94158, USA 5Neural Stem Cell Institute, Regenerative Research Foundation, Rensselaer, NY 12144, USA 6Departments of Neurology and Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90024, USA 7Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA 94158, USA 8Department of Molecular, Cellular and Developmental Biology, Neuroscience Research Institute, University of California, Santa Barbara, CA 93106, USA *Correspondence: shaggarty@mgh.harvard.edu http://dx.doi.org/10.1016/j.stemcr.2016.08.001 SUMMARY Frontotemporal dementia (FTD) and other tauopathies characterized by focal brain neurodegeneration and pathological accumulation of proteins are commonly associated with tau mutations.",Non-OADS,/arxiv_data1/oa_pdf/f2/78/main.PMC5032560.pdf
325 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/78/main.PMC5032560.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, six ﬁgures, and one table and can be found with thisarticle online at http://dx.doi.org/10.1016/j.stemcr.2016.08.001 .AUTHOR CONTRIBUTIONS Conceptualization, M.C.S., C.C., W.M., B.L.M., K.S.K., J.A.S., andS.J.H.",OADS,/arxiv_data1/oa_pdf/f2/78/main.PMC5032560.pdf
Stem Cell Rep. 7. http://dx.doi.org/10.1016/j.stemcr.2016.08.006 .,OADS,/arxiv_data1/oa_pdf/f2/78/main.PMC5032560.pdf
"Stem Cell Reports Report MMP-9 and MMP-2 Contribute to Neuronal Cell Death in iPSC Models of Frontotemporal Dementia with MAPT Mutations Md Helal U. Biswas,1Sandra Almeida,1Rodrigo Lopez-Gonzalez,1Wenjie Mao,2Zhijun Zhang,1,5 Anna Karydas,3Michael D. Geschwind,3Jacek Biernat,4Eva-Maria Mandelkow,4Kensuke Futai,2 Bruce L. Miller,3and Fen-Biao Gao1,* 1Department of Neurology 2Department of Psychiatry, Brudnick Neuropsychiatric Research Institute University of Massachusetts Medical School, Worcester, MA 01605, USA 3Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA 94143, USA 4German Center for Neurodegenerative Diseases, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany 5Present address: Neuroscience and Neuroengineering Research Center, Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao T ong University, Shanghai 200030, China*Correspondence: fen-biao.gao@umassmed.edu http://dx.doi.org/10.1016/j.stemcr.2016.08.006 SUMMARY How mutations in the microtubule-associated protein tau ( MAPT ) gene cause frontotemporal dementia (FTD) remains poorly under- stood.",Non-OADS,/arxiv_data1/oa_pdf/4d/c3/main.PMC5032669.pdf
"More than 40 pathogenic MAPT mutations have been described in more than 100 families with FTD ( Cruts et al., 2012 ; Alz- heimer Disease & Frontotemporal Dementia MutationDatabase, http://www.molgen.vib-ua.be/FTDMutations ).",Non-OADS,/arxiv_data1/oa_pdf/4d/c3/main.PMC5032669.pdf
This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/c3/main.PMC5032669.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2016.08.006 .,Non-OADS,/arxiv_data1/oa_pdf/4d/c3/main.PMC5032669.pdf
http://dx.doi.org/10.1016/j.stemcr.2016.08.002 SUMMARY The dermal Panniculus carnosus (PC) muscle is important for wound contraction in lower mammals and represents an interesting model of muscle regeneration due to its high cell turnover.,Non-OADS,/arxiv_data1/oa_pdf/58/95/main.PMC5032673.pdf
411 This is an open access article under the CC BY -NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/95/main.PMC5032673.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Results, Supple- mental Experimental Procedures, seven ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2016.08.002 .",Non-OADS,/arxiv_data1/oa_pdf/58/95/main.PMC5032673.pdf
Coe F. Available at: http://kidneystones.uchicago.edu/ci- trate-to-prevent-stones.,Non-OADS,/arxiv_data1/oa_pdf/ae/08/JVIM-30-1564.PMC5032870.pdf
"Tissues from 20 addi- tional horses (8 controls, 6 horses with heaves in exacerbation and6 in remission) were obtained from the Equine Respiratory Tissue Bank (http://www.btre.ca).",Non-OADS,/arxiv_data1/oa_pdf/e3/ec/JVIM-30-1739.PMC5032871.pdf
Equine Vet J 2015;47:494 – 501.23. http://www.safergrass.org/pdf/AAEP.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/ae/07/JVIM-30-1726.PMC5032872.pdf
Accessed from http://www.R-project.org Acknowledgment Supported by Aratana Therapeutics.,Non-OADS,/arxiv_data1/oa_pdf/d3/94/JVIM-30-1661.PMC5032880.pdf
Footnotes awww.rasdata.nu/tollare/ bhttp://www.k9data.com/default.asp?breed=3 Acknowledgments The authors thank Drs.,Non-OADS,/arxiv_data1/oa_pdf/8c/85/JVIM-30-1681.PMC5032881.pdf
The projected CO 2concentrations under the A2 and B1 scenarios were derived from the IPCC Data Distribution Center (http://www.ipcc-data.org/observ/ddc_co2.html).,OADS,/arxiv_data1/oa_pdf/d5/70/JGRG-120-724.PMC5032896.pdf
"We also thank Terry Sohl for providing the future land use scenarios, which are available in http://landcover-modeling.cr.",Non-OADS,/arxiv_data1/oa_pdf/d5/70/JGRG-120-724.PMC5032896.pdf
"GRACE, ERA Interim, MERRA, and NCEP/DOE data are avail-able from GRACE Tellus site (http://grace.jpl.nasa.gov), ECMWF data server (http://data-portal.ecmwf.int), Goddard Earth Sciences Data and InformationServices Center (http://disc.sci.gsfc.nasa.gov), and Earth System Research Laboratory (http://www.esrl.noaa.gov), respectively.",OADS,/arxiv_data1/oa_pdf/0a/30/JGRB-120-3617.PMC5032899.pdf
RACMO2.3 data are avail-able upon request in Institute for Marineand Atmospheric Research Utrecht (http://www.projects.science.uu.nl/ice- climate/models/antarctica.php).Journal of Geophysical Research: Solid Earth 10.1002/2014JB011755 SEO ET AL.,OADS,/arxiv_data1/oa_pdf/0a/30/JGRB-120-3617.PMC5032899.pdf
[Available at http://icesat4.gsfc.nasa.gov/cryo_data/ant_grn_drainage_systems.php.,Non-OADS,/arxiv_data1/oa_pdf/0a/30/JGRB-120-3617.PMC5032899.pdf
Intial inoculation and boosts were done according to the Cocalico’s standard protocol (availablein the public domain; http://www.cocalicobiologicals.com/ antibodies.html).,OADS,/arxiv_data1/oa_pdf/e9/38/i1552-5783-57-11-4886.PMC5032914.pdf
Direct contact between pericytes (NG2) and endothelial cells (Isolectin B 4) were quantiﬁed by colocalization analysis with BioImageXD (provided in the public domain at http://www.bioimagexd.org).,OADS,/arxiv_data1/oa_pdf/a2/cb/i1552-5783-57-11-4898.PMC5032915.pdf
"Quantiﬁcationwas done using IHC Proﬁler plugin in ImageJ software(http://imagej.nih.gov/ij/; provided in the public domain by National Institutes of Health, Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/a2/cb/i1552-5783-57-11-4898.PMC5032915.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/76/99/10.1177_2325967116665080.PMC5032918.pdf
Available from URL http://www.pewhispanic.org/2008/02/11/us-population-projections-2005–2050/.,Non-OADS,/arxiv_data1/oa_pdf/a8/ed/APL-19-262.PMC5032971.pdf
"Data assembly The dosing, covariate and pharmacokinetic-pharmacody- namic data were merged and formatted for the popula-tion analysis using R, Version 2.10.1 or higher (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/79/d3/APT-42-188.PMC5032981.pdf
Available from URL: http://www.who.int/reproductive-health/publi cations/mec.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d0/03/AJO-55-279.PMC5032983.pdf
"Adapted from http://commons.wikimedia.org/wiki/File:Nanomia_bijuga_whole_anima- l_and_growth_zones.svg, which was drawn by Freya Goetz.",OADS,/arxiv_data1/oa_pdf/f4/53/JEZ-324-435.PMC5032985.pdf
Available at: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Pro-gram.html.,Non-OADS,/arxiv_data1/oa_pdf/54/58/JHM-10-563.PMC5032986.pdf
Available at: http://www.cdc.gov/nchs/icd/icd9.htm.,Non-OADS,/arxiv_data1/oa_pdf/54/58/JHM-10-563.PMC5032986.pdf
Available at:http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp.,OADS,/arxiv_data1/oa_pdf/54/58/JHM-10-563.PMC5032986.pdf
"According to CAZY classification (Carbohydrate Ac- tive enZYmes, http://www.cazy.org/) [3], catalytic cores of α-l-arabinofuranosidases belong to GH3, 43, 51, 54, and 62 families.",Non-OADS,/arxiv_data1/oa_pdf/62/6c/BAB-62-727.PMC5032992.pdf
https://www.anses.fr/AVIS de l ’Anses relatif à une demande d'autorisation de mise sur le march /C19e d'un nouvel aliment ou d'un ingr /C19edient alimentaire: pr /C19eparation enzymatique contenant une activit /C19e protéase pour une utilisation dans les complémentsalimentaires.,Non-OADS,/arxiv_data1/oa_pdf/1e/fb/APT-42-273.PMC5032996.pdf
"However, such accumulation and clustering of Sema4D-expressingcells were not observed in OA synovium (Figure 1C).CD3 and CD20 were colocalized in Sema4D-stainedfollicle-like germinal centers, indicating that the Sema4D-expressing cells were synovial infiltrating lymphocytes(see Supplementary Figure 1, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39086/abstract).",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"ADAMTS-4 significantly induced the release of sSema4D into the culture supernatant (Figure 3C) (see Supplementary Figure 2, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"CD72 is a receptor for Sema4D, and a CD72 ligationantibody also induced TNF aand IL-6 production in CD141monocytes, in which Sema4D induced dephos- phorylation of CD72 (see Supplementary Figures 4 and5, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.co m/doi/10.1002/art.39086/abstract).",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"Mice treated with anti-Sema4D antibody exhibited poor induction of angiogenesis at sites of inflammation (see Supplemen-tary Figures 7A and B, available on the Arthritis & Rheu- matology web site at http://onlinelibrary.wiley.com/doi/ 10.1002/art.39086/abstract).",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"Additionally, the serum level of anticollagen antibody was reduced in these animals (see Supplementary Figure 8, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"We also showed thatsSema4D induced dephosphorylation of CD72 (see Supple- mentary Figure 5, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/art.39086/abstract).",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"This Sema4D loop may have a central role in RA inflammation and the asso- ciated joint destruction (see Supplementary Figure 9,available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39086/abstract).",Non-OADS,/arxiv_data1/oa_pdf/96/24/ART-67-1481.PMC5032998.pdf
"PhD Dissertation [Online] , Université Paris Sud –Paris XI, November, 2013. https://tel.archives-ouvertes.fr/tel-00906791 (accessed Feb 9, 2015) [48] M. Guilhaus.",Non-OADS,/arxiv_data1/oa_pdf/3f/06/RCM-29-1187.PMC5033000.pdf
"Estimated cancer Incidence, Mortality and Prevalence in 2012 worldwide, web site: http://globocan.iarc.fr/Default.aspx Klug SJ, Hukelmann M, Hollwitz B, D €uzenli N, Schopp B, Petry KU, Iftner T. 2007.",Non-OADS,/arxiv_data1/oa_pdf/78/87/JMV-87-1960.PMC5033003.pdf
"Available from URL: https://hwa.gov.au/sites/ uploads/HWA-Annual-Report-2011-2012_0.pdf 2 Battye KM, McTaggart K. Development of a model for sustainable delivery of outreach allied health services to remote north-west Queensland, Australia.",Non-OADS,/arxiv_data1/oa_pdf/2b/2c/AJR-24-29.PMC5033004.pdf
[Cited 2 September 2014] Available from URL: http://www.wacountry.health.wa .gov.au/ﬁleadmin/sections/allied_health/WACHS_R_AH _ProSupport_ClinSupervision.pdf 12 NSW Institute of Rural Clinical Services and Teaching.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/AJR-24-29.PMC5033004.pdf
Available from URL: http://www.ruralheti.health .nsw.gov.au/__documents/initiatives/rural-allied-health -project/rural_nsw_allied_health_clinical_supervision _paper_ﬁnal.pdf 13 The Allied & Scientiﬁc Health Ofﬁce.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/AJR-24-29.PMC5033004.pdf
"Available from URL: http://nrha.org.au/12nrhc/wp-content/uploads/2013/ 06/Ducat-Wendy_ppr.pdf 16 Dawson M, Phillips B, Leggat SG.",Non-OADS,/arxiv_data1/oa_pdf/2b/2c/AJR-24-29.PMC5033004.pdf
"Available from URL: http://www.qsrinternational.com/ 23 Hyrkäs K. Clinical supervision, burnout and job satisfac- tion among mental health psychiatric nurses in Finland.",Non-OADS,/arxiv_data1/oa_pdf/2b/2c/AJR-24-29.PMC5033004.pdf
Genotyping of the SNPs was made by the LGC Genomics in the UK (http://www.lgcgenomics.com) usingthe KASPar chemistry—a competitive allele-speciﬁc poly- merase chain reaction (PCR) SNP genotyping system per- formed with ﬂuorescence resonance energy transfer (FRET) quencher cassette oligos.,OADS,/arxiv_data1/oa_pdf/5a/53/ADB-21-481.PMC5033010.pdf
http://www.ema.eu- ropa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003102.pdf (accessed 27 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/JAT-36-238.PMC5033012.pdf
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/JAT-36-238.PMC5033012.pdf
Official Journal of the European Com-munities L 77. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/JAT-36-238.PMC5033012.pdf
Council Directive of 24 November 1986. http://ec.europa.eu/food/fs/aw/aw_legislation/scien-tific/86-609-eec_en.pdf (accessed 27 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/JAT-36-238.PMC5033012.pdf
http://www.who.int/biologicals/publications/nonclinical_evaluation_vaccines_nov_2003.pdf (accessed 27 February2014).,Non-OADS,/arxiv_data1/oa_pdf/6f/d2/JAT-36-238.PMC5033012.pdf
http://www.mayo.edu/re- search/documents/gmatchsas/doc-10027248 Accessed 17/03/2012.,Non-OADS,/arxiv_data1/oa_pdf/c2/75/PDS-24-738.PMC5033013.pdf
"Accessed June 9, 2014.Available at: http://www.accessdata.fda.gov/drug- satfda_ docs/label/2010/022575lbl.pdf.",OADS,/arxiv_data1/oa_pdf/da/1e/AJH-90-577.PMC5033020.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at: http://guidance.nice.org.uk/TA151/ Guidance/pdf/English.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at:http://www.ispad.org/resource-type/ idﬁspad-2011-global-guideline-diabetes- childhood-and-adolescence.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
"Available at: http://www.nice.org.uk/guidance/ index.jsp?action=download&o=41320.Accessed May 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/ medicines/000258/human_med_000935.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at: http://www.ema.europa.eu/ema/index.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
Available at: http://www.medtronic- diabetes.co.uk/product-information/ infusion-sets/safety- ﬁrst.html.,Non-OADS,/arxiv_data1/oa_pdf/8b/c2/DMRR-32-21.PMC5033023.pdf
"URL: http://ambermd.org [7] B. R. Brooks, C. L. Brooks, III, A. D. Mackerell, L. Nilsson, R. J. Petrella, B. Roux, Y.",OADS,/arxiv_data1/oa_pdf/54/e7/JCC-36-1259.PMC5033024.pdf
"URL: http://www.charmm.org [8] W. Smith, T. R. Forester, J. Mol.",OADS,/arxiv_data1/oa_pdf/54/e7/JCC-36-1259.PMC5033024.pdf
1–23 URL: http://espressomd.org/.,Non-OADS,/arxiv_data1/oa_pdf/54/e7/JCC-36-1259.PMC5033024.pdf
"URL: http://www.gromos.net [12] S. J. Plimpton, J. Comput.",OADS,/arxiv_data1/oa_pdf/54/e7/JCC-36-1259.PMC5033024.pdf
"URL: http://lammps.san- dia.gov/ [13] R. Friedberg, J. E. Cameron, J. Chem.",OADS,/arxiv_data1/oa_pdf/54/e7/JCC-36-1259.PMC5033024.pdf
"Available at: http://www.geobaby.com/articles/11-baby (accessed on August 10, 2010).",Non-OADS,/arxiv_data1/oa_pdf/9a/2e/APA-105-24.PMC5033030.pdf
"Coordinates for these regionsare given in Table I. MarsBaR (http://marsbar.sourceforge.net) was used to create spherical ROIs, centered around the meta-analysis coordinates, with a 10 mm diameter.",OADS,/arxiv_data1/oa_pdf/a5/58/HBM-36-3703.PMC5033031.pdf
"Medtronic Vascular Inc., 2014, http://www.medtronic.com/wcm/groups/mdtcom_sg/@mdt/@endov/documents/documents/talent-aaa-clinical-update.pdf  4.",Non-OADS,/arxiv_data1/oa_pdf/ac/eb/10.1177_2050313X16670304.PMC5033069.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Substance Abuse and Rehabilitation 2016:7 131–141Substance Abuse and Rehabilitation Dovepress submit your manuscript | www.dovepress.com Dovepress 131 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S108302 Factors associated with opioid overdose: a   10-year retrospective study of patients in a large  integrated health care system Joseph A Boscarino1  H Lester Kirchner2  James M Pitcavage1  Vijay R Nadipelli3  Naoko A Ronquest3  Michael H Fitzpatrick4  John J Han5 1Center for Health Research,   2Biomedical and Translational  Informatics, Geisinger Clinic, Danville,   PA, 3Indivior Inc., Richmond,  VA,   4Emergency Medicine Service Line,   Central Division, Geisinger Clinic,  Danville,  5Geisinger Interventional  Pain Center, Danville, PA, USAObjective: Opioid overdoses (ODs) have been increasing, and harm reduction efforts are a  priority.",Non-OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
"Keywords: opioids, overdose antidote, naloxone, health care access, health care costs, services  utilization, prescription drugs Introduction The prevalence of prescription opioid misuse has increased over the past decade.1–5  Opioid overdose (OD) and mortality due to OD have also increased during this  period.1–6 One initiative is to expand access to naloxone for use in both licit and illicit  narcotic overdose cases.7,8 Naloxone, an antidote for opioids, has a history of safe  and effective use by health care systems and providers in the treatment of OD and by Correspondence: Joseph A Boscarino Center for Health Research, Geisinger Clinic, 100 North Academy Avenue, MC 44-00, Danville, PA 17822, USA Tel +1 570 214 9622   Email jaboscarino@geisinger.eduJournal name: Substance Abuse and Rehabilitation Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Boscarino et alRunning head recto: Opioid overdoses in an integrated health care systemDOI: http://dx.doi.org/10.2147/SAR.S108302",Non-OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
"Substance Abuse and Rehabilitation 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/substance-abuse-and-rehabilitation-journalSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials, reviews and commentaries on all areas of addiction and substance abuse and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 141 Opioid overdoses in an integrated health care system  13.,Non-OADS,/arxiv_data1/oa_pdf/c0/90/sar-7-131.PMC5033108.pdf
Agr Ecosyst Environ 2007; 118:1–5; http://dx.doi.org/ 10.1016/j.agee.2006.05.014 Benbrook C. A review and assessment of impact of genet- ically engineered crops on pesticide use in the US – the ﬁrst sixteen years.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Environ Sci Eur 2012; 24:24;http://dx.doi.org/10.1186/2190-4715-24-24 Bernacchi, et al.",OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Soil Sci Soc Am J 2008; 72:693–701; http://dx.doi.org/10.2136/sssaj2007.0233 Brimner T, Gallivan G, Stephenson G. Inﬂuence of herbi- cide-resistant canola on the environmental impact ofweed management.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Pest Manag Sci 2005; 61(1):47– 52; PMID:15593073; http://dx.doi.org/10.1002/ps.967 Brookes G. The beneﬁts of adopting GM insect resistant (Bt) maize in the EU: First results from 1998–2006.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Available on the World Wide Web: http://www.pgeconomics.co.uk/pdf/bt_maize_in_spain.pdf Brookes G. The farm-level impact of herbicide-tolerant soybeans in Romania.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996–2004.AgbioForum 2006; 8(2&3):187–96; Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996–2005.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Agbioforum 2007; 9 (3):1–13; Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996–2006.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Agbioforum 2008; 11(1):21–38; Available on theWorld Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996–2008.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"AgBioforum 2010;13(1):76–94; Available on the World Wide Web:http://www.agbioforum.orgBrookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996–2009.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"GM Crops 2012; 3:1–9; http://dx.doi.org/10.4161/gmcr.19925 Brookes G, Barfoot P. Key environmental impacts of global GM crop use 1996–2011.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"GM Crops 2013; 4:1–11; http://dx.doi.org/10.4161/gmcr.22748 Brookes G, Barfoot P. Key environmental impacts of GM crops 1996–2012.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"GM Crops 2014; 5:149–60; http://dx.doi.org/10.4161/gmcr.28449 Brookes G, Barfoot P. Environmental impacts of GM crop use 1996–2013: impacts on pesticide use and carbonemissions.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Agron J 2000; 100; 1013–9; http://dx.doi.org/10.2134/agronj2007.0121 Commonwealth Scientiﬁc and Industrial Research Orga- nisation (CSIRO).,OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Available on the World Wide Web: http://www.ctic.purdue.edu/CTIC/Biotech.html Derpsch R, Friedrich T, Kassam A, Hongwen L. Current status of adoption on no-till farming in the world andsome of its main beneﬁts.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"67:1831– 41; http://dx.doi.org/10.2136/sssaj2003.1831 Fernandez-Cornejo J, Wechsler S, Livingston M, Mitchell L. Genetically engineered crops in the United States.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Science 2010; 330:222–5; PMID:20929774; http://dx.doi.org/10.1126/sci- ence.1190242; www.sciencemag.org IMRB International.,OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Available on the World WideWeb: http://www.ipccnggip.iges.or.jp/public/2006gl/ pdf/4_Volume4/V4_02_Ch2_Generic.pdf Ismael Y, Bennett R, Morse S, Buthelezi T. Bt Cotton and pesticides.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Soil Till Res 2005; 83:73–94; http://dx.doi.org /10.1016/j.still.2005.02.010Johnson S, Strom S. Quantiﬁcation of the impacts on US agriculture of biotechnology-derived crops planted in 2006.",OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Available on theWorldwide Web: http://www.ncfap.org Kleiter G. The effect of the cultivation of GM crops on the use of pesticides and the impact thereof on the envi-ronment, RIKILT, Institute of Food Safety, Wagenin-gen, Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Plos One 2014; 9:e111629; PMID:25365303; http://dx.plos.org/10.1371/ journal.pone.0111629 Kovach J, Petzoldt C, Degni J, Tette J.",OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Available on theWorldwide Web: http://www.nysipm.cornell.edu/publi cations/EIQ.html Lal R. Enhancing crop yields in the developing countries through restoration of the soil organic carbon pool in agricultural lands.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
17: 2: 197– 209; http://dx.doi.org/10.1002/ldr.696 Lal R. Beyond Copenhagen: mitigating climate change and achieving food security through soil carbon sequestration.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Food Security, 2010; 2(2):169–77;http://dx.doi.org/10.1007/s12571-010-0060-9 Lal R. Soil carbon sequestration impacts on global climate change and food security.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Science 2004; 304(5677):1623–7; PMID:15192216; http://dx.doi.org/10.1126/science.1097396 Lazarus WF.,OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Soil Till Res 2005; 83:25– 52; http://dx.doi.org/10.1016/j.still.2005.02.008 Michigan State University.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
Available from: http://surf.kbs.msu.edu Monsanto Brazil.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Appl Environ Soil Sci 2013; Article ID 617504; PMID:26949393; http://dx.doi.org/10.1155/ 2013/617504 Peterson R, Schleier J.",OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
A probabilistic analysis reveals fundamental limitations with the environmental impact quotient and similar systems for rating pesticides.PeerJ 2014; 2:e364; PMID:24795854; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Plant J 2002; 31(4):423–30; PMID:12182701; http://dx.doi.org/ 10.1046/j.1365-313X.2002.01401.x Qaim M, De Janvry A. Bt cotton and pesticide use in Argentina: economic and environmental effects.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Envi- ron Dev Econ 2005; 10:179–200; http://dx.doi.org/ 10.1017/S1355770X04001883 Qaim M, Traxler G. Roundup Ready soybeans in Argen- tina: farm level, environmental and welfare effects, 6 th ICABR conference.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"2010 http://www.thel andonline.com/currente- dition/x1897235554/No-till-beneﬁts-add-up-with-diesel-fuel-savings Reicosky D. Conservation tillage and carbon cycling: soil as a source or sink for carbon University of Davis, USA.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Science 2000; 289; N 0(5486):1922–5; PMID:10988070; http://dx.doi.org/10.1126/science.289.5486.1922 Sankula S, Blumenthal E. Impacts on US agriculture of biotechnology-derived crops planted in 2003: An update of eleven case studies.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Available on the World Wide Web:http://www.ncfap.org Sankula S, Blumenthal E. Impacts on US agriculture of biotechnology-derived crops planted in 2005: An update of eleven case studies.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"Available on the World Wide Web: http://www.ncfap.org; PMID:NOT_FOUND Smyth SJ, Gusta M, Belcher K, Phillips PWB, Castle D. Changes in herbicide use following the adoption of HR canola in western Canada.",Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
2013 http://ecat.sc.egov.,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
SoilSci Soc Am J 2002; 66 November/December: 930– 1046; http://dx.doi.org/10.2136/sssaj2002.1930ENVIRONMENTAL IMPACT OF GM CROPS 103,Non-OADS,/arxiv_data1/oa_pdf/47/95/kgmc-07-02-1192754.PMC5033163.pdf
"17 Norre and colleagues studied the promoter  *Correspondence to: Roger Thilmony; Email: Roger.Thilmony@ars.usda.gov; Anne E Blechl; Email: Ann.Blechl@ars.usda.gov Submitted: 09/20/2013; Revised: 11/26/2013; Accepted: 11/27/2013; Published Online: 12/09/2013http://dx.doi.org/10.4161/gmcr.27371The wheat HMW-glutenin 1Dy10   gene promoter controls endosperm expression   in Brachypodium distachyon Roger Thilmony*, Mara e Guttman, Jeanie W Lin, and ann e Ble chl* UsDa-aRs; West ern Regional Research cente r; crop Im provement and Utilization Research Unit; alban y, ca Usa Keywords:  wheat, Brachypodium distachyon , high-molecular-weight glutenin, promoter, GUS Abbreviations: bp, base pair; CAT, chloramphenicol acetyltransferase; DAP, days after pollination; GFP, green fluorescent protein;  GUS, uidA -encoded β -glucuronidase; HMW-GS, high-molecular-weight glutenin subunit; MAR, matrix attachment region;  X-gluc, 5-bromo-4-chloro-3-indolyl- β-D-glucuronic acid The grass species Brachypodium distachyon has emerged as a model system for the study of gene structure and  function in temperate cereals.",Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Supplemental Material Supplemental Material may be found here: https://www.landesbioscience.com/journals/gmcrops/article/27371 / Figure  4.  spati al and temporal β -glucuronidase (GU s) acti vity in transgenic  Brachypodium .,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nat Biotechnol  1996 ; 14:1155-9;  PMID:9631070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Theor Appl Genet  2000 ; 100:319-27; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nat Biotechnol  1996 ; 14:875- 9; PMID:9631014 ; http://dx.doi.org/10.1038/ nbt0796-875 6.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Theor Appl Genet  1999 ; 99:851-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Cereal Res Commun  2007 ; 35:1543 -9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Breed Sci 2008 ; 58:121-8;  http://dx.doi.org/10.1270/jsbbs.58.121 12.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant  Prod Sci 2009 ; 12:341-4; http://dx.doi.org/10.1626/ pps.12.341 13.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant  Biotechnol J  2012 ; 10:533-44; PMID:22353344 ;  http://dx.doi.org/10.1111/j.1467-7652.2012.00685.x14.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Theor Appl Genet  2002 ;  105:937-45; PMID:12582919 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
J Plant Physiol  2003 ; 160:931-43; PMID:12964869 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Mol Biol   2002 ; 50:699-712; PMID:12374301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant  Biotechnol J  2009 ; 7:240-53; PMID:19175520 ;  http://dx.doi.org/10.1111/j.1467-7652.2008.00394.x 20.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
In Vitro Cell Dev Biol Plant 2008 ; 44:1- 7; http://dx.doi.org/10.1007/s11627-007-9082-1 22.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Growth Regul  2007 ; 51:217-29; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Sci  1989 ; 62:207-16; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nature  2010 ; 463:763- 8; PMID:20148030 ; http://dx.doi.org/10.1038/ nature08747 25.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Physiol  2001 ; 127:1539 - 55; PMID:11743099 ; http://dx.doi.org/10.1104/ pp.010196 26.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant  Biotechnol J  2008 ; 6:236-45; PMID:18004984 ;  http://dx.doi.org/10.1111/j.1467-7652.2007.00308.x 27.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Rep 2008 ; 27:471- 8; PMID:17999063 ; http://dx.doi.org/10.1007/ s00299-007-0472-y28.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Physiol 2011 ; 157:3- 13; PMID:21771916 ; http://dx.doi.org/10.1104/ pp.111.179531 29.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Theor Appl Genet  2008 ; 117:555- 63;   PMID:18528675 ; http://dx.doi.org/10.1007/ s00122-008-0799-y 30.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
J Exp Bot  2010 ; 61:1771 -83; PMID:20385545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
J Exp Bot 2012 ; 63:739-55; PMID:22016425 ;  http://dx.doi.org/10.1093/jxb/err298 32.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Funct Integr  Genomics  2010 ; 10:111-22; PMID:19707805 ;  http://dx.doi.org/10.1007/s10142-009-0135-x 33.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
J Exp Bot  2011 ; 62:735-48; PMID:21071680 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
J Cereal  Sci 2012 ; 56:2-8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Planta   2005 ; 2  21:523-30; PMID :15682278 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Rep  2007 ; 26:1195 -203; PMID:17340093 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Rep 2009 ; 28:1095 - 104; PMID:19373469 ; http://dx.doi.org/10.1007/ s00299-009-0700-8,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Mol Biol   2010 ; 74:293-305; PMID:20703807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Rep 2011 ; 30:2013 - 25; PMID:21706298 ; http://dx.doi.org/10.1007/ s00299-011-1109-8 43.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Tissue Organ  Cult 2011 ; 105:405-14; http://dx.doi.org/10.1007/ s11240-010-9880-8 44.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Mol Biol Rep 2006 ; 24:57-69;  http://dx.doi.org/10.1007/BF02914046 45.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Biotechnol J  2009 ; 7:867-82; PMID:19781006 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant  Mol Biol Rep  2012 ; 30:1138 -48; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Cell Rep 2013 ; 32:443-51; PMID:23283558 ;  http://dx.doi.org/10.1007/s00299-012-1376-z 48.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Theor Appl Genet  1998 ; 96:568-76; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Genome  2002 ; 45:367-80;  PMID:11962634 ; http://dx.doi.org/10.1139/g01-137 50.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Transgenic Res  1996 ; 5:213-8; PMID :8673150 ;  http://dx.doi.org/10.1007/BF01969712 52.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Gene  1986 ; 41:337-42; PMID:3011607 ;  http://dx.doi.org/10.1016/0378-1119(86)90117-4 53.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
PLoS One  2012 ; 7:e41916 ;  PMID:23028431 ; http://dx.doi.org/10.1371/ journal.pone.0041916 54.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Mol Biol Rep 1983 ;  1:19-21; http://dx.doi.org/10.1007/BF02712670 55.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Plant Mol Biol Rep 1987 ;  5:387-405; http://dx.doi.org/10.1007/BF0266774057.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nucleic Acids Res 2002 ; 30:325-7;  PMID:11752327 ; http://dx.doi.org/10.1093/ nar/30.1.325 59.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nucleic Acids Res 1999 ; 27:297- 300; PMID:9847208 ; http://dx.doi.org/10.1093/ nar/27.1.297 60.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Bioinformatics   2003 ; 19:1837 -43; PMID:14512356 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nucleic Acids Res  1999 ; 27:2924 -30; PMID:10390535 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
Nucleic Acids Res 1985 ; 13:8729 - 37; PMID:3001648 ; http://dx.doi.org/10.1093/ nar/13.24.8729,OADS,/arxiv_data1/oa_pdf/15/7b/kgmc-05-01-10927371.PMC5033164.pdf
"Statistics of oilseed rape seeds import into Japan from Canada, Australia (2 most active exporters), and other countries in 2009—2014 Year 2009 2010 2011 2012 2013 2014 Total amount of import [A]a2,072,402 2,344,304 2,318,994 2,408,423 2,461,041 2,411,348 Canada total 1,957,239 2,145,095 2,260,447 2,331,636 2,309,279 2,243,361Proportion of import from Canada (%)94.4 91.5 97.5 96.8 93.8 93.0 Australia total 114,592 198,712 57,918 75,749 151,641 167,834 Proportion of import from Australia (%)5.5 8.5 2.5 3.1 6.2 7.0 Other countries 571 497 629 1,038 121 153 Proportion of import from other countries (%)0.028 0.021 0.027 0.043 0.005 0.006 Discharge at each port and from each country Port of Yokkaichi, total [B] 90,341 90,204 118,948 104,047 85,189 114,944Proportion of discharge at Yokkaichi (%) [B/A]4.4 3.8 5.1 4.3 3.5 4.8 From Canada [C] 84,119 81,500 117,984 104,047 72,612 109,811 Proportion of import from Canada (%) [C/B]93.1 90.4 99.2 100.0 85.2 95.5 From Australia [D] 6,222 8,704 964 — 12,577 5,133 Proportion of import from Australia (%) [D/B]6.9 9.6 0.8 — 14.8 4.5 Port of Kashima, total [E] 162,036 197,886 170,148 199,269 217,462 212,951 Proportion of discharge at Kashima (%) [E/A]7.8 8.4 7.3 8.3 8.8 8.8 From Canada [F] 162,036 197,886 170,148 194,815 212,222 208,198 Proportion of import from Canada (%) [F/E]100.0 100.0 100.0 97.8 97.6 97.8 From Australia [G] — — — 4,454 5,240 4,753 Proportion of import from Australia (%) [G/E]— — — 2.2 2.4 2.2 Number of exporter countries11 13 11 10 7 7 Number of ports at which oilseed was discharged b12 13 (1) 13 14 (1) 12 13 (1) The source of these data is the trade statistics of the Ministry of Finance of Japan (http://www.customs.go.jp/toukei/info/index_e.htm).",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"GM Crops 2011;2:201-210; PMID:22179196; http://dx.doi.org/10.4161/gmcr.2.3.18931 Aono M, Wakiyama S, Nagatsu M, Nakajima N, Tamaoki M, Kubo A, Saji H. Detection of feral transgenic oilseedrape with multiple-herbicide resistance in Japan.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Envi- ron Biosafety Res 2006; 5:77-87; PMID:17328854; http://dx.doi.org/10.1051/ebr:2006017 Bailleul D, Ollier S, Huet S, Gardarin A, Lecomte J.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
PLoSONE 2012; 7:e32752; http://dx.doi.org/10.1371/jour-nal.pone.0032752 Canola Council of Canada.,Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Canola Council of Canada,Winnipeg, Manitoba, Canada 2014; http://www.canola council.org/ Crawley MJ, Brown SL.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Proc Roy Soc London B 1995; 259:49-54; http://dx.doi.org/ 10.1098/rspb.1995.0008 Crawley MJ, Brown SL.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Proc Roy Soc London B 2004; 271:1909-1916; http://dx.doi.org/10.1098/rspb.2004.2814 D e v o sY ,H a i l sR S ,M e s s /C19e a nA ,P e r r yJ N ,S q u i r eG R .",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Trans genic Res 2012; 21:1-21; PMID:21526422; http://dx.do i.org/10.1007/s11248- 011-9515-9 Elling B, Neuffer B, Bleeker W. Sources of genetic diver- sity in feral oilseed rape ( Brassica napus ) populations.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Basic Appl Ecol 2009; 10:544-553; http://dx.doi.org/10.1016/j.baae.2009.01.005 Hecht M, Oehen B, Schulze J, Brodmann P, Bagutti C. Detection of feral GT73 transgenic oilseed rape (Brassica napus ) along railway lines on entry routes to oilseed factories in Switzerland.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
Environ Sci Pollut Res 2014; 21:1455-1465; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"N Z J Bot 2004; 42:815-832; http://dx.doi.org/10.1080/0028825X.2004.9512932 Knispel A, McLachlan SM.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Environ Sci Pollut Res 2010; 17:13-25; http://dx.doi.org/10.1007/ s11356-009-0219-0Knispel AL, McLachlan SM, Van Acker RC, Friesen LF.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Environ Biosafety Res 2009; 8:33-44; PMID:19419652; http://dx.doi.org/10.1051/ebr/ 2009001 Nishizawa T, Tamaoki M, Aono M, Kubo A, Saji H, Naka- jima N. Rapeseed species and environmental concerns related to loss of seeds of gene tically modiﬁed oilseed rape in Japan.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"GM Crops 2010; 1:143-156; PMID:21912204;http://dx.doi.org/10.4161/gmcr.1.3.12761 Peltzer D, Ferriss S, FitzJohn RG.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
J Appl Ecol 2008; 45: 467-475;http://dx.doi.org/10.1111 /j.1365-2664.,OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Theor Appl Genet 2001; 102:841-846; http://dx.doi.org/10.1007/ s001220100583 Pivard S, Adamczyk K, Lecomte J, Lavigne C, Bouvier A, Deville A, Gouyon PH, Huet S. Where do the feral oil- seed rape populations come from?",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"J Appl Ecol 2008a; 45:476-485; http://dx.doi.org/10.1111/j.1365- 2664.2007.01358.x Pivard S, Dem /C20sar D, Lecomte J, Debeljak M, D /C20zeroski S. Characterizing the presence of oilseed rape feral popu- lations on ﬁeld margins using machine learning.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Ecol Model 2008b; 212:147-154; http://dx.doi.org/10.1016/j.ecolmodel.2007.10.012 Reuter H, Menzel G, Pehlke H, Breckling B.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Environ Sci Pollut Res2008; 15:529-535; http://dx.doi.org/10.1007/s11356- 008-0049-5 Saji H, Nakajima N, Aono M, Tamaoki M, Kubo A, Wakiyama S, Hatase Y, Nagatsu M. Monitoring theescape of transgenic oilseed rape around Japanese ports and roadsides.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Environ Biosafety Res 2005; 4:217-222; PMID:16827549; http://dx.do i.org/10.1051/ebr:2006003 Schoenenberger N, D’Andrea L. Surveying the occur- rence of subspontaneous glyphosate-tolerant geneti- cally engineered Brassica napus L. (Brassicaceae) along Swiss railways.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Environ Sci Eur 2012; 24:23. http://www.enveurope.c om/content/ 24/1/23; http:// dx.doi.org/10.1186/2190-4715-24-23 Schulze J, Frauenknecht T, Brodmann P, Bagutti C. Unexpected diversity of feral genetically modiﬁed oil- seed rape ( Brassica napus L.) despite a cultivation and import ban in Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
PLoS One 2014; 9:e114477; PMID:25464509; http://dx.doi.org/10.1371/ journal.pone.011447736 Nishizawa et al.,OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"GM Crops & Food 2014; 5:195- 203; PMID:25437238; http://dx.doi.org/10.4161/ 21645698.2014.947843 von der Lippe M, Kowarik I.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Ecography 2007a; 30:483-490; http://dx.doi.org/10.1111/j.2007.0906-7590.05072.x von der Lippe M, Kowarik I.",Non-OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"Long-distance dispersal of plants by vehicles as a driver of plant invasions.Conserv Biol 2007b; 21:986-996; PMID:17650249; http://dx.doi.org/10.1111/j.1523-1739.2007.00722.x von der Lippe M, Kowarik I.",OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
Diversity Distrib 2008; 14:18-25; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
Environ Biosafety Res 2006; 5:67-75; PMID:17328853; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/47/kgmc-07-01-1138196.PMC5033165.pdf
"The second implication is an implied renegotiation of the EU Treaty as to what power is allocated to the EU as a central  Correspondence to: Drew L Kershen; Email: dkershen@ou.edu Submitted: 12/05/2013; Revised: 01/30/2014; Accepted: 12/31/2013; Published Online: 01/09/2014http://dx.doi.org/10.4161/gmcr.27777European decisions   about the “Whack-a-mole” game Drew L Kershen College of Law; unive rsity of oklah oma; norma n, oK usA",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"Pioneer Hi-Bred Italia Sri against the Minister of  Agr iculture, Food, and Forest Policy  (Italy) (6 Sept  2012) available from http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=CELEX:62011CJ0036:EN:HTML 2.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"Comp any Monsanto SAS against the Minister of  Agriculture, Food, and Fisheries  (France) (1 August  2013) available from http://www.conseil-etat.fr/fr/selection-de-decisions-du-conseil-d-etat/ce_1er_aout_2013_association_generale-producteurs_mais_agpm_et_autres.html 3.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"Pione er Hi-Bred International, Inc. against the  European Commission  (26 Sept 2013) available from  http://curia.europa.eu/juris/document/document.jsf?doclang=EN&text=&pageIndex=1&part=1&mode=req&docid=142241&occ=first&dir=&cid=9055644.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"Hung ary against the European Commission  (13 Dec  2013), available from http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEC:62010TJ0240:ES:HTML  (no translation into English as of Jan  31, 2014) 5.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
Available from: http://www.euractiv.com/cap/brussels-reopens-12-year-old-gmo-news-531549 11.,Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"“EU loses lawsuit against Polish GM feed ban”: http://www.eurofoodlaw.com/food-technology/genetic-modification/eu-loses-lawsuit-against-polish-gm-feed-ba n-91967.htmlDespite the delay on implementation of the 2006 law, the Polish government, by executive actions, has blocked the growing of genetically engineered crops by Polish farmers.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"M Kuntz, A Ricroch, and J Davison, “EFSA rejects Italian request for a ban on Monsanto’s MON810 maize,” BlogActiv Team (Oct. 9, 2013),http://guests.blogactiv.eu/2013/12/05/efsa-rejects-italian-request-for-a-ban-on-mon-810-maize/  (In case this blogpost  disappears, the author also has a copy of this cited BlogActive post in his personal files.",Non-OADS,/arxiv_data1/oa_pdf/d1/e3/kgmc-05-01-10927777.PMC5033171.pdf
"*Correspondence to: Stuart J Smyth; Email: stuart.smyth@usask.ca Submitted: 08/12/2013; Revised: 12/06/2013; Accepted: 12/09/2013; Published Online: 12/20/2013http://dx.doi.org/10.4161/gmcr.27465Investment, regulation, and uncertainty Managing new plant breeding techniques stuart J smyth1,*, Jillian McDonald1, and Jose Falck-Zepeda2 1Department Bioresource Policy, Business and econo mics; University of saska tchewan; saska toon, sK canad a; 2International Food Policy Research Institute (IFPRI);  Washington, D c Usa Keywords:  barriers; biotechnology; innovation; investment uncertainty, policy, risk as with any technological innovation, time refines the technology, improving upon the original version of the inno - vati ve product.",Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Available from:: http://www.basf.com/group/corporate/en/func - tion/conversions:/publish/content/news-and-media relations/news-releases/downloads/2010/P179-Amflora-e.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Available from: http://www.gatesfoundation.org/annual-letter/2012/Pages/home-en.aspx .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Available from: http://www.fao.org/fileadmin/templates/wsfs/docs/expert_paper/How_to_Feed_the_World_in_2050.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Nature 2010;  466:531-2;  PMID:20671664 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
J Agric Econ 1998; 39:99-111; http://dx.doi.org/10.1111/j.1477-9552.1988.tb00565.x 15.,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Am J Agric Econ 1989; 71:9-19; http://dx.doi.org/10.2307/1241770 16.,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Am J Agric Econ 1992; 74:583-91; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Available online at: http://giannini.ucop.edu/media/are-update/files/articles/v12n2_5.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Journal of Financial Economics 1987;18: 7-27; http://dx.doi.org/10.1016/0304-405X(87)90059-6 .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
J Econ Dyn Control 2008; 32:2191-213; http://dx.doi.org/10.1016/j.jedc.2007.10.003 33.,OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
International Food and Agribusiness Management Review 2001; 4:51-66; http://dx.doi.org/10.1016/S1096-7508(01)00070-2 34.,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
J Econ Dyn Control 2000; 24:219-25; http://dx.doi.org/10.1016/S0165-1889(99)00005-6 35.,OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Trends Biotechnol 2013; 31:375-83; PMID:23601269 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
N Biotechnol 2014; 31:18-27; PMID:23851284 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
http://www.nature.com/news/transgenics-a-new-breed-1.12887 .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
J Agric Econ 2008; 59:463-86; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
Online at: http://www.efsa.europa.eu/en/faqs/faqgmo.htm .,Non-OADS,/arxiv_data1/oa_pdf/f4/7e/kgmc-05-01-10927465.PMC5033172.pdf
"COAG comprises the Prime Minister, the Australian State Premiers and Chief Ministers, and the President of the © David Tribe *Correspondence to: David Tribe; Email: detribe@gmail.comSubmitted: 04/23/2014; Revised: 09/01/2014; Accepted: 09/08/2014 http://dx.doi.org/10.4161/21645698.2014.964120 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Tribe D. GMO Pundit weblog entry 19 April 2012 Available from: http://gmopundit.blogspot.com.au/ 2012/04/australian-coalition-of-woo-pull-their.html 6.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://sustainablefoodtrust.org/team/george-kailis/ Accessed 31 August 2014 7.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://www.parliament.wa.gov.au/parliament%5Ccommit.nsf/ (Evidence+Lookup+by+Com+ID)/A2D3CE6671F420C0482 57831003B01CC/$ﬁle/ep.gen.021122.tro.002.gk.d.doc.pdf Accessed 1 Sept 20148.,OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://www.stockjournal.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Food Chem Toxi-col 2012; 50:4221–31; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
2014 Available from: http://data.daff.gov.au/data/warehouse/9aap/2014/apgpfd9abp_20140220/ AgProdGrthPstRfmFtrOppsv1.0.0.pdf 14.,OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://dx.doi.org/10.1177/0963662514542372.2014 20.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Biotechnol J 2007; 2:1169–78; http://dx.doi.org/10.1002/ biot.200700105 21.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://agriculturalcompetitiveness.dpmc.gov.au/ 22.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://www.nvtonline.com.au/ 24.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from: http://www.abc.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from http://www.riskworld.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Overarching Strategic Statement for the Food Regulatory System 10 October 2013.Available from: https://www.health.gov.au/internet/ main/publishing.nsf/Content/foodsecretariat-stategic- statement 31.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Available from:http://www.premier.vic.gov.au/newsroom/news_item_ archive.asp?id=37632.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Avail- able from: http://www.ogtr.gov.au/internet/ogtr/ publishing.nsf/content/gtbill-3/$FILE/expguidebill.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
Food Con- trol 2003; 14: 357–365; http://dx.doi.org/10.1016/ S0956-7135(03)00043-4 38.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
FoodControl 2003; 14: 409–16; http://dx.doi.org/10.1016/ S0956-7135(03)00037-9 39.,Non-OADS,/arxiv_data1/oa_pdf/4d/cf/kgmc-05-03-964120.PMC5033177.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Brookes G, Barfoot P. The income and production effects of biotech crops globally 1996-2009, International Journal of Biotechnology, 2011; 12(1/2):1-49; http://dx.doi.org/10.1504/IJBT.2011.042680.",OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Brookes G, Barfoot P. The income and production effects of biotech crops globally 1996-2010, GM Crops 2012; 3(4):265-273; http://dx.doi.org/10.4161/gmcr.20097.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Brookes G, Barfoot P. The income and production effects of biotech crops globally 1996-2011, GM Crops 2013;4(1):1-10; http://dx.doi.org/10.4161/gmcr.22748.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Brookes G, Barfoot P. Economic impact of GM crops: the global income and production effects 1996-2012, GMCrops 2014; 5(1):65-75; http://dx.doi.org/10.4161/ gmcr.28278.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
Int Journal Biotechnology 2005; 7(1/2/3); http://dx.doi.org/10.1504/IJBT.2005.006447.,OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Science, 2010, Vol 330, 222-225.www.sciencemag.org; http://dx.doi.org/10.1126/ science.1190242.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
Weed Technology 2010; 24: 523-528; http://dx.doi.org/ 10.1614/WT-D-10-00033.1 Khan M. Roundup Ready sugar beet in America.,Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"AgriculturalEconomics 2013; 44:323-335; http://dx.doi.org/ 10.1111/agec.12014 Marra M, Pardey P, Alston J.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Reducing the risk of her-bicide resistance: best management practices and recommendations, Weed Sci 2012; 60(special edi- tion):31–62; http://dx.do i.org/10.1614/WS-D-11- 00155.1.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
The Plant Journal2002; 31(4): 423-430; PMID:12182701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Envi- ronment and Development Economics 2005; 10: 179- 200; http://dx.doi.org/10.1017/S1355770X04001883 Qaim M, Traxler G. Roundup Ready soybeans in Argen- tina: farm level & aggregate welfare effects, Agricul- tural Economics 2005; 32(1):73-86; http://dx.doi.org/10.1111/j.0169-5150.2005.00006.x.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"Spanish Journal of Agri-cultural Research 2012; 10(4): 867-876; http://dx.doi.org/10.5424/sjar/2012104-448-11 Sankala S, Blumenthal E. Impacts on US agriculture of biotechnology-derived crops planted in 2003- anupdate of eleven case studies, Washington: NCFAP.",Non-OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
International Journal of Biotechnology 2008; 10(2/3): 167-183; http://dx.doi.org/10.1504/IJBT.2008.,OADS,/arxiv_data1/oa_pdf/de/83/kgmc-06-01-1022310.PMC5033178.pdf
"In most cases the unintended escape of volunteers occurs within agricultural ﬁelds, where either the seed lots of conven-tional crops are mixed with GM seeds or seeds from GM cropsgerminate within the next season `s crop, as was the case for © Gerhart U Ryffel *Correspondence to: Gerhart U Ryffel; Email: gerhart.ryffel@uni-due.de Submitted: 03/21/2014; Revised: 05/28/2014; Accepted: 06/02/2014http://dx.doi.org/10.4161/21645698.2014.945883 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
(b)Different GM crop species listed in ISAAA GM Approval Database (http://www.isaaa.org/gmapprovaldatabase/).,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
(c)Genes listed in approved GM crops (http://www.isaaa.org/ gmapprovaldatabase/).,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Curr Genomics 2013; 14:468-76; PMID: 24396278; http://dx.doi.org/10.2174/ 13892029113146660013 2.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Biotechnol J 2013; 11:395-407; PMID: 23421562; http://dx.doi.org/10.1111/pbi.12055 3.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Pest Manag Sci 2008; 64:428-40; PMID: 18181145; http://dx.doi.org/ 10.1002/ps.1517 4.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
J Sci Food Agric 2014; 94:381-7; PMID:23965758; http://dx.doi.org/10.1002/jsfa.6358 5.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Can J Plant Sci 2006; 86:1-23; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 2008; 26:506-17; PMID: 18676047; http://dx.doi.org/10.1016/j.tibtech.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Sci Europe 2012; 24:23; http://www.enveurope.com/content/24/1/23 8.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Sci Pollut Res 2014; 21:1455-65; PMID: 23917737; http://dx.doi.org/10.1007/s11356-013- 1881-9 9.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Weed Sci 2000; 48:688-94; WOS:000166182800008; http://dx.doi.org/ 10.1614/0043-1745(2000)048[0688:PFBHRB] 2.0.CO;2 10.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2009; 18:4145-50; PMID: 19143938; http://dx.doi.org/10.1111/j.1365-294X.2008.03993.x 14.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
PLoS ONE 2009; 4: e5734; PMID: 19503610; http://www.plosone.org/ article/info%3Adoi%2F10.1371%2Fjournal.pone.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nat Biotechnol 2011; 29:23-4; PMID: 21221094; http://dx.doi.org/10.1038/nbt.1752 16.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Biotechnol 2010; 27:545-51; PMID: 20609417; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
"Wegier A, Pineyro-Nelson A, Alarcon J, Galvez- Mariscal A, varez-Buylla ER, Pinero D. Recent long-distance transgene ﬂow into wild populations conforms to historical patterns of gene ﬂow in cot- ton (Gossypium hirsutum) at its centre of origin.Mol Ecol 2011; 20:4182-94; PMID: 21899621; http://dx.doi.org/10.1111/j.1365- 294X.2011.05258.x 18.",OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Breeding Reviews 2009; 31:21-187; http://dx.doi.org/10.1002/9780470593783.ch2 19.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nature 1996; 380:31; WOS:A1996TY87700040; http://www.nature.com/nature/journal/v380/n6569/pdf/380031a0.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2012; 21:4663-4; PMID: 23009646; http://dx.doi.org/10.1111/j.1365-294X.2012.05695.x 21.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2006; 15:4243-55; PMID: 17054516; http://dx.doi.org/10.1111/ j.1365-294X.2006.03072.x 22.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
GM Crops Food 2013; 4:4663-4: PMID: 23988874; http://dx.doi.org/10.4161/gmcr.26303 24.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 2011; 29:284-93; PMID: 21388698; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Ann N Y Acad Sci 2009; 1168:72-99; PMID: 19566704; http://dx.doi.org/10.1111/j.1749-6632.2009.04576.x 27.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Biosafety Res 2009; 8:1-14; PMID: 19419648; http://dx.doi.org/10.1051/ebr/2009003 28.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 2013; 31:332-4; PMID:23706302; http://dx.doi.org/10.1016/j.tibtech.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nat Rev Genet 2003; 4:806- 17; PMID: 14526376; http://dx.doi.org/10.1038/ nrg1179 31.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2013; 202:679-88; PMID: 23905647; http://dx.doi.org/10.1111/nph.12428 32.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2014; 202:360-62; PMID: 24645782; http://dx.doi.org/10.1111/nph.12615 33.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2014; 202:367-69; PMID: 24645784; http://dx.doi.org/10.1111/nph.12683 34.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2014; 202:370-72; PMID: 24645785; http://dx.doi.org/10.1111/nph.12748 35.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2014; 202:363-66; PMID: 24645783; http://dx.doi.org/10.1111/ nph.12684 36.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Ecol Appl 2003; 13:279-86; http://dx.doi.org/10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2 37.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
New Phytol 2006; 170:429-43; PMID: 16626466; http://dx.doi.org/10.1111/ j.1469-8137.2006.01710.x 38.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
"Nat Biotechnol 2010; 28:900-3; PMID: 20829822; http://dx.doi.org/10.1038/nbt0910-900 39. de Jong TJ, Rong J.",OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Annu Rev Plant Biol 2011; 62:251-72;PMID: 21526968; http://dx.doi.org/10.1146/ annurev-arplant-042110-103751 41.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
"In: Banana Breeding Progress and Challenges, Pillay M, Tenkuano A Eds, CRC Press 2011; 219-36;http://dx.doi.org/10.1201/b10514-12 42.",Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nature 2004; 432:222-5; PMID: 15538370;http://dx.doi.org/10.1038/nature03048 256 Volume 5 Issue 4 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Annu Rev Plant Biol 2014; 65:579- 606; PMID: 24313845; http://dx.doi.org/10.1146/ annurev-arplant-050213-040119 44.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 2010; 28:3-8; PMID: 19857909; http://dx.doi.org/10.1016/j.tibtech.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Biosafety Res 2010; 9:67-73;PMID: 21288462; http://dx.doi.org/10.1051/ebr/ 2010009 46.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Breed Sci 2012; 62:124-32; PMID: 23136523; http://dx.doi.org/10.1270/ jsbbs.62.124 47.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nat Biotechnol 2004; 22:687-91; PMID:15175691; http://dx.doi.org/10.1038/nbt976 48.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Genet Mol Res 2013; 12:988-94; PMID: 23613244; http://dx.doi.org/10.4238/2013.April.2.14 50.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Acta Biologica Cracoviensia Series Botanica 2010; 52:87-96; WOS:000283386700011; http://dx.doi.org/10.2478/v10182-010-0011-y 52.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Reprod 2013; 26:159-79; PMID: 23852378; http://dx.doi.org/10.1007/s00497-013-0222-y 53.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Theor Appl Genet 2010; 121:919-29; PMID: 20512558; http://dx.doi.org/10.1007/s00122-010-1360-3 54.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Cell 2004; 16 Suppl:S228-45; PMID: 15131250; http://dx.doi.org/10.1105/tpc.017921 55.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nat Rev Genet 2013; 14:840-52; PMID: 24240513; http://dx.doi.org/10.1038/nrg3605 58.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
EMBO Rep 2014; 15:138- 41; PMID: 24451237; http://dx.doi.org/10.1002/embr.201338365 59.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 2013; 31:397-405;PMID: 23664777; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Annu Rev Plant Biol 2004; 55:289-313; PMID:15377222; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Mol Biol 2011; 75:621-31; PMID: 21359553; http://dx.doi.org/10.1007/s11103-011-9756-2 62.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Biotechnol Lett 2013; 35:2177-83;PMID: 23974493; http://dx.doi.org/10.1007/ s10529-013-1310-7 63.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Can J Plant Sci 2007; 87:753-62; WOS:000251635700008; http://dx.doi.org/10.4141/CJPS06033 64.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Pest Manag Sci2009; 65:723-31; PMID: 19367567; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Biotechnology Journal 2013; 11:649- 58; WOS:000322989000002; http://dx.doi.org/ 10.1111/pbi.12084 66.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Trends Biotechnol 1999; 17:361-6; PMID: 10461182; http://dx.doi.org/10.1016/ S0167-7799(99)01340-2 67.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Biotechnol J 2006; 4:23-33; PMID:17177782; http://dx.doi.org/10.1111/j.1467- 7652.2005.00153.x 68.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
PLoS ONE 2008; 3:e1818; PMID:18350155; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
PLoS ONE 2012; 7:e31625; PMID: 22359609; http://dx.doi.org/10.1371/ journal.pone.0031625 70.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
PLoS ONE 2013; 8:e81645; PMID: 24324711; http://dx.doi.org/10.1371/journal.pone.0081645 71.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2007; 16:4423-25; PMID: 17850268; http://dx.doi.org/10.1111/j.1365-294X.2007.03520.x 72.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Crop Protection 2013; 49:40-51;http://www.sciencedirect.com/science/article/pii/ S0261219413000495 73.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Pest Manag Sci 2009; 65:1124-29; PMID:19530257; http://dx.doi.org/10.1002/ps.180274.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Pest Manag Sci 2011; 67:921-31; PMID:21370396; http://dx.doi.org/10.1002/ps.2132 75.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Weed Science 2008;56:32-6; http://dx.doi.org/10.1614/WS-07-033.1 76.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Weed Science 2010; 58:395-401; http://dx.doi.org/10.1614/ WS-D-10-00027.1 77.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Plant Cell 2010; 22:1653-7;PMID: 20581306; http://dx.doi.org/10.1105/tpc.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2007; 16:3801-13; PMID: 17850547; http://dx.doi.org/ 10.1111/j.1365-294X.2007.03448.x 79.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Biosafety Res 2006; 5:77- 87; PMID: 17328854; http://dx.doi.org/10.1051/ ebr:2006017 81.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Bio- safety Res 2009; 8:33-44; PMID: 19419652; http://dx.doi.org/10.1051/ebr/2009001 82.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environ Sci Pollut Res Int 2009; 16:120-6; PMID: 19050951; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Jarq-Japan Agricultural Research Quarterly 2011; 45:181-5; http://dx.doi.org/10.6090/jarq.45.181 84.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
gmcrops 2011; 2:201-10; PMID: 22179196; http://dx.doi.org/ 10.4161/gmcr.2.3.18931 85.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Agronomy Journal 2003; 95:1342-7; http://dx.doi.org/10.2134/ agronj2003.1342 87.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Weed Science 2008;56:72-80; http://dx.doi.org/10.1614/WS-07-097.1 www.landesbioscience.com 257 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
The establishment of genetically engineered canola pop- ulations in the U.S. PLoS ONE 2011; 6:e25736;PMID: 21998689; http://dx.doi.org/10.1371/ journal.pone.0025736 89.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Theoreti-cal and Applied Genetics 2003; 107:528-39; WOS:000185004200017; http://dx.doi.org/ 10.1007/s00122-003-1278-0 91.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2008; 17:1387-95; PMID: 17971090; http://dx.doi.org/10.1111/ j.1365-294X.2007.03567.x 93.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Nature 2001; 414:541-3; PMID: 11734853; http://dx.doi.org/doi:10.1038/ 35107068 94.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Frontiers in Ecology and the Environment 2007; 5:247-52; http://dx.doi.org/ 10.1890/1540-9295(2007)5[247:TPIMIT]2.0.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
"Agriculture, Ecosystems & Environment 2008;123:109-15; http://dx.doi.org/10.1016/j.agee.",OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Mol Ecol 2009;18:750-61; PMID: 19143938; http://dx.doi.org/ 10.1111/j.1365-294X.2008.03993.x 97.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Journal of Applied Ecology 2008; 45:486-94; WOS: 000254192500011; http://dx.doi.org/10.1111/ j.1365-2664.2007.01430.x 98.,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
Environmental Sciences Europe 2013; 25:34; http://www.enveurope.com/content/25/1/34 258 Volume 5 Issue 4 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/59/98/kgmc-05-04-945883.PMC5033179.pdf
"In terms of the share of the 5 arable crops in which GM HT technology have been commercialised, GM HT traits accountedfor 88% of the total US plantings to these 5 crops in 2013 (there © Graham Brookes *Correspondence to: Graham Brookes; Email: graham.brookes@btinternet.comSubmitted: 05/23/2014; Revised: 08/18/2014; Accepted: 08/24/2014 http://dx.doi.org/10.4161/21645698.2014.958930 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
"Brookes G, Barfoot P. Economic impact of GM crops: the global income and production effects 1996–2012.GM Crops 2014a; 5:1; 1-11 Available on open access at http://www.landesbioscience.com; http://dx.doi.org/ 10.4161/gmcr.28278 2.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
2013; ISBN 978-1-892456-55-9. http://www.isaaa.org 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
"Brookes G, Barfoot P. Key global environmental impacts of global GM crop use 1996–2012, GM Crops, Forthcoming (2014b); Available on open access at http://www.landesbioscience.com 4.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
2003; Avail- able on the World Wide Web: http://www.ncfap.org5.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
Available from: http://www.nysipm.cornell.edu/ publications/EIQ.html 6.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
Pest Manage Sci 2005; 61:1; http://dx.doi.org/10.1002/ps.967 7.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
Available from: http://www.ncfap.org9.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
Available from: http://www.ncfap.org 10.,Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
"Survey of weed control and prodcution practices on sugar beet in Minnesota and Eastern North Dakota in 2011, 2012; North Dakota State University, http://www.sbreb.org/research/weed11/ 11.",Non-OADS,/arxiv_data1/oa_pdf/d6/dc/kgmc-05-04-958930.PMC5033181.pdf
"It is also hoped the analysis continues to make a contribution to greater understanding of the impact of this technology and facilitates  *Correspondence to: Graham Brookes; Email: graham.brookes@binternet.com Submitted: 08/01/2014; Revised: 04/03/2014; Accepted: 05/03/2014; Published Online: 11/03/2014http://dx.doi.org/10.4161/gmcr.28449Key global environmental impacts   of genetically modified (GM) crop use 1996–2012 Peter Barfoot and Graham Brookes* PG economics; Dorchester, UK Keywords:  GMO, pesticide, active ingredient, environmental impact quotient, carbon sequestration, biotech crops, no tillage against the background of increasing awareness and appreciation of issues such as global warming and the impact of  man kind’s activities such as agriculture on the global environment, this paper updates previous assessments of some key  environmental impacts that crop biotechnology has had on global agriculture.",Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
GM Crops 2011; 2:34-49;  PMID:21844697 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
GM Crops Food  2012 ; 3:129-37; PMID:22534352 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Environ Dev Econ 2005 ; 10:179-200; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Plant J   2002 ; 31:423-30; PMID:12182701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Science   2010 ; 330:222-5; PMID:20929774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Pest Manag Sci  2005 ; 61:47-52; PMID:15593073 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Sci Soc Am  J 2003 ; 67:1831 -41; http://dx.doi.org/10.2136/ sssaj2003.1831 24.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Science  2000 ; 289:1922 -5;  PMID:10988070 ; http://dx.doi.org/10.1126/ science.289.5486.1922 27.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Tillage Res  2005 ; 83:73-94; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Tillage  Res 2005 ; 83:25-52; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Sci Soc Am J 2002 ; 66:930-1046 ;  http://dx.doi.org/10.2136/sssaj2002.1930 30.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Available  from: http://ecat.sc.egov.usda.gov33.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Available from: http://www.thelandonline.com/currentedition/x1897235554/No-till-benefits-add-up-with-diesel-fuel-savings 34.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Agron J 2002 ; 100:1013 -9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Agric Ecosyst Environ 2007 ; 118:1-5;  http://dx.doi.org/10.1016/j.agee.2006.05.014 37.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Sci Soc Am J 2008 ; 72:1370 -4;  http://dx.doi.org/10.2136/sssaj2007.0342 38.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Soil Sci Soc Am J 2008 ; 72:693-701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Science  2004 ;  304:1623 -7; PMID :15192216 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Land Degrad  Dev 2005 ; 17:197-209; http://dx.doi.org/10.1002/ ldr.696 41.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Food Security  2010 ; 2:169-77;  http://dx.doi.org/10.1007/s12571-010-0060-9 42.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
http://surfkbs.msu.edu 44.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
Available on the Worldwide  Web: http://www.canola-council.org 51.,Non-OADS,/arxiv_data1/oa_pdf/15/b9/kgmc-05-02-10928449.PMC5033182.pdf
"From the 29 identified GM maize sam - ples, 9 (31%) showed one DNA fragment of 123 bp that was  *Correspondence to: Mohammed A Ibrahim-Alobaide; Email:  mohammed.al-obaide@ttuhsc.edu Submitted: 09/16/2013; Revised: 12/07/2013; Accepted: 12/16/2013; Published Online: 01/02/2014http://dx.doi.org/10.4161/gmcr.27542Unconventional P-35S sequence identified   in genetically modified maize Nisreen al-hmo ud1,2, Nawar al-huss eini2, Mohammed a Ibr ahim- alo baide2,†,*, eric Kübler3, Mahmoud Farfoura4,   hyth am aloby di5, and hiyam al-R ousan1 1Biosafety Unit; Royal scie ntific soci ety; amma n, Jordan; 2environment Management and Technology Postgraduate Programme; Princess suma ya University for Technology;  amma n, Jordan; 3school for Life scienc es; University of appl ied scienc es Northwestern swit zerland; Muttenz, swit zerland; 4Knowledge sector; Royal scientific society;  amma n, Jordan; 5Biomedica, LL c; ster ling heig hts, MI U sa †current affiliation: scho ol of Pharmacy; Texas Tech University heal th scie nces cent er; amar illo, TX U sa Keywords:  CaMV P-35S, DNA sequence analysis, genetic events, GMO, PCR, UGM The cauliflower Mosaic Virus 35 s pr omoter sequence, caMV P -35s, is on e of several commonly used genetic targets  to detect genetically modified maize and is found in most GMOs.",Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
"Sequence comparison of V3 with the cauliflower mosaic virus genome composed of 8024 bp, accession V00141/J02048 (http://www.ncbi.nlm.nih.gov/nuccore/V00141), showed 24 differences, 20 base pair substitutions, and four dele - tions, and the matching V00141 sequence is located between positions 7048 and 7435 ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
The Basic Local Alignment Search Tool (BLAST) of the  NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was searched for the matching sequences of 386 bp sequence.,OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
GM Crops Food 2013; 4:74-83; PMID:23549349 ; http://dx.doi.org/10.4161/ gmcr.24176 3.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Mol Breed 2003; 11:249-58; http://dx.doi.org/10.1023/A:1023461305848 4.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Mol Breed 2010; 25:527-40; http://dx.doi.org/10.1007/s11032-009-9351-2 5.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
GM Crops 2010; 1:199-206; PMID:21844674 ;  http://dx.doi.org/10.4161/gmcr.1.4.132256.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Biotechnol Lett 2006; 28:1983-91; PMID:17080241 ;  http://dx.doi.org/10.1007/s10529-006-9194-4 7.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Transgenic Res 2012; 21:1191-214; PMID:22576225 ;  http://dx.doi.org/10.1007/s11248-012-9617-z 9.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Food Chem Toxicol 2012; 50:3215-21;  PMID:22709787 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Anal Bioanal Chem 2010; 396:2175-87; PMID:19856176 ; http://dx.doi.org/10.1007/ s00216-009-3186-x 11.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Anal Bioanal Chem 2010; 396:1991-2002; PMID:19876618 ; http://dx.doi.org/10.1007/ s00216-009-3237-3 13.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Biotechnology 2010; 9:499-505; http://dx.doi.org/10.3923/biotech.2010.499.505 15.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
2012; http://www.ncbi.nlm.nih.gov/nuccore/JX139718.1 .,OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Available from: http://www.ncbi.nlm.nih.gov/nuccore/GX181970.118.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Available from: http://www.ncbi.nlm.nih.gov/nuccore/A18053.1 19.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Plant Physiol 2013; 161:1918-29; PMID:23435694 ; http://dx.doi.org/10.1104/ pp.113.214528 20.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Available from: http://www.ncbi.nlm.nih.gov/nuccore/JQ693018 21.,OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
Biotechnol Adv 2012; 30:1318-35; PMID:22333321 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5e/37/kgmc-05-01-10927542.PMC5033183.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"Int J Biotechnol2011; 12(1/2): 1-49; http://dx.doi.org/10.1504/ IJBT.2011.042680 Brookes G, Barfoot P. The income and production effects of biotech crops globally 1996–2010.",OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"GM Crops 2013; 4(1):1-10; http://dx.doi.org/10.4161/ gmcr.22748 Brookes G, Barfoot P. Economic impact of GM crops: the global income and production effects 1996–2012.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"GM Crops 2014; 5(1):65-75; PMID:24637520; http://dx.doi.org/10.4161/gmcr.28278 Brookes G, Barfoot P. Global income and production impacts of using GM crop technology 1996–2014.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
Available from: http://www.jrc.ec.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
Int J Biotechnol 2005; 7(1/2/3):84-94; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
222-225; PMID:20929774; http://dx.doi.org/10.1126/ science.1190242 IMRB.,OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
WeedTechnol 2010; 24:523-8; http://dx.doi.org/10.1614/ WT-D-10-00033.1 Khan M. Roundup Ready sugar beet in America.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
GM Crops 2011; 2 (3):163-8; PMID:22008311; http://dx.doi.org/10.4161/gmcr.2.3.17591 Monsanto Australia.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"Plant J 2002; 31(4):423-30; PMID:12182701; http://dx.doi.org/10.1046/ j.1365-313X.2002.01401.x Qaim M, De Janvry A. Bt cotton in Argentina: analysing adoption and farmers willingness to pay.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"Envi- ron Dev Econ 2005; 10: 179-200; http://dx.doi.org/10.1017/S1355770X04001883 Qaim M, Traxler G. Roundup Ready soybeans in Argen- tina: farm level & aggregate welfare effects.",OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
Agr Econ2005; 32(1):73-86; http://dx.doi.org/10.1111/j.0169-5150.2005.00006.x Ramon G. Acceptability survey on the 80–20 bag in a bag insect resistance management strategy for Bt corn.,Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"Available from: http://www.ncfap.org Traxler G, Godoy-Avila S. Tr ansgenic cotton in Mex- ico.",Non-OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
International Journal of Biotechnology 2008; 10(2/3):167-183; http://dx.doi.org/10.1504/IJBT.2008.018352 Yorobe J.,OADS,/arxiv_data1/oa_pdf/62/28/kgmc-07-01-1176817.PMC5033184.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and repro-duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Plant Biotechnol J 2005; 3:275–307; PMID:17129312;http://dx.doi.org/10.1111/j.1467-7652.2005.00130.x Barfoot P, Brookes G. Key global environmental impacts of genetically modiﬁed (GM) crop use 1996–2012.GM Crops and Food 2014; 5(2); PMID:24637726;http://dx.doi.org/10.4161/gmcr.28449 Brooks KJ.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Fla Entomol 2008; 91(4):523–30; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Curr Opin Biotechnol 2006;17(2):105–12; PMID:16483761; http://dx.doi.org/10.1016/j.copbio.2006.01.01196 Baktavachalam et al.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Environ Biosafety Res 2011; 10(4):73–101; PMID:22781085; http://dx.do i.org/10.1051/ebr/2012004 CERA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://www.cera-gmc.org/ﬁles/cera/uploads/Cry1f-monograph-rev1.pdf CFIA.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Availablefrom: http://www.inspection.gc.ca/plants/plants-with- novel-traits/approved-unde r-review/decision-documents/ dd2002-41/eng/1311872961735/1311873078751 Clark BW, Phillips TA, Coats JR. Environmental fate and effects of Bacillus thuringiensis (Bt) proteins from transgenic crops: a review.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Agric Food Chem 2005; 53:4643–53; PMID:15941295; http://dx.doi.org/10.1021/jf040442k Craig W, Tepfer M, Degrassi G, Ripandelli D. An over- view of general features of risk assessments of geneti-cally modiﬁed crops.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Euphytica 2008; 164:853–80; http://dx.doi.org/10.1007/s10681-007-9643-8 CTNBIO.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://cera-gmc.org/docs/decdocs/09-060-001.pdf DA-BPI.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://biotech.da.gov.ph/Approval_Registry.php DA-BPI.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://biotech.da.gov.ph/Approval_Registry.php DA-BPI.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://biotech.da.gov.ph/Decision_docs_propa.php DAFF.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
2014 [cited 2015 Feb 05].Available from: http://www.daff.gov.za/doc/General% 20Release%20Approvals.pdfDelaney B.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Gen Appl Sys Toxicol 2009; 1–14; http://dx.doi.org/10.1002/ 9780470744307.gat139 Delaney B, Astwood JD, Cunny H, Conn RE, Herouet GC, Macintosh S, Meyer LS, Privalle L, Gao Y, Matts- son J, Levine M. ILSI International Food Biotechnol-ogy Committee Task Force on Protein Safety.Evaluation of protein safety in the context of agricul- tural biotechnology.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Food Chem Toxicol 2008; 46(2): S71–97; PMID:18348900; http://dx.doi.org/10.1016/j.fct.2008.01.045 Drottar KR, Krueger HO.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
EFSA J 2004; 124: 1–18; http://dx.doi.org/ 10.2903/j.efsa.2004.124 EFSA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
EFSA J 2005a; 182:1–22; http://dx.doi.org/10.2903/j.efsa.2005.182 EFSA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
EFSA J 2005b; 181:1–33; http://dx.doi.org/ 10.2903/j.efsa.2005.181 EFSA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
1):S2–70; PMID:18328408; http://dx.doi.org/10.1016/ j.fct.2008.02.008 EFSA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Scientiﬁc Opinion of the Panel on Genetically Modiﬁed Organisms on an application (Reference EFSA-GMO-UK-2005-21) for the placing on the mar-ket of the insect-resistant and herbicide-tolerant genet-ically modiﬁed maize 59122 £1507£NK603 for food and feed uses, import and processing under Regu- lation (EC) No 1829/2003 from Pioneer Hi-Bred Inter-national, Inc. EFSA J 2009b; 1050:1–32; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"EFSA J 2010; 8:1–37; http://www.efsa.europa.eu/en/ search/doc/1781.pdf Estruch JJ, Warren GW, Mullins MA, Nye GJ, Craig JA, Koziel MG. Vip3A, a novel Bacillus thuringiensis vegetative insecticidal protein with a wide spectrum ofactivities against lepidopteran insects.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
J Dairy Sci 2007; 90(12):5706–13; PMID:18024763; http://dx.doi.org/10.3168/jds.2007-0480 FDA.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://gain.fas.usda.gov/Re cent%20GAIN%20Publications/ Agricultural%20Biotechnology%20Annual_Bogota_Colombia_6-12-2013.pdf GAIN Honduras – Agricultural Biotechnology Annual.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
2012 [cited 2013 Dec 12].Available from: http://gain.fas.usda.gov/Recent% 20GAIN%20Publications/Agr icultural%20Biotechnology% 20Annual_Tegucigalpa_Honduras_7-16-2012.pdf GAIN Korea – Agricultural Biotechnology Annual.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Available from:http://gain.fas.usda.gov/R ecent%20GAIN%20Publications/ Agricultural%20Biotechnology%20Annual_Seoul_ Korea%20-%20Republic%20of_7-17-2013.pdf Gallagher SP, Grimes J, Beavers JB.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"New York, NY: Springer Science; 2012; 305–25; http://dx.doi.org/10.1007/978-94-007-3021-2_16 Hanley AV, Huang ZY, Pett WL.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Crop Prot 2011; 30(2):168–72; http://dx.doi.org/10.101 6/j.cropro.2010.10.005 Health Canada.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Available from: http://www.hc-sc.gc.ca/fn-an/gmf-agm/appro/32bg_agrevo-ct_agrevo-eng.php Heide BR, Heir E, Holck A.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Eur FoodRes Technol 2008; 227(2):527–35; http://dx.doi.org/ 10.1007/s00217-007-0751-498 Baktavachalam et al.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Reg Toxicol Pharma 2014; 68(1):171–4; PMID:23851038; http://dx.do i.org/10.1016/j.yrtph.2013.07.003 Herman RA, Wolt JD, Halliday WR.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Agric Food Chem 2002; 50(24):7076–8; PMID:12428962;http://dx.doi.org/10.1021/jf025630u H/C19erouet C, Esdaile DJ, Mallyon BA, Debruyne E, Schulz A, Currier T, Hendrickx K, van der Klis RJ, Rouan D.Safety evaluation of the phosphinothricin acetyltrans- ferase proteins encoded by the pat and bar sequences that confer tolerance to glufosinate-ammonium herbi-cide in transgenic plants.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Regul Toxicol Pharmacol2005; 41(2):134–49; PMID:15698537; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Eur Food Res Technol 2009; 230(2):185–94; http://dx.doi.org/10.1007/s00217-009-1155-4 Hoxter K, Krueger H, Porch J.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Soil Biol Biochem 2008; 40:559–86; http://dx.doi.org/10.1016/j.soilbio.2007.11.002 ISAAA Briefs Nos.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://www.isaaa.org/ resources/publications/briefs/default.asp ISAAA.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://www.isaaa.org/gmapprovaldatabase/ James C. Global status of commercialized Biotech/GM Crops: 2013.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Environ Biosafety Res 2008; 7(3):123–49; PMID: 18801324; http://dx.doi.org/10.1051/ebr:2008014 Kim JH, Kim SY, Lee H, Kim YR, Kim HY.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
J Agric Food Chem2010; 58(10):6018–26; PMID:20438128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
J Biomed Biotechnol 2005; 2005(4):326–52; PMID:16489267; http://dx.doi.org/10.1155/JBB.2005.326 Kuhn JO.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Plant Biotechnol J 2013; 11(7):781–84; PMID:23786622; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Food Chem Toxicol2008; 46(10):S20–3; PMID:18708115; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Regul Toxicol Pharmacol 2006; 44(2):136–43; PMID:16406630; http://dx.doi.org/10.1016/ j.yrtph.2005.11.005 Ladics GS, Cressman RF, Herouet GC, Herman RA, Pri- valle L, Song P, Ward JM, McClain S. Bioinformatics and the allergy assessment of agricultural biotechnol- ogy products: industry practices and recommenda-tions.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Regul Toxicol Pharmacol 2011; 60(1):46–53; PMID:21320564; http://dx.doi.org/10.1016/j.yrtph.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Food Chem Toxicol 2007; 45(4):551–62; PMID:17097206; http://dx.doi.org/10.1016/j.fct.2006.09.016 Maggi VL.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Available from: http://croplife.org/wp- content/uploads/2014/04/ Getting-a-Biotech-Crop-to- Market-Phillips-McDougall-Study.pdf McLaren J, Copping L. Transgenic maize - the registra- tion status of lines that have been commercialised: the ﬁrst in a series that examines the GM crop market.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Outlooks Pest Manage 2011; 22(2):66–73; http://dx.doi.org/10.1564/22apr07 McNaughton JL, Zeph L. Broiler study nutritional evalua- tion of Bt Cry1F maize corn from Bacillus thuringiensis subsp .a i z a w a i and phosphinothricin-n-acetyltransferase.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"1):399–400; http://www.poul tryscience.org/meeting-abstracts/jam04/398.PDF Mendelsohn M, Kough J, Vaituzis Z, Matthews K. Are Bt crops safe?",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Nat Biotechnol 2003; 21(9):1003–9; PMID:12949561; http://dx.doi.org/10.1038/nbt0903- 1003 Meyer T. Comparison of amino acid sequence similarity of Cry1F and PAT proteins to known allergen proteins.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Food Control 2010; 21(4):456–61;http://dx.doi.org/10.1016/j.foodcont.2009.07.006 Pawlowski WP, Somers DA.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Mol Biotechnol 1996; 6(1):17–30; PMID: 8887358; http://dx.doi.org/10.1007/BF02762320 Que Q, Chilton MM, de Fontes CM, He C, Nuccio M, Zhu T, Wu Y, Chen JS, Shi L. Trait stacking in transgenic crops-challenges and opportunities.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
GM Crops Food 2010; 1(4):220– 9; http://dx.doi.org/10.4161/gmcr.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Transgenic Res 2012; 21(3):655–64; PMID:22002083; http://dx.doi.org/10.1007/s11248-011-9560-4 Raybould A, Kilby P, Graser G. Characterising microbial protein test substances and establishing their equiva- lence with plant-produced proteins for use in riskassessments of transgenic crops.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Transgenic Res 2013; 22(2):445–60; PMID:23065372; http://dx.doi.org/ 10.1007/s11248-012-9658-3 Rimachi LFG, Alcantara JD, Aquino YV, Ortiz R. Detect- ing adventitious transgenic events in a maize center of100 Baktavachalam et al.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Nat Bio- technol 2008; 26:203–8; PMID:18259178; http://dx.doi.org/10.1038/nbt1381 Romeis J, Meissle M. Non-target risk assessment of Bt crops – Cry protein uptake by aphids.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Appl Entomol 2011; 135:1–6 http://dx.doi.org/10.1111/j.1439-0418.2010.01546.x Rowe JD, Amijee F, Brody SD, Wandrey GG, Dreyer CC.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Dordrecht, The Neth-erlands: Springer; 2012:335–75; http://dx.doi.org/ 10.1007/978-94-007-2156-2_16 Scheideler SE, Rice D, Smith B, Dana G, Saubert T. Eval- uation of nutritional equivalency of corn grain from DAS- Ø15Ø7-1 (Herculex I) in the diets of laying hens.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Appl Poult Res 2008; 17(3):383–9; http://dx.doi.org/10.3382/japr.2007-00080 Sears MK, Hellmich RL, Stanley-Horn DE, Oberhauser KS, Pleasants JM, Mattila HR, Siegfried BD, DivelyGP.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Agric FoodChem 2008; 56(19):8962–8; PMID:18767858; http://dx.doi.org/10.1021/jf800501z Siebert MW, Babock JM, Nolting S, Santos AC, Adamc- zyk JJ Jr, Neese PA, King JE, Jenkins JN, McCarty J,Lorenz GM, et al.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Fla Entomol 2008; 91(4):555–65; http://dx.doi.org/10.1653/0015-4040-91.4.555 Siegel JP.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Invertebr Pathol 2001; 77: 13–21; PMID:11161988; http://dx.doi.org/10.1006/ jipa.2000.5000 Sindt J, Drouillard J, Loe E, Kessen T, Sulpizio M, Mont- gomery S, Rice D, Hinds M, Smith B, Owens F, DanaG, Hunst P. Effect of corn containing the Cry1F pro- tein on performance of beef heifers fed a ﬁnishing dietbased on steam-ﬂaked corn.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Food Chem Toxicol 2012; 50(3-4):1134–48; PMID:22155268;http://dx.doi.org/10.1016/j.fct.2011.11.048 Stauffer C, Zeph L. Compositional analysis of maize MPS hybrid line 1507.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Food Sci Technol Res 2010; 16 (5):421–30; http://dx.doi.org/10.3136/fstr.16.421 Thompson GD, Dalmacio SC, Criador IV AR, Alvarez ER, Hechanova RF.",Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Transgenic Res 2014; 23(2):257–64; PMID:24026808;http://dx.doi.org/10.100 7/s11248-0 13-9748-x Tian JC, Wang XP, Long LP, Romeis J, Naranjo SE, Hell- mich RL, Wang P, Earle ED, Shelton AM.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
PLoS One 2013; 8(3):e60125; PMID:23544126; http://dx.doi.org/10.1371/journal.pone.0060125 Trigo EJ.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
2011 [cited 2015 May 05].Available from: http://www.argenbio.org/adc/uploads/ 15_years_Executive_summary_of_GM_crops_in_Ar gentina.pdf US EPA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://www.epa.gov/op pbppd1/biopesticides/ ingredients_keep/factsheets/factsheet_006481.htm US EPA.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://bch.cbd.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Available from: http://www.aphis.usda.gov/brs/aphisdocs/00_13601p.pdf USDA APHIS.,Non-OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Available from: http://cera-gmc.org/docs/decdocs/02122001.pdf Vachon V, Laprade R, Schwartz JL.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
J Invertebr Pathol2012; 111:1–12; PMID:22617276; http://dx.doi.org/ 10.1016/j.jip.2012.05.001 Van Frankenhuyzen K. Insecticidal activity of Bacillus thuringiensis crystal proteins.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"J Invertebr Pathol 2009; 101:1–16; PMID:19269294; http://dx.doi.org/10.1016/ j.jip.2009.02.009 Wehrmann A, Van Vliet A, Opsomer C, Botterman J, Schulz A.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Nat Biotech 1996; 14(10): 1274–8; PMID:9631092; Available from http://www.nature.com/nbt/journal/v14/n10/pdf/nbt1096-1274.pdf Whalon ME, Wingerd BA.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Arch Insect Biochem Physiol 2003; 54:200–11; PMID:14635181; http://dx.doi.org/10.1002/arch.10117 Wolt JD.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"A mixture toxicity approach for environmental risk assessment of multiple insect resistance genes.Environ Toxicol Chem 2011; 30(3):763–72;PMID:21298718; http://dx.doi.org/10.1002/etc.427 Wolt JD, Conlan CA, Majima K. An ecological risk assessment of Cry1F maize pollen impact to palegrass blue butterﬂy.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"Environ Biosafety Res 2005; 4(4):243–51; PMID:16827552; http://dx.doi.org/ 10.1051/ebr:2006005 Xu Z, Hennessy DA, Sardana K, Moschini G. The real- ized yield effect of genetically engineered crops: US maize and soybean.",OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
Crop Sci 2013; 53(3):735–45;http://dx.doi.org/10.2135/cropsci2012.06.0399102 Baktavachalam et al.,OADS,/arxiv_data1/oa_pdf/f8/21/kgmc-06-02-1054093.PMC5033190.pdf
"3Standardization helps to ensure the reliability and reproducibility of the studies, and provides decision-makers with readily interpretable data.4 © Alan Raybould, Andrea Burns, and Mick Hamer *Correspondence to: Alan Raybould; Email: alan.raybould@syngenta.comSubmitted: 04/07/2014; Revised: 07/09/2014; Accepted: 07/25/2014 http://dx.doi.org/10.4161/21645698.2014.950540 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
Transgenic Res 2011; 20:1-22; PMID:20938806; http://dx.doi.org/10.1007/s11248-010- 9446-x 4.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
Transgenic Res 2011; 20:599-611; PMID:20839052; http://dx.doi.org/10.1007/s11248-010-9442-1 8.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
Transgenic Res 2012; 21:813-42; PMID:22120952; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
Environ Entomol 2010; 39:707-14; PMID: 20388306; http://dx.doi.org/10.1603/EN09037 10.,OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
Arch Environ Contam Toxicol 2008; 55:584-92; PMID:18347840; http://dx.doi.org/10.1007/s00244-008-9150-5 28.,Non-OADS,/arxiv_data1/oa_pdf/c3/bb/kgmc-05-04-950540.PMC5033194.pdf
"*Correspondence to: Michael Wach; Email: mwach@ilsi.org Submitted: 04/23/2013; Revised: 09/20/2013; Accepted: 09/20/2013; Published Online: 09/23/2013http://dx.doi.org/10.4161/gmcr.26560Surrogate species selection for assessing potential  adverse environmental impacts   of genetically engineered insect-resistant plants  on non-target organisms Keri Carstens,1 Bonifacio Cayabyab,2 Adinda De Schrijver,3 Patricia G Gadaleta,4 Richard L Hellmich,5 Jörg Romeis,6 Nicholas  Storer,7 Fernando H valic ente,8 and Michael wach9,* 1DuPont Pioneer; Johnston, iA USA; 2National Crop Protection Center-Crop Protection Cluster; College of Agriculture; University of the Philippines Los Baños; Laguna,  Philippines; 3Biosafety and Biotechnology Unit; insti tute of Public Health; Brussels, Belgium; 4Biotechnology Directorate; Ministry of Agriculture, Livestock and Fisheries;  Buenos Aires, Argentina; 5USDA–ARS; Corn insec ts and Crop Genetics Research Unit and Department of entom ology; iowa St ate University; Ames, iA USA; 6Agroscope  Reckenholz-Tänikon Research Station ART; Zurich, Switzerland; 7Dow AgroSciences LLC; india napolis, iN USA; 8National Research Center for Milo and Sorghum; Sete Lagoas,  MG Brazil; 9Center for envir onmental Risk Assessment; iLSi Res earch Foundation; washi ngton, DC USA Keywords:  biosafety, environmental risk assessment, non-target organisms, surrogate species, tiered testing Abbreviations: ERA, environmental risk assessment; GE, genetically engineered; GEIR, genetically engineered insect resistant;  NTO, non-target organism Most regulatory authorities require that developers of  genetically engineered insect-resistant (G eiR) cro ps evaluate  the potential for these crops to have adverse impacts on val - ued non-target organisms (NTOs), i.e., organisms not intended  to be controlled by the trait.",Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
ctnbio.gov.brhttp://www.efsa.europa.eu/ en/efsajournal/doc/1877.pdf http://www.efsa.europa.eu/ en/efsajournal/doc/1879.pdfNAhttp://biotech.da.gov.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://isaaa.org/resources/publica - tions/briefs/44/executivesummary/default.asp 2.,OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Biol Lett 2010; 6:74-7; PMID:19740894 ;  http://dx.doi.org/10.1098/rsbl.2009.0612 5.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Environ Biosafety Res 2006; 5:57-65;  PMID:17328852 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Nat Biotechnol 2008; 26:203-8; PMID:18259178 ;  http://dx.doi.org/10.1038/nbt1381 7.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.pdf8.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Chemosphere 2013; 90:901-9;  PMID:23062830 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
J Agric Food Chem 2011; 59:5877-85;  PMID:21247173 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Transgenic Res 2011; 20:1-22; PMID:20938806 ; http://dx.doi.org/10.1007/ s11248-010-9446-x16.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://www.efsa.europa.eu/en/supporting/pub/334e.htm 19.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Transgenic Res 2012; 21:813-42; PMID:22120952 ;  http://dx.doi.org/10.1007/s11248-011-9569-8 20.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Environ Biosafety Res 2008; 7:35-56; PMID:18384728 ; http://dx.doi.org/10.1051/ ebr:2008003 21.,OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
Available from: http://cera-gmc.org/uploads/pub_01_2013.,Non-OADS,/arxiv_data1/oa_pdf/d6/f4/kgmc-05-01-10926560.PMC5033195.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available at: http://soygrowers.com/ ctstudy/ctstudy_ﬁles/frame.htm Angers DA, Eriksen-Hamel NS.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Soil Sci Soc Am J 2008; 72:1370-4;http://dx.doi.org/10.2136/sssaj2007.0342 Asia-Paciﬁc Consortium on Agricultural Biotechnology (APCoAB).,OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Soil Sci Soc Am J 2008; 72:693-701; http://dx.doi.org/10.2136/sssaj2007.0233 Brimner T, Gallivan G, Stephenson G. Inﬂuence of herbi- cide-resistant canola on the environmental impact ofweed management.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
at: http://www.pgeconomics.co.uk/pdf/bt_maize_in_s- pain.pdf Brookes G. The farm-level impact of herbicide-tolerant soybeans in Romania.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Available at: http://www.agbioforum.org Brookes G. The impact of using GM insect resistant (Bt) maize in Europe since 1998.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Int J Biotechnol 2008;134: 3-4 Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996-2004.AgbioForum 2006; 8(2&3):187-96, Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996-2005.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: socio-economic and environmental effects 1996-2006.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available on theWorld Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: environmental effects 1996-2008.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available on the World Wide Web: http://www.agbioforum.org Brookes G, Barfoot P. Global impact of biotech crops: envi- ronmental effects 1996-2009.",OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"GM Crops 2011; 2(issue 1):34-49; http://dx.doi.org/10.4161/gmcr.2.1.15529 Brookes G, Barfoot P. Global impact of biotech crops: envi- ronmental effects 1996-2010.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Agronomy J 2002; 100:101 3-9; http://dx.doi.org/ 10.2134/agronj2007.0121 Canola Council of Canada.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Available at: http://www.canola-council.org Commonwealth Scientiﬁc and Industrial Research Orga- nisation (CSIRO).,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available at: http://www.ctic.purdue.edu/CTIC/Biotech.htmlDerpsch R, Friedrich T, Kassam A, Hongwen L. Current status of adoption on no-till farming in the world and some of its main beneﬁts.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Soil Sci Soc Am J 2003; 67:1831-41; http://dx.doi.org/10.2136/sssaj2003.1831 Fernandez-Cornejo J, Wechsler S, Livingston M, Mitchell L. Genetically engineered crops in the United States.2014.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available at: http://www.ncfap.org/reports/biotech/insectcontrolbeneﬁts.pdf Hutchison W, Burkness EC, Mitchell PD, Moon RD, Leslie TW, Fleischer SJ, Abrahamson M, HamiltonKL, Steffey KL, Gray ME, et al.",OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Science 2010;330:222-5; PMID:20929774; http://dx.doi.org/ 10.1126/science.1190242 IMRB International.,OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available at: http://www.ipccnggip.iges.or.jp/public/2006gl/pdf/4_Volume4/V4_ 02_Ch2_Generic.pdf Ismael Y, Bennett R, Morse S, Buthelezi T. Bt Cotton and pesticides.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Soil Tillage Research 2005; 83:73-94. http://dx.doi.org/10.1016/j.still.2005.02.010 Johnson S, Strom S. Quantiﬁcation of the Impacts on US Agriculture of Biotechnology-Derived Crops Plantedin 2006.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"PLOS One 2014; 9(11): e111629; PMID:25365303; http://dx.doi.org/10.1371/ journal.pone.0111629 Kovach J, Petzoldt C, Degni J, Tette J.",OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Science 2004; 304 (5677):1623-7; PMID:15192216; http://dx.doi.org/ 10.1126/science.1097396 Lal R. Enhancing crop yields in the developing countries through restoration of the soil organic carbon pool in agricultural lands.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Land Degradation Dev 2005; 17(2):197-209; http://dx.doi.org/10.1002/ldr.696 Lal R. Beyond copenhagen: mitigating climate change and achieving food security through soil carbonsequestration.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Soil Tillage Res 2005;83:25-52; http://dx.doi.org/10.1016/j.still.2005.02.008 Michigan State University.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Available at: http://surfkbs.msu.edu Monsanto Brazil.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"PeerJ 2014 2:e364; http://dx.doi.org/ 10.7717/peerj.364 Pray C, Huang J, Hu R, Roselle S. Five years of Bt cotton in China – the beneﬁts continue.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Plant J 2002; 31 (4):423-30; PMID:12182701; http://dx.doi.org/ 10.1046/j.1365-313X.2002.01401.x Qaim M, De Janvry A. Bt cotton and pesticide use in Argentina: economic and environmental effects.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Available at: http://www.thelandonline.com/cur rentedition/x1897235554/No-till-beneﬁts-add-up-with- diesel-fuel-savings Reicosky D. Conservation tillage and carbon cycling: soil as a source or sink for carbon.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
Available at: http://www.farmdoc.uiuc.edu/manage /newsletters/fefo06_07/ fefo06_07.html USDA Comet-VR.,Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Available at: http://ecat.sc.egov.usda.gov West T, Post W. Soil organic carbon sequestration rates by Tillage and crop rotation: a global analysis.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Bio- geosci Discuss 2006; 3:1679-714; http://dx.doi.org/10.5194/bgd-3-1679-2006 Appendix 1: Details of Methodology as Applied to 2012 Calculations of Environmental Impact Associated with Pesticide Use Changes GM IR maize (targeting stalk boring pests) 2013 CountryArea of trait (‘000 ha)Maximum area treated for stalk boring pests: pre GM IR (‘000 ha)Average ai use GM crop (kg/ha)Average ai use if conventional (kg/ha)Average ﬁeld EIQ/ha GM cropAverage ﬁeld EIQ/ha if conventionalAggregate change in ai use (‘000 kg)Aggregate change in ﬁeld EIQ/ha units (millions) US 26,964 3,548 0.23 0.58 12.8 32.8 ¡1,242 ¡35.5 Canada 1,243 74 0.04 0.64 4.8 24.8 ¡44 ¡1.2 Argentina 3,423 0 0 0 0 0 0 0Philippines 715 Very low – assumed zero00 0 0 0 0 South Africa 2,719 1,768 0 0.09 0 3.2 ¡165 ¡6.0 Spain 137 43.9 0.36 1.32 0.9 26.9 ¡42 ¡1.1 Uruguay 107 Assumed to be zero: as Argentina00 0 0 0 0 Brazil 11,880 7,330 0 targeted at stalk boring pests0.36 targeted at stalk boring pests0 targeting stalk boring pests21.5 ¡2,609 ¡157 Colombia 65.9 48.5 0 targeted at stalk boring pests0.56 targeted at stalk boring pests0 targeting stalk boring pests15.9 ¡27 ¡0.77 Note : 1.",Non-OADS,/arxiv_data1/oa_pdf/88/9b/kgmc-06-02-1025193.PMC5033196.pdf
"Results and Discussion HT cropsThe primary impact of GM HT (largely tolerant to the broad  spectrum herbicide glyphosate) technology has been to provide  *Correspondence to: Graham Brookes; Email: graham.brookes@btinternet.com Submitted: 01/02/2014; Accepted: 02/04/2014; Published Online: 02/05/2014http://dx.doi.org/10.4161/gmcr.28098Economic impact of GM crops The global income and production effects 1996–2012 Graham Brookes* and Peter Barfoot PG economics Ltd; Dorchester, UK Gra ham Brookes and Peter Barfoot are agricultural economists with PG econo mics UK Ltd, specialists in assessing the impact of new technology in agriculture.",Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Int J Biotechnol 2011; 12:1-49; http://dx.doi.org/10.1504/IJBT.2011.042680 3.,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
GM Crops Food  2012 ; 3: 265-72; PMID:22750951 ;  http://dx.doi.org/10.4161/gmcr.20097 4.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Agric Econ 2005 ; 32:73-86; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
GM Crops  2011 ; 2:163-8; PMID:22008311 ;  http://dx.doi.org/10.4161/gmcr.2.3.17591 21.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Weed  Technol  2010 ; 24:523-8; http://dx.doi.org/10.1614/ WT-D-10-00033.1 31.,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Science   2010 ; 330:222-5; PMID:20929774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Plant J   2002 ; 31:423-30; PMID:12182701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Int J  Biotechnol  2005 ; 7; http://dx.doi.org/10.1504/ IJBT.2005.006447 35.,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Environ Dev Econ 2005 ; 10:179-200; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Span J Agric Res 2012 ; 10:867-76;  http://dx.doi.org/10.5424/sjar/2012104-448-11 54.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Int J Biotechnol 2008 ; 10:167-83;  http://dx.doi.org/10.1504/IJBT.2008.018352,OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
Agric Econ  2013 ; 44:323-35; http://dx.doi.org/10.1111/ agec.12014 67.,Non-OADS,/arxiv_data1/oa_pdf/41/34/kgmc-05-01-10928098.PMC5033197.pdf
"© Adrian Dubock *Correspondence to: Adrian Dubock; Email: adrian@dubock.eu; contact@goldenrice.orgSubmitted: 07/30/2014; Revised: 09/16/2014; Accepted: 09/16/2014 http://dx.doi.org/10.4161/21645698.2014.967570 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
"It should also be noted that Dr.Tang’s project focused not only on golden rice, but also onother food sources of vitamin A, including spinach and pureBeta-carotene (B-C) in oil.Evidence-based peer-reviewed information about geneticallymodiﬁed foods is available at: http://www.nature.com/nbt/journal/v23/n4/abs/nbt1082.html.",Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Nature 1953; 4356: 737-8; PMID:13054692;http://dx.doi.org/10.1038/171737a0 2.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.nobelprize.org/nobel_prizes/chemistry/ laureates/1980/berg-article.html3.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Science 2000; 287: 303-5; PMID:10634784;http://dx.doi.org/10.1126/science.287.5451.303 4.,OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
J Plant Biochem Biotechnol 2012; 21:68-75; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
2012: 30:208-9; http://dx.doi.org/10.1038/ nbt.2145 10.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: https://www.cbd.int/doc/legal/ cbd-en.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Nutr Rev 2009; 67:17- 20; PMID:19146502; http://dx.doi.org/10.1111/ j.1753-4887.2008.00137.x 16.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: ftp://ftp.cordis.europa.eu/pub/fp7/kbbe/docs/a-decade-of-eu- funded-gmo-research_en.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.fao.org/ docrep/006/y5160e/y5160e00.htm 18.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Curr Opin Biotechnol 2006: 17:174-8; PMID:16522366; http://dx.doi.org/ 10.1016/j.copbio.2006.02.009 19.,OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.cyberounds.com/cmecontent/art508.html 20.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://mvgs.iaea.org 21.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.geneticliteracyproject.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Lancet 1999; 354: 1353-1354; PMID:10533866; http://dx.doi.org/10.1016/ S0140-6736(98)05860-7 24.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Nature 1999; 399:214; PMID:10353241; http://dx.doi.org/10.1038/20338 25.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Lancet 1999; 354:1314-5;PMID:10533853; http://dx.doi.org/10.1016/S0140- 6736(99)00340-2 27.,OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.forbes.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.forbes.com/sites/ henrymiller/2014/07/16/a-wealthy-activist-is-a-poor-advocate-for-the-poor 31.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.telegraph.co.uk/ news/worldnews/asia/in dia/10917731/India-targets- Prince-Charles-aide-in-war-on-Greenpeace.html 32.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Avail- able from: http://www.theguardian.com/sustainable- business/2014/jul/16/ngos-nonproﬁts-gmos-genetically-modiﬁed-foods-biotech 33.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.wto.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://nasaconline.org/dmdocuments/agric-biotech-conf/Agricultural biotechnology in Europe and Africa-Anne Glover.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.foo dnavigator.com/Legislation/ GM-cultivation-proposal-agreed-in-Europe 38.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Am J Clin Nutr 2009; 90:680-5; http://dx.doi.org/10.3945/ajcn.2009.28041 41.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Global identity preservation costs in agricultural supply chains.Can J Agric Econ Can d Agroecon 2005; 49:605-615; http://dx.doi.org/10.1111/j.1744-7976.2001.tb00330.x 45.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.cbd.int/doc/lists/cpb-ratiﬁcations.pdf 46.,OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://bicol.da.gov.ph/News/2013/Aug10a.html 48.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Science 2013; 341:1320; http://dx.doi.org/10.1126/science.1245017 49.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Am J Clin Nutr 2012; 96:658-664; PMID:22854406; http://dx.doi.org/10.3945/ajcn.111.030775 53.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Am J Clin Nutr 2009; 89:1-8; http://dx.doi.org/ 10.3945/ajcn.2008.27119 54.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.courthousenews.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://news.sciencemag.org/asiapaciﬁc/2014/07/researcher-sues-block-retraction-golden-rice-paper 57.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.the-scientist.com/?articles.view/articleNo/40529/title/ GM-Rice-Researcher-Fights-Retraction 58.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/8101396 59.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: https://www.gov.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.svd.se/opinion/ ledarsidan/saboterar-odlingar-med-gmo-grodor_ 8686736.svd www.landesbioscience.com 221 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from: http://www.telegraph.co.uk/news/ politics/10978678/Owen-Paterson-Im-proud-of-standing-up-to-the-green-lobby.html 63.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
Available from:http://giannini.ucop.edu/media/are-update/ﬁles/ articles/V17N3_1.pdf 65.,Non-OADS,/arxiv_data1/oa_pdf/d8/bd/kgmc-05-03-967570.PMC5033200.pdf
"To help researchers choose a tool thatbest suits their speciﬁc research needs, we review the functionality of various CRISPR design toolsincluding our own, the CRISPR Genome Analysis Tool (CGAT; http://cropbioengineering.iastate.edu/cgat).",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"To locate resources of interest, tools that enable browse and search function- ality are available from the website at http://crdd.osdd.net/servers/crisprge/.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"CRISPR tool and resources examined Tool Name Species Publication Web Address s vertebrates, invertebrates, plantsMa et al., 2013 http://cas9.cbi.pku.edu.cn/ CCTop vertebrates, invertebrates, plants,Stemmer et al., 2015 http://crispr .cos.uni-heidelberg.de/ CGAT Plants This paper http://cbc.gdcb.iastate.edu/cgat/ CHOPCHOP vertebrates, invertebrates, plantsMontague et al., 2014 https://chopchop.rc.fas.harvard.edu/ COSMID vertebrates, invertebrates Cradick et al., 2014 https://crispr .bme.gatech.edu/ CRISPR design vertebrates, invertebrates, arabidopsisN/A http://crispr .mit.edu/ CRISPRdirect vertebrates, invertebrates, fungiNaito et al., 2014 http://crispr .dbcls.jp/ Crispr Finder Vertebrates invertebrates fungiGrissa et al., 2007 http://crispr .u-psud.fr/Server/ CrisprGE*various: plants, animals, fungi, prokaryotes, protistsKaur et al., 2015 http://crdd.osdd.net/servers/crisprge/ CRISPR Multitargetervertebrates, invertebrates,plantsPrykhozhij et al., 2015 http://www.multicrispr .net/ Crispr-P Plants Lei et al., 2014 http://cbi.hzau.edu.cn/crispr/ CRISPRseek vertebrates, invertebrates, fungi, plants, protistsZhu et al., 2014 http://www.bioconductor .org/packages/ release/bioc/html/CRISPRseek.html CROP-IT vertebrates: mouse and humanSingh et al., 2015 http://cheetah.bioch.virginia.edu/AdliLab/ CROP-IT/homepage.html E-crisp vertebrates, invertebrates, plants, fungi, protistsHeigwer et al., 2014 http://www.e-crisp.org/E-CRISP/ ﬂyCRISPR invertebrates Gratz et al., 2014 http://ﬂycrispr .molbio.wisc.edu/ GT-SCAN vertebrates, invertebrates, plants, fungiO’Brien and Bailey, 2014 http://ﬂycrispr .molbio.wisc.edu/ sgRNAcas9 vertebrates, invertebrates Xie et al., 2014 http://www.biootools.com/col.jsp?id=140 SSFinder N/A Upadhyay and Sharma, 2014https://code.google.com/p/ssﬁnder/ *queries sgRNA sequences against experimentally validated sgRNAs for which genetic stocks are available.270 Brazelton et al.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
PostgreSQL 9.3 (http://www.postgresql.org/) is the relational database system (RDBMS).,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"For data retrieval, CGAT makes use of Post-greSQL’s procedural language extensibility with portions of the database query logic writ- ten in PL/Python (http://www.postgresql.org/docs/9.3/static/plpython.html).",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
The current ver- sion of the parser that processes genomic FASTA-formatted ﬁles into relational databasetables is written in the Go programming lan- guage (version 1.4.2) (https://golang.org/).,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
The website itself is written in Python 2.7.x using the 1.8.2 version of the Django framework (https://www.djangoproject.com/).,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Finally, the client-side functionality of the tool is written inJavascript using the 1.3.9 version of the Angu- larJS framework (https://angularjs.org/).",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"FUNDING Efforts by SZ were supported by the Iowa State University’s Crop Bioengineering Consor- tium, a Presidential Initiative (described athttp://cropbioengineering.iastate.edu/).",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Sci-ence 2007; 315(5819):1709-12; PMID:17379808; http://dx.doi.org/10.1126/science.1138140 Beerli RR, Barbas CF.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Nat Biotech 2002; 20(2):135-141; http://dx.doi.org/10.1038/nbt0202-135 Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Ann Rev Phytopa-thol 2010; 48:419-36; http://dx.doi.org/10.1146/ annurev-phyto-080508-081936 Boch J, Bonas U, Lahaye T. TAL effectors–pathogen strategies and plant resistance engineering.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"New Phy-tol 2014; 204, 823-32; PMID:25539004; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Curr Opin Plant Biol 2014; 19:99-104; PMID:24907530; http://dx.doi.org/10.1016/j.pbi.2014.05.007 Carte J, Christopher RT, Smith JT, Olson S, Barrangou R, Moi- neau S, Terns MP.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Genetics 2010; 186:757-61.; PMID:20660643;http://dx.doi.org/10.1534 /genetics.110.120717 Cradick TJ, Qiu P, Lee CM, Fine EJ, Bao G. COSMID: A Web-basedToolforIdentifyingandValidatingCRISPR/CasOff-targetSites.MolTherapyNucleicAcids2014;3: e214;http://dx.doi.org/10.1038/mtna.2014.64 Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E.CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Nature 2011; 471 (7340):602-607; PMID:21455174; http://dx.doi.org/10.1038/nature09886 Gaj T, Gersbach CA, Barbas CF.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.Trends Biotech 2013; 31(7):397-405; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Genetics 2014; 196(4):961-71; PMID:24478335; http://dx.doi.org/10.1534/genetics.113.160713 Grissa I, Vergnaud G, Pourcel C. CRISPRFinder: a web tool to identify clustered regularly interspaced shortpalindromic repeats.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
Nucleic Acids Res 2007; 35(Web Server issue):W52-7; PMID:17537822; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Nat Methods 2014; 11 (2):122-3; PMID:24481216; http://dx.doi.org/10.1038/nmeth.2812 Holkers M, Maggio I, Liu J, Janssen JM, Miselli F, Mus- solino C, Recchia A, Cathomen T, Gon ¸calves MAFV.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Bioinformatics 2014; 31 (7):1120-3; PMID:25414360; http://dx.doi.org/10.1093/bioinformatics/btu743 O’Brien A, Bailey TL.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
Bioinformatics 2014; 30(18):2673-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Development 2014; 141(21):4042-4054; PMID:25336735; http://dx.doi.org/10.1242/dev.102186 Prykhozhij SV, Rajan V, Gaston D, Berman JN.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"PloS One 2015; 10(3): e0119372; PMID:25742428; http://dx.doi.org/ 10.1371/journal.pone.0119372 Rath D, Amlinger L, Rath A, Lundgren M. The CRISPR-Cas immune system: Biology, mechanisms and applications.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Cell Rep 2014 9 (3):1151-1162; PMID:25437567; http://dx.doi.org/ 10.1016/j.celrep.2014.09.044 Ruiz i Altaba A, Perry-O’Keefe H, Melton DA.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Nat Biotech2014; 32(4):347-55; http://dx.doi.org/10.1038/ nbt.2842 Singh R, Kuscu C, Quinlan A, Qi Y, Adli M. Cas9-chro- matin binding information enables more accurateCRISPR off-target prediction.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
Science 1928; 68:186-7; PMID:17774921; http://dx.doi.org/10.1126/science.68.1756.186Stadler LJ.,OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Proc Natl Acad Sci U S A 1944; 30 (6):123-8.; PMID:16588634; http://dx.doi.org/ 10.1073/pnas.30.6.123 Stemmer M, Thumberger T, Del Sol Keyer M, Wittbrodt J, Mateo JL.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"PloS One2015; 10(4):e0124633; PMID:25909470; http://dx.doi.org/10.1371/journal.pone.0124633 Upadhyay SK, Sharma S. SSFinder: High throughput CRISPR-Cas target sites prediction tool.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"Mol Plant Pathol 2009; 10(6)749-66; PMID:19849782; http://dx.doi.org/ 10.1111/j.1364-3703.2009.00590.x Wright DA, LI T, Yang B, Spalding MH.",OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"PLoS One 2014; 9(6):e100448; PMID:24956386;http://dx.doi.org/10.1371/journal.pone.0100448 Z h a n gY ,G eX ,Y a n gF ,Z h a n gL ,Z h e n gJ ,T a nX , J i nZ - B ,Q uJ ,G uF .C o m p a r i s o no fn o n - c a n o n i c a lPAMs for CRISPR/Cas9-mediated DNA cleavage in human cells.",Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
PloS One 2014; 9(9):e108424;PMID:25247697; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/43/00/kgmc-06-04-1137690.PMC5033207.pdf
"4 Combining the findings of lack of  adverse changes from unintended effects Expert opinion vs. empirical evidence The precautionary principle applied to GM crops Rod A Herman1,* and Alan Raybould2 1Dow AgroSciences LLC; Indianapolis, IN USA; 2Syngenta; Jealott’s Hill International Research Centre; Bracknell, UK Keywords:  evidence-based regulation,  expert opinion, risk assessment, precautionary principle, government regulation *Correspondence to: Rod A Herman;   Email: raherman@dow.com Submitted: 01/12/2014Revised: 02/21/2014Accepted: 02/22/2014Published Online: 02/26/2014 http://dx.doi.org/10.4161/gmcr.28331",Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
J Agric Food Chem 2013; 61:8349-55; PMID:23865444 ; http://dx.doi.org/10.1021/ jf401178d 4.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
J Agric Food Chem 2013; 61:11695-701; PMID:23414177 ; http://dx.doi.org/10.1021/ jf400135r 5.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Crop Sci 2007; 47:367-73; http://dx.doi.org/10.2135/cropsci2005.09.0334 8.,OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
J Agric Sci 2008; 146:483-90; http://dx.doi.org/10.1017/S00218596080078679.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Cell Mol Life Sci 2005; 62:1182-97; PMID :15761667 ;  http://dx.doi.org/10.1007/s00018-005-4539-z 11.,OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Biotechnology (N Y) 1995; 13:1094-8;  PMID:9636282 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Environ Biosafety Res 2008; 7:123-49; PMID:18801324 ; http://dx.doi.org/10.1051/ ebr:2008014 13.,OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Transgenic Res 2012; 21:655-64; PMID:22002083 ;  http://dx.doi.org/10.1007/s11248-011-9560-415.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Regul Toxicol Pharmacol 2011; 61:292-5; PMID:21906650 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Int J Food Sci Nutr 2007; 58:125-41;  PMID:17469768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
Environ Int 2006; 32:1066-71; PMID:16899295 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c9/f7/kgmc-05-01-10928331.PMC5033208.pdf
"He responded enthusiastically, describing how this technology can be beneficial to developing countries  Correspondence to CS Prakash; Email: prakash@mytu.tuskegeee.edu Submitted: 02/07/2014; Accepted: 02/07/2014; Published Online: 02/19/2014 http://dx.doi.org/10.4161/gmcr.28278A look at the recent news from around the world  on genetically modified food and crops Cs prakash tuskegee University; tuske gee, aL Usa",Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.chipotle.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://mobile.businessweek.com/articles/2014-01-30/is-chipotles-anti-gmo-cam - paign-scaring-up-customers 3.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.huff - ingtonpost.com/dr-robert-t-fraley/saying-not-really-to-chip_b_4718918.html 4.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.fool.com/investing/general/2014/01/17/hain-celestial-and-whole-foods-meet-gmo-challenge.aspx 5.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.nytimes.com/2014/01/05/us/on-hawaii-a-lonely-quest-for-facts-about-gmos.html?pagewanted=2&_r=2&ref=general&src=me&pagewanted=print 6.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
"http://www.desmoinesregister.com/article/20140104/BUSINESS01/301040016/?dm_i=1ANQ,23FZE,6LPZY5,7K562&gcheck=1&nclick_check=1 8.",Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.npr.org/blogs/the - salt/2014/01/08/260782518/this-gmo-apple-wont-brown-will-that-sour-the-fruits-image 9.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.washington - post.com/blogs/govbeat/wp/2014/01/10/maine-becomes-second-state-to-require-gmo-labels/ 10.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.concordmonitor.com/home/10334442-95/new-hampshire-house-kills-gmo-labeling-bill11.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.newyorker.com/reporting/2014/01/06/140106fa_fact_specter 12.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.nytimes.com/2014/02/05/us/ chinese-implicated-in-agricultural-espionage-efforts.html?_r=0 13.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.you - tube.com/watch?v=sxsf4MGDRVk&feature=youtu.be 14.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.agpro - fessional.com/news/Latin-America-divided-over-GMOs-230100441.html 16.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.farmersguardian.com/home/ara - ble/hostility-to-gm-putting-eu-in-global-slow-lane-report/61350.article?dm_i=1ANQ%2C24113%2C6LPZY5%2C7MCW6%2C1 17.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
"Available from: http://www.euractiv.com/cap/eu-policy- making-gmos-lost-track-analysis-531364?dm_i=1ANQ,1YLJP,6LPZY5,71RUT,1 18.",Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
"Available from: http://www.europeanvoice.com/article/2013/decem - ber/eu-court-blocks-gm-potato-cultivation/79086.aspx?dm_i=1ANQ,22LPC,6LPZY5,7H2D7,1 19.",Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.bbc.co.uk/news/uk-25873931 20.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.welt.de/politik/ausland/arti - cle122021827/Der-genveraenderte-Reis-der-Leben-retten-kann.htm21.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.scmp.com/news/china/article/1403337/hybrid-rice-pioneer-yuan-longping-backs-geneti - cally-modified-foods 22.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=11979 23.,OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
"Available from: http://www.the - dailystar.net/online/cultivation-of-bt-brinjal-begins-7971?dm_i=1ANQ,25BTX,6LPZY5,7RBEU,1 24.",Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://m.economictimes.com/news/economy/policy/bt-brinjal-jairam-ramesh-expresses-disappointment-as-government-fails-to-put-in-place-an-independent-regulator/articleshow/29217049.cms 25.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.capitalfm.co.ke/business/2014/01/kenya-to-lift-ban-commercialise-gmos/ 26.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.bbc.co.uk/news/business-25876110 27.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.spyghana.com/reject-gmos-ghana-samia-nkrumah/ 28.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.scienceinafrica.co.za/gm_full.htm 29.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
Available from: http://www.elsevier.com/about/press-releases/research-and-journals/elsevier-announces-article-retraction-from-journal-food-and-chemical-toxicology 30.,Non-OADS,/arxiv_data1/oa_pdf/08/7c/kgmc-05-01-10928278.PMC5033211.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2016:8 115–125Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  115 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S83472Atypical teratoid/rhabdoid tumors: challenges and  search for solutions Ahitagni Biswas1  Lakhan Kashyap1  Aanchal Kakkar2  Chitra Sarkar2  Pramod Kumar Julka1 1Department of Radiotherapy &  Oncology, 2Department of Pathology,   All India Institute of Medical Sciences,   New Delhi, IndiaAbstract:  Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant embryonal central  nervous system tumor commonly affecting children <3 years of age.",Non-OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
"Keywords: atypical teratoid/rhabdoid tumor, intracranial, medulloblastoma, primitive neuro- ectodermal tumor Introduction Rhabdoid tumor was originally described by Beckwith and Palmer as a variant of Wilms  tumor with a rhabdosarcomatous component.1 Apart from kidney,1 rhabdoid tumors  have been reported from many organs, including soft tissues2 and central nervous sys- tem (CNS).3 Atypical teratoid/rhabdoid tumor (AT/RT) of CNS was first recognized in  1987, when it was simply referred to as “rhabdoid tumor”.4 It was defined as a distinct  entity in 19965 and included in World Health Organization classification of CNS tumors  in 2000.6 AT/RT currently constitutes one of three major CNS embryonal tumors in Correspondence: Ahitagni Biswas Department of Radiotherapy & Oncology, All India Institute of Medical Sciences, Ansarinagar, New Delhi 110029, India   Tel +91 90 1359 0854   Email dr_ahitagni@yahoo.co.inJournal name: Cancer Management and Research Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Biswas et alRunning head recto: Atypical teratoid/rhabdoid tumorsDOI: http://dx.doi.org/10.2147/CMAR.S83472",Non-OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
"Cancer Management and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 125 Atypical teratoid/rhabdoid tumors  68.,Non-OADS,/arxiv_data1/oa_pdf/32/1b/cmar-8-115.PMC5033212.pdf
"They provide a critical process for countries to  *Correspondence to: Naglaa A Abdallah; Email: naglaa_a@hotmail.com Submitted: 07/09/2014; Accepted: 07/09/2014; Published Online: 07/30/2014http://dx.doi.org/10.4161/gmcr.32208The impact of possible climate changes   on developing countries The needs for plants tolerant to abiotic stresses Naglaa a abdallah1,*, Vivian Moses2, and CS Prakash3 1Cairo University; Cairo, Egypt; 2King’s College; london, U K; 3tuskegee University; tuske gee, al USa",Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://www.climatechange.gov.au/climate-change/climate-science/understanding-climate-change .,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available in: http://www.agricul - tureandfoodsecurity.com/content/1/1/3 3.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Availabe in: http://www.agricultureandfoodse - curity.com/content/1/1/7 4.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Glob Environ Change 2010; 20:577-85; http://dx.doi.org/10.1016/j.gloenvcha.2010.07.001 6.,OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://www.grida.no/publications/other/ipcc_tar/8.,OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://www.ipcc.ch/publications_and_data/publications_ipcc_fourth_assessment_report_wg2_report_impacts_adaptation_and_vulnerability.htm 9.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at:  http://report.mitiga - tion2014.org/spm/ipcc_wg3_ar5_summary-for-poli - cymakers_approved.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://www.agricul - tureandfoodsecurity.com/content/1/1/9 11.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://unfccc.int/files/adaptation/cancun_adaptation_framework/application/pdf/naptechguidelines_eng_high__res.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://unfccc.int/resource/docs/2014/ sbi/eng/04.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Science 2010; 327:818-22;  PMID:20150489 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Climatic Change 2007; 81:1-7; http://dx.doi.org/10.1007/s10584-005-9007-0 .,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at: http://www.ipcc.ch/publications_and_data/publications_ipcc_fourth_assessment_report_wg2_report_impacts_adaptation_and_vulnerability.htm 17.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available at:  http://report.mitiga - tion2014.org/spm/ipcc_wg3_ar5_summary-for-poli - cymakers_approved.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Theor Appl Genet 2003; 107:1215-25; PMID:12898030 ; http://dx.doi.org/10.1007/ s00122-003-1357-2,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Euphytica 2005; 142:169-96; http://dx.doi.org/10.1007/s10681-005-1681-5 20.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
ISAAA; Available from: http://www.isaaa.org/resources/publications/briefs/46/executivesummary/ .21.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Available from: http://www.isaaa.org/resources/publications/ pocketk/32/default.asp 22.,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
Indian Journal of Plant Sciences 2013; 2:54-62; http://www.cibtech.org/jps.htm .,Non-OADS,/arxiv_data1/oa_pdf/03/54/kgmc-05-02-10932208.PMC5033213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
The complete agenda and report can be accessed at: http://www.ilsi.org/FoodBioTech/ Documents/2013%20International% 20Meeting%20on%20Comparative%20Approaches/ Meeting%20Materials/Summary_Report_ Meeting_Safety_Assessment_of_GM.pdf A series of presentations by experts in their ﬁelds was provided to stimulate discussions and to provide all participants with a baselineunderstanding of key issues for later consider- ation.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
To 2Link to List of Speakers: http://www.ilsi.org/ FoodBioTech/Documents/2013%20International% 20Meeting%20on%20Comparative%20Approaches/ Meeting%20Materials/c_Speakers_Meeting_Safety_ Assessment_of_GM.pdfWORKSHOP ON COMPARATIVE APPROACHES TO SAFETY ASSESSMENT 77,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Crit Rev Toxicol 2013; 43 S2:1-24; PMID:24164514;http://dx.doi.org/10.3109/10408444.2013.842955 Brune PD, Culler AH, Ridley WP, Walker K. Safety of GM crops: compositional analysis.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
J Agric Food Chem 2013; 61:8243-7; PMID:24266762; http://dx.doi.org/10.1021/jf401097q Burachik M. The trade dispute about genetically engi- neered products: argentina against the european com-munities.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
Reg Toxicol Pharmacol 2014; 69:154-70; PMID:24662477; http://dx.doi.org/10.1016/j.yrtph.2014.03.003 Codex Alimentarius.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
Cell 2006; 127:1309-21;PMID:17190597; http://dx.doi.org/10.1016/j.cell.2006.,OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
Available from: http://www.fao.org/ﬁlead min/user_upload/agns/topics/LLP/AGD803_6_Re port_En.pdf Flint-Garcia SA.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
J Agric Food Chem 2013; 61:8267 ¡76; PMID:23718780; http://dx.doi.org/ 10.1021/jf305511d Harrigan GG.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Natural variationin crop composition and the impact of transgenesis.Nat Biotechnol 2010; 28:402-4; PMID:20458297; http://dx.doi.org/10.1038/nbt0510-402 Herman RA., Chassy BM, Parrott W. Compositional assessment of transgenic crops: an idea whose time has passed.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Trend Biotechnol 2009; 27:555-7; PMID:19699543; http://dx.doi.org/10.1016/j.tibtech.2009.07.003 Herman RA, Price WD.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"J Agric Food Chem 2013;61:11695-701; PMID:23414177; http://dx.doi.org/ 10.1021/jf400135r Hoekenga OA, Srinivasan J, Barry G, Bartholomaeus A. Compositional analysis of genetically modiﬁed (GM) crops: key issues and future needs.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"J Agric Food Chem 61, 8248 ¡53; PMID:23746303; http://dx.doi.org/ 10.1021/jf401141r James C. Global status of commercialized biotech/GM crops: 2013.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Plant J 2001; 27, 503-28;PMID:11576435; http://dx.doi.org/10.1046/j.1365- 313X.2001.01119.x78 Bartholomaeus et al.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
Regul Toxicol Pharmacol 2011; 60:46- 53; PMID:21320564; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Trend Plant Sci 2013; 18, 704-14; PMID:24035234; http://dx.doi.org/ 10.1016/j.tplants.2013.08.007 Privalle LS, Gillikin N, Wandelt C, Bringing a transgenic crop to market: where compositional analysis ﬁts.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
J Agric Food Chem 2013; 61:8260 ¡6; PMID:23534903; http://dx.doi.org/10.1021/jf400185q Ricroch AE.,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"NewBiotechnol 2013; 30, 349-54; PMID:23253614; http://dx.doi.org/10.1016/j.nbt.2012.12.001 Sang T Genes and mutations underlying domestication transitions in grasses.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Plant Physiol 2009; 149, 63-70;PMID:19126696; http://dx.doi.org/10.1104/pp.108.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Plant Physiol 2013; 161 1587-94; PMID:23460691; http://dx.doi.org/10.1104/pp.112.209817Tanksley SD, The genetic developmental and molecu- lar bases of fruit size and shape variation in tomato.",Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Transgen Res 2010; 19, 425-36; PMID:19757133; http://dx.doi.org/ 10.1007/s11248-009-9321-9 Yang XS, Staub JM, Pandravada A, Riordan SG, Yan Y, Bannon GA, Martino-Catt SJ.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
"Food Nutr Sci 2013; 4:335-41; http://dx.doi.org/10.4236/ fns.2013.43044 Zhou J. Harrigan GG, Berman KH, Webb EG, Klus- meyer TH, Nemeth MA.",OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
J Agric Food Chem 2011; 59:8822-8; PMID:21797257; http://dx.doi.org/10.1021/jf2019038WORKSHOP ON COMPARATIVE APPROACHES TO SAFETY ASSESSMENT 79,Non-OADS,/arxiv_data1/oa_pdf/86/de/kgmc-06-02-1011886.PMC5033214.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 281–290Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  281 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S78428Managing eosinophilic esophagitis:  challenges  and solutions Nisha A Shah Dustin M Albert  Noah M Hall  Fouad J Moawad Department of Medicine,   Gastroenterology Service,   walter Reed National Military  Medical Center, Bethesda, MD, USAAbstract: Eosinophilic esophagitis (EoE) is a chronic and progressive immune-mediated  condition defined by symptoms of esophageal dysfunction and dense eosinophilic infiltration  of the esophageal mucosa.",Non-OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
"From a clinician’ s standpoint, reducing his-tologic and endoscopic inflammation with medications or specialized diets is a main Correspondence: Fouad J Moawad  Gastroenterology Service, Department of Medicine, walter Reed National Military Medical Center, 8901 wisconsin Avenue, Bethesda, MD 20889, USATel +1 301 295 4600Fax +1 301 295 4599Email moawad.fouad@scrippshealth.orgJournal name: Clinical and Experimental Gastroenterology Article Designation: ReviewY ear: 2016V olume: 9Running head verso: Shah et alRunning head recto: Review on eosinophilic esophagitisDOI: http://dx.doi.org/10.2147/CEG.S78428",Non-OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 290 Shah et al 66.,Non-OADS,/arxiv_data1/oa_pdf/f4/41/ceg-9-281.PMC5033215.pdf
"© Stuart J Smyth *Correspondence to: Stuart J Smyth; Email: stuart.smyth@usask.caSubmitted: 04/03/2014; Revised: 06/27/2014; Accepted: 07/09/2014 http://dx.doi.org/10.4161/21645698.2014.947843 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Nature 1953; 171:737-8; PMID: 13054692; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
PNAS 1974; 71: 7:2593-94; PMID: 4527935; http://dx.doi.org/ 10.1073/pnas.71.7.2593 3.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 15] Available from http://www.canolacouncil.org/markets-stats/ statistics/estimated-acreage-and-percentage/ 9.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 15] Avail- able from http://www.publications.gc.ca/Collection/ Statcan/21-004-X/21-004-XIE2002112.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 15] Available from http://www.isaaa.org/Resources/ publications/briefs 11.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Weed Technol 2011; 25:3:492-500; http://dx.doi.org/10.1614/WT- D-10-00164.1 13.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Agr Syst2011; 104:5:403-10; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 17] Available from http://www.gov.mb.ca/agriculture/market-prices-and-statistics/crop-statistics/pubs/november_estimates_of_ production.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 17] Available from http://www.agriculture.gov.sk.ca/Default.aspx?,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 17] Available from http://ecommons.usask.ca/handle/10388/ETD-2012-02- 344 18.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 21] Available from http://www.gmocompass.org/eng/database/enzymes/83.chymosin.html 27.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 21] Available from http://www.gmo-compass.org/eng/database/ingredients/124.yeast.html 28.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 21] Available from http://www.gmcc13.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 21] Available from http://www.cfa-fca.ca/upload/fact_sheets_CFA_C-287.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 21] Available from http://www.tpsgc-pwgsc.gc.ca/ongc-cgsb/programme-prog-ram/normes-standards/internet/ 032–0315/index-eng.html 32.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014Feb 21] Available from http://openparliament.ca/ bills/39-1/C-456/ 33.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Available from http://www.parl.gc.ca/House Publications/Publication.aspx?Language=E&Mode= 1&DocId=5110050&File=27 34.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Nat Biotechnol 2010; 28:1:23-5; PMID: 20062032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
NatBiotechnol 2009; 27:8:702-4; PMID: 19668173; http://dx.doi.org/10.1038/nbt0809-702 36.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed2014 Feb 28] Available from http://www.isaaa.org/ resources/publications/briefs/46/executivesummary/ default.asp 38.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Plant Biotechnol J 2013; 11:527-34; PMID: 23601418; http://dx.doi.org/10.1111/pbi.12070 39.,OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
Seed Sci Res 2011; 21:4:315-21; http://dx.doi.org/10.1017/S0960258511000213 40.,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
[accessed 2014 Feb 28[ Available from http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2013/2013-137- eng.php www.landesbioscience.com 203 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/f9/cd/kgmc-05-03-947843.PMC5033218.pdf
The 717 sequences and associated BLAST and gene model query tools are available via AspenDB(http://aspendb.uga.edu/s717).,OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Provided that the gene of interest is reasonably expressed (e.g.,, with a high read coverage), manual inspection of can-didate gRNAs against RNA-Seq alignments using programs such as the popular Integrative Genomics Viewer (http://www.broadinstitute.org/igv) is usually effective to conﬁrm their speciﬁcity.",Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
AGEseq is available as a standalone program or a Galaxy-compatible tool (https://toolshed.g2.bx.psu.edu) to supportweb-based data analysis.,OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Molecular Plant 2015; 8:1288-91; PMID:25749112; http://dx.doi.org/10.1016/j.molp.2015.02.011 Baltes NJ, Gil-Humanes J, Cermak T, Atkins PA, Voytas DF.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Cell 2014; 26:151-63; PMID:24443519; http://dx.doi.org/10.1105/tpc.113.119792 Boerjan W, Ralph J, Baucher M. Lignin biosynthesis.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
Annu Rev Plant Biol 2003; 54:519-46;PMID:14503002; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Biotechnol Adv 2015; 33:41-52; PMID:25536441; http://dx.doi.org/10.1016/ j.biotechadv.2014.12.006 Brooks C, Nekrasov V, Lippman ZB, Van Eck J. Efﬁcient gene editing in tomato in the ﬁrst generation using the clustered regularly interspaced short palindromic repeats/CRISPR-associated9 system.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Physiol2014; 166:1292-7; PMID:25225186; http://dx.doi.org/ 10.1104/pp.114.247577 Busov VB, Brunner AM, Meilan R, Filichkin S, Ganio L, Gandhi S, Strauss SH.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Annu Rev Biochem 2014; 83:409-39;PMID:24606144; http://dx.doi.org/10.1146/annurev-biochem-060713-035418 Chen H-Y, Babst BA, Nyamdari B, Hu H, Sykes R, Davis MF, Harding SA, Tsai C-J.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plane Cell Physiol 2014;55:1669-78; http://dx.doi.org/10.1093/pcp/pcu098 Coleman HD, Park JY, Nair R, Chapple C, Mansﬁeld SD.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Proc Natl Acad Sci 2008; 105:4501-6; http://dx.doi.org/10.1073/ pnas.0706537105 Dmitriev DA, Rakitov RA.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Nat Genet 2014; 46:1089-96;PMID:25151358; http://dx.doi.org/10.1038/ng.3075 Fan D, Liu T, Li C, Jiao B, Li S, Hou Y, Luo K. Efﬁcient CRISPR/Cas9-mediated targeted mutagenesis in Pop- ulus in the ﬁrst generation.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Scientiﬁc Reports 2015;5:12217; PMID:26193631; http://dx.doi.org/10.1038/ srep12217 Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
Nat Biotech 2014; 32:279-84; http://dx.doi.org/10.1038/nbt.2808 Gamalei Y.,OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
Trees 1989; 3:96-110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Bio- technol J 2003; 1:253-8; PMID:17163902; http://dx.doi.org/10.1046/j.1467-7652.2003.00024.x Harding SA, Leshkevich J, Chiang VL, Tsai CJ.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Physiol 2002; 128:428-38; PMID:11842147; http://dx.doi.org/10.1104/pp.010603 Hoenicka H, Lehnhardt D, Nilsson O, Hanelt D, Fladung M. Successful crossings with early ﬂoweringCRISPR EDITING IN POPULUS 213",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Biotechnol J 2014; 12:1066-74; PMID:24975279; http://dx.doi.org/10.1111/pbi.12213 Hu W-J, Kawaoka A, Tsai CJ, Lung J, Osakabe K, Ebi- numa H, Chiang VL.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Genetics 2005; 169:945-53; PMID:15489521; http://dx.doi.org/10.1534/genetics.104.034959 Jacobs TB, LaFayette PR, Schmitz RJ, Parrott WA.",Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"BMC Biotechnol 2015; 15:16; PMID:25879861;http://dx.doi.org/10.1186/s12896-015-0131-2 Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A Programmable dual-RNA-guidedDNA endonuclease in adaptive bacterial immunity.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"PlantGenome 2015; 8(1); http://dx.doi.org/10.3835/ plantgenome2014.10.0070 Klocko AL, Ma C, Robertson S, Esfandiari E, Nilsson O, Strauss SH.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"BMC Genomics 2009; 10:452;PMID:19775472; http://dx.doi.org/10.1186/1471- 2164-10-452 Kumar V, Jain M. The CRISPR-Cas system for plant genome editing: advances and opportunities.",Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Molecular Plant 2014; 7:1494-6; PMID:24719468; http://dx.doi.org/10.1093/mp/ssu044 Li J, Brunner A, Shevchenko O, Meilan R, Ma C, Skinner J, Strauss S. Efﬁcient and stable transgene suppressionvia RNAi in ﬁeld-grown poplars.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Transgenic Res 2008; 17:679-94; PMID:17929189; http://dx.doi.org/ 10.1007/s11248-007-9148-1 Litz R, Padilla G. Genetic transformation of fruit trees.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Curr Opinion Plant Biol 1998; 1:142-8; PMID:10066569; http://dx.doi.org/ 10.1016/S1369-5266(98)80016-2 Sander JD, Joung JK.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Nat Biotech 2014; 32:347-55; http://dx.doi.org/10.1038/nbt.2842 Sattler SE, Funnell-Harris DL, Pedersen JF.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Sci 2010; 178:229-38; http://dx.doi.org/10.1016/j.plantsci.2010.01.001 Srinivasan C, Dardick C, Callahan A, Scorza R. Plum (Prunus domestica) trees transformed with poplar FT1result in altered architecture, dormancy requirement, and continuous ﬂowering.",Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"PLoS ONE 2012; 7:e40715; PMID:22859952; http://dx.doi.org/10.1371/journal.pone.0040715 Swamy PS, Hu H, Pattathil S, Maloney VJ, Xiao H, Xue LJX, Chung JD, Johnson VE, Zhu Y, Peter G, et al.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
J Exp Botany 2015; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Physiol 2010; 154:874-86; PMID:20729393; http://dx.doi.org/10.1104/pp.110.159269 Voytas DF, Gao C. Precision genome engineering and agriculture: Opportunities and regulatory challenges.PLoS Biol 2014; 12:e1001877; PMID:24915127;http://dx.doi.org/10.1371/journal.pbio.1001877 Wagner A, Donaldson L, Kim H, Phillips L, Flint H, Steward D, Torr K, Koch G, Schmitt U, Ralph J. Sup-pression of 4-Coumarate-CoA Ligase in the Conifer- ous Gymnosperm Pinus radiata.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Plant Physiol 2009; 149:370-83; PMID:18971431; http://dx.doi.org/10.1104/pp.108.125765 Wang MB, Helliwell CA, Wu LM, Waterhouse PM, Pea- cock WJ, Dennis ES.",Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"RNA 2008; 14:903-13; PMID:18367720; http://dx.doi.org/10.1261/rna.760908 Xie K, Minkenberg B, Yang Y.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Molecular Plant 2014; 7:923-6; PMID: 24482433; http://dx.doi.org/10.1093/mp/ssu009 Xue L-J, Alabady MS, Mohebbi M, Tsai CJ.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Tree Genetics Geno-mics 2015; 11:82; http://dx.doi.org/10.1007/s11295- 015-0907-5 Xue LJ, Tsai CJ.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"Nucleic Acids Res 2014; 42:10903-14; PMID:25200087; http://dx.doi.org/10.1093/nar/gku806 Zhou X, Jacobs TB, Xue LJ, Harding SA, Tsai CJ.",OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
New Phytol 2015; 208:298-301; http://dx.do i.org/10.1111/nph.13470CRISPR EDITING IN POPULUS 215,Non-OADS,/arxiv_data1/oa_pdf/7b/1f/kgmc-06-04-1091553.PMC5033219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/ae/kgmc-07-01-1156826.PMC5033223.pdf
"Food Secu-rity 2011; 3(2):127-139; http://dx.doi.org/10.1007/ s12571-011-0124-5 Garcia-Alonso M, Raybould A.",Non-OADS,/arxiv_data1/oa_pdf/f0/ae/kgmc-07-01-1156826.PMC5033223.pdf
Transgenic Res 2014; 23(6):945-56; PMID:24154954; http://dx.doi.org/10.1007/s11248-013-9760-1 ICMR.,Non-OADS,/arxiv_data1/oa_pdf/f0/ae/kgmc-07-01-1156826.PMC5033223.pdf
"Agric Res 2012; 1(1):3-11;http://dx.doi.org/10.1007/s40003-011-0009-z Wolt JD, Keese P, Raybould A, Fitzpatrick JW, Burachik M, Gray A, Olin SS, Schiemann J, Sears M, Wu F. Problem formulation in the environmental risk assess-ment for genetically modiﬁed plants.",OADS,/arxiv_data1/oa_pdf/f0/ae/kgmc-07-01-1156826.PMC5033223.pdf
Transgenic Res 2010; 19(3):425-436; PMID:19757133; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/ae/kgmc-07-01-1156826.PMC5033223.pdf
"© Stuart J Smyth and Peter WB Phillips *Correspondence to: Stuart J Smyth; Email: stuart.smyth@usask.caSubmitted: 02/04/2014; Revised: 04/21/2014; Accepted: 05/09/2014 http://dx.doi.org/10.4161/21645698.2014.945880 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Bull Sci Technol Soc 2007; 27:4:274-86; PMID: 22973420; http://dx.doi.org/10.1177/0270467607- 300639 4.,OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
"FAO/WHO Codex Training Package: Section Four – Scientiﬁc Basis for Codex Work, 4.1 Risk analysis in the framework of Codex (26 Nov 2012) available from ftp://ftp.fao.",Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Emerg Infect Dis 1997; 3:483-87; PMID:9366601; http://dx.doi.org/10.3201/eid0304.970411 7.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Risk Anal 1995; 15:369-90; http://dx.doi.org/10.1111/j.1539-6924.1995.tb00330.x 9.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Nat Biotechnol 1999; 17:629; PMID: 10409344; http://dx.doi.org/10.1038/10837 15.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
GM canola found in mustard load (27 Nov 2012) available from http://www.producer.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Kershen D. Legal liability and agricultural biotechnol- ogy: Ten questions (27 Nov 2012) available from http://agribiotech.info/details/KershenFinal%2003% 20layout.pdf 20.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
"Endres AB, Johnson N. $750 million settlement in GM rice contamination (27 Nov 2012) available from http://www.farmdocdaily.illinois.edu/2011/07/750_million_settlement_in_gm_r.html 22.",Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Herculex I (1507) maize: Safety and gen- eral characteristics (27 Nov 2012) available fromhttp://www.europabio.org/sites/default/ﬁles/pages/ 1507_factsheet.pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Nat Biotechnol 2012; 30:197; PMID: 22398593;http://dx.doi.org/10.1038/nbt.2168 26.,OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Directive 2001/18/ ECof the European Parliament and of the Council of 12 March 2001 on the deliberate release into the envi- ronment of genetically modiﬁed organismsand repealing Council Directive 90/220/EEC (27 Nov 2012) available from http://eur-lex.europa.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
"J Publ Aff 2005, 5:299-311; http://dx.doi.org/10.1002/pa.30 31.",Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Avail-able from: http://www.bailii.org/uk/cases/UKHL/ 1932/100.html 33.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Environ Health Perspect 2006;114:237-41; http://dx.doi.org/10.1289/ehp.8221 34.,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
Outbreaks of E.coli O104: H4 infection: Update 30 (27 Nov 2012) available from http://www.euro.wh o.int/en/what-we-d o/health-topics/ emergencies/international-health-regulations/news/news/2011/07/outbreaks-of-e.-coli-o104h4-infection-update-30 www.landesbioscience.com 177 GM Crops & Food,Non-OADS,/arxiv_data1/oa_pdf/d2/c1/kgmc-05-03-945880.PMC5033226.pdf
"The Court confirmed that additional national authorization procedures, introduced on top of the existing approval process conducted by the European authorities (European Food Safety Authority) were  Correspondence to: Vivian Moses; Email: v.moses@qmul.ac.uk Submitted: 05/25/2014; Accepted: 05/25/2014; Published Online: 07/30/2014http://dx.doi.org/10.4161/gmcr.32207GM in the media Vivian Moses King’s College london; london, U K",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available  from http://www.wikileaks.org/plusd/cables/09MADRID482_a.html 2.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.prri.net/french-deal-gmos/ 3.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://uk.reuters.com/article/2008/01/16/science-france-gmo-dc-idUKPAB00373820080116 4.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.reuters.com/article/2011/11/28/france-gmo-idUSL5E7MS3EM20111128 5.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.reuters.com/article/2012/05/22/france-eu-gmo-idUSL5E8GMDRY20120522 6.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.euractiv.com/health/political-bans-gmos-eu-risks-sci-analysis-513694 7.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://ddata.over-blog.com/1/39/38/37/Point-by-point-analysis-of-French-arguments-to-ban-MON810_F.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.europa - bio.org/agricultural/press/european-court-justice-confirms-farmers-right-cultivate-gm-crops 9.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://curia.europa.eu/juris/document/document.jsf?text=&docid=126437&pageIndex=0&doclang=EN&mode=lst&dir=&occ=first”=1&cid=1195160 10.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.bloomberg.com/news/2012-09-06/court-says-eu-vetted-gmos-not-subject-to-country-approval.html 11.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://fracturedparadigm.com/2013/08/01/french-court-lifts-ban-on-grow - ing-monsanto-gm-corn/#axzz32TCspF4C12.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available at http://www.france24.com/en/20130803-france-uphold-ban-gm-corn-mon - santo-hollande-council-state 13.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available at http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000028724829&dateTexte=&categorieLien=id 14.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.academie-sciences.fr/presse/communique/pgm_170314.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://uk.reuters.com/article/2014/03/18/france-gmo-idUKL6N0MF4S420140318 16.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://sante2020.blog.lemonde.fr/2014/03/14/nous-sommes-tous-des-ogm/ 17.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.france24.com/en/20140505-france-ban-gm-corn-monsanto-geneti - cally-modified-crops-eu 18.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://in.reuters.com/article/2014/05/05/france-gmo-idINL6N0NR2MZ20140505 19.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.euractiv.com/sustainability/paris-wants-national-permits-gm-news-533597?dm_i=I1,27VAO,1OYE4A,812BU,1 20.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://blogs.nature.com/news/2014/05/uproar-as-anti-gm-vine-activists-acquitted-in-france.html 21.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.welt.de/politik/deutsch - land/article128138231/Die-hysterische-Republik-Deutschland.html 22.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.cropgen.org/article_441.html23.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.welt.de/regionales/frankfurt/arti - cle128237181/Hessen-will-weiter-auf-Gentechnik-verzichten.html 24.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from https://www.gov.uk/government/uploads/system/uploads/attach - ment_data/file/292174/cst-14-634a-gm-science-update.pdf 25.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.gmwatch.org/index.php/news/archive/2014/15349-gm-science-update-slammed-as-unadulterated-propaganda 26.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.gmfreeze.org/news-releases/247 27.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.dailymail.co.uk/news/article-2581387/Scientists-hidden-links-GM-food-giants-Disturbing-truth-official-report-said-UK-forge-Frankenfoods.html 28.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.dailymail.co.uk/news/article-2621058/Secret-emails-reveal-ministers-plotted-GM-lobbyists-Documents-two-worked-campaign-win-sceptical-consumers.html 29.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.dailymail.co.uk/sciencetech/article-2627122/Could-soon-farm-crops-disused-MINES-Growing-corn-colder-conditions-reduces-height-not-yield.html 30.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.independent.co.uk/voices/editorials/gm-technology-will-help-us-to-meet-the-global-food-challenge-but-brit - ain-is-in-danger-of-being-left-behind-9190648.html?origin=internalSearch,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.independent.co.uk/news/science/green-light-for-gm-first-official-report-into-genetically-modified-crops-in-five-years-recommends-safe-and-sustainable-rollout-in-brit - ain-9190490.html 32.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.dailymail.co.uk/news/article-2580588/Speed-GM-crops-UK-say-scientists-They-dismiss-opponents-arguments-neurosis.html 33.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.telegraph.co.uk/earth/agriculture/geneticmodifica - tion/10696804/Its-time-for-GM-crops-adviser-tells-David-Cameron.html 34.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.thetimes.co.uk/tto/sci - ence/article4033210.ece 35.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from https://www.gov.uk/government/uploads/system/uploads/attach - ment_data/file/288823/cst-14-634-gm-technolo - gies.pdf 36.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.theguard - ian.com/news/reality-check/2014/mar/14/gm-crops-safe-grow-eat-science- 37.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.theguardian.com/environment/2014/jan/07/owen-paterson-gm-crops-farming, http://www.fwi.co.uk/articles/10/03/2014/143692/owen-paterson-backs-eu-proposal-to-fast-track-gm-crops.htm 38.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available http://www.dailymail.co.uk/news/article-2605570/Ministers-covering-secret-meetings-GM-food-lobby-Owen-Paterson-refused-Freedom-Information-request-talks-Frankenfood.html 39.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.foodmanufacture.co.uk/Regulation/DEFRA-boss-agrees-Europe-without-GM-will-become-a-museum 40.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.genewatch.org/article.shtml?als[cid]=574133&als[itemid]=574495 41.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.spiked-online.com/newsite/article/environmentalism-has-become-a-religion/15033 -.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.allowgoldenricenow.org/ 43.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.welt.de/newsticker/dpa_nt/regioline_nt/hamburg - schleswigholstein_nt/article123956358/Greenpeace-Gruendungsmitglied-protestiert-gegen-Greenpeace.html44.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.taz.de/!131227/ 45.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.agrarheute.com/goldener-reis-greenpeace 46.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.tagesspiegel.de/mei - nung/portraet-patrick-moore-umweltaktivist-green - peace-sind-jetzt-die-boesen/9350958.html 47.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.abendblatt.de/newsticker/dpa_nt/regioline_nt/hamburgschleswigholstein_nt/article123956358/Greenpeace-Gruendungsmitglied-protestiert-gegen-Greenpeace.html 48.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.bild.de/regional/hamburg/greenpeacegruendungsmitglied-protesti - ert-34283656.bild.html 49.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.berliner-zeitung.de/newsticker/greenpeace-gruendungsmitglied-protestiert-gegen-green - peace,10917074,25916090.html 50.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.biotechnolo - gie.de/BIO/Navigation/DE/root,did=168218.html?listBlId=74462 51.",OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://programm.ard.de/TV/Themenschwerpunkte/Musik-und-Kultur/Alle-Kultursendungen/Startseite/?sendung=2800711392207131 52.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.morgenpost.de/newsticker/dpa_nt/regioline_nt/hamburgschleswigholstein_nt/article123956358/Greenpeace-Gruendungsmitglied-protestiert-gegen-Greenpeace.html 53.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.mopo.de/nachrichten/streit-um-den–goldenen-reis–ex-greenpeace-chef-demonstriert-in-hamburg-gegen-green - peace,5067140,25920896.html 54.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"Available from http://www.fr-online.de/newsticker/greenpeace-gruendungsmitglied-protestiert-gegen-green - peace,11005786,25916090.html 55.",Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.faz.net/aktuell/wissen/medizin/kampagne-gegen-greenpeace-machtkampf-um-den-goldenen-reis-12750595.html 56.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.topagrar.com/news/Home-top-News-Greenpeace-Gruender-kritisiert-Gentechnikgegner-1429137.html 57.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.scharf-links.de/42.0.html?&tx_ttnews[tt_news]=41875&tx_ttnews[backPid]=56&cHash=55ea842a8458.,OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.lopinion.fr/14-avril-2014/folle-epopee-riz-dore-11327 59.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://scienza.panorama.it/green/Greenpeace-Ambientalisti-Bugie 60.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.indivanados.tv/cms/?p=3992 61.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://bazonline.ch/wissen/natur/Wissenschaftler-gegen-Umweltschuetzer/story/16625020 62.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.swissinfo.ch/eng/science_technology/A_clear_case_for_golden_rice.html?cid=38385468 63.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.independent.co.uk/news/science/former-greenpeace-leading-light-condemns-them-for-opposing-gm-golden-rice-crop-that-could-save-two-million-children-from-starva - tion-per-year-9097170.html?origin=internalSearch 64.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.independent.co.uk/voices/editorials/if-the-environmentalist-movement-is-to-stay-relevant-it-must-embrace-worldchanging-technologies-like-gm-9096768.html 65.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.the - times.co.uk/tto/news/politics/article3992194.ece?CMP=OTH-gnws-standard-2014_02_01 66.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from https://www.youtube.com/watch?v=yxiQo7CDck4 67.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://irri.org/golden-rice/faqs/what-is-the-status-of-the-golden-rice-project-coordinated-by-irri 69.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.economist.com/news/leaders/21601850-technological-break - throughs-rice-will-boost-harvests-and-cut-poverty-they-deserve-support 70.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.economist.com/news/united-states/21601831-little-state-could-knee - cap-biotech-industry-vermont-v-science?fsrc=scn%2Ftw%2Fte%2Fpe%2Fed%2Fvermontvscience 71.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.foodsafetynews.com/2014/05/needs-author-account-vermonts-gmo-labeling-law-what-it-really-means-for-consumers/#.U39IeC-ppEk 72.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available at http://onlinelibrary.wiley.com/doi/10.1111/1750-3841.12478/abstract,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.thegrocer.co.uk/fmcg/fresh/sains - burys-ms-and-the-co-op-follow-tescos-lead-on-gm-feed/238400.article#.UWvQTYI1a8F 74.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.producer.com/daily/german-poultry-sector-ends-avoidance-of-gmo-soy-in-feed/75.,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
Available from http://www.capitalpress.com/Livestock/20140520/german-chicken-farms-buy-genetically-modified-soybeans,Non-OADS,/arxiv_data1/oa_pdf/5f/a1/kgmc-05-02-10932207.PMC5033228.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
Identiﬁcation of gRNA Target Sites The CRISPR design website was pro- grammed in a combination of Python 2 and PHP (http://stuparcrispr.cfans.umn.edu/ CRISPR/).,OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
Resource Information and Availability The web-tool used for CRISPR target identi- ﬁcation is available at http://stuparcrispr.cfans.umn.edu/CRISPR/.,OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Trends Biotechnol 2015;33:120-31; PMID:25496918; http://dx.doi.org/ 10.1016/j.tibtech.2014.11.008 Bhaya D, Davison M, Barrangou R. CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Annu Rev Genet 2011; 45:273-97; PMID:22060043; http://dx.doi.org/10.1146/annurev-genet-110410-132430 Bibikova M, Golic M, Golic KG, Carroll D. Targeted chromosomal cleavage and mutagenesis in Drosophilausing zinc-ﬁnger nucleases.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Mol Plant Microbe Interact 2001; 14:695-700; PMID:11386364; http://dx.doi.org/ 10.1094/MPMI.2001.14.6.695 Cai Y, Chen L, Liu X, Sun S, Wu C, Jiang B, Han T, Hou W. CRISPR/Cas9-Mediated Genome Editing in Soy- bean Hairy Roots.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"PLoS One 2015; 10:e0136064; PMID:26284791; http://dx.doi.org/10.1371/journal.pone.0136064 Canver MC, Bauer DE, Dass A, Yien YY, Chung J, Masuda T, Maeda T, Paw BH, Orkin SH.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"JBiol Chem 2014; 289:21312-24; PMID:24907273;http://dx.doi.org/10.1074/jbc.M114.564625 Cho SW, Kim S, Kim JM, Kim J-S.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nat Biotechnol 2013; 31:230-2; PMID:23360966; http://dx.doi.org/10.1038/nbt.2507 Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Genetics 2010; 186:757-61; PMID:20660643; http://dx.doi.org/10.1534/genetics.110.120717 Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marrafﬁni LA, et al.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Plant Genome 2012; 5:42; http://dx.doi.org/10.3835/plantgenome2012.06.0008 Curtis MD, Grossniklaus U.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Plant Physiol 2003; 133:462-9; PMID:14555774; http://dx.doi.org/10.1104/pp.103.027979 Dicarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nucleic Acids Res2013; 41:4336-43; PMID:23460208; http://dx.doi.org/10.1093/nar/gkt135 Govindarajulu M, Elmore JM, Fester T, Taylor CG.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Mol Plant Microbe Interact2008; 21:1027-35; PMID:18616399; http://dx.doi.org/ 10.1094/MPMI-21-8-1027 Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh J-RJ, Joung JK.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
Nat Biotechnol 2013; 31:227-9; PMID:23360964; http://dx.doi.org/10.1038/nbt.2501CRISPR/CAS MUTAGENESIS IN LEGUMES 251,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Plant Cell 2005; 17:1-11; PMID:16199614; http://dx.doi.org/10.1105/tpc.105.035394 Jacobs TB, LaFayette PR, Schmitz RJ, Parrott WA.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nat Biotechnol 2013; 31:233-9;PMID:23360965; http://dx.doi.org/10.1038/nbt.2508 Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A Programmable Dual-RNA-GuidedDNA Endonuclease in Adaptive Bacterial Immunity.2012; 337:816-21; PMID:22745249 Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc ﬁnger fusions to Fok I cleavage domain.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Plant J 1993; 4:403-10; PMID:8106085; http://dx.doi.org/10.1046/j.1365- 313X.1993.04020403.x Li J-F, Norville JE, Aach J, McCormack M, Zhang D, Bush J, Church GM, Sheen J. Multiplex and homolo- gous recombination–mediated genome editing in Ara- bidopsis and Nicotiana benthamiana using guide RNAand Cas9.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nat Biotechnol 2013; 31:688-91; PMID:23929339; http://dx.doi.org/10.1038/nbt.2654 Li Z, Liu ZB, Xing A, Moon BP, Koellhoffer JP, Huang L, Ward RT, Clifton E, Falco SC, Cigan AM.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Plant Physiol 2015; 169(2):960-70; PMID:26294043;http://dx.doi.org/10.1104/pp.15.00783 Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Science 2013;339:823-6; PMID:23287722; http://dx.doi.org/ 10.1126/science.1232033 Maluszynski M, Ahloowalia BS, Sigurbj €ornsson B. Appli- cation of in vivo and in vitro mutation techniques forcrop improvement.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nat Biotechnol 2011; 29:143-8; PMID:21179091; http://dx.doi.org/10.1038/nbt.1755 Murray EE, Lotzer J, Eberle M. Codon usage in plant genes.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nucleic Acids Res 1989; 17:477-498; PMID:2644621 http://dx.doi.org/10.1093/nar/17.2.477 Odell JT, Nagy F, Chua N-H. Identiﬁcation of DNA sequences required for activity of the cauliﬂower mosaic virus 35S promoter.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nature 1985; 313:810-2; PMID:3974711; http://dx.doi.org/; http://dx.doi.org/10.1038/313810a0 Quandt HJ, Puehler A, Broer I. Transgenic root nodules of Vicia hirsuta: a fast and efﬁcient system for the studyof gene expression in indeterminate-type nodules.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
MolPlant Microbe Interact 1993; 6:699-703; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nat Methods 2011; 8:67-9; PMID:21151135; http://dx.doi.org/10.1038/nmeth.1542 Schmutz J, Cannon SB, Schlueter J, Ma J, Mitros T, Nel- son W, Hyten DL, Song Q, Thelen JJ, Cheng J, et al.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Nature 2010; 463:178-83; PMID:20075913; http://dx.doi.org/10.1038/nature08670 Shan Q, Wang Y, Li J, Zhang Y, Chen K, Liang Z, Zhang K, Liu J, Xi JJ, Qiu J-L, et al.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
"Targeted genome modi- ﬁcation of crop plants using a CRISPR-Cas system.Nat Biotechnol 2013; 31:686-8; PMID:23929338; http://dx.doi.org/10.1038/nbt.2650 Sun X, Hu Z, Chen R, Jiang Q, Song G, Zhang H, Xi Y.",OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
Sci Rep 2015; 5:10342; PMID:26022141; http://dx.doi.org/10.1038/srep10342 Voytas DF.,OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
Annu Rev Plant Biol 2013; 64:327-50; PMID:23451779; http://dx.doi.org/10.1146/annurev- arplant-042811-105552252 Michno et al.,OADS,/arxiv_data1/oa_pdf/a9/3d/kgmc-06-04-1106063.PMC5033229.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
"This association is concerning, especially in the US, where substantial differences in access to healthcare, nutritious foods, and physical activity exist betweenmore and less af ﬂuent individuals and neighborhoods ( Phelan & Link, 2005 ;Braveman et al., 2001 ;Janssen et al., 2006 ;Burton, Flannery, & Bennett, 2010 ;Cohen, Doyle, & Baum, 2006 ;Iwane,Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ssmphSSM -Population Health http://dx.doi.org/10.1016/j.ssmph.2016.08.005 2352-8273/Published by Elsevier Ltd.",Non-OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
"Accessed 11 June, 2014, at 〈http://wwwthelancet.com/protocol-reviews/09PRT-8166 〉.",Non-OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
"(Accessed 20 October 2014, at 〈http://www.cdc.gov/ nchs/data/dvs/birth11-03 ﬁnal-acc.pdf 〉.).",OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
"National Center for Health Statistics, 2014. at 〈http://www.cdc.gov/nchs/data/nhis/earlyrelease/wireless201412.pdf 〉.).",OADS,/arxiv_data1/oa_pdf/80/c9/main.PMC5033249.pdf
"In preparation for the coming wave of genome sequencing needs, the Smithsonian Institution has established the Global Genome Initiative (GGI; http://www.ggi.si.edu/), which seeks to collect, voucher, and preserve genome-quality tissues from at least one species in each family and 50% of all the genera of life on Earth by 2020.",Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
"There are already in operation several well-funded and globally  important programs for the collection and preservation of plant genetic resources, such as the U.S. Department of Agriculture (USDA) Germplasm Resources Information Network (GRIN; http://www.ars-grin.gov/); the Millennium Seed Bank hosted   by Kew Gardens (http://www.kew.org/science-conservation/   collections/millennium-seed-bank), which has samples of more  1 Manuscript received 31 March 2016; revision accepted 27 July 2016.",Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
"Applications in Plant Sciences 2016 4(9): 1600039 Gostel et al.—Garden voucher and genome-quality tissue workflow doi:10.3732/apps.1600039http://www.bioone.org/loi/apps 2 of 8Voucher specimen handling and collection— The term “voucher speci- men” in this manuscript refers to a plant (or part of a plant) that has been col- lected, pressed, dried, labeled, mounted on archival paper, and deposited into a recognized herbarium (e.g., a member of Index Herbariorum [http://sweetgum   .nybg.org/science/ih/]).",Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
GRIN (http://www.ars-grin.gov/) remains an important alternative resource for Gardens and other per-sonnel for problematic unassessed taxon names.,Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
"These handling techniques are than 36,000 species (van Slageren, 2003); and the Svalbard  Global Seed Vault (http://www.regjeringen.no/en/topics/food-fisheries-and-agriculture/landbruk/svalbard-global-seed-vault), which houses viable, duplicate samples of important crops and their wild relatives (Fowler, 2008).",Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
"At least two high-quality photographic images were taken (habit and close up) for each specimen, and all collection information and im-ages were uploaded into the NMNH electronic record management database (http://collections.nmnh.si.edu/search/botany/).",OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
GGI–Gardens has also replicated this collection sheet as a custom project in the iNaturalist web application environment (http://www.inaturalist.org).,OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
"In many cases, the GGI–Gardens website (http://ggi.si.edu/ggi-gardens) will serve as an information repository for such best practices and to curate resources and documentation.",Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
A searchable list of recognized herbaria can  be found using Index Herbariorum (http://sweetgum.nybg.org/science/ih/).,Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
Website http://www.theplantlist.org/  [accessed 12 February 2016].,Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
Website http://sweetgum.nybg.org/ science/ih/ [accessed 12 February 2016].,Non-OADS,/arxiv_data1/oa_pdf/7d/57/apps.1600039.PMC5033361.pdf
The R scripts used for automated habitat delineation are available on GitHub (https://github.com/bw4sz/Drone/blob/master/Kmean.md).,OADS,/arxiv_data1/oa_pdf/4b/e0/apps.1600041.PMC5033362.pdf
Website http://www2.unil.ch/popgen/softwares/fstat.htm [accessed 16 August 2016].,Non-OADS,/arxiv_data1/oa_pdf/6c/22/apps.1600042.PMC5033363.pdf
"Applications in Plant Sciences 2016 4(9): 1600047 Lutsak et al.—Microsatellites in Cetraria aculeata doi:10.3732/apps.1600047http://www.bioone.org/loi/apps 2 of 4least five repeats using the MIcroSAtellite identification tool (MISA; Thiel et al.,  2003; http://pgrc.ipk-gatersleben.de/misa/misa.html).",OADS,/arxiv_data1/oa_pdf/89/dd/apps.1600047.PMC5033364.pdf
"Primers were designed using the Primer3 plugin in Geneious R7.1.9 (created by BioMatters, http://www.geneious.com/).",OADS,/arxiv_data1/oa_pdf/89/dd/apps.1600047.PMC5033364.pdf
Website https://www.researchgate.net/publication/   242331583_Holm-Bonferroni_Sequential_Correction_An_EXCEL_ Calculator_-_Ver._1.2 [accessed 25 August 2016].,OADS,/arxiv_data1/oa_pdf/89/dd/apps.1600047.PMC5033364.pdf
Website http://www.mobot.org/MOBOT/research/APweb/ [ac- cessed 12 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/c4/50/apps.1600053.PMC5033365.pdf
"Website https://expressionanalysis.github.io/   ea-utils/ [accessed 22 August 2016].Faircloth , b. c. 2008.",Non-OADS,/arxiv_data1/oa_pdf/6a/55/apps.1600056.PMC5033367.pdf
METHODS AND RESULTS Seeds representing all three grain amaranth species and their putative pro- genitor species (A. hybridus) were obtained from the publicly available U.S.  Department of Agriculture National Plant Germplasm System (USDA-NPGS) Amaranthus germplasm collection (http://www.ars-grin.gov/; Table 1).,OADS,/arxiv_data1/oa_pdf/e0/fe/apps.1600063.PMC5033369.pdf
"These reads were as-sembled using FALCON version 0.4 (https://github.com/PacificBiosciences/FALCON), which produced 9494 contigs, of which five showed high BLASTN (E-value = 0) homology and spanned nearly the entire length of chloroplast ge- nome from other plant species within the family Amaranthaceae, specifically Spinacia oleracea L. (NC_002202.1) and Beta vulgaris L. subsp.",OADS,/arxiv_data1/oa_pdf/e0/fe/apps.1600063.PMC5033369.pdf
a All origin information is derived from the Germplasm Resources Information Network (http://www.ars-grin.gov/npgs/).,OADS,/arxiv_data1/oa_pdf/e0/fe/apps.1600063.PMC5033369.pdf
Website http://arxiv.org/abs/1303.3997 [ac- cessed 31 August 2016].,Non-OADS,/arxiv_data1/oa_pdf/e0/fe/apps.1600063.PMC5033369.pdf
"After the introduction, the volume starts with an engaging 1 The Petrie–Flom Center, About Us,http://petrieflom.law.harvard.edu/about/overview (accessed Oct. 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/64/44/lsv055.PMC5033424.pdf
"2 ThePetrie–FlomCenter, TheFoodandDrugAdministrationinthe21stCentury:The2013Petrie-FlomCenterAn- nualConference ,http://petrieflom.law.harvard.edu/events/details/petrie-flom-center-annual-conference-the- food-and-drug-administration-in-th (accessedOct.22,2015).",Non-OADS,/arxiv_data1/oa_pdf/64/44/lsv055.PMC5033424.pdf
"3 Peter Barton Hutt, Historical Themes and Developments Over the Past 50 Years (2013) , https://vimeo.com/66653244 (accessedOct.22,2015).",Non-OADS,/arxiv_data1/oa_pdf/64/44/lsv055.PMC5033424.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/64/44/lsv055.PMC5033424.pdf
"Bill of Health, Harvard Law ,http://blogs.law.harvard.edu/billofhealth/2015/09/07/government-regulation-of- commercial-speech-is-amarin-pharmas-breakout-moment/ (accessedSep.7,2015)",Non-OADS,/arxiv_data1/oa_pdf/64/44/lsv055.PMC5033424.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"159 (2010); Ken R. Daniels, Wendy Kramer & Maria V. Perez-y-Perez, Semen Donors Who Are Open to Contact with Their Offspring: Issues and Implications for Them andTheirFamilies ,25REPROD.BIOMED.ONLINE670(2012);StrategyandInformationDirectorateHuman Fertilisation and Embryology Authority, N EW DONOR REGISTRATIONS ,http://www.hfea.gov.uk/3411.html (accessedDec.17,2014);KenDaniels, AnonymityandOpennessandtheRecruitmentofGameteDonors.PartI: SemenDonors ,10HUM.FERTIL.151(2007);DamienW.Riggs&LauraRussell, CharacteristicsofMenWilling toActasSpermDonorsIntheContextofIdentity-ReleaseLegislation ,26HUM.REPROD.266(2011);UschiVan denBroecketal., ASystematicReviewofSpermDonors:DemographicCharacteristics,Attitudes,MotivesandEx- periencesoftheProcessofSpermDonation ,19HUM.REPROD.UPDATE37(2013);JessicaElgot, UKSpermBank HasJustNineRegisteredDonors,BossReveals ,THEGUARDIAN,Aug.31,2015, http://www.theguardian.com/ science/2015/aug/31/britains-national-sperm-bank-wants-men-to-prove-their-manhood?CMP =sharebtn link(accessedSept.3,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"25SpermDonorsandChildSupport,F REEADVICE,http://family-law.freeadvice.com/family-law/child support/ artificialinsemination donorobligation.htm (accessedSept.4,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"28Millbank, supranote 14; Sperm Donation Laws by Country ,WIKIPEDIA,T H EF R E EE N C Y C L O P E D I A (2015),http://en.wikipedia.org/w/index.php?title=Sperm donation lawsbycountry&oldid=654148051 (accessedMar.31,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"Court Ruling ,http://www.cbc.ca/news/canada/british-columbia/ sperm-donor-identity-protected-by-b-c-court-ruling-1.1132062 (accessedSept.18,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"In Washington, a New Law Bans Anonymous SpermandEggDonors ,TIME,http://healthland.time.com/2011/07/22/where-do-some-babies-come-from- in-washington-a-new-law-bans-anonymous-sperm-and-egg-donors/ (accessedSept.1,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"nytimes.com/2011/09/06/health/06donor.html (accessed Dec. 31, 2014); Tom Blackwell, Limit Pregnan- cies by Same Sperm Donor: Fertility Experts National Post (2011),http://news.nationalpost.com/2011/09/ 08/limit-pregnancies-by-same-sperm-donor-fertility-experts/ (accessed Jan. 2, 2015); NYU News: Sperm DonationIndustryNeedsRegulation 2013,http://www.nyunews.com/2013/12/04/rawley-7/ (accessedJan.",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"1, 2015); Sperm Donor ‘Super Dads’—Why It’s Dangerous for One Donor to Sire Dozens ,A B CN EWSBLOGS, 2011,http://abcnews.go.com/blogs/health/2011/09/06/sperm-donor-super-dads-why-its-dangerous-for- one-donor-to-sire-dozens/ (accessed Jan. 2, 2015); Lindsey Porter, Why Limit Offspring Num- bers in Sperm Donation?",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"prezi.com (2013), https://prezi.com/qrkxf5klqbrb/why-limit-offspring- numbers-in-sperm-donation/ (accessedJan.2,2015); Id.",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"In a study of 144 couples who received counseling about oocyte donation in Brussels, more than two-thirds preferred known donation, aresponsemotivatedbyfearsoftheunknownoriginofgeneticmaterialandthetrust recipientshadinthedonortheyhadselected.42Aninterestinpreservingsharpbound- ariesbetweenthedonorsandtherecipientswasaprimarymotivationforwantingto maintainanonymityamongthosewhopreferredanonymity.Onestudyhasfoundthat parentswhohavereliedonspermdonationsaremoreinfavorofanonymitythanare thosewhohavereliedoneggdonations.43 34American Society for Reproductive Medicine and Society for Assisted Reproductive Technology, Birm- ingham, Alabama, Recommendations for Gamete and Embryo Donation: A Committee Opinion (2008), http://www.npg-asrm.org/uploadedFiles/ASRM Content/News andPublications/Practice Guidelines/ Guidelines andMinimum Standards/2008 Guidelines forgamete(1).pdf (accessedMar.13,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"36ASRM and SART Exert Pressure to Hinder Legislation in Several States ,SURROGACY 101 (2012), http://infertilityanswers.typepad.com/surrogacy 101/2012/02/asrm-and-sart-exert-pressure-to-hinder- legislation-in-several-states.html (accessedApr.3,2015).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"Measures Allthreegroupswereaskedaseriesofquestions,manyofwhichwerethesame.This studyfocusesontheanswertothetwothataskedrespondentshowstronglytheyagreed withthestatementthat‘donorsshould notbeanonymous’50andthat‘donorsshould belimitedinthenumberofoffspringthatcanbeproducedfromtheirdonations’.Inthe survey,somestatementswerephrasedaffirmativelyandothersnegativelytopreventa responsepatternfromoccurring.Bothofthesequestionswerescoredonafivepoint scale:1 =‘stronglyagree’;2 =‘agree’;3 =‘neutral’;4 =‘disagree’;5 =‘stronglydis- agree’.OnLikertscaleslikethis,themiddlepositionisassumedtorepresentaposition ofneitheragreeingnordisagreeing(inthiscaseneutrality)ratherthanconfusionabout attitudes.51 47MarthaC.Monroe&DamienC.Adams, IncreasingResponseRatestoWeb-BasedSurveysTheJournalofExten- sion(JOE) (2012),http://www.joe.org/joe/2012december/tt7.php (accessedMar.4,2015);MickCouper, WebSurveys:AReviewofIssuesandApproaches ,64PUBLICOPIN.Q.464(2000);KevinB.Wright, Research- ingInternet-Based Populations: AdvantagesandDisadvantagesofOnlineSurvey Research, OnlineQuestionnaire AuthoringSoftwarePackages,andWebSurveyServices ,10J.C OMPUTER-MEDIAT.COMMUN.(2005).",Non-OADS,/arxiv_data1/oa_pdf/78/98/lsv045.PMC5033425.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/f2/1f/lsv040.PMC5033426.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"See Associated Press, Turing Reneges On Drug Price Cut, Rival’s Version Sells Well, WASH.POST, Nov. 25, 2015, https://www.washingtonpost.com/ business/economy/turing-reneges-on-drug-price-cut-rivals-version-sells-well/2015/11/25/d2c22bd8-93cd- 11e5-b5e4-279b4501e8a6 story.html .",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"5Purchasingtherightstoanolddrugisgenerallymuchcheaperthandevelopinganewdrug.TuringpaidImpax Laboratories$55milliontoacquiretherightstomarketDaraprimintheUnitedStates.ImpaxLaboratories, Impax Announces Sale of Daraprim R/circlecopyrtto Turing Pharmaceuticals AG ,http://investors.impaxlabs.com/ Media-Center/Press-Releases/Press-Release-Details/2015/Impax-Announces-Sale-of-Daraprim-to-Turing- Pharmaceuticals-AG/default.aspx (accessed Jan. 15, 2016).",OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"Tufts University, How the Tufts Center for the Study of Drug Development Pegged the Cost of a New Drug at $2.6 Billion ,http://csdd.tufts.edu/files/uploads/ coststudybackgrounder.pdf (accessedJan.14,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"13See eg Centers for Medicare & Medicaid Services, Medicare Drug Spending Dashboard 2014, https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Dashboard/ Medicare-Drug-Spending/Drug Spending Dashboard.html (accessedJan.15,2016).",OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"16CentersforDiseaseControlandPrevention, HepatitisCFAQsforthePublic ,http://www.cdc.gov/parasites/ toxoplasmosis/health professionals/ (accessedJan.14,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"22Robert Langreth & Drew Armstrong, Clinton’s Tweet on High Drug Prices Sends Biotech Stocks Down , BLOOMBERG BUSINESS,http://www.bloomberg.com/news/articles/2015-09-21/clinton-s-tweet-on-high- drug-prices-sends-biotech-stocks-down (accessedDec.30,2015).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"34TheOrganizationforEconomicCo-operationandDevelopment(OECD)isaglobalassociationof34devel- opedcountries,includingtheUnitedStates.OECD, http://www.oecd.org/ (accessedDec.30,2015).",OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"Nevertheless many scholars have argued that Medicare’s ability to negotiate drug prices would be fundamentally impaired by its inability to walk away from many ne- gotiations.44MedicarePartDisrequiredtocover‘allorsubstantiallyall’drugsinsix 36CentersforMedicare&MedicaidServices, FederalUpperLimits ,http://www.medicaid.gov/Medicaid-CHIP- Program-Information/By-Topics/Benefits/Prescription-Drugs/Federal-Upper-Limits.html (accessed Dec.4,2015).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"41M.AsifIsmail, DrugLobbySecondtoNone ,CENTER FOR PUBLICINTEGRITY,http://www.publicintegrity.org/ 2005/07/07/5786/drug-lobby-second-none (accessedDec.30,2015).",OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"See David Nather, Washington has Big Hopes, But Little Power, to Negotiate Drug Prices , STAT,http://www.statnews.com/2016/01/06/medicare-negotiate- drug-prices/ (accessedJan.9,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"46US Food and Drug Administration, FDA Works to Lessen Drug Shortage Impact ,http://www.fda.gov/ ForConsumers/ConsumerUpdates/ucm258152.htm (accessedJan.20,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"55ExpressScripts, ExpressScriptsChampions $1perPillAccesstoanAlternativeforDaraprim ,http://lab.express- scripts.com/insights/drug-options/express-scripts-champions-1-per-pill-access-to-an-alternative-for- daraprim(accessedJan.15,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"56USFoodandDrugAdministration, CompoundingandtheFDA:QuestionsandAnswers ,http://www.fda.gov/ Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm339764.htm (accessed Dec.4,2015).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"65American Pharmacists Association, Frequently Asked Questions About Pharmaceutical Compounding , http://www.pharmacist.com/frequently-asked-questions-about-pharmaceutical-compounding (accessed Jan.15,2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/8d/lsw008.PMC5033427.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/e9/5b/lsw007.PMC5033428.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"11 WhoWeAre, GlobalGenes ,http://globalgenes.org/who-we-are-2/ (lastaccessedNov.24,2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"13 Kurt Karst, FDA Law Blog: The 2014 Numbers Are In: FDA‘s Orphan Drug Program Shatters Records , http://www.fdalawblog.net/fda lawbloghymanphelps/2015/02/the-2014-numbers-are-in-fdas-orphan- drug-program-shatters-records.html (lastaccessedNov.24,2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"RAVICTI: A SHORT CASE STUDY Urea cycle disorders (UCDs) precipitate increased blood ammonia levels leading to braindamageanddeath,andoccurinapproximately1in45,000personsintheUSA.16 Owingtopioneeringworkbyacademicresearchersdatingbacktothe1970s,17how- ever, a succession of closely related treatments for UCDs have come on the market between1987and2013.Ravictiisthelatestdruginthischainofproducts.Itschemical compositiondiffersonlyslightlyfromitsprecursorproduct,anditsregulatoryapproval turnedononephase3clinicaltrial,28daysinduration,involving44patients,whichwas designedtodemonstrateRavicti’s‘non-inferiority’totheexistingtherapyBuphenyl.18 TheFDAdescribedthetrialas‘essentiallyabioequivalencetrialbetweenRavictiand thecurrentlymarketedsodiumphenylbutyrateproduct’.19Thedrug’s‘benchtomarket cost’wasreportedly‘10%ofthatofatypicaldrug’.20Yet,Ravicti’smanufacturer,Hy- perionTherapeutics,whichenteredthescenelongaftermostoftheclinicalevidence baseandprecursorproductsweredeveloped,hassetRavicti’spriceatUS$250,000– 290,000perpatientperyear.21 16 Food and Drug Administration, Center for Drug Evaluation and Research: Application Number 203284Orig1s000 Summary Review (2013),http://www.accessdata.fda.gov/drugsatfda docs/nda/2013/ 203284Orig1s000SumR.pdf (lastaccessedNov.26,2015)[hereinafter RavictiFDAReview ].",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"The Other Half is Finding a Company to Market the Drug and Seek FDA Ap- proval.BALTIMORE SUN(1996),http://articles.baltimoresun.com/1996-10-13/business/1996287173 1 urea-cycle-disorder-orphan-drug-drug-companies (lastaccessedMay16,2013).",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"27 Hyperion-Ucyclyd/Medicis Collaboration Agreement (2007), http://agreements.realdealdocs.com/ Collaboration-Agreement/COLLABORATION-AGREEMENT-1774950/ (lastaccessedNov.24,2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"29 Hyperion Therapeutics Acquires Worldwide Rights to BUPHENYL, GlobeNewswire News Room (2013), http://globenewswire.com/news-release/2013/06/03/551549/10034885/en/Hyperion-Therapeutics- Acquires-Worldwide-Rights-to-BUPHENYL.html (lastaccessedNov.26,2015).",Non-OADS,/arxiv_data1/oa_pdf/dc/f6/lsv060.PMC5033429.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"FDA, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333701.htm (accessed Jan.3,2016) 2Kelly E. Lindner, Blood of the Dragon: the Sustainable Harvest and Replanting of the Croton Lechleri Tree ,8 4 HERBALGRAM 56(2009).",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
http://www.netsci.org/Science/Special/feature11.html (accessedMar.122012).,OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"24Susan Essoyan, Activists Tear Up 3 UH Patents for Taro ,HONOLULU STAR-BULL, June 21, 2006, http://archives.starbulletin.com/2006/06/21/news/story03.html 25Schlais,supranote21,at583,citingDonnaCraig, BiologicalResources,IntellectualPropertyRightsandInterna- tionalHumanRights:ImpactsonIndigenousandLocalCommunities ,inINTELLECTUALPROPERTYANDBIOLOGICAL RESOURCES (BurtonOnged.,2005)(‘InIPlaw,developinga suigeneris IPRisdevelopinganalternativeIPR thatisgovernedbyfundamentallydifferentprinciplesandmodesofprotection.A suigeneris systemcanbea wholenewIPR,modificationofexistingIPR,oracompletelynewIPRright....In 2000,PanamapassedLaw No.20,thefirstsuigenerisindigenousIPRintheworld.ThislawgrantstoPanama’sindigenousgroupsthe “exclusive,collectiveandperpetualrightstotheircreations,inventionsandtraditionalexpressions”.’)(internal citationsomitted).",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"Since the CBD was promulgated, a further host of trade-related IPR agreements (TRIPs) were signed.37 The TRIPs agreements, initially negotiated at the General Agreement on Tariffs and Trade in 1994, were conceived as an expansion of the CBD, clarifying the minimum standardsforregulatingIPRforWorldTradeOrganization(WTO)memberstates.38 29ConventiononBiologicalDiversity, https://www.cbd.int (accessedNov.6,2015).",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"Economic and Genetic Reductionism in Biotechnology Battles , 34GEOFORUM 203,211(2003);CBD, CBDPreambleandArticle15 ,https://www.cbd.int (accessedNov.6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"35ConventiononBiologicalDiversity, ListofParties ,https://www.cbd.int/information/parties.shtml (accessed Dec.6,2015).",OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"37WorldTradeOrganization, TRIPS:AgreementonTrade-RelatedAspectsofIntellectualPropertyRights,Preamble , https://www.wto.org/english/tratop e/tripse/tagm1e.htm(accessedDec.6,2015).",Non-OADS,/arxiv_data1/oa_pdf/6a/55/lsw003.PMC5033432.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/99/c5/lsw010.PMC5033434.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/df/07/lsw004.PMC5033435.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/48/c1/lsv058.PMC5033436.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/31/c8/lsv051.PMC5033437.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"The article be- ginswithabriefdiscussionofthetechnology.PartIIthendescribesthevariousways inwhichthetechnologymightbeusedforreproductivepurposes—tocreateachild— andto‘perfect’reproduction,i.e.,torefineprenataltesting.PartIIIturnstotheissues surroundingthereproductiveand‘improvement’aspectsofIVG.Itconcludesthat,un- derarelationalaccountofautonomy,IVGisarguablypreferabletosomeformsofART https://www.newscientist.com/article/dn3688-embryonic-stem-cells-turned-into-eggs/ (lastaccessedDec.",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"3, 2015); Sylvia P. Westphal, Stem Cells Can Become ‘Normal Sperm,’ NEWSCIENTIST(May 7, 2003), https://www.newscientist.com/article/dn3700-stem-cells-can-become-normal-sperm/ (last accessed Dec. 3,2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"2013) (quoting language from AssemblyMemberFelipeFuentesofCaliforniabilltoexpandthedefinitionofinfertilitytoinclude‘social’ infertility,asdistinguishedfrom‘medical’or‘physical’infertility).Whilesomequestionthe needto distin- guishthosewhoare‘medically’or‘physically’infertilefromthosewhoare‘socially’infertile,JulieShapiro, Do WeNeedtoTalkabout‘SocialInfertility?’ ,RELATEDTOPICS(Nov.4,2013), https://julieshapiro.wordpress.",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"55Society for Assisted Reproductive Technology, Risks of In Vitro Fertilization (IVF), http://www.sart.org/FACTSHEET RisksofInVitroFertilization/ (describing the risks as including ‘mildtomoderatepelvicandabdominalpain,...injurytoorgansneartheovaries,...[and]pelvicinfection’).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"Even before this ruling, more than 35 states and the District of Columbia al- lowedsame-sexmarriage.RichardSocarides, TheComingGay-MarriageRuling ,NEWYORKER,April8,2015, http://www.newyorker.com/news/news-desk/the-coming-gay-marriage-ruling (last accessed on Dec. 3, 2015).Thesedevelopmentsdemonstratehowmuchsocialattitudesonthisissuehavechanged.",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"Sarah Knapton, Three-Parent Babies: The Arguments for and Against ,TELEGRAPH, Feb. 3, 2015, http://www.telegraph.co.uk/news/science/ science-news/11386151/Three-parent-babies-the-arguments-for-and-against.html (quoting Professor DameSallyDavies)(lastaccessedDec.3,2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"Thiswasacaseinwhichthelesbianspouse,biologicalfather,andwomanwhogavebirthallmetthecriteriato bealegalparentofthesamechild.Giventhatnoneofthemwaswellequippedtoraisethechild,thestateappel- latecourtwassympathetictothechild’sargumenttohaveallthreerecognizedasparents.Nevertheless,itheld that,‘givenmanypriorpronouncementsfromthestate’shighestcourtonthesubject,itcouldnotawardthat statustoallthree’.JoannaGrossman, CaliforniaAllowsChildrentoHaveMoreThanTwoLegalParents ,Ver- dict.justicia.com, https://verdict.justia.com/2013/10/15/california-allows-children-two-legal-parents (last accessedDec.3,2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"144William Saletan, The Case Against Polygamy ,SLATE, June 29, 2015 http://www.slate.com/articles/ newsandpolitics/politics/2015/06/is polygamy nextaftergaymarriagechiefjusticerobertsobergefell dissent.html (lastaccessedDec.3,2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"Olga Khazan, Mul- tiple Lovers, Without Jealousy, ATLANTIC, July 21, 2014, http://www.theatlantic.com/health/archive/ 2014/07/multiple-lovers-no-jealousy/374697/ (last accessed Dec. 3, 2015).",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"See Paul Rincon, GenePeeks Firm to Offer ‘Digital Baby’ Screen for Sperm Donors, BBC, Oct. 2013, http://www.bbc.com/news/science-environment-24398312 (last accessed Dec. 3, 2015); Azeen Ghorayshi, This Company is Trying to Make More Perfect Babies ,BUZZFEED, July 12, 2015, http://www.buzzfeed.com/azeenghorayshi/more-perfect-babies (lastaccessedDec.3,2015).Forlessthan $2,000,thecompanycandeterminetheriskofroughly450geneticconditionsinthe‘virtual’babiescreatedby thesedigitalmodels.Itultimatelyplanstoexpanditsanalysistoincludeabout1000diseases,includingmore complexconditionslikediabetesandschizophrenia.Anditwilleventuallyofferitsservicestofertilecouples.",Non-OADS,/arxiv_data1/oa_pdf/bb/e1/lsv057.PMC5033438.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"Bolsters Pregnancy Hope of Many , New York Times, Feb. 25, 2016. http://www.nytimes.com/2016/ 02/26/health/uterus-transplant-cleveland-clinic.html?ref=health .",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"12Wikipedia, SurrogacyLawsbyCountry ,https://en.wikipedia.org/wiki/Surrogacy lawsbycountry;European Parliament, Directorate General for Internal Policies, Policy Department C: Citizens’ Rights and Constitutional Affairs,inACOMPARATIVE STUDYONTHEREGIMEOFSURROGACY INEUMEMBERSTATES(2013)(Thisreport coversEuropeanUnionnationsaswellasSouthAfricaandAustralia).",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"H.R., HUDOC (Sept. 26, 2014), http://hudoc.echr.coe.int/ sites/eng/pages/search.aspx?i =001-145389 .",OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"John A. Robertson, ‘Surrogacy, Israel, and the Nepal Earthquake’, BILL OF HEALTH,http://blogs.law.harvard.edu/billofhealth/2015/06/04/surrogacy-israel-and-the-nepal-earthquake Countriesthatdoallowrepatriationareinessencetransferringsurrogacytaskstoothercountriesbecauseof themoralandpolicyobjectionswhichtheyhaveagainsthiringasurrogateontheirownsoiltogestateone’s child.",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"Department of Health and Human Services, Health Services Research Administration, Organ Procure- ment and Transplantation Network, (http://optn.transplant.hrsa.gov/latestData/step 2.asp )Dorry L. Segev etal,PerioperativeMortalityandLong-termSurvivalFollowingLiveKidneyDonation ,303JAMA959,969(2010) (.03%mortalityand <1%riskofmajormorbidity).",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"Joanna Sugden, India Restricts Foreigners’ Access to Surrogate Mothers ,THEWALLSTREETJOURNAL, Oct. 29, 2015,http://www.wsj.com/articles/india-restricts-foreigners-access-to-surrogate-mothers-1446132042 50Thereisastrongargumentforapresumptivemoralandlegalrighttouseassistedreproductivetechniquesto have genetically related offspring.",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"57For the United Kingdom, see Bianca Jackson, Surrogacy: A Guide to Current Law (Part 1) ,FAM.L .WK., http://www.familylawweek.co.uk/site.aspx?i =ed127038",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"68John A. Robertson, Surrogacy Contracts Directly Enforcible in Pennsylvania ,BILL OFHEALTHBLOG, 2015,http://blogs.law.harvard.edu/billofhealth/2015/11/30/surrogacy-contracts-directly-enforcible-in- pennsylvania/ 69Thailandhas barredall surrogacyfornon-citizensofThailand.India,a mainsurrogacydestination,has now beenshutdowntopreventexploitation.JoannaSugden, IndiaRestrictsForeigners’AccesstoSurrogateMothers , THEWALLSTREETJOURNAL,Oct.29,2015.",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"ThisargumentshouldalsohavesomeappealinGreatBritain,Spain,andotherna- tionswhichpermitpaideggdonationbutnotpaidsurrogacy.75True,thedonor’sand surrogate’s burdens are not exactly comparable, but paid egg donation does impose 71Joanna Sugden, India Restricts Foreigners’ Access to Surrogate Mothers; Move to Limit Service to Mar- ried Indian Couples, T HEWALLSTREETJOURNAL.S e esupranotes 48. http://www.wsj.com/articles/india- restricts-foreigners-access-to-surrogate-mothers-1446132042 (accessedOct.29,2015).",Non-OADS,/arxiv_data1/oa_pdf/fe/85/lsw011.PMC5033439.pdf
"G OV,Federal Policy for the Protection of Human Subjects ,http://www.hhs.gov/ohrp/ humansubjects/commonrule/ (accessedJan.6,2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"2COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICALSCIENCES (CIOMS), I NTERNA- TIONALETHICALGUIDELINES FOR BIOMEDICAL RESEARCH INVOLVING HUMANSUBJECTS (2002), http://www.cioms.ch/publications/layout guide2002.pdf (Book).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
";seegenerallyPcori, Patient-CenteredOutcomesResearch ,http://www.pcori.org/research-results/patient- centered-outcomes-research (accessedJan.4,2016).",OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"Use of Stored Biospecimens Biospecimensarematerialstakenfromthehumanbody—forinstance,blood,tissue, saliva,andurine—thatcanbeusedforeitherclinicalorresearchpurposes.24‘Billions’ of biospecimens are now in storage.25Because biospecimens contain a tremendous amountofbiologicalinformation,theycanbeusedbyresearcherstoidentify‘therole thatgenesplayindiseaseformation...developnewdiagnostictestsandtargetedtreat- ments for specific diseases and to investigate how genes interact with environmental factors’.26Theymayalsolaythenecessaryfoundationfor‘personalizedmedicine’,treat- mentscustomizedtoanindividual’sgeneticprofile.27 Atpresent,theCommonRuleappliestothesecondaryresearchuseofbiospecimens (meaninguseofspecimensoriginallycollectedforanotherpurpose,eitherclinicalcare http://www.hhs.gov/ohrp/sachrp/commsec/november3,2015lettertothehhssecretary.html (accessedJan4, 2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"21AnotherpossibilityisthatHHScouldissueasecondNPRMratherthanafinalrule,anapproachadvocatedby severalcommenters.SeeegPublicResponsibilityinMedicineandResearch(PRIM&R), DraftofPRIM&R’s NPRMComments ,http://www.primr.org/publicpolicy/nprmresources/ (accessedJan.4,2016).",OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"23HHS,NPRM2015—Summary ,http://www.hhs.gov/ohrp/humansubjects/regulations/nprm2015summary .html(accessedJan4.2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"24NationalCancerInstitute(NCI),BiorepositoriesandBiospecimenResearchBranch(BBRB), FAQs-NCIand Biorepositories ,http://biospecimens.cancer.gov/patientcorner/faq.asp#q1 (accessedJan.4,2016).",OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"Informed Consent Documents Asmentionedabove,therearelong-standingcomplaintsaboutinformedconsentdoc- uments, ‘namely, that they are too long, too complicated, and filled with legal text 38HHS,IRBG UIDEBOOK (1993),http://www.hhs.gov/ohrp/archive/irb/irb chapter1.htm 39Hudson&Collins, supranote7,at2295.",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"42National Institutes of Health (NIH), Request for Comments on Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research ,https://grants.nih.gov/grants/ guide/notice-files/NOT-OD-15-026.html (accessedJan.4,2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"47Eg Elisa A. Hurley, PRIM&R, Unpacking the NPRM: Single IRB Review and Continuing Review , http://blog.primr.org/nprm-single-irb-review/ (accessedJan.5,2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"48SACHRP, RecommendationsontheNoticeofProposedRulemakingentitled“FederalPolicyfortheProtectionofHu- man Subjects ,”http://www.hhs.gov/ohrp/sachrp/commsec/attachmenta:recommendationsnprmletter1/5/ 16.html(accessedJan25,2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"59CIOMS,Guidelines—PublicConsultation ,http://www.cioms.ch/index.php/guidelines-test (accessedJan.4, 2016).",OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"62CIOMS, R EVISION OF CIOMS 2002 I NTERNATIONAL ETHICALGUIDELINES FOR BIOMEDICAL RESEARCH INVOLVING HUMANSUBJECTS:DRAFTGUIDELINES (2015),http://www.cioms.ch/ images/stories/guidelines demo/AllGuidelines-1-25.pdf (accessedJan.4,2015).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
",http://www.hhs.gov/ohrp/policy/faq/informed-consent/what-does-coercion-or-undue- influence-mean.html (accessedJan.4,2016).",Non-OADS,/arxiv_data1/oa_pdf/95/ff/lsw001.PMC5033440.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/0d/5c/lsw002.PMC5033441.pdf
"7Malanga et al., supranote 2, at 7; see eg CIGNA, Prophylactic Oophorectomy or Salpingo- oophorectomy With or Without Hysterectomy ,CIGNAMEDICALCOVERAGE POLICY, Feb. 15, 2015, https://cignaforhcp.cigna.com/public/content/pdf/coveragePolicies/ medical/mm 0026 coveragepo- sitioncriteria prophylactic oopherectomy.pdf (accessed Dec. 2, 2015); United Healthcare, Genetic Testing for Hereditary Breast and/or Ovarian Cancer Syndrome (HBOC) ,UNITEDHEALTHCARE MEDICALPOLICY 3, Dec. 1, 2014, https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Proto-cols/ Medical%20Policies/C&S/ genetic testing for hereditary breast ovarian cancer syndrome hboc CS.pdf (accessedDec.2,2015).",Non-OADS,/arxiv_data1/oa_pdf/0d/5c/lsw002.PMC5033441.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/36/2d/lsw005.PMC5033442.pdf
"NAT’LPUB.RADIO, July 1, 2010, http://www.npr.org/templates/story/story.php?storyId =128043329.",Non-OADS,/arxiv_data1/oa_pdf/36/2d/lsw005.PMC5033442.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/71/2a/lsw006.PMC5033443.pdf
"(2015),http://dx.doi.org/10.1016/j.brainresbull.2015.12.003 (accessedJan.9,2016).",OADS,/arxiv_data1/oa_pdf/71/2a/lsw006.PMC5033443.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/29/ef/lsv041.PMC5033444.pdf
"2010 Census Quick Facts, http://www.census.gov/quickfacts/#table/PST045214/00 (accessedOct.7,2015).ButtheFBIcrimestatis- tics for 2010 show that they were arrested for 39% of all violent crimes (a 300% overrepresentation), 52% of all homicides (400% overrepresentation) and 56% of all robberies (430% overrepresentation).",OADS,/arxiv_data1/oa_pdf/29/ef/lsv041.PMC5033444.pdf
"43a, https://www.fbi.gov/about-us/cjis/ucr/crime-in-the-u.s/2010/crime-in-the-u.s.-2010/tables/table-43 (ac- cessedOct.7,2015).Granted,theseare arrestratesandnot conviction rates,butnationalvictimsurveyshave shownthearrestratesmirrorthecrimerates,andthatsincethemid-1970sUSblackshavebeendispropor- tionately committing violent crime, and been the disproportionate victims of it.",OADS,/arxiv_data1/oa_pdf/29/ef/lsv041.PMC5033444.pdf
"1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/iew085.PMC5033483.pdf
(http://biocontrol.ucr.edu/hoddle/ red_banded_whiteﬂy.html) Consultado: December 2015.,Non-OADS,/arxiv_data1/oa_pdf/e3/a1/iew085.PMC5033483.pdf
"5. https://extension.usu.edu/ﬁles/publications/ factsheet/degree-days08.pdf Nakahara, S. 1995.",Non-OADS,/arxiv_data1/oa_pdf/e3/a1/iew085.PMC5033483.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/90/opth-10-1779.PMC5033495.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1779–1783Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1779Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11381 4 Cosmetic and functional outcomes of frontalis  suspension surgery using autologous fascia lata  or silicone rods in pediatric congenital ptosis hsi-Wei Chung1,2 lay leng seah1,2,3 1Department of Ophthalmology,   singapore national eye Centre,   2Department of Ophthalmology, Y ong  loo lin school of Medicine, national  University of singapore, 3Department  of Clinical sciences, Duke- nUs  graduate Medical school, singaporePurpose:  Cosmetic and functional outcomes of frontalis suspension surgery using autologous  fascia lata (FL) or silicone rods (SRs) in pediatric congenital ptosis.",Non-OADS,/arxiv_data1/oa_pdf/27/90/opth-10-1779.PMC5033495.pdf
"A recent study by Lee et al found better cosmetic results and lower  recurrence rate with SRs compared to preserved FL in a Korean population.9 Their study Correspondence: hsi-Wei Chung singapore national eye Centre, 11 Third  hospital avenue, 168751, singapore Tel +65 6322 8311 Fax +65 6323 1903 email ychung77@yahoo.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Chung and Seah Running head recto: Frontalis suspension surgery using FL or SR DOI: http://dx.doi.org/10.2147/OPTH.S113814",Non-OADS,/arxiv_data1/oa_pdf/27/90/opth-10-1779.PMC5033495.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/27/90/opth-10-1779.PMC5033495.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/90/opth-10-1779.PMC5033495.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 123–127Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 123 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S109156Effects of gamma irradiation on the biomechanical  properties of peroneus tendons Christopher M Aguila1 Gaëtan J-R Delcroix2–5 David N Kaimrajh6 Edward L Milne6 H Thomas T emple5,7 Loren L Latta2,6 1Department of Biological Sciences,   Florida International University,   Miami, FL, USA; 2Department of  Orthopaedics, Miller School of Medicine, University of Miami,  Miami, FL, USA;  3Research Service &  Geriatric Research, Education, and Clinical Center, Bruce W. Carter Veterans Affairs Medical Center,  Miami, FL, USA;  4Interdisciplinary Stem  Cell Institute, University of Miami,  Miami, FL, USA;  5Vivex Biomedical Inc.,   Marietta, GA, USA; 6Max Biedermann  Institute for Biomechanics, Miami Beach, FL, USA;  7Translational  Research and Economic Development,  Nova Southeastern University, Fort-Lauderdale, FL, USAPurpose: This study was designed to investigate the biomechanical properties of nonirradiated  (NI) and irradiated (IR) peroneus tendons to determine if they would be suitable allografts, in  regards to biomechanical properties, for anterior cruciate ligament reconstruction after a dose  of 1.5–2.5 Mrad.",Non-OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
"1–4 Patellar bone-tendon-bone (PBTB) Correspondence: Christopher M Aguila Department of Research, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, USATel +1 305 674 2790Email Cagui025@fiu.eduJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Aguila et alRunning head recto: Irradiation of peroneus tendonsDOI: http://dx.doi.org/10.2147/OAJSM.S109156",Non-OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/a6/oajsm-7-123.PMC5033496.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b8/17/opth-10-1791.PMC5033498.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1791–1795Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1791Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11501 6 noninvasive detection of microaneurysms in  diabetic retinopathy by swept-source optical  coherence tomography sarah Cheng Theodore leng Department of Ophthalmology, Byers  eye institute at stanford, stanford  University school of Medicine, Palo  alto, C a, UsaBackground and objectives:  A method of identifying retinal vascular microaneurysms  (MAs) in nonproliferative diabetic retinopathy (NPDR) using swept-source optical coherence  tomography (SS-OCT).",Non-OADS,/arxiv_data1/oa_pdf/b8/17/opth-10-1791.PMC5033498.pdf
"Spectral domain OCT (SD-OCT)  is widely available, provides clear resolution of individual retinal layers, and has  been used to explore key pathological processes.9–11 In recent years, researchers  have explored the potential of using SD-OCT to detect MAs.12–14 Preliminary studies Correspondence: Theodore leng Byers eye institute at stanford,  stanford University school of Medicine,  2452 Watson Court, Palo alto,  Ca 94303, Usa Tel +1 650 498 4264 Fax +1 888 565 2640 email tedleng@stanford.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Cheng and Leng Running head recto: Diabetic retinopathy microaneurysm detection by SSOCT DOI: http://dx.doi.org/10.2147/OPTH.S115016",Non-OADS,/arxiv_data1/oa_pdf/b8/17/opth-10-1791.PMC5033498.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b8/17/opth-10-1791.PMC5033498.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/17/opth-10-1791.PMC5033498.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Research and Reports in Urology 2016:8 165–168Research and Reports in Urology Dovepress submit your manuscript | www.dovepress.com Dovepress  165 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S110658Xanthogranulomatous prostatitis with   prostato-rectal fistula: a case report and   review of the literature Liyong Xing   Zhifei Liu   Gang Deng   Huan Wang   Yanfeng Zhu   Peng Shi   Bingyue Huo   Yindong Li Department of Urology, Tangshan  People’s Hospital, Tangshan, People’s Republic of ChinaPurpose: Xanthogranulomatous prostatitis (XP) is a rare form of nonspecific granulomatous  prostatitis that can clinically mimic high-grade prostatic carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
"The glove was covered with blood when the index finger was withdrawn  Correspondence: Zhifei Liu Department of Urology, Tangshan People’s Hospital, 65 Shengli Road, Tangshan 063000, People’s Republic of ChinaEmail liuzhifei1107@163.comJournal name: Research and Reports in Urology Article Designation: CASE REPORTY ear: 2016V olume: 8Running head verso: Xing et alRunning head recto: Xanthogranulomatous prostatitis with prostato-rectal fistulaDOI: http://dx.doi.org/10.2147/RRU.S110658",Non-OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
"Research and Reports in Urology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Research and Reports in Urology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/research-and-reports-in-urology-journalResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics: Pathology, pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of urological disease.",Non-OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 168 Xing et al 13.,Non-OADS,/arxiv_data1/oa_pdf/bb/be/rru-8-165.PMC5033499.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/eb/ott-9-5693.PMC5033500.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5693–5698OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5693Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10968 3 Clinical comparative investigation of efficacy  and toxicity of cisplatin plus gemcitabine or  plus Abraxane as first-line chemotherapy for  stage III/IV non-small-cell lung cancer Dan Ai1,2 Yan Guan2 Xiu-Ju Liu2 Chu-Feng Zhang1,2 Peng wang1,2 Hong-Lu Liang1,2 Qi-Sen Guo2 1School of Medicine and Life Sciences,  University of Jinan-Shandong Academy  of Medical Sciences, China; 2Shandong  Cancer Hospital affliated to Shandong  University, Shandong Academy of  Medical Sciences, Jinan, Shandong, ChinaPurpose:  The purpose of this study was to observe the clinical efficacy and toxicity of cisplatin  in combination with gemcitabine or Abraxane as first-line chemotherapy for stage III/IV non- small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/30/eb/ott-9-5693.PMC5033500.pdf
"Keywords:  cisplatin, Abraxane, gemcitabine, advanced non-small-cell lung cancer, chemotherapy Introduction Lung cancer is one of the most common malignant tumors, of which advanced  non-small-cell lung cancer (NSCLC) accounts for ~80%–85%.1 Nearly 75%–80% of Correspondence: Qi-Sen Guo Shandong Cancer Hospital affiliated to  Shandong University, Shandong Academy  of Medical Sciences, 440 Jiyan Road, Jinan  250117, Shandong, China Tel +86 156 2406 5976 email m15624065976@163.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Ai et al Running head recto: Cisplatin in combination with gemcitabine or Abraxane for NSCLC DOI: http://dx.doi.org/10.2147/OTT.S109683",Non-OADS,/arxiv_data1/oa_pdf/30/eb/ott-9-5693.PMC5033500.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/30/eb/ott-9-5693.PMC5033500.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/eb/ott-9-5693.PMC5033500.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/2e/opth-10-1785.PMC5033501.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1785–1790Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1785Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11018 0 agreement of noninvasive tear break-up time  measurement between T omey r T -7000  auto refractor-Keratometer and Oculus  Keratograph 5M ryan lee1,2  sharon Yeo1 han T un aung3 louis T ong1,2,4,5 1Ocular surface research group,   singapore eye research institute,   2Y ong loo lin school of Medicine,   national University of singapore,   3school of health sciences, ngee  ann Polytechnic, 4Duke-n Us  Medical school, singapore; 5Cornea  and external eye Disease service,   singapore national eye Centre,   singaporeBackground:  It is difficult to standardize assessment of dry eye in different clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/e4/2e/opth-10-1785.PMC5033501.pdf
"Keywords:  tear break-up time, tear film, Oculus Keratograph, Tomey RT-7000, dry eye Introduction Dry eye syndrome is a multifactorial disorder of the ocular surface with significant  health care burden, causing ocular discomfort, visual disturbance, and tear film  instability with potential damage to the ocular surface.1,2 The tear film nourishes the  avascular cornea and also contributes to the refractive power of the eye.3,4 An unstable  tear film that breaks down rapidly in between blinks results in excessive exposure of  the cornea, leading to devitalized corneal epithelium and visual disturbances.4 Tear  film instability is hence a key feature of dry eye.Correspondence: louis Tong Cornea and external eye Disease service,  singapore national eye Center, 11 Third  hospital avenue, singapore 168751 Tel +65 6227 7255  Fax +65 6322 4599 email louis.tong.h.t@snec.com.s g Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lee et al Running head recto: Agreement of noninvasive tear break-up time measurement DOI: http://dx.doi.org/10.2147/OPTH.S110180",Non-OADS,/arxiv_data1/oa_pdf/e4/2e/opth-10-1785.PMC5033501.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e4/2e/opth-10-1785.PMC5033501.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/2e/opth-10-1785.PMC5033501.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5721–5727OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5721Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10051 8 Proton beam therapy: clinical utility and current  status in prostate cancer Kosj Yamoah Peter AS Johnstone Radiation Oncology Department,   Moffitt Cancer Center and Research  institute, Tampa, FL, USAAbstract:  Proton beam therapy has recently become available to a broader population base.",Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
"Both X-rays and gamma rays  provide photons; these completely penetrate the target and may be captured on film Correspondence: Peter AS Johnstone Radiation Oncology Department,  Moffitt Cancer Center and Research  institute, 12902 Magnolia Drive, Tampa,  FL 33612, USA email Peter.Johnstone@Moffitt.or gJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Y amoah and Johnstone Running head recto: Proton beam therapy DOI: http://dx.doi.org/10.2147/OTT.S100518",Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
Available from: http://www.proton-therapy.org/map.htm.,Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/c3/ott-9-5721.PMC5033502.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e4/3a/ott-9-5713.PMC5033503.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 5713–5720OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5713Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11021 9 a negative regulation loop of long noncoding rna   hOTair and p53 in non-small-cell lung cancer nailiang Zhai1 Y ongfu Xia1 rui Yin2 Jinping liu3 Fuquan gao1 1Department of respiratory Medicine,   affiliated hospital of Binzhou  Medical University, 2Department  of respiratory Medicine, People’s  hospital of Binzhou city, 3Department  of Pharmacology, Binzhou Medical  University, Binzhou, shandong,   People’s republic of chinaAbstract:  Non-small-cell lung cancer (NSCLC) is one of the leading causes of cancer-related  death worldwide, and the 5-year survival rate is still low despite advances in diagnosis and  therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/e4/3a/ott-9-5713.PMC5033503.pdf
"When activated, p21 inhibits CDK1, CKD2, and CDK4/6 complex, result - ing in cell cycle arrest at G1 and S phases.12 New clinical research indicates that the correspondence: Fuquan gao Department of respiratory Medicine,  Affiliated Hospital of Binzhou  Medical University, 661 huanghe  2nd road, Binzhou, shandong,  256603, People’s republic of china Tel +86 543 325 8728 email fuquan_gao@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhai et al Running head recto: P53 and HOTAIR regulation loop in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S110219",Non-OADS,/arxiv_data1/oa_pdf/e4/3a/ott-9-5713.PMC5033503.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/3a/ott-9-5713.PMC5033503.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/3a/ott-9-5713.PMC5033503.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/f1/main.PMC5033506.pdf
Contents lists available at ScienceDirect Case Reports in Women's Health journal homepage: www.elsevier.com/locate/crwh http://dx.doi.org/10.1016/j.crwh.2015.09.0012214-9112/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/f1/main.PMC5033506.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/f1/main.PMC5033506.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/da/2f/lst001.PMC5033517.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"2HUMANHEREDITY AND HEALTH IN AFRICA(H3AFRICA)INITIATIVE,http://www.h3africa.org/ (accessed 1November2013).H3Africaisanongoingglobalefforttoapplygenomicscienceandassociatedtechnologies to furtherunderstandthebiologicalandenvironmentaldeterminantsofcommondiseaseswiththegoalof improvingthehealthofAfricanpopulations.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"31000G ENOMESPROJECT,http://www.1000genomes.org (accessed2November2013).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"4INTERNATIONAL CANCERGENOMECONSORTIUM (ICGC),http://www.icgc.org (accessed2November2013).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"5INTERNATIONAL RAREDISEASESRESEARCH CONSORTIUM (IRDiRC), http://www.irdirc.org (accessed 2November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"6ELECTRONIC MEDICALRECORDS AND GENOMICS(eMERGE) N ETWORK,http://emerge.mc.vanderbilt.edu/ (accessed2November2013).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"7DATABASE OF GENOTYPES AND PHENOTYPES (DBGAP), http://www.ncbi.nlm.nih.gov/gap/ (accessed 30October2013).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"8EUROPEANBIOINFORMATICS INSTITUTE,http://www.ebi.ac.uk/(accessed30October2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"9DNAD ATABANK OFJAPAN,http://www.ddbj.nig.ac.jp/(accessed30October2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeealsoEuropeanCommission,EuropeanResearchInfrastructureConsortium(ERIC), http://ec.europa.eu/research/infrastructures/index en.cfm?pg=eric (accessed7January2014).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"11White Paper, Creating a Global Alliance to Enable Responsible Sharing of Genomic and Clinical Data (3 June2013), http://oicr.on.ca/files/public/White paper20130603FINAL.pdf (accessed7January2014) [hereinafter,WhitePaper].",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Agency, Draft Policy 70: Publication and Access to Clinical-Trial Data (proposed 24 June 2013),http://www.ema.europa.eu/docs/en GB/document library/Other/2013/06/WC500144730.pdf (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"ASS’N,WORLDMEDICALASSOCIATION DECLARATION OF HELSINKI:ETHICALPRINCIPLES FOR MEDICALRE- SEARCHINVOLVING HUMANSUBJECTS(1964) (amended 2013), http://www.wma.net/en/30publications/ 10policies/b3/ (accessed 7 January 2014) [hereinafter D ECLARATION OF HELSINKI]; THENAT’LCOMM’N FOR THE PROT.OFHUMANSUBJECTS OF BIOMEDICAL &BEHAVIORAL RESEARCH,THEBELMONTRE- PORT:ETHICALPRINCIPLES AND GUIDELINES FOR THE PROTECTION OF HUMANSUBJECTS OF RESEARCH (1979),http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"(forthcoming,2014), http://www.nature.com/ejhg/journal/vaop/ncurrent/ full/ejhg2013131a.html (accessed6January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"22SeiichiMorietal., UtilizationofGenomicSignaturestoIdentifyPhenotype-SpecificDrugs ,4PLoSOnee6772 (2009),http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006772 (accessed 7 January2014);GeoffreyS.Ginsburg, RealizingtheOpportunitiesofGenomicsinHealthCare ,309JAMA1463 (2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Wethinkthatthelegalregulationofethicsreview,whenperceivedorimplemented asthesoleregulatorytooltouse,presentsintractableproblemsfor21stcenturyhealth 25COLLABORATIVE ONCOLOGICAL GENE-ENVIRONMENT STUDY,http://www.cogseu.org/ (accessed1November 2013).SeealsoEditorial,OpentoInterpretation ,31NatureBiotech.661(2013).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"26Heather Widdows, Between the Individual and the Community: The Impact of Genetics on Ethical Models ,2 8 NewGenet.&Soc.173,175(2009)(‘Theethicalfocusofbioethicsis(orhasbeen)almostexclusivelythe individual.’); O NORAO’NEILL,BROADENING BIOETHICS:CLINICALETHICS,PUBLICHEALTH AND GLOBAL HEALTH,NUFFIELDCOUNCIL ON BIOETHICSLECTURE(24 May 2011), http://www.nuffieldbioethics.org/ sites/default/files/files/Broadening bioethics clinicalethicspublichealth&globalhealth.pdf (‘[M]odern medical ethics has been radically individualistic.’) (accessed 7 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"32Bartha M. Knoppers et al., Towards a Data Sharing Code of Conduct for International Genomic Research , 3GenomeMed.46(2011), http://genomemedicine.com//content/3/7/46 (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"37PUBLICPOPULATION PROJECT IN GENOMICS AND SOCIETY(P3G),http://www.p3g.org/ (accessed 3November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"44Witness,forexample,thedevelopmentofReg4ALL( https://www.reg4all.org/ ),awebsiterunbythenon- profitGeneticAlliancethatgivespatientspersonalprivacycontrolsandgreatersayinhowtheirdataisused formedicalresearch.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"46AmyA.Lemkeetal., PublicandBiobankParticipantAttitudestowardGeneticResearchParticipationandData Sharing,13Pub.HealthGenomics368,374(2010)(findingthatparticipantsinfocusgroupsidentifiedtrust inaresearchorganization‘asakeypositiveinfluencetoparticipationingeneticresearch.’) 47JantinadeVriesetal., EthicalIssuesinHumanGenomicsResearchinDevelopingCountries ,12BMCMed.Ethics 5(2011), http://www.biomedcentral.com/1472-6939/12/5 (accessed7January2014);NancyE.Kass, The Structure and Function of Research Ethics Committees in Africa: A Case Study , 4 PLoS Medicine e03 (2007), http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0040003 (accessed7Jan- uary2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"50MALARIAGENOMICEPIDEMIOLOGY NETWORK(MALARIAGEN),http://www.malariagen.net/ (accessed 5November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"52WORLDHEALTHORG., STRATEGIC INITIATIVE FOR DEVELOPING CAPACITY IN ETHICALREVIEW, http://www.who.int/sidcer/en/ (accessed1November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Althoughthismulti-stepprocessandoverallstrategywasultimatelysuccessfulinse- curingthefirststepinethicalapprovalandlaunchingtheprojectontime,thelaunching oftheprojectdoesnotimplythateverypartwillbeapproved.Furthermore,theprocess 75BREASTCANCERASSOCIATION CONSORTIUM ,http://ccge.medschl.cam.ac.uk/consortia/bcac/ (accessed 31October2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeeNationalHealthandMedicalResearchCouncil,NationalEthicsAp- plicationForm, https://www.neaf.gov.au/default.aspx (accessed7 January 2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"H EALTHRESEARCH COUNCIL OF NEWZEALAND, http://www.hrc.govt.nz/ethics-and-regulatory (accessed 3 November 2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Additionally, the National EthicsAdvisoryCommitteeindependentlyadvisestheNewZealandMinisterofHealthonethicalissuesre- latedtohealthanddisabilityresearchandservicesanddeterminesnationallyconsistentethicalstandards.N A- TIONALETHICSADVISORYCOMMITTEE ,http://neac.health.govt.nz/ (accessed1November2013).Applying for HDEC review requires the completion of a national application form.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeeHealth and Disability Ethics Committees, HDEC Form, http://ethics.health.govt.nz/system/files/documents/pages/HDEC-form.doc (accessed6January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"91LACOMMISSION NATIONALE DE L ’INFORMATIQUE ET DES LIBERT ´ES,http://www.cnil.fr/accessible/non/ (ac- cessed2November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"94DEP’TVET.AFFAIRS,VACENTRALIRB,http://www.research.va.gov/vacentralirb/ (accessed7January2014).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"95CAN.INST.HEALTHRESEARCH,NATURALSCI.&ENG’GRESEARCHCOUNCILOF CANADA&SOC.SCI.&HUMAN- ITIESRESEARCHCOUNCIL OF CANADA,TRI-COUNCILPOLICYSTATEMENT :ETHICALCONDUCT FOR RESEARCH INVOLVING HUMANS,http://www.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/ (ac- cessed7January2014)[hereinafterTCPS].",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Seegenerally EuropeanCommission,CommissionDecisionsontheAdequacyoftheProtection ofPersonalDatainThirdCountries, http://ec.europa.eu/justice/data-protection/article-29/index en.htm (accessed5November2013).Todate,theEuropeanCommissionhasrecognizedtheadequacyofdatapro- tectionlawsofAndorra,Argentina,Australia,Canada,Switzerland,FaeroeIslands,Guernsey,StateofIsrael, IsleofMan,Jersey,theUSDepartmentofCommerce’sSafeHarborPrivacyPrinciples,andthetransferofAir PassengerNameRecordtotheUnitedStates’BureauofCustomsandBorderProtection.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"Hearing on 22/23 February 2000, http://www.europarl.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"The CBPR System consists of several core documents.125‘Accountability Agents’ areapprovedbyAPECtoreview,certify,monitor,andenforcetheprivacypracticesof participatingcompaniestoensurecompliancewithCBPRrequirements.OnceanAc- countabilityAgentcertifiesacompany,itsprivacypoliciesandpracticesbecomebind- ingastothatcompanyandwillbeenforceablebyanappropriateauthority,suchasa regulator.Thoughavoluntaryandself-regulatoryinitiative,anenforceablecodeofcon- ductgovernsthebehaviorofparticipatingcompanies(forexample,theFederalTrade CommissionisthedesignatedenforcementauthorityfortheUS).Todate,theUSand MexicohavebeenacceptedasCBPRSystemparticipatingeconomies.126 Asafeharborframeworkcanalsoapplytoresearchethicsreview.Forexample,the USalreadyhasasafeharbor-typearrangementinitsCommonRule:‘[I]faDepartment orAgencyheaddeterminesthattheproceduresprescribedbytheinstitutionaffordpro- tectionsthatareatleastequivalenttothoseprovidedinthispolicy,theDepartmentor Agencyheadmayapprovethesubstitutionoftheforeignproceduresinlieuofthepro- ceduralrequirementsprovidedinthispolicy.’127Itisintriguingwhythissubsectionhas satdormantsinceitsimplementationin1991.128AccordingtotheSecretary’sAdvisory CommitteeonHumanResearchProtections(SACHRP): [T]here have been no determinations of equivalent protections, even as re- searchhasglobalizedandseveralcountrieshavedevelopedrobusthumansub- jects protection and regulatory mechanisms, consistent with their own na- tional laws and cultural values, and requested that (the OHRP) deem their 122Seegenerally EXPORT.GOV,http://export.gov/Safeharbor/ (accessed5November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"123APECElec.CommerceSteeringGrp.,APECCross-BorderPrivacyRulesSystem:Policies,Rules,Guidelines, http://www.apec.org/Groups/Committee-on-Trade-and-Investment/˜/media/Files/Groups/ECSG/ CBPR/CBPR-PoliciesRulesGuidelines.ashx (accessed7January2014)[hereinafterAPECCBPRSystem].",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"124APEC Privacy Framework, http://www.apec.org/Groups/Committee-on-Trade-and-Investment/ ∼/ media/Files/Groups/ECSG/05 ecsgprivacyframewk.ashx (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"126APECElec.CommerceSteeringGrp., ConsumerProtectioninAsia-PacificGetsBoostasMexicoJoinsPrivacy Regime,APEC(16January2013), http://www.apec.org/Press/News-Releases/2013/0116 cbpr.aspx.On7 June2013,theJapanesegovernmentsubmittedanapplicationtoparticipateintheCBPRSystem.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeeToshio Aritake,JapanMinistryFilesApplicationtoJoinAPECCross-BorderPrivacyRulesSystem,B LOOMBERG BNA (18June2013), http://www.bna.com/japan-ministry-files-n17179874584/ (accessed7January2014).",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"on Human Research Protections, SACHRP Minutes (19–20 July 2011), http://www.hhs.gov/ohrp/sachrp/mtgings/mtg07-11/july2011minutes.pdf.pdf (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"131THEINTERNATIONAL CONFERENCEON HARMONISATIONOF TECHNICAL REQUIREMENTSFOR REGISTRATIONOF PHARMACEUTICALSFOR HUMANUSE(ICH),http://www.ich.org (accessed6November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"139BattelleMem’lInst.,2013GlobalFundingR&DForecast, http://www.battelle.org/docs/default-document- library/2013-R-and-D-Funding-Forecast.pdf?sfvrsn=4#page=3 (accessed7January2014);TheWorldBank, 2013StatesandMarkets,WorldDevelopmentIndicators:ScienceandTechnology, http://data.worldbank.",OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"(L121)37(EC), http://www.eortc.be/Services/Doc/clinical-EU- directive-04-April-01.pdf (accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeeCONSENTTO RESEARCH, http://weconsent.us/ (accessed4November2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"1, 27 (2010); Hogan Lovells Privacy Team, US-EU Safe Harbor Under Pressure ,PRIVACYTRACKER(2 August 2013), https://www.privacyassociation.org/privacy tracker/ post/useusafeharborunderpressure(accessed 7 January 2014) (quoting Viviane Reding, European Commissioner for Justice, Fundamental Rights and Citizenship, as finding that the Safe Harbor ‘may not besosafeafterall’andthattheEuropeanCommissionplanstoconductafullreviewofSafeHarborbythe endof2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"SeealsoEuropeanCommission,RestoringTrustinEU-USdataflows-FrequentlyAskedQues- tions(27November2013), http://europa.eu/rapid/press-release MEMO-13-1059 en.htm(callingonU.S.",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"187Dep’t of Commerce, U.S.-EU Joint Statement on Privacy from EU Commission Vice-President Viviane Reding and U.S. Commerce Secretary John Bryson (19 March 2012), http://www.commerce.gov/news/ press-releases/2012/03/19/us-eu-joint-statement-privacy-eu-commission-vice-president-viviane-re (acces- sed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"191ConstitutionoftheWorldHealthOrganization,art.II, §§a,b,22July1946,62Stat.2679,14U.N.T.S.185, http://www.who.int/governance/eb/who constitution en.pdf(accessed7January2014).",Non-OADS,/arxiv_data1/oa_pdf/b5/b4/lst002.PMC5033519.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/26/79/lst005.PMC5033520.pdf
"KEYWORDS: brain stimulation, harm reduction, regulation, transcranial direct current stimulation, cognitive enhancement devices, technology policy C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/ad/03/lsu018.PMC5033527.pdf
"4tDCSSubreddit, tDCSSubreddit, http://www.reddit.com/r/tDCS/ (lastaccessedJune,2014).",OADS,/arxiv_data1/oa_pdf/ad/03/lsu018.PMC5033527.pdf
"http://www.scientificamerican.com/article/should-we-use-devices-to-make-us-smarter/ ?&WT.mc id=SAMB20140205 8http://www.foc.us at oxford university press on August 9, 2016 http://jlb.oxfordjournals.org/ Downloaded from",Non-OADS,/arxiv_data1/oa_pdf/ad/03/lsu018.PMC5033527.pdf
"AEONMAGAZINE, Sept. 6, 2014. http://aeon.co/ magazine/psychology/would-dabbling-in-cranial-stimulation-make-me-smarter/ 12RoiC.Kadoshetal., ModulatingNeuronalActivityProducesSpecificandLong-lastingChangesinNumericalCom- petence,20C URR.BIOL.2016,2020(2010).",Non-OADS,/arxiv_data1/oa_pdf/ad/03/lsu018.PMC5033527.pdf
"KEYWORDS: cognitiveenhancementdevices,medicaldevices C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/ee/8b/lsu017.PMC5033528.pdf
"This is an Open Access article distributed under the terms of the Cre- ative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc- nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"2John F. Sargent, Jr., Federal Research and Development Funding: FY2013 , Congressional Research Service, https://www.fas.org/sgp/crs/misc/R42410.pdf (lastaccessedSep13,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Science Agencies Get Some Relief in 2014 Budget ,SCIENCEMAGAZINE, Jan. 14, 2014, http://news.sciencemag.org/funding/2014/01/u.s.-science-agencies-get-some-relief-2014-budget (last ac- cessedSep13,2014).Theproposedfederalbudgetfor2013includes$29.9billionforNIHfunding,$16.9 billioninfundingforNASA,and7.2billioninfundingfortheNSF.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"4Jeanne Sahadi, 43% Pay No Federal Income Taxes, CNNM ONEY, Aug. 29, 2013, http://money.cnn.com/ 2013/08/29/pf/taxes/who-doesnt-pay-federal-income-taxes/ (last accessed Sep 13, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"See also Chuck Marr & Chye-Ching Huang, Misconceptions and Realities about Who Pays Taxes , (2013), http://www.cbpp.org (lastaccessedSep13,2014);U.S.CensusBureau, StateandCountryQuickFacts ,U.S. CensusBureauWebsite, http://quickfacts.census.gov/qfd/states/00000.html (lastaccessedSep13,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"5NationalScienceFoundation, Chapter5.AcademicResearchandDevelopment ,NationalScienceFoundation Website,http://www.nsf.gov/statistics/seind12/c5/c5h.htm (lastaccessedSep13,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Nearly 1.8 million articles would have been producedintheUnitedStates, http://firstmonday.org/article/view/2309/2163 (lastaccessedDec9,2014).",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"8R&D Magazine, Global Funding of R&D ,R & D M AGAZINE, Dec. 9, 2013, http://www.rdmag.com/ articles/2013/12/global-funding-r-d .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"This funding includes R&D investment, as well as governmental sci- encefunding,includingdefenseinvestments.GlobalgrossdomesticexpenditureonR&D(GERD)is$1576 billion,andtheUnitedStatesGERDis$465billion(publishablescience13percentoftotal).SeealsoInter- nationalMonetaryFund, WorldEconomicOutlook:Hopes,Realities,Risks, InternationalMonetaryFundOrg., http://www.imf.org/external/pubs/ft/weo/2013/01/pdf/text.pdf .GlobalGDPgrowthfor2014isapprox- imatedatabout4percentfrom3percentin2013.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"4, 2011), http://www.idea.org/blog/2011/04/04/open-access-journals-stats-by-field-key-facts/ .Thispublishingalso includesself-archiving,whichdoesnotincludepeerreview.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"115, 128 (2001), http://www.ncbi.nlm.nih.gov/pubmed/11319423 .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"12PerO.Seglen, WhytheImpactFactorofJournalsShouldNotBeUsedforEvaluatingResearch ,314BMJ498, 502 (1997), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2126010/ (last accessed Sep 12, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"18See,e g ,Royal Society Publishing, Open Access , Royal Society Publishing Website (2014), http:// royalsocietypublishing.org/open-access (describingtheOAoptionsfortraditionaljournals,listingOAjour- nals, and listing a discount cost for institutions to publish OA); Royal Society of Chemistry, Open Ac- cess at the RSC , Royal Society of Chemistry (2014), http://www.rsc.org/publishing/journals/openscience (describing the OA option for traditional journals, including paying a fee as an alternate to a tradi- tionalmodel);andElsevierWebsite, Agreements ,ElsevierWebsite(2014), http://www.elsevier.com/about/ open-access/open-access-policies/funding-body-agreements (listingeachjournalandspecificpublishingop- tionsforeach,forexampleself-archivinglimitationsandwhetherthejournalisOAorOAfriendly).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"19MarkWare&MichaelMcCabe, TheSTMReport:AnOverviewofScientificandScholarlyJournalPublishing , STMAssociationWebpage(Nov.2012), http://www.stm-assoc.org/2012 1211STMReport2012.pdf 20Heather Morrison, Freedom for Scholarship in the Internet Age (Jan. 21, 2012) (unpublished Ph.D. dissertation, School of Communication, Simon Fraser University) (on file with author), http://pages.cmns.sfu.ca/heather-morrison/open-thesis-draft-introduction-march-2011/ .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"M ED.LIBR.ASS’N255, 257 (2011), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133891/ .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"telegraph.co.uk/finance/2890544/MPs-damn-profits-of-scientific-publishers.html 23Bill Cope & Mary Kalantzis, Signs of Epistemic Disruption: Transformation of the Knowledge SystemoftheAcademicJournal ,14FIRSTMONDAY(2009),http://firstmonday.org/htbin/cgiwrap/bin/ojs/ index.php/fm/article/view/2309/2163 seesupranote7.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"24Kenneth Rochel de Camargo, Jr., The Publishing Industry Against Open Access Journals, 46 REV.SA´UDE P´UBLICAS¨AOPAULO(2012),http://dx.doi.org/10.1590/S0034-89102013005000006 (last accessed April 20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"See also George Monbiot, Academic Publishers Make Murdoch Look Like a Socialist , THEGUARDIAN, Aug. 29 2011, http://www.theguardian.com/commentisfree/2011/aug/29/academic- publishers-murdoch-socialist .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"ASS’N255, 258 (2011), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133891/ .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"4, 2012), http://www.fromthebottomoftheheap.net/2012/03/04/the-cost-of-subscribing-to-academic- journals/.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"27Peter Suber, Open Access Overview , Peter Suber Website (Dec. 16, 2013), http://legacy.earlham.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"edu/∼peters/fos/overview.htm 28Ted Bergstrom & Preston McAfee, Journal Cost-Effectiveness 2011, Journal Prices Website (2011), http://journalprices.com/ 29Harvard University, Functional Classification of Operating Expenses , Harvard University Financial Report Fiscal Year 2010 (2010), http://cdn.wds.harvard.edu/fad/2010 fullfinreport.pdf (last accessed April 20, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"30IanSample, HarvardUniversitySaysItCan’tAffordJournalPublishers’Prices ,THEGUARDIAN,Apr.24,2012, http://www.theguardian.com/science/2012/apr/24/harvard-university-journal-publishers-prices 31Eric Priest, Copyright and the Harvard Open Access Mandate ,1 0N WJ .T ECH.INTELL.PROP.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"1 (2012), http://scholarlycommons.law.northwestern.edu/cgi/viewcontent.cgi?article=1172&context=njtip .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"See also Ray Delgado,Faculty Senate Approves Resolution Regarding Pricey Journals , Stanford Report, (Feb. 25, 2004), http://news.stanford.edu/news/2004/february25/journals-225.html (describing Stanford University’s Senate’spolicyagainstpublishinginReedElseviertitles);PaulS.Lapinskietal., SupportingPublicAccessto ResearchResults ,75C.R ES.LIBR.20(2014), http://crl.acrl.org/content/75/1/20.full.pdf+html (describing broadresearchlibraryinvolvementinchampioningtheNIHOAmandate).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"32SPARC,OpenAccessFunds ,SPARCWebsite, http://www.sparc.arl.org/initiatives/funds .TheScholarlyPub- lishingandAcademicResourcesCoalition(SPARC)jump-startedmanyuniversityOAjournals.",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"33WoltersKluwer, AboutMedknow ,WoltersKluwerHealthWebsite, http://www.medknow.com/aboutus.asp 34RichardWellen, OpenAccess,Megajournals,andMOOCs:OnthePoliticalEconomyofAcademicUnbundling , SAGEO PEN(2013), DOI:10.1177/2158244013507271.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"36Jeffrey Beall, List of Predatory Publishers 2014 , Scholarly Open Access: Critical Analysis of Scholarly Open-Access Publishing Website (Jan. 2, 2014), http://scholarlyoa.com/2014/01/02/list-of-predatory- publishers-2014/ .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"39TheodoreC.Bergstrom&CarlT.Bergstrom, Can‘AuthorPays’JournalsCompetewith‘ReaderPays?’ Nature Website(2004), http://www.nature.com/nature/focus/accessdebate/22.html 40Directory of Open Access Journals, Search, DOAJ Website (2014), http://www.doaj.org/search .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"THE NIH FUNDING CONTRACT BiologicalscienceandmedicalresearchersfundedbytheNIHmustdepositfinal,pub- lished articles in PubMed Central (‘PubMed’), a green OA repository, one of many fundingtermsrequiredbytheNIH.Asthelargestrecipientofsciencefundingoutside oftheDepartmentsofEnergyandDefense,theNIHsethighstandardstoqualifyforre- searchfunding.Grantproposalsmustpassarigorousevaluationprocessincludingtwo roundsofpeerreviewandscoring.45OncetheresearcherbecomesaPrincipalInvesti- gator(PI),46thePImustfulfillalloftheobligationsspecifictothegrant,includingany termsandconditionsrequiredtousefederalfundsforresearch.47Thesetermsandcon- ditionsrequiredepositingpeer-reviewed,publishedarticlesinPubMedCentralwithin 41See,e g ,Open Society Foundations, Open Access Initiative , OSF Website (Nov. 13, 2012), http://www.opensocietyfoundations.org/grants/open-access-initiative ; Budapest Open Access Initiative, Grants, Budapest Open Access Initiative Website, http://www.budapestopenaccessinitiative.org/grants ; Wellcome Trust, Wellcome Trust Open Access Funding , Wellcome Trust Website, http://www.wellcome.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"ac.uk/about-us/policy/spotlight-issues/Open-access/Guides/wtx036803.htm 42MichaelW.Carroll, CreativeCommonsandtheOpennessofOpenAccess ,368NEWENG.JMED.789,791(2013), http://www.nejm.org/doi/full/10.1056/NEJMp1300040 43Id.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"45Office of Extramural Research, National Institutes of Health, Grants & Funding: Award Management ,N I H Website,http://grants.nih.gov/grants/managing awards.htm#overview 46APIistypicallyresponsibleformeetingalloftherequirementsofthegrantproposal,includingtermsandcon- ditions,regardlessofwhetherornotthePIhimself/herselfactuallycompletesresearchorwritestheresulting academicarticle.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"In 1887 Congress passed the Tucker and Little Tucker Acts, waiving a sovereign immunity defense in 48OfficeofExtramuralResearch,NationalInstitutesofHealth, Grants&Funding:8.2AvailabilityofResearch Results:Publications,IntellectualPropertyRights,andSharingResearchResources ,NIHGrantsPolicyStatement (2012),http://grants.nih.gov/grants/policy/nihgps 2012/nihgps ch8.htm# Toc271264948 49Public Access to NIH Research Made Law , Science Codex Website (2007), http://www.sciencecodex.com/ publicaccessmandatemadelaw 50SeeNationalInstitutesofHealthPublicAccess, infranote53.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"51Executive Office of the President National Science and Technology Council, Interagency Public Access Coordination: A Report to Congress on the Coordination of Policies Related to the Dissemination and Long- Term Stewardship of the Results of Federally Funded Scientific Research, Whitehouse.gov Website (2012), at12,http://www.whitehouse.gov/sites/default/files/microsites/ostp/public access-final.pdf .Seventy-five percentcomplianceillustratesastrongresponseofPIstorequiredversus‘recommended’termsand,likely, increasedawarenessthroughNIHmonitoringandresponsetonon-compliance.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"53National Institutes of Health Public Access, NOT-OD-12-160: Upcoming Changes to Public Access Pol- icy Reporting Requirements and Related NIH Efforts to Enhance Compliance , NIH Website (2012), http://grants.nih.gov/grants/guide/notice-files/NOT-OD-12-160.html",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"372 (1966), http://scholarship.law.duke.edu/cgi/viewcontent.cgi?article=2031&context=dlj ; Department ofHealthandHumanServices, PA-13-347:NIHSupportforConferencesandScientificMeetings, NIHWebsite, http://grants.nih.gov/grants/guide/pa-files/PA-13-347.html ;AlissaMarque, ANewAppealsBoard:Provid- ing Consistency and Clarity in the Growing World of Grants and Cooperative Agreements ,4 1PUB.CONT.L .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"§§6301-6308(1977).SeealsoChrisJensen, GrantsandCooperativeAgreements:WolvesinSheep’s Clothing, Attorney.com, http://www.attny.com/gci01983.html .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"65DannyKingsley, A SmallBill in the US, A GiantImpact for Research Worldwide , The ConversationWebsite (Jan. 26, 2012), http://theconversation.com/a-small-bill-in-the-us-a-giant-impact-for-research-worldwide- 4996.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"68Stephen Palmer & David J. Torgerson, Definitions of Efficiency , 318 BMJ 1136, http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"775 (1981), http://chicagounbound.uchicago.edu/cgi/viewcontent.cgi?article=2821& context=journal articles.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"71Thomas J. Miceli, The Use of Economics for Understanding Law: An Economist’s View of the Cathedral, University of Connecticut Department of Economics Working Paper Series, at 7, http://ideas.repec.org/p/uct/uconnp/2011-25.html (last accessed Sep 12, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Producers Producers in today’s economic scenario are PIs and other researchers conducting fundedresearchandpublishingresults.Despitetheobviousbenefitsofpublishingin anOArepositoryduetoworldwideaccessibilityanddisseminationandanNIHcon- tractualrequirementtodeposit,researchersranktheirpreferences,seekingtomaximize theirownbenefitand‘dedicateresources’toachievetheirownobjectives.Theprimary 72John Houghton, Bruce Rasmussen & Peter Sheehan, Economic and Social Returns on Invest- ment in Open Archiving Publicly Funded Research Outputs , Report to SPARC (July 2010) at 4, 8, http://sparc.arl.org/sites/default/files/vufrpaa.pdf 73Id.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"75Seegenerally,S.Harnad, OAImpactAdvantage =EA+(AA)+(QB)+QA+(CA)+UA ,EprintsWebsite (2005),http://eprints.ecs.soton.ac.uk/12085/ (describing the advantages for OA articles against non-OA versions).",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"objectiveincludespublishinginahandfulofprestigiousjournalstoreceiveacademic creditthroughhigh-impactpublication,themarchtowardstenure.77 Researcherswhopublishinthesejournalsreceivenopaymentforthearticlesand oftenlosepublication,reproduction,andderivativerights,typicallyforthelifeofthe copyright,tothepublisher,unlesstheresearcherpaysanadditionalfeeorhasreputa- tionalbargainingpower.Becauseonly10percentofjournalsareOA,alargemajorityof journalswillnotprovideimmediateaccesstoresearchpublication,andevenwithOA, manyauthorsretainfewrightswithrespecttoself-archiving,derivativeworks,ordistri- bution,activitiesthatcouldenhancebroadknowledgetransfer.Thepaywall-dominated anduse-restrictingnatureofscientificknowledgedisseminationisadirectresultofboth afailuretoenforceOApublishingwhereitisrequiredandafailureofuniversitycom- mitteestoincentivizesharingbehavior.78 Insomecases,researchersmaynotevenreceivewhattheybargainedfor:citations andnotoriety.Studieshaveillustratedthatajournal’simpactfactorisnotastrongpre- dictorforcitationvolumeofanindividualwork,79andinmanycases,publishingina traditionalorhybridjournalandnotinanOArepositoryminimizescitationvolume.80 77Zo¨eC o r b y n , A Threat to Scientific Communication ,TIMESHIGHEREDUCATION , Aug. 13, 2009, http://www.timeshighereducation.co.uk/407705.article 78The Royal Society, Science as an Open Enterprise , Royal Society Website (2012), http://royalsociety.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Generalpublicconsumersessentiallypayforscientificresearchtwice:firstwhentax payersfundsciencethroughtaxesandsecondwhentheydownloadthescholarship.85 Public consumers who may learn from research or write about research online have 81American Library Association, Number of Libraries in the United States , ALA Website, http://www.ala.org/tools/libfactsheets/alalibraryfactsheet01 .Thetotalnumberofacademiclibrariesinthe UnitedStateshasreached3689.SeealsoU.S.DepartmentofCommerce, ProfileAmericaFactsforFeatures— Back to School: 2011-2012, Census.gov website (2012), http://www.census.gov/newsroom/releases/ archives/facts forfeaturesspecialeditions/cb11-ff15.html .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"82Elsevier,DatabaseLinking ,ElsevierWebsite(2014), http://www.elsevier.com/about/content-innovation/ database-linking#about-database-linking .",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"(Dec. 5, 2011), http://journal.frontiersin.org/Journal/ 10.3389/fncom.2011.00055/full .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"uu.nl/index.php/lq/article/view/7877/8084 87The Economist Website, The Price of Information ,THEECONOMIST , Feb. 4, 2012, http://www.economist.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"com/node/21545974 88KarenM.Albert, OpenAccess:ImplicationsforScholarlyPublishingandMedicalLibraries ,94J.M ED.LIBR.ASS’N 253,263(2006), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1525322/ 89SeeWellen, supranote34,HouseofCommonsScienceandTechnologyCommitteeinWellen.",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"(2009),http://go.nature.com/uqrxqw .Aspreviouslymentioned,themargin forthebigfourpublishersismarkedlyhigherthanaverageforprintandonlinesubscriptionjournals.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"The ‘Big Deal’ Bunding of Academic Journals ,7 2ANTITRUST L.J., 121 (2004), https://www.law.berkeley.edu/faculty/rubinfeldd/ Profile/publications/Edlin-Rubinfeld%20ALJ%20Paper.pdf 93Roberta Cuel, Diego Ponte & Alessandro Rossi, Towards an Open/Web 2.0 Scientific Publishing Industry?",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Preliminary Findings and Open Issues , Liquid Publications Project, https://www.academia.edu/1074663/ TowardsanOpenWeb2.0Scientific Publishing IndustryPreliminary FindingsandOpenIssues(last accessedSep13,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"94SteveHitchcock, TheEffectofOpenAccessandDownloads(’Hits’)onCitationImpact:ABibliographyofStudies , University of Southampton (2013), http://opcit.eprints.org/oacitation-biblio.html .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"96DianeHarleyetal., TheInfluenceofAcademicValuesonScholarlyPublishingandCommunicationPractices ,10 J. ELEC.PUB.2(2007), http://dx.doi.org/10.3998/3336451.0010.204 .Harleyetal.interviewedscholarsin avarietyoffields,andtheoverwhelmingmajoritystatedthatthereisnorewardforchangingthestatusquo,",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"97FrancisHeylighen, WhyisOpenAccessDevelopmentsoSuccessful?StigmergicOrganizationandtheEconomicsof Information, OpenSourceJahrbuch(BerndLutterbeck,MatthiasB ¨arwolff&RobertA.Gehringeds.,2007), http://arxiv.org/ftp/cs/papers/0612/0612071.pdf .Inadditiontointeractionstogaininformationrequiring verylittleeffortonthepartofaconsumer,informationdoesnotdiminishinvalueasitisaccessedmoreoften (non-rivalgood);often,itincreasesinvaluethemoreindividualscitetoit.However,peerreviewisacritical andfoundationalelementforscientificpublishing.WhileOAmodelshavetremendouspotential,OAmust employthesamestringentrequirementsinpeerreviewtominimizedamagingandlessefficientoutcomesas othersrelyonthesepublications.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"See also Konstantin Kakaes , Scientists’ Victory over the Research Works ActisLiketheSOPADefeat ,SLATE,Feb.28,2012 http://www.slate.com/blogs/future tense/2012/02/28/ researchworksactelsevierandpoliticians backdownfromopenaccessthreat.html.S c i e n t i s t sh a v e similarlysignedanElsevierboycott,originallyinresponsetothenow-defunctResearchWorksAct.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"101Charlotte Tschider, Investigating the ‘Public’ in the Public Library of Science ,1 1FIRSTMONDAY(2006), http://firstmonday.org/ojs/index.php/fm/article/view/1340/1260 .Wheninformationistechnicallyacces- sibletothepublicandreadable,thepublictendstocommentmoreofteninpublicforums.",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"342 SCIENCE60, 65 (2013), http://www.sciencemag.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"111Id.See also David Malakoff, Open-Access Group Sanctions Three Publishers After Science ‘Sting’ , AAAS.org (Nov.11,2013), http://news.sciencemag.org/people-events/2013/11/open-access-group-sanctions-three- publishers-after-science-sting (describingtheoutcomeofBohannon’sOAsting).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Unilateralaction First,theNIHshouldcontinueexercisingtheirrightstostopmultiyearfundingtoPIs whodonotcomplywithalltermsandconditionsoftheiragreement.Accordingtothe NIHcontractsignedbyeachPI,theNIHmayunilaterallystopperformingwhengrant officersbecomeawareofnon-compliance.Additionally,anyissuesmaybetransferred 112PubMedHelp FAQs , PubMed Website (2014), http://www.ncbi.nlm.nih.gov/books/NBK3827/ #pubmedhelp.FAQs .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"116John Willinsky, The Access Principle: The Case for Open Access to Research and Scholarship (2006), http://arizona.openrepository.com/arizona/handle/10150/106529 .",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"122NationalInstitutesofHealth, PublicAccessPolicy ,NIHWebsite(2013), http://publicaccess.nih.gov/faq.htm (lastaccessedSep9,2014).",OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"125John P. Holder, Increasing Access to the Results of Federally Funded Scientific Research , White House Web- site (Feb. 22, 2013), http://www.whitehouse.gov/sites/default/files/microsites/ostp/ostp publicaccess memo2013.pdf 126H.R.3547—113thCong.(2013-2014),Jan.17,2014.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Megajournals, while scientifically accurate, may provide an alternate 144Organisationfor Economic Co-Operation and Development, OECD Policy Roundtables: Oligopoly ,O E C D Website(1999),at7, http://www.oecd.org/daf/competition/1920526.pdf 145BrettKraabel, WTO,FreeTrade,andOligopolies (2004),http://bkraabel.free.fr/publications/white papers/ WTOBananaWars.pdf.WhiletheFTCcanbringchargesforholdinga65percentmonopolyinterest,the UnitedKingdomrequires40percent,andtheentitymustabuseitspowertowarrantlegalaction.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"146European Commission Research & Innovation, Report of the European Commission—Public Consulta- tion on Open Research Data , European Commission Website (Oct. 2013), http://ec.europa.eu/research/ science-society/document library/pdf 06/report 2013-07-open researchdata-consultation.pdf .Afterpre- sentingaworkingversionofthispapertotheAssociationofEuropeanResearchLibraries,aSpanishcolleague attheLiguedesBiblioth `equesEurop ´eenesdeRecherche(LIBER)sharedthatSpainwouldnotconsidera mandatoryrequirement,andthatculturally,alegalremedywouldnotbeappropriate,despitelimitedcompli- ancewithexistingOArequirements.",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"148Organisation for Economic Co-operation and Development, Science, Technology, and Industry Scoreboard: Innovation Growth and Knowledge Economies , OECD Website (2011), at 9, 10, http://www.oecd.org/ sti/sci-tech/48712591.pdf",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Futureresearch WhileexistingresearchseemstopointtogreenOArepositoriesasthemostefficient model for the sciences, more research is still needed to investigate whether a reposi- tory,withlimitedadditionalprocesses,wouldprovemoreeconomicallyefficientforto- talpublishinginvestment,orifanalternateoptimalbalanceofjournalsandrepositories wouldadvanceaccessibility,verifiability,andusabilityofknowledgeresources.Todate, thefullscaleofmodelsincludingmegajournals,OA,hybrid,traditional,andtraditional- embargo have not been evaluated together to determine which access method or 149DamienBesancenot&RaduVranceanu, AModelofScholarlyPublishingwithHybridAcademicJournals ,ES- SEC Working Paper (2014), http://papers.ssrn.com/sol3/papers.cfm?abstract id=2419849 (last accessed Sep13,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/9f/lsu025.PMC5033529.pdf
"Sincerely, I. Glenn Cohen, JD Co-Editor-in-Chief ,JournalofLawandtheBiosciences, Harvard Law School Nita Farahany, JD,PhD Co-Editor-in-Chief, JournalofLawandtheBiosciences, Duke University Hank Greely, JD Co-Editor-in-Chief ,JournalofLawandtheBiosciences, Stanford University C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/a2/13/lsu026.PMC5033530.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/e9/df/lsu020.PMC5033531.pdf
"Onereasonwhytheeffectoftheproposalmaybelimitedinthiscohortisthatsig- nificantrisksarisefromthewaythatmanyCEDs(suchastDCS)areused.Theriskof 2Practical ethics, “Whoa Though, Does It Ever Burn”—Why the Consumer Market for Brain Stimulation DevicesWillBeaGoodThing,AsLongAsItisRegulated ,http://blog.practicalethics.ox.ac.uk/2014/04/whoa- though-does-it-ever-burn-why-the-consumer-market-for-brain-stimulation-devices-will-be-a-good-thing-as- long-as-it-is-regulated/ (lastaccessedJune13,2014).",Non-OADS,/arxiv_data1/oa_pdf/e9/df/lsu020.PMC5033531.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/5d/6e/lsu029.PMC5033532.pdf
"2014, at 3, https://www.cast-science.org/file.cfm/media/products/ digitalproducts/CAST IssuePaper54weboptimized 29B2AB16AD687.pdf (lastaccessedJune29,2014) (thestudentwouldliketorecognizethatthispaperprovidesanexcellentandcomprehensivesourceoflegalandsci- entificanalysisonGElabeling.)",Non-OADS,/arxiv_data1/oa_pdf/5d/6e/lsu029.PMC5033532.pdf
"14Agriculture & Fisheries & Biotechnology, European Commission , A Decade of EU-Funded GMO Re- search(2001–2010), 2011, at 21, http://ec.europa.eu/research/biosociety/pdf/a decadeofeu-funded gmoresearch.pdf (lastaccessedJune29,2014).",Non-OADS,/arxiv_data1/oa_pdf/5d/6e/lsu029.PMC5033532.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/e5/6a/lsu023.PMC5033533.pdf
"20WORLDHEALTHORGANIZATION , 2012 G LOBALPROGRESSREPORT ON IMPLEMENTATION OF THE WHO FRAMEWORK CONVENTIONON TOBACCOCONTROL20(2012),http://apps.who.int/iris/handle/10665/79170 (accessed19August2014).ThiswasonlyamongthecountriesthatreportedtheirprogresstotheWHO;itis likelythatcountriesthatdidnotreporthadevenlowerimplementationrates.",Non-OADS,/arxiv_data1/oa_pdf/e5/6a/lsu023.PMC5033533.pdf
"25Joint Action and Learning Initiative on National and Global Responsibilities for Health (JALI), Plat- form for a Framework Convention on Global Health: Realizing the Universal Right to Health , May 14, 2014, http://www.jalihealth.org/documents/platform-for-an-fcgh-march-2014-full-4-7-14.pdf(accessed 19 August2014).Gostintriestodownplaythe‘hard’natureoftheproposedFCGH,writingthatitcould‘begin asasoft,nonbindinginstrument’andmorphintoamorebindingsetofrulesovertime.Gostin, GlobalHealth Law,supranote4,at437.",Non-OADS,/arxiv_data1/oa_pdf/e5/6a/lsu023.PMC5033533.pdf
"31”, http://www.state.gov/documents/organization/138850.pdf (accessed19August2014).",Non-OADS,/arxiv_data1/oa_pdf/e5/6a/lsu023.PMC5033533.pdf
"Roger S. Magnusson & David Patterson, The Role of Law and Governance Re- formintheGlobalResponsetoNon-CommunicableDiseases ,GLOBALIZATION HEALTH[onlinefirst,June,2014], http://www.globalizationandhealth.com/content/pdf/1744-8603-10-44.pdf(accessed19August2014).",Non-OADS,/arxiv_data1/oa_pdf/e5/6a/lsu023.PMC5033533.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/d4/17/lsu019.PMC5033534.pdf
"17Case C-219/11, Brain Products GmbH v. BioSemi VOF, 2012 EUR-Lex CELEX LEXIS 62011CJ0219 (Nov. 22, 2012), http://eur-lex.europa.eu/legal-content/EN/TXT/?qid=1402800429191&uri=CELEX: 62011CJ0219 (accessed11August2014).",Non-OADS,/arxiv_data1/oa_pdf/d4/17/lsu019.PMC5033534.pdf
"This change will eliminate the ambiguity of the medical purpose requirement and clearly place CEDs 19Seee.g.UnitedKingdomMedicinesandHealthcareProductsRegulatoryAgency, NewLegislationonMedical Devices,http://www.mhra.gov.uk/Howweregulate/Devices/Legislation/NewLegislationonMedicalDevices/ (accessed 11 August 2014) (Providing a timeline for when proposed European modifications to the MDD willcomeintoeffect).",Non-OADS,/arxiv_data1/oa_pdf/d4/17/lsu019.PMC5033534.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"3Diane B. Paul, Promoting Safe and Effective Genetic Testing in the United States , National Institute of Health, National Human Genome Research Institute (2006), http://www.genome.gov/10002397 (last accessed September2,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"5R.Howell, CurrentPracticesandExpansionofNewbornScreening ,CenterforDiseaseControl(Aug.18,2011), http://www.cdc.gov/cdcgrandrounds/pdf/grehrallfinal18aug2011.pdf (lastaccessedJune1,2014).",OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"6National Institute of Child Health and Human Development, National Institutes of Health, Brief History of Newborn Screening (2013),http://www.nichd.nih.gov/health/topics/newborn/conditioninfo/ pages/history.aspx (lastaccessedJune1,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"Based on the statistics published from California’s newborns screening program be- tweenJuly2005andApril2009,2,105,119newbornswerescreened,andofthose4580 werereferredtoametabolicclinicforfollow-up.Ultimately,754oftheseinfants(16%) 8SamCrowe, ABriefHistoryofNewbornScreeningintheUnitedStates:StaffDiscussionPaper ,President’sCoun- cil on Bioethics (2008), https://bioethicsarchive.georgetown.edu/pcbe/background/newborn screening crowe.html (lastaccessedJune1,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"10National Human Genome Research Institute, National Institutes of Health, The Human Genome Project: FrequentlyAskedQuestions (2010),http://www.genome.gov/11006943 (lastaccessedJune1,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"12NationalHumanGenomeResearchInstitute,NationalInstitutesofHealth, CentersforMendelianGenomics (2013),http://www.genome.gov/27546192 (lastaccessedSeptember2,2014).",OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"(2014),http://www.ncbi.nlm.nih.gov/pubmed/?term=public+views+on+participating+in+ newborn+screening+using (lastaccessedJune1,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"Currently,fewstudiesexplorestakeholders’viewpointsregardingWG-NBS.Sucha dramaticexpansionofNBSshouldnotbeimplementedmerelybecauseitispossible— it should provide information that parents want, and it should fit into a revised list 26Council of Europe, Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Genetic Testing for Health Purposes (2008),http://conventions.coe.int/Treaty/en/Treaties/Html/203.htm (lastaccessedJune1,2014).",Non-OADS,/arxiv_data1/oa_pdf/21/ce/lsu027.PMC5033535.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/cd/87/lsu024.PMC5033536.pdf
"KEYWORDS: ACMG recommendations, autonomy, incidental findings, preimplantationgeneticdiagnosis,wholegenomesequencing INTRODUCTION In March 2013, the American College of Medical Genetics and Genomics (ACMG) publishedrecommendationsforreportingincidentalfindings(IFs)afterwhole-exome C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"14Symplur, #ACMGMtg Healthcare Social Media Hashtag Analytics ,http://www.symplur.com/healthcare- hashtags/acmgmtg/ (accessedJun.1,2014).",OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"Inactuality,theWorkingGroupoutlinedanoptionforpatientstodeclinelearning aboutIFsidentifiedbythetestinglaboratory,throughpretestinformedconsentcon- versationswithageneticprofessional.Thiswouldshiftdiscussionanddecision-making about IFs to the more suitable context of patient and medical provider, rather than 22ACMG,Incidental Findings in Clinical Genomics: A Clarification ,http://www.genomicslawreport.com/ index.php/2013/07/30/the-amg-gene-screening-recommendations/ (accessedJun.1,2014).",Non-OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"25JohnConley, TheACMGGeneScreeningRecommendations ,http://www.genomicslawreport.com/index.php/ 2013/07/30/the-amg-gene-screening-recommendations/ (accessedJun.1,2014).",OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"45AmbryGenetics, ExomeQ&A ,http://ambrygen.com/exome-qa (accessedJun.1,2014).",OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"46Baylor College of Medicine Whole Genome Laboratory, Whole Exome Sequencing Requisition , https://www.bcm.edu/geneticlabs/index.cfm?PMID=21320 (accessedJun.1,2014).",Non-OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"47GeneDx, XomeDx—Frequently Asked Questions ,http://www.genedx.com/wp-content/uploads/2013/03/ XomeDxFAQs.pdf (accessedJun.1,2014).",OADS,/arxiv_data1/oa_pdf/ee/d8/lsu028.PMC5033537.pdf
"2IntergovernmentalPanelonClimateChange, http://www.ipcc.ch/report/ar5/index.shtml (accessedMay20, 2014).",OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"3UnitedNationsTaskTeamonSocialDimensionsofClimateChange, TheSocialDimensionsofClimateChange , Discussion Draft ,https://www.iom.int/jahia/webdav/shared/shared/mainsite/activities/env˙degradation/ cop17/SDCC-Social-dimensions-of-climate-change-Paper.pdf (accessedMay20,2014).",Non-OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"An action framework for agriculture and food security ,http://www.zaragoza.es/contenidos/medioambiente/ onu//newsletter12/880˙eng.pdf (accessedJune25,2014).",Non-OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"http://www.scienceadvice.ca/uploads/eng/assessments%20and% 20publications%20and%20news%20releases/Shale%20gas/ShaleGas fullreportEN.pdf (accessed June 25, 2014).",Non-OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"12Request for Comments on the Ethical Considerations of Neuroscience Research and the Application of Neuroscience Research Findings, Federal Register, 31 January 2014, https://www.federalregister.gov/ articles/2014/01/31/2014-02072/request-for-comments-on-the-ethical-considerations-of-neuroscience- research-and-the-application-of (accessedMay20,2014).",Non-OADS,/arxiv_data1/oa_pdf/77/d8/lsu015.PMC5033538.pdf
"JournalofLawandtheBiosciences,224–236 doi:10.1093/jlb/lsu012 PeerCommentary AdvanceAccessPublication0 2014 Lawandneuroscience: recommendationssubmittedtothe President’sBioethicsCommission OwenD.Jones1,∗,RichardJ.Bonnie2,B.J.Casey3, AndreDavis4,DavidL.Faigman5,MorrisHoffman6, ReadMontague7,StephenJ.Morse8,MarcusE.Raichle9, JenniferA.Richeson10,ElizabethScott11, LaurenceSteinberg12,KimTaylor-Thompson13, AnthonyWagner14andGideonYaffe15 1.JoeB.WyattDistinguishedUniversityProfessor,NewYorkAlumniChancellor’sChairinLaw, andProfessorofBiologicalSciences,VanderbiltUniversity,Director,MacArthurFoundation ResearchNetworkonLawandNeuroscience 2.HarrisonFoundationProfessorofMedicineandLaw,ProfessorofPsychiatryandNeurobehavioralSciences, Director,InstituteofLaw,PsychiatryandPublicPolicy,ProfessorofPublicPolicy,FrankBattenSchoolof LeadershipandPublicPolicy,UniversityofVirginia 3.SacklerProfessorforDevelopmentalPsychobiology,Director,SacklerInstitute,WeillCornellMedicalCollege 4.Judge,UnitedStatesCourtofAppealsfortheFourthCircuit 5.JohnF.DigardiDistinguishedProfessorofLaw,DirectoroftheUCSF/UCHastingsConsortiumonLaw, Science&HealthPolicy,UniversityofCalifornia,Hastings 6.DistrictJudge,SecondJudicialDistrict,StateofColorado 7.ProfessorofPhysics,ProfessorofPsychiatryandBehavioralMedicine,Director,HumanNeuroimaging Laboratory,Director,ComputationalPsychiatryUnit,VirginiaTech,UniversityCollege,London 8.FerdinandWakemanHubbellProfessorofLaw,ProfessorofPsychologyandLawinPsychiatry, UniversityofPennsylvania 9.ProfessorofRadiologyandNeurology,WashingtonUniversity 10.JohnD.andCatherineT.MacArthurFoundationProfessorofPsychology,FacultyFellow,Institutefor PolicyResearch,NorthwesternUniversity 11.HaroldR.MedinaProfessorofLaw,ColumbiaUniversity 12.DistinguishedUniversityProfessor,LauraH.CarnellProfessorofPsychology,TempleUniversity 13.ProfessorofClinicalLaw,NewYorkUniversity 14.ProfessorofPsychology,DirectoroftheStanfordMemoryLab,AssociateDirectoroftheCognitiveand NeurobiologicalImagingCenter;StanfordUniversity 15.ProfessorofLaw,ProfessorofPhilosophy&Psychology,YaleUniversity ∗Correspondingauthor.E-mail: owen.jones@vanderbilt.edu C/circlecopyrtTheAuthors2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"Althoughthelegalsystemisalreadygrapplingwithhowtoengageresponsiblywith a floodof new neurosciencestudies, it remains unclear how this relationship willde- velop.Forexample,itisunclearwhetherneuroscientificcapabilitiesandneuroscientific 1Foroverviews,seeOwenD.Jones,Ren ´eMarois,MarthaJ.Farah,HenryT.Greely, LawandNeuroscience, 33 J.Neuroscience17624(2013), http://papers.ssrn.com/sol3/papers.cfm?abstract id=2432452 ;andOwenD.",OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"Takingnoteofrapidneuroscientificadvances,PresidentObamarecentlycharged hisBioethicsCommissionto‘identifyproactivelyasetofcoreethicalstandards’inthe neurosciencedomain.3And,inlightoftheintersectionofneurosciencewithcriminal justicespecifically,PresidentObamachargedtheCommissiontoconsiderimplications ‘relatingto... theappropriateuseofneuroscienceinthecriminal-justicesystem’.4 TheMacArthur Foundation Research Network on Law and Neuroscience (the ‘Re- searchNetwork’)isaninterdisciplinarycollaborativeinitiativesupportedbytheJohn D.andCatherineT.MacArthurFoundationandisheadquarteredatVanderbiltUni- versity since 2010.5The Research Network addresses a focused set of closely related problems at the intersection of neuroscience and criminal justice, such as: 1) inves- tigating law-relevant mental states of, and decision-making processes in, defendants, witnesses,jurors,andjudges;2)investigatinginadolescentstherelationshipbetween brain development, cognitive capacities, and decision-making; and 3) assessing how 3PresidentialChargetotheCommissionfortheStudyofBioethicalIssues,July1,2013, http://bioethics.gov/ sites/default/files/news/Charge%20from%20President%20Obama.pdf (accessedJuly9,2013) 4Id.",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"5TheMacArthurFoundationResearchNetworkonLawandNeuroscience ,http://www.lawneuro.org/ ;Network Overview,http://www.lawneuro.org/networkoverview.pdf",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"SHEN,LAW ANDNEUROSCIENCE (2014);and TheLawandNeuroscience Bibliography , http://www.lawneuro.org/bibliography.php 7Request for Comments on the Ethical Considerations of Neuroscience Research and the Application of Neuroscience Research Findings, Federal Register, January 31, 2014, https://www.federalregister.gov/ articles/2014/01/31/2014-02072/request-for-comments-on-the-ethical-considerations-of-neuroscience -research-and-the-application-of",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"TheResearchNetworkisaninterdisciplinarycollaborativeinitiativesupportedby theJohnD.andCatherineT.MacArthurFoundationandheadquarteredatVanderbilt Universitysince2010.TheResearchNetworkaddressesafocusedsetofclosely-related problems at the intersection of neuroscience and criminal justice, such as: 1) inves- tigating law-relevant mental states of, and decision-making processes in, defendants, witnesses,jurors,andjudges;2)investigatinginadolescentstherelationshipbetween 1Presidential Charge to the Commission for the Study of Bioethical Issues, July 1, 2013, at http://bioethics.gov/sites/default/files/news/Charge%20from%20President%20Obama.pdf 2Id.",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"3Request for Comments on the Ethical Considerations of Neuroscience Research and the Application of Neuroscience Research Findings, Federal Register, January 31, 2014, https://www.federalregister.gov/ articles/2014/01/31/2014-02072/request-for-comments-on-the-ethical-considerations-of-neuroscience -research-and-the-application-of",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"Recommendations: i.Recommendation1 :TheCommissionshouldrecommendfederalfund- ingfortrainingprogramstoaidjudges(aswellasparoleofficers,others 4TheMacArthurFoundationResearchNetworkonLawandNeuroscience: http://www.lawneuro.org/ 5Ineachofthepasttwoyears,forexample,theResearchNetwork’s EducationandOutreach programhasspon- soredaColloquiumforFederalJudgesonLaw,Neuroscience,andCriminalJustice .Acrossthesetwoyears,135 federaljudgesappliedfor35availableslots.",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"Recommendations: i.Recommendation4 :The Commission should recommend that NIH encourage research, including longitudinal research, that robustly 6Seegenerally,NationalResearchCouncil, ReformingJuvenileJustice:ADevelopmentalApproach (Washington, DC:TheNationalAcademiesPress(2013)),available: http://www.nap.edu/catalog.php?record˙id=14685 .",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
", russpoldrack.org (April 6, 2013),available: http://www.russpoldrack.org/2013/04/how-well-can-we-predict-future-criminal.html",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"Respectfullysubmitted, TheMacArthurFoundationResearchNetworkonLawandNeuroscience www.lawneuro.org 9Presidential Charge to the Commission for the Study of Bioethical Issues, July 1, 2013: http://bioethics.gov/sites/default/files/news/Charge%20from%20President%20Obama.pdf",Non-OADS,/arxiv_data1/oa_pdf/cc/9a/lsu012.PMC5033539.pdf
"2AmericanCancerAssociation, BreastCancer:EarlyDetection ,http://www.cancer.org/cancer/breastcancer/ moreinformation/breastcancerearlydetection/breast-cancer-early-detection-pdf (updated 24 October 2013).",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"3American Cancer Association, Ovarian Cancer , http://www.cancer.org/cancer/ovariancancer/ detailedguide/ovarian-cancer-pdf23(updated21March2013).",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"25See, eg,Phillippa Brice, Myriad European BRCA1 Patent Upheld in Amended Form , PHG Foundation (26November2008),http://www.phgfoundation.org/news/4412/(lastaccessed26February2014).",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"30See, eg,Rusconi E. William, Patenting and Licensing of the Breast Cancer Susceptibility Genes BRCA1 andBRCA2 (11February2005),http://www.genome.duke.edu/centers/cpg/case-histories/clinical-genetic- testing/documents/NAS%20Patents%20and%20BRCA%202-11-2005%20(2).pdf (last accessed 26 Febru- ary2014).",OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"LEGAL IMPLICATIONS WhileMyriad’simpactinexpandingaccesstogenetestingmaybebluntedbyremain- ing cDNA and method claims under §101, a 2009 Federal Circuit decision, In re Kubin, may have the opposite effect.45Beyond the §101 test at issue in Myriad,a n y DNAclaimsstillhavetomeettheotherpatentabilityrequirements:novelty( §102),46 nonobviousness( §103),47andsufficientlyexplicitdescription( §112).48InKubin,the Courtsetastricterstandardforthe §103requirement,holdingthatsignificantexisting knowledgeaboutthe(1)proteincodedbyageneand(2)techniquesnecessaryforiso- latingandsequencingthegenemakesthegeneitselfunpatentablyobvious.49Underthe 39U.S.PatentandTrademarkOffice, AIAStudiesandReports ,http://www.uspto.gov/aia˙implementation/aia˙ studies˙reports.jsp(accessed25February2014).",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"55Hank Greely, Myriad Decision Invoked in Appeal of Suit to Invalidate Embryonic Stem Cell Patent Claims , Stanford Law and Biosciences Blog (4 July 2013), http://blogs.law.stanford.edu/lawandbiosciences/ 2013/07/04/myriad-decision-invoked-in-appeal-of-suit-to-invalidate-embryonic-stem-cell-patent-claims/ (lastaccessed26February2014).",Non-OADS,/arxiv_data1/oa_pdf/9e/db/lsu007.PMC5033540.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/38/90/lsu022.PMC5033541.pdf
"This approach is consistent with the Commission’s Charter,describingitsmissionasincludinganexaminationof“theintersection ofscienceandhumanrights”,aswellaswiththeUNCommissiononHuman Rights 1999 resolution on “Human Rights and Bioethics”, which states that 2See,forexample, http://www.psychology.iastate.edu/-glwells/The Justice%20Project Eyewitness Identification %20APolicyReview.pdf 3http://www.scribd.com/doc/100608855/New-NJ-Instruction-On-eyewitness-identification 4www.aaas.org/page/srhrl-human-rights-activities",Non-OADS,/arxiv_data1/oa_pdf/38/90/lsu022.PMC5033541.pdf
"Sincerely, AlanI.Leshner 5http://www.unhchr.ch/Huridocda/Huridocansf/O/d85deea99805eb:ffi8025676600491100",Non-OADS,/arxiv_data1/oa_pdf/38/90/lsu022.PMC5033541.pdf
"The former President, who completed his term of office in Feb. 2014, is Dr Steven E. Hyman, Director of the Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, and President-Elect of The Society for Neuroscience ( http://www.sfn.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/ce/7e/lsu014.PMC5033543.pdf
She has recently presented at the World Economic Forum 2014 in Davos on achieving better outcomes globally for individuals with mental health disorders and on the effects of poverty on the brain (http://youtu.be/worqvUbYMSA ).,Non-OADS,/arxiv_data1/oa_pdf/ce/7e/lsu014.PMC5033543.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/ce/7e/lsu014.PMC5033543.pdf
http://ir.lawnet.fordham.edu/flr/vol80/iss1/9 ).,Non-OADS,/arxiv_data1/oa_pdf/ce/7e/lsu014.PMC5033543.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"25DeathPenaltyInformationCenter, Executionsin2012 ,LethalInjection (2013),http://www.deathpenaltyinfo.",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"2328407, http://ssrn.com/abstract =2328407(accessedFeb.16,2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"30Lundbeck, Lundbeck Overhauls Pentobarbital Distribution Program to Restrict Misuse , Press Release (1 July 2011),http://investor.lundbeck.com/releasedetail.cfm?ReleaseID =605775(accessedFeb.16,2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"32SeeJuliette Jowit, UK to Ban Export of Drug Approved for Use in US Executions ,Th eG u a r d i a n( 1 0 July 2012), http://www.guardian.co.uk/world/2012/jul/10/uk-ban-export-drug-us- executions (accessed Feb.16,2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"33SeeAssociated Press, Another Manufacturer Blocks Propofol For Execution Use , USA Today (28 September 2012), http://www.usatoday.com/story/money/business/2012/09/27/manufacturer-blocks-proprofol- execution-use/1598109/.",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"See also, Jeannie Nuss, Arkansas Turns to Different Lethal Injection Drug , Associated Press (19 April 2013), http://news.yahoo.com/arkansas-turns-different-lethal-injection- drug-214639034.html(accessedFeb.16,2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"35SeeDeathPenaltyInformationCenter ,StatebyStateLethalInjection ,http://www.deathpenaltyinfo.org/state- lethal-injection(accessed2January2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"FDA Announces Import of Injectable Nutrition Drugs(2013), http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm354272.htm (accessedFeb.16,2014).",Non-OADS,/arxiv_data1/oa_pdf/fe/f4/lsu006.PMC5033544.pdf
"KEYWORDS: human rights, judges, neuroscience, policy, Presidential Commission There is no doubt that continued developments in neuroscience hold great promise for improving our understanding of disease and behavior, leading to reduced human suffering.Yet,aswithanyotherareaofresearchanditspossibleapplications,suchad- vancesdonotarrivefreeofworrisomequestions.Theywillpromptconcernsabouthow greaterknowledgeofthebrainwillaffectourattitudetowardcognitionandemotion,or shapeviewsaboutpersonalresponsibility,disabilityandfreewill,orinfluencepolicies andapproachestowardlearning,criminaljustice,andwarfare.Itis,therefore,appropri- ateforsocietytohavearobustconversationaboutwhatsuchadvanceswillmeanand howweshould“manage”them.Animportantstepinthatdirectionistherecentsolic- itationofpubliccommentbythePresidentialCommissionfortheStudyofBioethical Issues on “Ethical Considerations of Neuroscience Research and the Applications of NeuroscienceResearchFindings”.1 1Federal Register, Request for Comments on the Ethical Considerations of Neuroscience Research and the Ap- plication of Neuroscience Research Findings , Jan. 31, 2014, https://www.federalregister.gov/articles/2014/ 01/31/2014-02072/request-for-comments-on-the-ethical-considerations-of-neuroscience-research-and-the- application-of (lastaccessedJuly22,2014).",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"Neuroscience will at some point usher in new understandings of human nature, morality,autonomy,intentionality,andfreewill,and,indoingso,willraiseconcerns about whether uncovering new insights into the brain will undermine basic human 2AAAS,http://www.aaas.org/about-aaas (lastaccessedJuly22,2014).",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"4AAAS,Judicial Seminars on Emerging Issues in Neuroscience ,http://www.aaas.org/page/judicial-seminars- emerging-issues-neuroscience (lastaccessedJuly22,2014).",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"5AAAS,HumanRightsActivities ,http://www.aaas.org/page/srhrl-human-rights-activities (lastaccessedJuly22, 2014).",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"6The Universal Declaration of Human Rights, Article 18,http://www.un.org/en/documents/udhr/ (last ac- cessedJuly22,2014).",Non-OADS,/arxiv_data1/oa_pdf/a8/ec/lsu013.PMC5033546.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"E. Richards, Why I Froze My Eggs (And You Should, Too) ,WALLSTREETJOURNAL, 4 May 2013, at C1; Talk of the Nation: No Longer Experimental, Egg Freezing May Appeal to More Women (NPR radio broad- cast9May2013),availableat http://www.npr.org/programs/talk-of-the-nation/2013/05/09/182313974/ ?showDate=2013-05-09 (accessed21February2014)(radiobroadcast).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
",AbovetheLaw(22April2013) http://abovethelaw.com/2013/04/should-egg-freezing-be-a-fringe-benefit-offered-by-your-firm/ (acce- ssed20February2014).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"58SeeCoriell Institute for Medical Research, Biobank Catalogue (2013),http://www.coriell.org/research- services/cell-culture/biobank-catalog (accessed 20 February 2014); Medical Research Council, UK Biobank (2013),http://www.mrc.ac.uk/Ourresearch/Ethicsresearchguidance/Biobank/index.htm (accessed21February2014).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"A shortage of eggs has plagued some embryonic stem cell researchers, in part because of bans on paying egg donors (even though egg donors for infertility can be paid).73The successful production of embryonic stem cell lines through somatic cell nucleartransferwillspurdemandforresearcheggs74aswilltheUK’srecentapproval ofexperimentaltreatmentofmitochondrialDNAdefectsusingdefect-freepartialegg 70Elizabeth Cohen, Egg Freezing Changing Fertility Treatments, CNN,http://www.cnn.com/2012/10/22/ health/frozen-egg-banks/ (accessed20February2014).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"Jane Hughes & James Gallagher, Egg Donor Compensation Is To Triple Under New HFEA Guidelines , BBC (19 October 2011),http://www.bbc.co.uk/news/health-15356148 ;http://www.hfea.gov.uk/egg-donation-and-egg- sharing.html (accessed20February2014).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"75Kate Kelland, Britain plans world’s first go-ahead for ‘3-parent’ IVF babies , Reuters (28 June 2013), http://www.reuters.com/article/2013/06/28/us-mitochondria-britain-idUSBRE95Q1J020130628 (acce- ssed20February2014).Suchtreatmentswillinvolvedonoreggswhichwillbeenucleatedandhavethediploid pronucleusofthepatient’sfertilizedeggtransferredtoheregg.Otheroptionsmayincludecytoplasmicinjec- tionsfromhealthyeggs.Perfectingthistechniqueandvariationsonitwilldependonarobustsupplyofeggs forresearch.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"79EMPIRESTATESTEMCELLBOARD,STATEMENTONTHE COMPENSATIONOF OOCYTEDONORS(2009),available athttp://stemcell.ny.gov/sites/default/files/documents/files/ESSCB Statement onCompensation of OocyteDonors.pdf (accessed 20 February 2014); Beth E. Roxland, New York State‘s Landmark Policies onOversightandCompensationforEggDonationtoStemCellResearch,7RegenerativeMed.397(2012).",OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"(PressRelease) ASRM Office of Public Affairs, Newest Assisted Reproductive Technologies Outcomes Data Released; SART Reports 59, 466 ART Babies Born; ART Multiple Birth Rates Continue to Decline (05 February 2013), avail- able at http://www.asrm.org/Newest AssistedReproductive Technologies Outcomes DataReleased/ (accessed20February2014).",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"97DenisCampbell, FertilityExpertsinMoralWarningOverEggFreezing ,TheGuardian, http://www.guardian.",Non-OADS,/arxiv_data1/oa_pdf/52/c9/lsu002.PMC5033547.pdf
"1 (4 September 2013), http://www.healthit.gov/facas/sites/faca/files/ FDASIARecommendationsDraft030913 v2.pdf(accessed12January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"4Health IT, Clinical Decision Support (CDS) ,http://www.healthit.gov/policy-researchers-implementers/ clinical-decision-support-cds (accessed8January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"11OFFICE OF THE NAT’LCOORDINATOR FOR HEALTHINFORMATION TECHNOLOGY ,DEP’TO FHEALTH ANDHUMANSERV., CLINICALDECISIONSUPPORTWORKSHOP MEETINGSUMMARY(25–26 August 2009), http://www.healthit.gov/sites/default/files/nc-cds-workshop-meeting-summary-f-2.pdf (accessed4January 2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"12HEALTHINFORMATION TECHNOLOGY POLICYCOMM.CERTIFICATION /ADOPTIONWORKGROUP ,TESTIMONYOF JEFFREYSHUREN,DIRECTOR OF FDA’SCENTER FOR DEVICES AND RADIOLOGICAL HEALTH(25February2010), http://www.cchfreedom.org/pdfs/Health%20IT%20Deaths%20-%20FDA%20jeffrey%20Shuren.pdf (ac- cessed5January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"B IPARTISAN POLICYCENTER, http://bipartisanpolicy.org/ (accessed5January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"44E-mail from Bradley Merrill Thompson, General Counsel, Clinical Decision Support Coalition, to The Honorable Fred Upton, Henry Waxman, Joe Pitts, & Frank Pallone, Committee on Energy and Com- merce (18 November 2013), http://assets.fiercemarkets.com/public/newsletter/fiercemobilehealthcare/ cdsletter11-23.pdf (accessed8February2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"SeeGregSlabodkin, MRCtoCongress:Don‘tPassLegisla- tion,WaitforFDASIAReport ,FierceMobileHeathcare(2January2014), http://www.fiercemobilehealthcare .com/story/mrc-congress-dont-pass-legislation-wait-fdasia-report/2014-01-02 (accessed5January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"49Greg Slabodkin, PROTECT Act Would Deregulate High-Risk Software, Mobile Medical Applications , FierceMobileHeathcare (13 February 2014), http://www.fiercemobilehealthcare.com/story/protect-act- would-deregulate-high-risk-cds-mobile-medical-apps/2014-02-13 (accessed18February2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"51Greg Slabodkin, Senate Bill Undermines FDA Regulatory Role , FierceMobileHeathcare (10 February 2014), http://www.fiercemobilehealthcare.com/story/senate-bill-undermines-fda-regulatory-role/2014-02-10 (ac- cessed12February2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"52SeeBradley Merrill Thompson & M. Jason Brooke, FDA’s Approach to Clinical Decision Support Software: A Brief Summary , FierceHealthIT (28 December 2011), http://www.fiercehealthit.com/special-reports/ fdas-approach-clinical-decision-support-software-brief-summary (accessed5January2014).",Non-OADS,/arxiv_data1/oa_pdf/b9/30/lsu004.PMC5033548.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"9European Medicines Agency, European Public Assessment Reports , http://www.ema.europa.eu/ema/index.",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"Or- ange Book: Approved Drug Products with Therapeutic Equivalence Evaluations , FDA (February 2014), http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"12JessicaMazer,PharmaceuticalCareMgmt.Ass’n, GenericSubstitution:TheScienceandSavings,D.C.Governors’ Staff Briefing (9 March 2011), http://amcp.org/WorkArea/DownloadAsset.aspx?id =10530 (accessed 13 February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"14For up-to-date information on state-level biosimilar legislation, see Kurt R. Karst, The Biosimilars State Legislation Scorecard , FDA L. Blog (4 September 2013) http://www.fdalawblog.net/fda law bloghymanphelps/2013/09/biosimilars-state-legislation-scorecard.html(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"40Lynne Taylor, Germany: ‘EU’s Most Favourable Market for Biosimilars ’, Pharma Times (30 May 2013), http://www.pharmatimes.com/article/13-05-30/Germany EUsmostfavourable marketforbiosimilars.",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"Ass’n, CLHIA Report, Ensuring the Affordability, Accessibility and Sustainability of Prescription Drugs in Canada , at 25, http://www.clhia.ca/domino/html/clhia/CLHIA LP4WLND Webstation.nsf/resources/CLHIA Prescription DrugPaper/$file/CLHIA Prescription DrugPolicy PaperEN.pdf(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"198 rState-levellegislationonfollow-onbiologicsubstitution doses),withoverhalfoftheseapprovedwithinthepastdecade.42Biologicshave be- comeespeciallyimportantinthefieldsofoncology,43rheumatology,44andendocrinol- ogy.45Onaverage,therapeuticbiologicsaremorethan20timesasexpensiveasphar- maceuticaldrugs,withtreatmentsrangingfromtenstohundredsofthousandsofdol- lars per year, with an average annual cost of $16,425.46In 2010, eight of the top ten highestexpenditureMedicarePartBdrugswerebiologics,withthehighestexpenditure drugclaiming$2billioninMedicarefunds.47Thehighestaverageannualexpenditure perMedicarebeneficiaryin2010wasforabiologiccosting$216,833.48 The high cost of biologics can be partially explained by higher manufacturing and qualitycontrolcosts,aswellasalackofcompetitionfromgenerics;industryestimates of R&D for new biologics are comparable to those for new pharmaceutical drugs.49 While stressing the importance of cost-effectiveness analysis keyed to differences in bioequivalence,50many commentators have begun calling for substitution of less ex- pensive follow-on biologics as an important strategy for reducing healthcare costs,51 particularlyinthefieldofoncology,whichhasseenexponentiallyincreasingmedicine prices.52A2008studyestimatedthatsubstitutionoffollow-onbiologicsinthetop12 biologiccategoriescouldresultinU.S.savingsofover$100billioninthefirstdecade.53 Generic erythropoietin is projected to save eight billion Euros in Germany alone by 2020.54Recognizing the large potential for cost savings from increased competition, theFederalTradeCommissionhascalledforpubliccommentsonnewlegislationim- pactingfollow-onbiologics.55 42SeeFDA,UserFeeBillableBiologicProductsandPotenciesApprovedUnderSection351ofthePHSAct (Decem- ber2013),http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CBER/ ucm122936.htm; FDA, CDER Therapeutic Biologic Products (2013), http://www.fda.gov/downloads/ forindustry/userfees/prescriptiondruguserfee/ucm164641.pdf(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"46Robert J. Shapiro et al., The Potential American Market for Generic Biological Treatments and the As- sociated Cost Savings , at 4 (2008), http://www.sonecon.com/docs/studies/0208 GenericBiologicsStudy.",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"Gov’t Accountability Office, Medicare: High-Expenditure Part B Drugs , GAO-13-46R, at 7 (2012), http://www.gao.gov/assets/650/649459.pdf(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"64Andrew Pollack, Biotech Firms, Billions at Risk, Lobby States to Limit Generics , New York Times (29 Jan- uary 2013), http://www.nytimes.com/2013/01/29/business/battle-in-states-on-generic-copies-of-biotech- drugs.html?hpw(accessed13February2014).",Non-OADS,/arxiv_data1/oa_pdf/5c/55/lsu005.PMC5033549.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"2DanielleFriedman, PerkUp:FacebookandAppleNowPayforWomentoFreezeEggs ,NBCN EWS,Oct.14,2014, http://www.nbcnews.com/news/us-news/perk-facebook-apple-now-pay-women-freeze-eggs-n225011 (ac- cessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"5See eg Rachel Walden, Why Corporate Promotion of Egg Freezing Isn’t a “Benefit” to All Women ,OURBODIES OURSELVES BLOG, Oct. 28, 2014, http://www.ourbodiesourselves.org/2014/10/apple-facebook-cover- egg-freezing/ (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"7Roberton, supranote 1, at 22; See also Ronald F. Feinberg, Elective Egg Freezing: 10 Thoughts From an REI,RHEUMATOLOGY NETWORK, Oct. 16, 2014, http://www.rheumatologynetwork.com/ivf/elective-egg- freezing-10-thoughts-rei .",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"11FrozenEggBank, Homepage ,https://www.eggfreezing.com/ (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"12Eggsurance, Homepage ,http://www.eggsurance.com/ (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"Generally, fringe benefits are included in gross income for tax purposes.SeeKellyP.Erb, AppleSeedsPerkWars,AddsEggFreezingasEmployeeBenefit ,http://www.forbes.",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"No Longer Experimental, Egg Freezing May Appeal to More Women, NPR Interview - Neal Conan, host, and Sarah Elizabeth Richards, May 09, 2013, available at http://www.npr.org/2013/05/09/ 182622625/no-longer-experimental-egg-freezing-may-appeal-to-more-women (accessedDec.22,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
",http://uscfertility.org/fertility-preservation/egg- freezing-faqs/ (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"18The Surrogacy Source, Agency Fees & Surrogate Mother Costs ,http://www.thesurrogacysource.com/ip fees.",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"19See SAMA—Resource Group for Women and Health, Birthing a Market: A Study on Commercial Surrogacy 118, 119 (2012), http://www.samawomenshealth.org/downloads/Birthing%20A%20Market.pdf (accessed Dec.22,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"23CoastalSurrogacy, SurrogacyProcedure ,http://www.coastalsurrogacy.com/sg parcosts.php (accessedNov.",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"Agency Fees & Surrogate Mother Costs, The Surro- gacySource, http://www.thesurrogacysource.com/ip fees.htm?type=Intended%20Parent (accessedDec.22, 2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"26SeeegGrowingGenerations, EggDonation:UnderstandingCosts ,http://www.growinggenerations.com/egg- donor-program/intended-parents/egg-donor-cost/ (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"27JenniferHaylett, OneWomanHelpingAnother:EggDonationasaCaseofRelationalWork ,40POL.SOC’Y223– 247,230-231(2012), http://pas.sagepub.com/content/40/2/223 (accessedNov.21,2014).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"31Extend Fertility, Why Freeze Eggs ,http://www.extendfertility.com/why-freeze-eggs/ (accessed Nov. 23, 2014)(‘eggfreezingprovidesawayforwomentobetheirowndonors’).",Non-OADS,/arxiv_data1/oa_pdf/29/6e/lsu037.PMC5033550.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontactjournals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/26/71/lsv007.PMC5033551.pdf
"See id.at 1047, 1059. http://www.nydailynews.com/news/national/ percentage-non-hispanic-whites-hits-all-time-63-article-1.1371772",Non-OADS,/arxiv_data1/oa_pdf/26/71/lsv007.PMC5033551.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"2Antimicrobial Resistance, CDC, Threat Report 2013 ,http://www.cdc.gov/drugresistance/ threat-report-2013/index.html (accessedNov.30,2014).",OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"4National Strategy for Combating Antibiotic-Resistant Bacteria (2014),http://www.whitehouse.gov/ sites/default/files/docs/carb nationalstrategy.pdf (accessedNov.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"7FDA,Consumer Updates—Phasing Out Certain Antibiotic Use in Farm Animals ,http://www.fda.gov/ ForConsumers/ConsumerUpdates/ucm378100.htm (accessedDec.28,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"8MarynMcKenna, WhiteHouseActionsonAntibioticResistance:BigSteps,PlusDisappointments ,WIRED(2014), http://www.wired.com/2014/09/wh-amr-pcast/ (accessedNov.30,2014).",OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"9Sara Reardon, White House Takes Aim At Antibiotic Resistance ,NATURE(2014),http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"17PresidentialCouncilCallsforNewAntibioticsinUpcomingReportonAntibioticResistance ,FOODSAFETYNEWS, http://www.foodsafetynews.com/2014/07/pcast-previews-upcoming-report-on-antibiotic-resistance/ (ac- cessedNov.30,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"The phase-out was a 12-year process, culminating in the removal of antibiotic use in its hatcheries.30In order to compensate for the effect that the antibiotics pro- duced,thecompanyhasnowimprovedthedietsofitschickensbyusingall-vegetable feed,usingprebioticsandprobiotics,increasingvaccinationsforitschickens,andclean- ingitschickenhousesmorediligently.31PurdueFarmsexecutiveBruceStewart-Brown explainedthatthechickensthatreceiveprobioticsstayhealthierandgrowfasterthan thosethatdonot,andthateventhoughtheygrowslowerthantherestoftheindustry, 25JohnsHopkinsBloombergSchoolofPublicHealth, PoultryWorkersatIncreasedRiskofCarryingAntibiotic- Resistant E. coli ,http://www.jhsph.edu/news/news-releases/2007/price-poultry-workers.html (accessed Nov.30,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"ORG, http://www.npr.org/blogs/thesalt/2014/02/14/276976353/americans-want-antibiotic-free -chicken-and-the-industry-is-listening (accessedNov.30,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"29Perdue Farms Inc., Antibiotics Position Statement (2014),http://www.perduefarms.com/News Room/ Statements andComments/details.asp?id=545&title=Antibiotics%20Position%20Statement (accessed Nov.29,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"30Maryn McKenna, Chicken Company Perdue Takes Big Steps to Reduce Antibiotic Use ,WIRED(2014), http://www.wired.com/2014/09/abx-perdue/ (accessedNov.30,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"The farmers managed to meet this goal in two.35Pigs were kept healthy by altering their feed recipes, increasing barn 32DanCharles, GivingChickensBacteria...ToKeepThemAntibiotic-Free ,NPR.ORG,http://www.npr.org/blogs/ thesalt/2014/09/22/350590488/giving-chickens-bacteria-to-keep-them-antibiotic-free (accessed Nov. 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"33Maryn McKenna, The Future of Chicken ,SLATE, 2014,http://www.slate.com/articles/health andscience/ feedtheworld/2014/04/antibiotics inchickenvencomatic patiosystemmakesbirdshealthierdrug.2.",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"ORG,http://www.npr.org/ blogs/thesalt/2012/03/23/149221287/europes-mixed-record-on-animal-antibiotics (accessed Nov. 30,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"39Margaret Munro, As Canada Dawdles, Denmark Shows the World How to Stop Mass Medicating Animals , CANADA.COM(2014),http://o.canada.com/news/national/as-canada-dawdles-denmark-shows-the-world -how-to-stop-mass-medicating-animals (accessedDec.12,2014).",Non-OADS,/arxiv_data1/oa_pdf/e8/fb/lsv005.PMC5033552.pdf
"This is an Open Access article distributed under the terms of the Cre- ative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc- nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"HISTORICAL DEVELOPMENT OF POLICIES AND BROADENING THE APPLICATION Data sharing policies emerged following the Bermuda Principles developed in 1996 during the First International Strategy Meeting on Human Genome Sequencing in Bermuda.5Under these principles, endorsed by multiple international funding agen- cies,humangenomesequenceinformation‘ ...shouldbefreelyavailableandinthepub- licdomaininordertoencourageresearchanddevelopmentandtomaximizeitsbene- fittosociety’.6Followingthe1996meetinginBermuda,theHumanGenomeProject demonstratedthevalueofpre-publicationreleaseofdata,whichledtodiscoveryofin- formation on 30 disease genes.7In 1997, a second meeting reaffirmed the Bermuda Principlesandaddressedissuesrelevanttodataquality.Alsoin1997,theNationalHu- man Genome Research Institute (NHGRI) adopted its policy echoing the language fromthe1996and1997BermudaPrinciples.Thispolicyappliedtoallresearcherscon- ducting large-scale research funded by NHGRI.8Between its original policy in 1997 and 2003, the NHGRI extended and amended its data sharing policy three times to apply to broader types of data and to incorporate more specific details regarding the sharingofandaccesstodata.TheNIHadoptedsimilarguidelinesandpolicies,begin- ningin1999withguidelinesthatappliedtoallNIH-fundedresearchers.9In2003,the 4NationalScienceFoundation, AwardandAdministrationGuide:OtherPostAwardRequirementsandConsidera- tions,http://www.nsf.gov/pubs/policydocs/pappguide/nsf13001/aag˙6.jsp#VID4 (accessedOct.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"5HumanGenomeProjectInformationArchive, PoliciesonReleaseofHumanGenomicSequenceDataBermuda— Quality Sequence ,http://www.ornl.gov/sci/techresources/Human˙Genome/research/bermuda.shtml (ac- cessedJuly20,2014).",OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"7TorontoInternationalDataReleaseWorkshopAuthors, PrepublicationDataSharing ,461NATURE168(2009) 8National Human Genome Research Institute, Current NHGRI Policy for Release and Database Deposition of SequenceData 1997,http://www.genome.gov/10000910 (accessedJuly20,2014).",OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"A second wave of policies began to recognize growing capabilities to produce larger sequences and that nuances specific to different types of data sets may justify 10FinalNIHStatementonSharingResearchData,NOT-OD-03–032(Feb.26,2003), https://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"Thepolicyexplicitlystatesthat,instudiesinitiatedaftertheeffectivedateofthepolicy, NIHexpects‘toobtainparticipants’consentfortheirgenomicandphenotypicdatato beusedforresearchpurposesandtobesharedbroadly’.Thepolicygoesontoprovide 21National Human Genome Research Institute, Genetic Information Nondiscrimination Act (GINA) of 2008 , http://www.genome.gov/24519851 (accessedJuly21,2014).",OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"23NationalInstitutesofHealth, LacksFamilyReachUnderstandingtoShareGenomicDataofHeLaCells (Aug.7, 2013),http://www.nih.gov/news/health/aug2013/nih-07.htm (accessedJuly21,2014).",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"30Department of Health and Human Services, Regulatory Changes in ANPRM ,http://www.hhs.gov/ohrp/ humansubjects/anprmchangetable.html (accessedFeb.11,2014).",Non-OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"34RosalinaJamesetal., ExploringPathwaystoTrust:ATribalPerspectiveonDataSharing ,16GENET.MED.820, 826(2014), http://www.nature.com/gim/journal/vaop/ncurrent/full/gim201447a.html (accessedOct.20, 2014).",OADS,/arxiv_data1/oa_pdf/8c/c0/lsu032.PMC5033553.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"29, 2010, http://www.hinews.cn/news/system/2010/03/29/010779670.shtml (ac- cessed Dec. 18, 2014); Surrogacy Agents Soliciting Clients with Prices and 250,000 Yuan for Surrogacy (/ZdZ1039/ZdZ4225 /ZdZ7270/ZdZ7344/ZdZ6970/ZdZ11565/ZdZ7475/ZdZ1059/ZdZ6151/ZdZ6441/ZdZ4302/ZdZ998/ZdZ183025/ZdZ819/ZdZ2331/ZdZ1355/ZdZ13989/ZdZ10827/ZdZ4220), CHINANATIONALRADIO(/ZdZ857/ZdZ3113/ZdZ5035/ZdZ6617/ZdZ13437), Dec. 27, 2011,http://china.cnr.cn/yaowen/201112/t20111227˙508980110.shtml (accessedDec.18,2014); Discov- eringtheDirtyofSurrogacy:theSurrogateMotherNeedPaytheFeesforMiscarriageandAbortionofAbnormal Fetus(/ZdZ6425/ZdZ1039/ZdZ4225/ZdZ21501/ZdZ4993:/ZdZ8813/ZdZ979/ZdZ543/ZdZ10916/ZdZ5262/ZdZ3393/ZdZ13818/ZdZ16997/ZdZ14102/ZdZ4893/ZdZ1830),S. METROPOLIS DAILY(/ZdZ2179/ZdZ6885/ZdZ17961/ZdZ4910/ZdZ6097),Aug.27,2012, http://www.takungpao.com/society/content/2012-08/27/content˙998672.htm (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"23,2009,http://wbnews.daynews.com.cn/news/sx/784319.html (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"13,2009,http://www.nbweekly.com/news/observe/200904/9586.aspx (accessedDec.18,2014).Thenum- berwasestimatedbasedonthenumberofsurrogacyarrangedbytheInternetsurrogacyagencies.Itislikely underestimatedbecausethoseprivatesurrogacyarrangementshavenotbeencountedin.",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"11ChinaCouplewithEightBabiesSparksSurrogacyDebate ,BBCN EWS,Dec.21,2011, http://www.bbc.co.uk/ news/world-asia-china-16275624 (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"The twenty-five-year-old plaintiff, as surrogate mother, was in- troducedtothedefendantbyathirdparty.Accordingtotheirsurrogacycontract,the plaintiffagreedtobearachildforthedefendant,andinreturn,thedefendantwouldpay theplaintiffaservicefeeof60,000yuan.Theplaintiffgavebirthtoamalechildoneyear later.Thedefendantandhiswifesurreptitiouslytookthechildawayanddisappeared after successfully applying the child’s medical birth certificate in their own names as biologicalparents,usingtheirownbirthpermit.26Therefore,theplaintiffsuedthede- fendantandclaimedtheservicefeeof60,000yuanpromisedbythedefendantunder thesurrogacycontract.Thecourtrefusedtoacceptthecase.Theplaintifflaterchanged thecauseofactiontoaclaimofsolecareandcontrolofthechild.27 Case6:Theplaintiff’ssonhadprematurelydiedyearsagoandhiswifewasnolonger fertile.OnSeptember8,2006,theplaintiffgottoknowthedefendantandtheyentered 23A Twenty-year-old Woman Involved in a Lawsuit for Undertaking Surrogacy for 150,000 Yuan and the Biological Father of the Surrogate Child Awarded Sole Care and Control (20/ZdZ4525/ZdZ3837/ZdZ390815/ZdZ819 /ZdZ1647/ZdZ1039/ZdZ4225/ZdZ10827/ZdZ4220/ZdZ5669/ZdZ4292/ZdZ2340/ZdZ6086/ZdZ1703/ZdZ7279/ZdZ5246/ZdZ4245/ZdZ4220/ZdZ10827/ZdZ10082), GUANGXINEWS(/ZdZ5035/ZdZ16043/ZdZ6876/ZdZ19239/ZdZ13437), Sept. 13, 2008, http://www.gxnews.com.cn/staticpages/20080913/newgx48cb0c3f-1664889.shtml (accessed Dec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"27SurrogacyContractWasNotRecognisedbyLawandaSurrogateMother’sClaimforSoleCareandControlWas Refused(/ZdZ1039/ZdZ4225/ZdZ2171/ZdZ16602/ZdZ825/ZdZ2307/ZdZ1289/ZdZ6096/ZdZ14481/ZdZ19295/ZdZ812/ZdZ1039/ZdZ4225/ZdZ3743/ZdZ2308/ZdZ7200/ZdZ6086/ZdZ1703/ZdZ7279/ZdZ15831/ZdZ6142),DAHEWANG (/ZdZ3667/ZdZ8671/ZdZ13437),May24,2010, http://www.dahe.cn/xwzx/dysj/dybd/t20100524˙1807374.htm (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"29AWomaninChangdeUndertookSurrogacyandTriggeredaFightforChild,andtheCourtConfirmedValidityof theSurrogacyContract (/ZdZ4964/ZdZ5347/ZdZ3743/ZdZ4220/ZdZ1039/ZdZ4225/ZdZ5185/ZdZ2301/ZdZ3686/ZdZ4220/ZdZ3667/ZdZ5956/ZdZ8705/ZdZ19342/ZdZ1872/ZdZ1759/ZdZ1039/ZdZ4225/ZdZ2171/ZdZ16602/ZdZ7221/ZdZ6772),HUNANHONGWANG (/ZdZ9090 /ZdZ2179/ZdZ13262/ZdZ13437),Aug. 18, 2010, http://unn.people.com.cn/GB/14778/21707/12468135.html (accessedDec.",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"13, 2013, http://politics.people.com.cn/n/2013/0313/c1001-20773632.html (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"63Themedicalbirthcertificateisoneofthesupportingdocumentsforthehouseholdregistrationofachild;see ASeventeen-year-oldGirlHopestoGettheHouseholdRegistrationbutFailsDuetotheLackoftheMedicalBirth Certificate (17/ZdZ4525“/ZdZ21501/ZdZ5987”/ZdZ3743/ZdZ4245/ZdZ11304/ZdZ5987/ZdZ2319/ZdZ13414/ZdZ5196/ZdZ1830/ZdZ10827/ZdZ16621/ZdZ6970/ZdZ5987/ZdZ2319/ZdZ1994/ZdZ825/ZdZ946),CIXIDAILY(/ZdZ5748/ZdZ9174/ZdZ6929/ZdZ6097),Apr.17,2014, http://news.cnnb.com.cn/system/2014/04/17/008039277.shtml (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"81UncoveringtheProfitChainofSurrogacyandtheSurrogateMotherReceivingaMinimumServiceFeeof200,000 Yuan If She Gives Birth to a Male Child (/ZdZ6425/ZdZ12036/ZdZ1039/ZdZ4225/ZdZ1877/ZdZ11254/ZdZ18986/ZdZ1039/ZdZ4225/ZdZ3764/ZdZ3764/ZdZ10827/ZdZ10851/ZdZ4245/ZdZ7212/ZdZ1146/ZdZ18072/ZdZ201520/ZdZ819), NANFANGDAILY(/ZdZ2179/ZdZ6885/ZdZ6929/ZdZ6097), Nov. 28, 2011, http://zuche.qingdaonews.com/content/2011-11/28/ content˙9025439.htm (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"29, 2010, http://www.hinews.cn/news/system/2010/03/29/010779670.shtml (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"89This may avoid difficult cases similar to the reported story where an Australian couple abandoned the Down syndrome baby born of surrogacy; see Lindsay Murdoch, Australian Couple Leaves Down Syndrome Baby with Thai Surrogate ,THESYDNEYMORNINGHERALD, Aug. 1, 2014, http://www.smh.",Non-OADS,/arxiv_data1/oa_pdf/1e/fc/lsu036.PMC5033554.pdf
"KEYWORDS: bioethics,genomics,genomictechnologies,militaryethics, geneticdiscrimination,personalizedgenomics C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com.",Non-OADS,/arxiv_data1/oa_pdf/09/71/lsu030.PMC5033555.pdf
"NATURENEWS(2014),http://www.nature.com/ news/is-the-1-000-genome-for-real-1.14530 (accessedNovember28,2014).",Non-OADS,/arxiv_data1/oa_pdf/09/71/lsu030.PMC5033555.pdf
"7Susannah Baruch, Mark Nunes & Jay Platt, Genetics and Public Policy Center, Berman School of Bioethics, John Hopkins University, NW (Jan. 10, 2006), http://www.dnapolicy.org/news.past.php?action= detail&past eventid=25(accessedNovember28,2014).",OADS,/arxiv_data1/oa_pdf/09/71/lsu030.PMC5033555.pdf
"Instead,wewanttocommentonhoweggfreezingislikelytoincreaseexistingclass stratificationinanincreasinglyunequaleconomicsystem.First,wedescribethecurrent winner-take-alleconomicsystem.Themostsuccessfulwomenfindthatcuttingbackon longhourscomesatasteeppriceintermsofcareersandincome.Atthesametime,the C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"15, 2013, http://www.theatlantic.com/sexes/archive/2013/03/getting-married-later-is-great-for-college -educated-women/274040/ (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"7Kay Hymowitz et al., The Great Crossover (2013), http://twentysomethingmarriage.org/the-great -crossover/ (lastaccessedDec11,2014).Forthosewithlessthanahighschooleducation,theaverageageof firstbirthis20;forthosewithsomecollegebutwithoutadiploma,itis24.SeeId.,fig.11.",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"8Adam Looney & Michael Greenstone, The Marriage Gap: The Impact of Economic and Technical Change in Marriage Rates (2012), http://www.hamiltonproject.org/papers/the marriagegaptheimpact ofeconomic andtechnological changeonma/(lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"9Gretchen Livingston & D’vera Cohen, Record Share of New Mothers are College-Educated (2013), http://www.pewsocialtrends.org/2013/05/10/record-share-of-new-mothers-are-college-educated/ (lastac- cessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"10Christine R. Schwartz, Earnings Inequality and the Changing Association between Spouses’ Earnings, 115 AM.J.SOC.1524(2010);KnotYet,IDo,butLater,Figs7and8, http://twentysomethingmarriage.org/i-do -but-later/ (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"14SeeJacquelineE.King, Gender Equity in Higher Education: 2010,(2010), http://www.latimes.com/science/ sciencenow/la-op-males13–2008jul13-story.html (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"17, 2014, http://www.businessweek.com/articles/2014-04-17/new-egg-freezing-technology-eases-womens-career- family-angst#p1 (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"See eg http://politicalgates.blogspot.com/2011/12/citigroup- plutonomy-memos-two-bombshell.html (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"20See, eg How Much do Egg Donors Get Paid?, http://www.assistedfertilityblog.com/how-much-do-egg -donors-get-paid/ (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"21See eg Egg Sharing at Care Fertility (2014), http://www.carefertility.com/donation-programme-sc3/ egg-sharing-sj1/ (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"22For some of the complexities involved in selling eggs, see Naomi Cahn & Jennifer Collins, Fully In- formedConsentforEggDonors,16V IRTUALMENTOR49(2014), http://virtualmentor.ama-assn.org/2014/ 01/hlaw2-1401.html (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"; Susan L. Crockin & Judith Daar, Letter to the Editor, 16 V IRTUALMENTOR302 (2014), http://virtualmentor.ama-assn.org/2014/04/corr1-1404.html (lastaccessedDec11,2014).",Non-OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"24SeeCLAUDIAGOLDIN&LAWRENCEF.KATZ,DYNAMICSOFTHE GENDERGAPFORYOUNGPROFESSIONALSINTHE FINANCIAL AND CORPORATE SECTORS(2008),http://fairmodel.econ.yale.edu/ec483/katz.pdf (lastaccessed Dec11,2014).",OADS,/arxiv_data1/oa_pdf/7d/36/lsu033.PMC5033556.pdf
"KEYWORDS: genomictesting,G →Pmap,genomicregulatorynetworks, development,proportionality C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/80/be/lsu035.PMC5033557.pdf
"They ex- plore, then, in some detail, the question of how the military ought to move forward in cases where there is a compelling reason to deploy a genomic technology which 8JASON,T HE$100G ENOME:IMPLICATIONS FOR THE DOD43(2010), http://www.fas.org/irp/agency/dod/ jason/hundred.pdf (accessedDec.10,2014).",Non-OADS,/arxiv_data1/oa_pdf/80/be/lsu035.PMC5033557.pdf
"Sincerely, I. Glenn Cohen ,JD Co-Editor-in-Chief ,JournalofLawandtheBiosciences, Harvard Law School Nita Farahany ,JD,PhD Co-Editor-in-Chief ,JournalofLawandtheBiosciences, Duke University Hank Greely ,JD Co-Editor-in-Chief ,JournalofLawandtheBiosciences, Stanford University C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/00/25/lsv010.PMC5033558.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/14/48/lsu034.PMC5033559.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/9f/bd/lsv001.PMC5033560.pdf
"5Nir Eyal,Informed Consent ,i nSTANFORD ENCYCLOPEDIA OF PHILOSOPHY (Edward N. Zalta ed., fall 2011), http://plato.stanford.edu/archives/fall2011/entries/informed-consent/ .",Non-OADS,/arxiv_data1/oa_pdf/9f/bd/lsv001.PMC5033560.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/98/48/lsu031.PMC5033562.pdf
"Department of Health & Human Services, Code of Federal Regulations, http://www.hhs.gov/ ohrp/humansubjects/guidance/45cfr46.html(accessedOct.3,2014).",Non-OADS,/arxiv_data1/oa_pdf/98/48/lsu031.PMC5033562.pdf
"Department of Health & Human Services, The Belmont Report , http://www.hhs.gov/ ohrp/policy/belmont.html/(accessedAug.13,2013).",Non-OADS,/arxiv_data1/oa_pdf/98/48/lsu031.PMC5033562.pdf
"42PanelonResearchEthics, TCPS2—2ndEditionofTri-CouncilPolicyStatement:EthicalConductforResearchIn- volving Humans , http://www.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/ (accessed Aug.13,2013).",Non-OADS,/arxiv_data1/oa_pdf/98/48/lsu031.PMC5033562.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"This harmony is part of the motivation behind these regulations, as the FDA has ex- pressed concern that manufacturers of IVDs will attempt to classify themselves as LDTs to avoid FDA regulatory oversight.4However, whether the FDA even has the 1NationalCenterforBiotechnologyInformation,ClinVarsubmissions, http://www.ncbi.nlm.nih.gov/clinvar/ submitters/ (accessedDec.23,2014).",Non-OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"3Molika Ashford, AMP Members Reiterate Position on LDT Regulation; Questions to FDA Suggest Confusion Remains,https://www.genomeweb.com/clinical-genomics/amp-members-reiterate-position-ldt-regulation -questions-fda-suggest-confusion-re (accessedDec.26,2014).",OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"6Centers for Medicare & Medicaid Services, LDT and CLIA FAQs ,http://www.cms.gov/ Regulations-and-Guidance/Legislation/CLIA/Downloads/LDT-and-CLIA FAQs.pdf (accessed Dec. 22,2014)(CMSexplanationofCMSandFDAauthorityonLDTs).",OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"13Edward R. Ashwood, Letter to OMB from Lab Leaders (2014),http://www.acla.com/wp-content/uploads/ 2014/07/Letter-to-OMB-from-Lab-Leaders.pdf (accessedNov.1,2014).",Non-OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"sciencemag.org/health/2014/09/fda-defends-plan-regulate-lab-developed-tests (accessed Sept. 10, 2014) (number of certified laboratories); Audrey Huang, G ENETICS &PUBLICPOLICYCENTER,FDA Regulation of Genetic Tests (2008),http://www.dnapolicy.org/images/issuebriefpdfs/FDA Regulation ofGeneticTestIssueBrief.pdf(accessedNov.1,2014)(numberofgeneticconditionswithtestsoffered).",OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"Unaddressed risks GenetictestinginformsseriousmedicaldecisionsandthishaspromptedtheFDAtoact inanattempttoguaranteetheiranalyticalandclinicalefficacy.However,reportsabout harmsfromgenetictestingoftendonotfocusontheaccuracyormarketingofatest, butthemisuseormisinterpretationofthesetestsbyphysiciansandpatients.22Many genetictestsmayinvariablyproduceambiguousoruncertainresults,whichmayhave seriousconsequencesforthepatient.TheFDAhopestoprotectthepatientbyassuring theanalyticalandclinicalefficacyofgenetictesting,butthisfocusesattentiononthe wrongpartofproblem.Notallphysiciansareequippedwiththetoolstoaccuratelyun- derstandthesetestscorrectly.GeneticcounselorsfromARUPLaboratoriesreviewed physician-orderedgenetictestsandfoundthataround30%ofthesewereincorrectly ordered.23 Inappropriateclinicalapplicationisoneofthebiggestrisksofgenetictesting,andit cannotbesolvedbyFDAaction.Thisisaproblemwiththepracticeofmedicine,and canonlybeaddressedthroughbettereducationandguidelinesforphysiciansonhow toapplytheseteststoclinicalcare.Attentiontothevalidityofthetests,typicallyquite high,isadistractionandwilldivertattentionandresourcesawayfromthelargerissue ofbetterincorporatingthesetestsintocare.NotonlywilltheFDA’sactionsreducethe numberofoveralltestsandprovidersandslowthepaceofinnovation,butitmayalso 19JefferyN.Gibbs,AllysonB.Mullen&MelissaWalker, 510(k)StatisticalPatterns ,MEDICALDEVICEAND DIAG- NOSTICINDUSTRYNEWS(2014),http://www.mddionline.com/article/510k-statistical-patterns-12-02-2014 (accessedDec.26,2014).",Non-OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"22EgBethDaley, OversoldandMisunderstood ,NEWENGLANDCENTER FOR INVESTIGATIVE REPORTING (2014), http://features.necir.org/prenatal-testing (accessedDec.26,2014)discussesthemisinterpretationofthere- liabilityoftestsandtheiruseforscreeningandnotdiagnosticpurposes,andDeniseGrady&AndrewPollack, FindingRisks,NotAnswers,inGeneTests ,THENEWYORKTIMES,Sept.23,2014,discusstheuncertainclinical utilityformanygenetictests.",OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"23ARUP Laboratories, Value of Genetic Counselors in the Laboratory (2011),http://www.aruplab.com/files/ resources/genetics/White-paper-1-value-of-GCs-in-lab.pdf (accessedDec.26,2014).",OADS,/arxiv_data1/oa_pdf/f5/b5/lsv002.PMC5033563.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/e0/05/lsv006.PMC5033564.pdf
"7Julian Savulescu & Tony Hope, Ethics of Research ,i nTHEROUTLEDGE COMPANION TOETHICS781 (John Skorupski,ed.,2010).See http://www.amazon.co.uk/Routledge-Companion-Ethics-Philosphy-Companions/ dp/0415415160 8JulianSavulescu, SafetyofParticipantsofNon-TherapeuticResearchMustbeEnsured ,316Brit.Med.J.891,892 (1998).",Non-OADS,/arxiv_data1/oa_pdf/e0/05/lsv006.PMC5033564.pdf
"16Julian Savulescu, Aubrey de Grey & Nick Bostrom, The War Against Ageing ,A B C :T HEDRUM(2009), http://www.abc.net.au/news/2009-02-17/38100 (accessedJan.12,2015).",Non-OADS,/arxiv_data1/oa_pdf/e0/05/lsv006.PMC5033564.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"3The Senate of Texas, Senator John Whitmire: District 15 ,http://www.whitmire.senate.state.tx.us/ (accessed Dec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"4Bill Analysis ,http://www.capitol.state.tx.us/tlodocs/83R/analysis/html/SB00344F.htm (accessed Dec. 04, 2014).",OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"5Maurice Chammah, Bill Addresses Changing Science in Criminal Appeals, THETEXASTRIBUNE, Feb. 04, 2013,http://www.texastribune.org/2013/02/04/criminal-justice-advocates-renew-call-flawed-scien/ (ac- cessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"344 History ,http://www.capitol.state.tx.us/BillLookup/History.aspx?LegSess=83R &Bill=SB344 (accessedDec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"10Interestingly,Rep.Wu,whowaselectedin2012,isaformerprosecutorintheHarrisCountyDistrictAttor- ney’sOffice.TexasHouseofRepresentatives, TexasHouseMemberRep.Wu ,http://www.house.state.tx.us/ members/member-page/?district=137 (accessedDec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"16Chuck Lindell, Henderson Granted New Trial in Baby’s 1994 Death ,STATESMAN , Dec. 05, 2012, 7:12 PM,http://www.statesman.com/news/news/local/henderson-granted-new-trial-in-babys-1994-death/ nTNRC/ (accessedJan.27,2015).MsHendersonallegedlyhadbeatentheinfanttodeath.",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"17ColleenCurry, DeathRowWomanCouldGetNewTrialOver‘DroppedBaby’Evidence ,ABCN EWS,May24, 2012,http://abcnews.go.com/US/death-row-babysitter-convicted-killing-baby-trial/story?id=16424587 (accessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"152 rNewscience,oldconvictionsTexasSenateBill344 2007formurderingherfostersonbypoisoninghimwithsalt.21However,DrMichael Moritz,aleadingexpertonsaltintoxication,recentlyconcludedthatthechildlikelyate something himself, since he was a chronic overeater, which caused his salt overdose, therebyrefutingthescientifictestimonygiveninMsOverton’soriginaltrial.22Specifi- cally,JudgeCochranwrote,‘The disconnectbetweenchangingscienceandreliableverdicts thatcanstandthetestoftime hasgrown inrecentyearsasthespeedwithwhichnewsci- enceandrevisedscientificmethodologiesdebunkwhathadbeenthoughtofasreliable forensicsciencehasincreased.’23 Both theHenderson andOvertondecisions came a year after the Court of Crimi- nalAppealsreceivedalotofpubliccriticismforitsdecisioninthecaseofNealRob- bins.24In1999,NealRobbinswasconvictedofcapitalmurderforthedeathofhisgirl- friend’sinfantchild.25Originally,themedicalexaminertestifiedatMrRobbins’strial thatthechilddiedfromasphyxiationbycompression26,butin2007,sherecantedher testimonyandamendedtheautopsyreporttoreflectthatthecauseofdeathwasunde- termined.27Nonetheless,althoughthemedicalexaminerandotherexpertsagreedthat heroriginaltestimonywasnotsupportedbyscience,theCourtofCriminalAppeals, ina5–4opiniondeclaredthatthemedicalexaminer’soriginaltestimony‘hasnotbeen provenfalse’.28Unsurprisingly,JudgeCochranwroteadissentingopinioninMrRob- bins’scase,stating,‘given...seriousconcernsabouttheimpactof[themedicalexam- iner’s]testimonyattrialonthecriticalandhotlydisputedissueof[thechild’s]causeof death,Iagreethatapplicantdidnotreceiveafundamentallyfairtrialbasedupon reliable scientificevidence ’.29 USE OF SB 344 After SB 344 became effective, Mr Robbins filed a subsequent application for a writ ofhabeascorpusunderSB344.30OnOctober21,2013,20daysafterSB344became effective,JudgeK.MichaelMaysrecommendedanewtrialforMrRobbins.31Under SB 344, like Mr Robbins, it is very likely that both Ms Henderson and Ms Overton would have also received new trials, if the Court of Criminal Appeals had originally ruledagainstthemastheydidforMrRobbins.Mostfamously,the‘SanAntonioFour 21TomDart, TexasMother’sMurderConvictionOverturnedinSaltPoisonCase ,THEGUARDIAN,Sept.18,2014, 5:21 PM, http://www.theguardian.com/world/2014/sep/18/texas-mother-murder-conviction-overton -salt-poison-overturn (accessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"24Scott Henson, ME Testimony False According to Science but not Texas Law ,GRITS FOR BREAKFAST, Jul.19,2011, http://gritsforbreakfast.blogspot.com/2011/07/me-testimony-false-according-to-science.html (accessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"30MaryA.Robbins, NewTexasStateLawTakesCapitalMurderCaseBacktoCourt ,ALME XPERTWITNESSBLOG, Dec.09,2013, http://blogs.almexperts.com/index.php/2013/12/ (accessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"32MarkGodsey, Breaking:WithToday’sReleaseoftheSanAntonioFour,TexasNowOntheCuttingEdgeofEfforts to Free the Innocent ,HUFFINGTON POST:CRIME, Jan. 23, 2014, 6:58 PM, http://www.huffingtonpost.com/ mark-godsey/with-todays-release-of-th b4296813.html (accessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"36House Research Organization, http://www.hro.house.state.tx.us/pdf/ba83R/SB0344.PDF (accessed Dec. 23,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"40HerInstitute, JunkScience ,http://www.herinst.org/envcrisis/science/uncertainty/junk.html (accessedDec.",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"41Nathan A. Schachtman, The Rise and Rise of Junk Science ,http://schachtmanlaw.com/the-rise-and-rise-of -junk-science/ (accessedDec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"43WhatisJunkScience ,JUNKSCIENCE,http://junkscience.com/what-is-junk-science/ (accessedDec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"50Emily Swanson, Americans Have Little Faith in Scientists, Science Journalists: Poll ,HUFFINGTON POST: SCIENCE, Dec. 22, 2013, 10:31 AM, http://www.huffingtonpost.com/2013/12/21/faith-in-scientists n4481487.html (lastassessedJan.27,2015).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"55InnocenceProject, AbouttheInnocenceProject ,http://www.innocenceproject.org/about/ (accessedDec.04, 2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"08, 2014, 6:30 AM, http://www.popularmechanics.com/science/health/what-can-we-do-about-junk-science-16674140 (as- sessedJan.27,2015)(‘Junksciencesticksbecauseitpreysonthepublic’sfearanddistrust.’).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"58Innocence Project, Unreliable or Improper Forensic Science ,http://www.innocenceproject.org/understand/ Unreliable-Limited-Science.php (accessedDec.04,2014).",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"17, 2012, http://www.washingtonpost.com/pb/local/crime/forensic-techniques-are -subject-to-human-bias-lack-standards-panel-found/2012/04/17/gIQADCoMPT story.html (accessedJan.",Non-OADS,/arxiv_data1/oa_pdf/8d/7d/lsv004.PMC5033565.pdf
"C/circlecopyrtTheAuthor2015.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/68/99/lsv003.PMC5033566.pdf
"2014–18, 57–59, 2014), http://ssrn.com/abstract=2407265 (accessedDec.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/68/99/lsv003.PMC5033566.pdf
"53Judicial Education Center, University of New Mexico, Overview of Torts ,http://jec.unm.edu/ education/online-training/torts-tutorial (accessedNov.25,2014).",Non-OADS,/arxiv_data1/oa_pdf/68/99/lsv003.PMC5033566.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/f1/opth-10-1797.PMC5033587.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1797–1801Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1797Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11074 9 The association of hematologic inflammatory  markers with atherogenic index in type 2 diabetic  retinopathy patients Müberra Akdog ˘an1 Yasemin Ustundag-Budak2 Kagan huysal2 1Department of Ophtalmology,   2Department of Clinical laboratory,   Yüksek i˙htisas education and  research hospital, Bursa, T urkeyBackground:  Atherogenic dyslipidemia is particularly common in people with type 2 diabetes  (DM2).",Non-OADS,/arxiv_data1/oa_pdf/bf/f1/opth-10-1797.PMC5033587.pdf
"Diabetic retinopathy (DR) is responsible for decreased vision and  blindness; studies estimate that 28.5%–40.3% of patients with type 2 diabetes (DM2)  had DR.3 Retinal abnormalities in DR patients are microaneurysms, intraretinal hemor - rhages, lipid exudates, macular edema, capillary occlusion, cotton-wool spots, retinal  thickening, and neovascularization.4 The duration of hyperglycemia and abnormal  blood lipid levels (such as, total cholesterol, low-density lipoprotein [LDL], and  triglyceride) are defined risk factors for development and progression of DR.4 Evidence suggests that platelets from patients with DM2 have increased reactivity and  baseline activation compared to healthy controls.5 Mean platelet volume (MPV) and platelet Correspondence: Yasemin Ustundag-Budak Mimar sinan Mahallesi emniyet  Caddesi Polis Okulu Karşısı, Yildirim,  16330, Bursa, Turkey Tel +90 53 2482 3692 email yaseminbudak2000@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Akdog ˘an et al Running head recto: Inflammatory markers with atherogenic index in diabetic retinopathy DOI: http://dx.doi.org/10.2147/OPTH.S110749",Non-OADS,/arxiv_data1/oa_pdf/bf/f1/opth-10-1797.PMC5033587.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/bf/f1/opth-10-1797.PMC5033587.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/f1/opth-10-1797.PMC5033587.pdf
"(B) Photos of ﬁve random ﬁelds per well were taken; the numbers of pyknotic and total number of cells were quantiﬁed using ImageJ software (http://imagej.nih.gov/ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA), and the number of pyknotic cells was plotted as the percentage of total number of cells.",OADS,/arxiv_data1/oa_pdf/3a/de/i1552-5783-57-11-4581.PMC5033602.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2295–2304International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2295RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S10970 0 what else should we know about experiencing  COPD?",Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
"The present study recognizes psychological burdens which a  patient diagnosed with COPD may experience, yet also searches for factors that, despite  progressing illness, protect, stabilize, or improve mental health, quality of life (QoL),  and well-being – no matter if this means individual dispositional trait or interventions  provided from the outside.Correspondence: Marta Rzadkiewicz Department of Medical Psychology,  Medical University of Warsaw, Żwirki i  wigury 81, 02-091 warsaw, Poland Tel +48 22 506 769 634 Fax +48 22 572 05 42 email mrzadkiewicz@wum.edu.p l Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Rzadkiewicz et al Running head recto: In search of alleviation of psychological burden in COPD DOI: http://dx.doi.org/10.2147/COPD.S109700",Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
"Available from: http://www.who.int/ mediacentre/factsheets/fs315/en /, http://www.who.int/respiratory/copd/ en/.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
"Available from: http://apps.who.int/iris/bitstream/10665/148114/1/   9789241564854_eng.pd f. Accessed February 16, 2016.",OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
Available  from: http://www.hqlo.com/content/11/1/19 0.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3010890/pdf/HTA-06-1 1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/43/d9/copd-11-2295.PMC5033607.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 291–293International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 291 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S113339Progressive loss of vision caused by asymptomatic  pituitary macroadenoma: role of OCT Víctor Manuel  Asensio-Sánchez  Javier Foncubierta Ophthalmology Department, Clinical  University Hospital of Valladolid,  Valladolid, SpainIntroduction: Most pituitary adenomas are clinically inactive.",Non-OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"8Correspondence: Javier Foncubierta Calle Librería, 9,  Valladolid 47002, SpainTel +34  600 075 585Email javi_foncu@hotmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Asensio-Sánchez and FoncubiertaRunning head recto: Loss of vision caused by asymptomatic pituitary macroadenomaDOI: http://dx.doi.org/10.2147/IMCRJ.S113339",Non-OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 293 Loss of vision caused by asymptomatic pituitary macroadenoma Goldmann perimetry4 and automated static perimetry.14,15  This fact gives OCT prognostic value regarding the visual  outcome, as demonstrated in different studies.16,17 OCT is a  useful tool to assess the structural and functional damage of ganglion cells, objectively and quantitatively.",Non-OADS,/arxiv_data1/oa_pdf/f0/cb/imcrj-9-291.PMC5033608.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/73/ijn-11-4735.PMC5033609.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4735–4741International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4735OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11402 5 Monte carlo and analytic simulations in  nanoparticle-enhanced radiation therapy autumn D Paro1 Mainul hossain2 Thomas J Webster1,3,4 Ming su1,4 1Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 2Nano science Technology  center and school of electrical  engineering and computer science,   University of central Florida,   Orlando, Florida, Usa; 3excellence  for advanced Materials research,   King abdulaziz University, Jeddah,   saudi arabia; 4Wenzhou Institute  of Biomaterials and engineering,   chinese academy of science,   Wenzhou Medical University, Zhejiang,   People’s  republic of chinaAbstract:  Analytical and Monte Carlo simulations have been used to predict dose enhancement  factors in nanoparticle-enhanced X-ray radiation therapy.",Non-OADS,/arxiv_data1/oa_pdf/4d/73/ijn-11-4735.PMC5033609.pdf
"Compton  scattering and photoelectric effects dominate when metallic nanoparticles are used  as imaging contrast agents.4,5 As photoelectrons and Auger electrons are released  due to the photoelectric effect, they travel through the cell and hydrolyze water  molecules creating free radicals that interact with DNA causing DNA damage, and  eventually cell death.6,7 Analytical and Monte Carlo methods have been used to calculate the production  of secondary electrons in terms of the dose enhancement factor (DEF).8,9 The DEF  is defined as the ratio of the average radiation dose absorbed by the tumor when it is correspondence: Ming su Department of chemical engineering,  Northeastern University, 360 huntington  ave, Boston, Ma 02115, Usa Tel +1 617 373 6219 email m.su@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Paro et al Running head recto: Simulations in nanoparticle-enhanced radiation therapy DOI: http://dx.doi.org/10.2147/IJN.S114025",OADS,/arxiv_data1/oa_pdf/4d/73/ijn-11-4735.PMC5033609.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4d/73/ijn-11-4735.PMC5033609.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/73/ijn-11-4735.PMC5033609.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fc/94/copd-11-2259.PMC5033610.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2259–2260International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2259Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S11702 8 The use of high-flow nasal oxygen in COPD  patients Pedro Silva Santos1 Antonio M esquinas2 1Pulmonology Unit, Centro  Hospitalar e Universitário de  Coimbra – Hospitais da Universidade  de Coimbra, Coimbra, Portugal;   2Internsive Care Unit, Hospital  Morales Meseguer, Múrcia, SpainDear editor High-flow nasal cannula (HFNC) oxygen therapy is an innovative and useful mode for  the treatment of patients with respiratory failure.1–3 It delivers heated and humidified  air providing higher and more expected gas flow rates and fraction inspired oxygen  (FiO2) than traditional oxygen therapy.2 We read the article by Bräunlich et al1 carefully and congratulate the authors on  their study about the use of nasal high-flow therapy in COPD patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/94/copd-11-2259.PMC5033610.pdf
"2016;61(4):529–541.Correspondence: Pedro Silva Santos Centro Hospitalar e Universitário de  Coimbra, Praceta Prof Mota Pinto,  Coimbra 3000-075, Portugal tel +351 239 400 400 email pedrorssantos@gmail.co mJournal name: International Journal of COPD Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Silva Santos and Esquinas Running head recto: Use of high-flow nasal oxygen in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S117028",Non-OADS,/arxiv_data1/oa_pdf/fc/94/copd-11-2259.PMC5033610.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fc/94/copd-11-2259.PMC5033610.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/94/copd-11-2259.PMC5033610.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2081–2089International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2081OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11074 6 Invasive coronary angiography in patients with  acute exacerbated COPD and elevated plasma  troponin Carmen Pizarro1,* neele herweg-steffens1,* Martin Buchenroth2 Wolfgang schulte3 Christian schaefer1 Christoph hammerstingl1 nikos Werner1 georg nickenig1 Dirk skowasch1 1Department of Internal Medicine  II – Cardiology, Pneumology and  angiology, University hospital Bonn,   Bonn, germany; 2Department of  Pneumology, Johanniter hospital  Bonn, Bonn, germany; 3Department of  Pneumology, Malteser hospital Bonn/ rhein-sieg, Bonn, germany *These authors contributed equally  to this workBackground:  In acute exacerbation of COPD, increased plasma levels of cardiac troponin are  frequent and associated with increased mortality.",Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
"Apart from accelerating the rate of lung function decline,5 periexacerbational Correspondence: Carmen Pizarro Department of Internal Medicine II –  Cardiology, Pneumology and angiology,  University hospital Bonn, sigmund-Freud- straße 25, 53105 Bonn, germany Tel +49 228 287 15259 Fax +49 228 287 14323 email carmen.pizarro@ukb.uni-bonn.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Pizarro et al Running head recto: Invasive coronary angiography in acute exacerbated COPD patients DOI: http://dx.doi.org/10.2147/COPD.S110746",Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/53/copd-11-2081.PMC5033611.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 223–234International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 223 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S93887 Update on current management of chronic kidney  disease in patients with HIV infection Nina E Diana Saraladevi Naicker Department of Internal Medicine,   Faculty of Health Sciences, University of the Witwatersrand, Johannesburg,  South AfricaAbstract: The prevalence of HIV -associated chronic kidney disease (CKD) varies geographically  and depends on the definition of CKD used, ranging from 4.7% to 38% globally.",Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
"In North America and Europe, HIV -associated CKD prevalence ranges from 4.7%–9.7% (CKD being defined as Correspondence: Saraladevi Naicker Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, 7 York Road, Parktown, Johannesburg 2193, South AfricaTel +27 11 717 2709Email Saraladevi.Naicker@wits.ac.zaJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Diana and NaickerRunning head recto: Chronic kidney disease in patients with HIV infectionDOI: http://dx.doi.org/10.2147/IJNRD.S93887",Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
Available from:  http://www.who.int/hiv/en/.,Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
Available from: http://www.usrds.org/atlas12.aspx.,OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 234 Diana and Naicker  121.,Non-OADS,/arxiv_data1/oa_pdf/97/b2/ijnrd-9-223.PMC5033612.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2287–2294International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2287OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11428 1 Breakdown of lung framework and an increase in  pores of Kohn as initial events of emphysema and  a cause of reduction in diffusing capacity akira Y oshikawa,1 shuntaro  sato,2,3 T omonori Tanaka,1  Mikiko hashisako,1,4 Yukio  Kashima,5,6 T omoshi Tsuchiya,7  naoya Yamasaki,7 Takeshi  nagayasu,7 hiroshi Yamamoto,2  Junya Fukuoka1,6 1nagasaki educational and Diagnostic Center of  Pathology (neDCP), Department of Pathology,  2Clinical research Center, n agasaki University  hospital, nagasaki, 3Division of Biostatistics,  Kurume University school of Medicine, Fukuoka,  4research Institute for Diseases of the Chest,  graduate school of Medical sciences, Kyushu  University, Fukuoka, 5Department of Pathology,  hyogo Prefectural awaji Medical Center,  sumoto, 6Department of Pathology, 7Division of  surgical Oncology, Department of Translational  Medical sciences, nagasaki University graduate  school of Biomedical sciences, nagasaki,  JapanPurpose:  Pulmonary emphysema is the pathological prototype of chronic obstructive pulmonary  disease and is also associated with other lung diseases.",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
"Various lung studies have been performed using observation by a scanning electronic  microscope.15–17 In cases with emphysema, Nagai et al reported an increase in pores of  Kohn, which are pathways for collateral ventilation between two adjacent alveoli.16,18,19Correspondence: Junya Fukuoka Department of Pathology, nagasaki University  graduate school of Biomedical sciences, 1-7-1,  sakamoto, nagasaki, 852-8501, Japan Tel +81 95 819 7055 Fax +81 95 819 7054 email fukuokaj@nagasaki-u.ac.j p Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Y oshikawa et al Running head recto: Lung framework and pores of Kohn in emphysema DOI: http://dx.doi.org/10.2147/COPD.S114281 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
Or use: http://youtu.be/D9aBddozBg 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
Available from: http://goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/c8/7c/copd-11-2287.PMC5033613.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/63/0a/ijn-11-4719.PMC5033614.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 4719–4733International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4719OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11337 5 The synergistic effect of TiO2 nanoporous  modification and platelet-rich plasma treatment  on titanium-implant stability in ovariectomized rats Nan Jiang1,2 Pinggong Du2 Weidong Qu2 lin li2 Zhonghao liu2 songsong Zhu1 1State Key Laboratory of Oral  Diseases and Department of Oral  and Maxillofacial surgery, West  china hospital of stomatology,   sichuan University, chengdu,   2Yantai city stomatological  hospital, Yantai, People’s  Republic of ChinaAbstract:  For several decades, titanium and its alloys have been commonly utilized for  endosseous implantable materials, because of their good mechanical properties, chemical  resistance, and biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/63/0a/ijn-11-4719.PMC5033614.pdf
"But associated low bone mass, wear and loss characteristics,  and high coefficients of friction have limited their long-term stability, especially in  certain abnormal intraosseous conditions, such as postmenopausal osteoporosis, which  is characterized by low osseous mass and microenvironmental disruption of bones.1–3  Under these circumstances, the stability of implants depends on two aspects: 1) the  osseous microenvironment around the implant, resting with the quality and quantity  of the bone substance; and 2) the osseointegration (OI) of the implant, defined as the  performance of direct bone–implant interface bonding.4 Many attempts, such as drug correspondence: songsong Zhu West china college of stomatology,  sichuan University, 14 ren Min Nan  road, chengdu, sichuan 610041,  People’s Republic of China Tel +86 28 6115 3299 email zss_1977@163.co m  Zhonghao liu Yantai city stomatological  hospital, 142 North Main  street, Yantai, shandong 264001,  People’s Republic of China Tel +86 156 1555 6066 email dentlzh@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Jiang et al Running head recto: TiO2 modification and PRP on Ti implant stability in OVX rats DOI: http://dx.doi.org/10.2147/IJN.S113375",Non-OADS,/arxiv_data1/oa_pdf/63/0a/ijn-11-4719.PMC5033614.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/63/0a/ijn-11-4719.PMC5033614.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/0a/ijn-11-4719.PMC5033614.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/12/f6/mder-9-325.PMC5033616.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/12/f6/mder-9-325.PMC5033616.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 325–329Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 325 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S97902 A simple, wide bandwidth, biopotential amplifier  to record pacemaker pulse waveform Paolo Bifulco1  Gaetano Dario Gargiulo2  Maria Romano3  Mario Cesarelli1 1Department of Electrical Engineering  and Information T echnology,   University of Naples “Federico II”,  Naples, Italy;  2The MARCS Institute,   Western Sydney University, Penrith,  NSW, Australia;  3DMSC, University  “Magna Graecia”, Germaneto,  Catanzaro, ItalyAbstract: Reliable detection of pacemaker pulses is getting more and more important in  electrocardiography (ECG) diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/12/f6/mder-9-325.PMC5033616.pdf
"Hence, the need of more adequate instrumentation has been recognized by medical associations 7 and technical standard organizations.8–10 Essentially, use of ECG amplifiers  with wider bandwidth and higher sampling frequency is recommended.3–5,11 Indeed, Correspondence: Mario Cesarelli   Department of Electrical Engineering  and Information Technology, University of Naples “Federico II”, Via Claudio 21, Naples I-80125, Italy Tel +39 81 768 3788   Email cesarell@unina.itJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Bifulco et alRunning head recto: Amplifier to record pacemaker pulse waveformDOI: http://dx.doi.org/10.2147/MDER.S97902",Non-OADS,/arxiv_data1/oa_pdf/12/f6/mder-9-325.PMC5033616.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/12/f6/mder-9-325.PMC5033616.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2261–2268International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2261OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11077 9 Myocardial performance index correlates with  the BODe index and affects quality of life in  COPD patients Daniela graner schuwartz  Tannus-silva1 João Batista Masson-silva1 lays silva ribeiro1 Marcus Barreto Conde2,3 Marcelo Fouad rabahi1 1Faculty of Medicine, Federal  University of goias, goiânia, goiás,   2Instituto de Doenças do Tórax da  Universidade Federal do rio de  Janeiro, rio de Janeiro, 3Faculdade de  Medicina de Petrópolis, Petrópolis,   rio de Janeiro, BrazilBackground and objective:  COPD, a systemic illness associated with the impairment of  different organs, affects patient prognosis and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
"Based on Correspondence: Daniela graner  schuwartz Tannus-silva Departamento de Medicina Interna,  Faculdade de Medicina, Universidade  Federal de goiás, rua 235 c/1a avenida  s/n, setor Universitário, 74605-020,  goiânia, goiás, Brazil Tel +55 62 98124 9930 Fax +55 62 4009 1928 email danielatannus@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Tannus-Silva et al Running head recto: RV dysfunction and COPD DOI: http://dx.doi.org/10.2147/COPD.S110779",Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
Available from: http://goldcopd.org/.,Non-OADS,/arxiv_data1/oa_pdf/b9/0e/copd-11-2261.PMC5033620.pdf
"Perit Dial Int  2016; 36(5):481–508  epub ahead of pr int: 09 June 2016 http://dx.doi.org/10.3747/pdi.2016.00078 This single copy is for your personal, non-commercial use only.",Non-OADS,/arxiv_data1/oa_pdf/00/bb/pdi_36_5_005.PMC5033625.pdf
Avail - able online at: https://clinicaltrials.gov/ct2/show/NCT01293799 113.,Non-OADS,/arxiv_data1/oa_pdf/00/bb/pdi_36_5_005.PMC5033625.pdf
- Korean J Orthod 2016;46:212-9 http://dx.doi.org/10.4041/kjod.2016.46.5.267267www.e-kjo.orgpIssN 2234-7518 eIssN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/a2/ce/kjod-46-267.PMC5033765.pdf
"In our study, the point of application of force was  at the bracket height and the force vector was extending  www.e-kjo.org http://dx.doi.org/10.4041/kjod.2016.46.5.267This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.posteriorly on the same level if not slightly more occlusal.",Non-OADS,/arxiv_data1/oa_pdf/a2/ce/kjod-46-267.PMC5033765.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.269",Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 270 http://dx.doi.org/10.4041/kjod.2016.46.5.269 INTRODUCTION   Arch width discrepancy is a common orthodontic  problem for which the treatment of choice is maxillary expansion.,Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 271 http://dx.doi.org/10.4041/kjod.2016.46.5.269 to three groups during an 18-month recruitment period.,Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 272 http://dx.doi.org/10.4041/kjod.2016.46.5.269 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 273 http://dx.doi.org/10.4041/kjod.2016.46.5.269 Summit Orthodontic Services, Munroe Falls, OH, USA).",Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 274 http://dx.doi.org/10.4041/kjod.2016.46.5.269 landmark positions.,OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 275 http://dx.doi.org/10.4041/kjod.2016.46.5.269 evaluated, a 1-week interval was implemented before  the second or third round of examination was under-taken.",Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 276 http://dx.doi.org/10.4041/kjod.2016.46.5.269 intra-plate distance was calculated for distance 11,  between the right medial and lateral plates posteriorly, at 0.41 ± 1.46 mm.",OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 277 http://dx.doi.org/10.4041/kjod.2016.46.5.269 demonstrated that patients later in adolescence exhibited  larger skeletal movement with less dentoalveolar after-effects from bone-borne expanders.,Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 278 http://dx.doi.org/10.4041/kjod.2016.46.5.269 be located in the anterior of the sphenoid bone,  particularly the pterygoid plates.",Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"Stepanko and Lagravère • Sphenoid bone changes in maxillary expansion www.e-kjo.org 279 http://dx.doi.org/10.4041/kjod.2016.46.5.269 DC, Miller AJ.",Non-OADS,/arxiv_data1/oa_pdf/34/69/kjod-46-269.PMC5033766.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.280",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 281 http://dx.doi.org/10.4041/kjod.2016.46.5.280 INTRODUCTION   During the past decade, nonextraction treatment has  become increasingly popular for correction of Class II malocclusions.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 282 http://dx.doi.org/10.4041/kjod.2016.46.5.280 Class I canine and molar relationship, normal overjet and  overbite, and well-aligned and interdigitated arches.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 283 http://dx.doi.org/10.4041/kjod.2016.46.5.280 Landmarks and reference planes for measurements    The facial axis (FA) point27 is easily recognized and  does not change during orthodontic treatment, unlike  the incisal edge or cusp tip.22 Therefore, the FA points of  the 3D virtual maxillary models were used as appropriate reference points to measure tooth movement.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 284 http://dx.doi.org/10.4041/kjod.2016.46.5.280 Statistical analysis   There was no statistically significant difference in  individual tooth movement between the right and left sides at T0 and T1 (Table 1); therefore, the mean values for both sides of each tooth were used.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
1 nonextraction-tx www.e-kjo.org 285 http://dx.doi.org/10.4041/kjod.2016.46.5.280 Changes in molar rotation   The maxillary molars showed statistically significant  distal-in rotation between T0 and T1.,Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
1 nonextraction-tx www.e-kjo.org 286 http://dx.doi.org/10.4041/kjod.2016.46.5.280 measure; two-dimensional and 3D.,OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 287 http://dx.doi.org/10.4041/kjod.2016.46.5.280 of the anterior segment led to lingual inclination and  downward displacement of the incisal edges, as well as intrusion of the posterior segment, including the premolars and molars, which resulted in steepening of the occlusal plane.",Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
1 nonextraction-tx www.e-kjo.org 288 http://dx.doi.org/10.4041/kjod.2016.46.5.280 to the arch wire.,Non-OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"1 nonextraction-tx www.e-kjo.org 289 http://dx.doi.org/10.4041/kjod.2016.46.5.280 D, Kalayci A. Intraosseous screw-supported upper  molar distalization.",OADS,/arxiv_data1/oa_pdf/20/ff/kjod-46-280.PMC5033767.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.290",Non-OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
"Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 291 http://dx.doi.org/10.4041/kjod.2016.46.5.290 INTRODUCTION   Distalization of the maxillary molars is an important  treatment modality for patients with Class II maloc-clusion, but several concerns have been raised regarding the eruption of the second and third molars during or after distalization.",Non-OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
"Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 292 http://dx.doi.org/10.4041/kjod.2016.46.5.290 Appliance design (Figure 2) Modified palatal anchorage plate   An MPAP (Jeil Medical, Seoul, Korea) was fixed in the  paramedian palatal region at the sagittal level of the center of the first molar by three miniscrews (length, 8 mm; diameter, 2 mm; Jeil Medical).",Non-OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 293 http://dx.doi.org/10.4041/kjod.2016.46.5.290 of rotation that is produced by 150- g with a given shape  and length.,OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 294 http://dx.doi.org/10.4041/kjod.2016.46.5.290 Table 2.,OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 295 http://dx.doi.org/10.4041/kjod.2016.46.5.290 tendencies of the maxillary dentition.,Non-OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
"Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 296 http://dx.doi.org/10.4041/kjod.2016.46.5.290   The displacements can be explained by the rotational  nature of the force applied by the TMA spring wire and the relationship between its point of application and the position of the center of resistance of the multi-rooted teeth, which is suggested to be located somewhere between the furcation area and 1–2 mm cervical to the root apex.",Non-OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 297 http://dx.doi.org/10.4041/kjod.2016.46.5.290 MPAP Bone-anchored pendulum Cervical-pull headgearFigure 7.,OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 298 http://dx.doi.org/10.4041/kjod.2016.46.5.290 distal tipping combined with extrusion.,OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 299 http://dx.doi.org/10.4041/kjod.2016.46.5.290 8.,OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
"Kang et al • Eruption Effect on Molar Distalization www.e-kjo.org 300 http://dx.doi.org/10.4041/kjod.2016.46.5.290 Vardimon AD, et al.",OADS,/arxiv_data1/oa_pdf/87/d2/kjod-46-290.PMC5033768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.301",Non-OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 302 http://dx.doi.org/10.4041/kjod.2016.46.5.301 INTRODUCTION   Conventional orthognathic surgery requires presurgical  orthodontic treatment to achieve dental decompensa-tion and establish stable surgical occlusion.,Non-OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 303 http://dx.doi.org/10.4041/kjod.2016.46.5.301 porion) and passed through the nasion.,OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
"Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 304 http://dx.doi.org/10.4041/kjod.2016.46.5.301 anteriorly and 5.7 mm (SD, 1.0 mm) superiorly in the  CS group, and 2.1 mm (SD, 1.0 mm) anteriorly and 5.3 mm (SD, 2.0 mm) superiorly in the POGS group.",OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
"Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 305 http://dx.doi.org/10.4041/kjod.2016.46.5.301 both groups, none of the skeletal landmarks showed any  statistically significant transverse movement (Table 5).",Non-OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
"Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 306 http://dx.doi.org/10.4041/kjod.2016.46.5.301 significant differences in variables, except Wits and  IMPA.",OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 307 http://dx.doi.org/10.4041/kjod.2016.46.5.301 mandibular relapse would be expected when the amount  of mandibular setback exceeds 13 mm.,Non-OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
"Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 308 http://dx.doi.org/10.4041/kjod.2016.46.5.301 patients undergoing IVRO, Nihara et al.27 reported an  “adaptive rotation” of the distal segment in the short- term period after surgery.",OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
Ann et al • Postsurgical changes after IVRO in patients undergoing POGS www.e-kjo.org 309 http://dx.doi.org/10.4041/kjod.2016.46.5.301 orthognathic surgery in skeletal Class III malocclusion  with a surgery-first approach.,Non-OADS,/arxiv_data1/oa_pdf/3c/85/kjod-46-301.PMC5033769.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.310",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 311 http://dx.doi.org/10.4041/kjod.2016.46.5.310 INTRODUCTION   Periodontal disease is common in adult dentition.,Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 312 http://dx.doi.org/10.4041/kjod.2016.46.5.310 as the lateral direction, −y as the posterior direction, and  +z as the superior direction, to analyze the displacement of the individual teeth under intrusive force (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 313 http://dx.doi.org/10.4041/kjod.2016.46.5.310 incisor moved laterally 3.0 µm, posteriorly 4.2 µm, and  superiorly 5.6 µm in case A.",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 314 http://dx.doi.org/10.4041/kjod.2016.46.5.310   With regard to the lateral incisor, the midpoint of the  incisor edge of the lateral incisor moved medially 2.2 µm, anteriorly 2.9 µm, and superiorly 2.9 µm in case B (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 315 http://dx.doi.org/10.4041/kjod.2016.46.5.310 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 316 http://dx.doi.org/10.4041/kjod.2016.46.5.310 vertical displacements of the canine were the greatest in  case D. In case A, the minimum amount of horizontal displacement of the canine was observed.",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 317 http://dx.doi.org/10.4041/kjod.2016.46.5.310 exhibited uncontrolled tipping of the central and lateral  incisors (Figure 4).,Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 318 http://dx.doi.org/10.4041/kjod.2016.46.5.310 than the other cases, which was similar in pattern with  0- and 2-mm bone loss conditions.",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 319 http://dx.doi.org/10.4041/kjod.2016.46.5.310   In case A, the maximum von Mises stresses on the  central incisor apical and cervical areas were 2.8 g/mm 2 and 1.1 g/mm2 respectively.",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 320 http://dx.doi.org/10.4041/kjod.2016.46.5.310 and F (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 321 http://dx.doi.org/10.4041/kjod.2016.46.5.310 teeth being intruded as a segment, the degree of labial  tilting of the anterior teeth increased in all cases as bone loss increased (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"Cho et al • Miniscrew position for anterior teeth intrusion www.e-kjo.org 322 http://dx.doi.org/10.4041/kjod.2016.46.5.310 K, Sugawara J. Nonextraction treatment with  temporary skeletal anchorage devices to correct a Class II Division 2 malocclusion with excessive gingival display.",Non-OADS,/arxiv_data1/oa_pdf/57/4e/kjod-46-310.PMC5033770.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSOriginal Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.323",Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
"Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 324 http://dx.doi.org/10.4041/kjod.2016.46.5.323 INTRODUCTION   Orthopedic expansion of the palate was first described  approximately 150 years ago in a case review by Angell.1  It has also been reported that in growing children, expansion of maxillary width can improve posterior cross bite, increase nasal width, reduce nasal resistance, and improve breathing.",Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 325 http://dx.doi.org/10.4041/kjod.2016.46.5.323 patients is shown in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
"Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 326 http://dx.doi.org/10.4041/kjod.2016.46.5.323 little or no interdigitation; B, scalloped high-density  midpalatal suture line; C, two parallel, scalloped, high-density midpalatal suture lines close to each other; D, invisible suture line in palatine bone; and E, actual suture is not visible in at least a portion of the maxilla.",Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
"Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 327 http://dx.doi.org/10.4041/kjod.2016.46.5.323 the intra-examiner reliability demonstrated substantial  agreement, with weighted kappa coefficients from 0.71 (95% CI 0.56−0.86).",OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
"Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 328 http://dx.doi.org/10.4041/kjod.2016.46.5.323 optimal fractal dimension cut-off value of 1.0235, a  test in which fractal dimension was used to predict the variable that splits maturation stages into A–C and D or E resulted in the following values: Sensitivity 64.9%, specificity 86.6%, false positive rate 35.1%, false negative rate 13.4%, positive predictability 80.3%, and negative predictability 74.6%.",Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 329 http://dx.doi.org/10.4041/kjod.2016.46.5.323 methods used.,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
Kwak et al • Midpalatal suture maturation evaluation www.e-kjo.org 330 http://dx.doi.org/10.4041/kjod.2016.46.5.323 17.,Non-OADS,/arxiv_data1/oa_pdf/6d/bb/kjod-46-323.PMC5033771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of ORTHODONTICSReview Article pISSN 2234-7518 • eISSN 2005-372Xhttp://dx.doi.org/10.4041/kjod.2016.46.5.331",Non-OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 332 http://dx.doi.org/10.4041/kjod.2016.46.5.331 INTRODUCTION   The assessment of facial growth as well as the  development of dental occlusion is part of the process of diagnosing orthodontic abnormalities that if pre-vented or treated would provide measurable benefits to patients.,Non-OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 333 http://dx.doi.org/10.4041/kjod.2016.46.5.331 were collected.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 334 http://dx.doi.org/10.4041/kjod.2016.46.5.331 Table 1.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 335 http://dx.doi.org/10.4041/kjod.2016.46.5.331 Table 1.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 336 http://dx.doi.org/10.4041/kjod.2016.46.5.331 Table 1.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 337 http://dx.doi.org/10.4041/kjod.2016.46.5.331 Table 2.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 338 http://dx.doi.org/10.4041/kjod.2016.46.5.331 QUADAS tool (Table 2).,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
"Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 339 http://dx.doi.org/10.4041/kjod.2016.46.5.331 type, but this was shown to generally overestimate  interpremolar width in 2 of the studies included in the current review.",OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
"Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 340 http://dx.doi.org/10.4041/kjod.2016.46.5.331 grown from 0% to 50%,38 which is not surprising as  numerous studies have shown that 3D measurements  closely approximate anatomic measurements,37,39 suppor- ting the accuracy of CBCT scans.",OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 341 http://dx.doi.org/10.4041/kjod.2016.46.5.331 clinical conclusions could be drawn.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Available from: http://handbook.cochrane.org/chapter_5/5_defining_the_review_question_and_developing_criteria_for.htm 16.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
Sawchuk et al • Assessment of maxillary transverse deficiencies www.e-kjo.org 342 http://dx.doi.org/10.4041/kjod.2016.46.5.331 group.,OADS,/arxiv_data1/oa_pdf/f5/90/kjod-46-331.PMC5033772.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e8/1c/40800_2016_Article_35.PMC5033796.pdf
"[http://dx.doi.org/10.1302/0301-620X.90B1.19767 ] [PMID: 18160502 ] [3] Dias JJ, Wildin CJ, Bhowal B, Thompson JR. Should acute scaphoid fractures be fixed?",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.2106/JBJS.D.02305 ] [PMID: 16203878 ] [4] Davis EN, Chung KC, Kotsis SV, Lau FH, Vijan S. A cost/utility analysis of open reduction and internal fixation versus cast immobilization for acute nondisplaced mid-waist scaphoid fractures.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1097/01.prs.0000201461.71055.83 ] [PMID: 16582791 ] [5] Desai VV, Davis TR, Barton NJ.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1054/jhsb.1999.0197 ] [PMID: 10597938 ] [6] Gellman H, Caputo RJ, Carter V, Aboulafia A, McKay M. Comparison of short and long thumb-spica casts for non-displaced fractures of the carpal scaphoid.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1007/s12178-011-9072-0 ] [PMID: 21475561 ] [8] Cooney WP, Dobyns JH, Linscheid RL.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
[http://dx.doi.org/10.3109/17453677508989259 ] [PMID: 1199711 ] [11] Russe O. Fracture of the carpal navicular.,Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1142/S0218810499000198 ] [PMID: 11089151 ] [15] Lozano-Calderón S, Blazar P, Zurakowski D, Lee SG, Ring D. Diagnosis of scaphoid fracture displacement with radiography and computed tomography.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.2106/JBJS.E.01211 ] [PMID: 17142420 ] [16] Temple CL, Ross DC, Bennett JD, Garvin GJ, King GJ, Faber KJ.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1016/j.jhsa.2005.01.001 ] [PMID: 15925164 ] [17] Geoghegan JM, Woodruff MJ, Bhatia R, et al.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1177/1753193409105189 ] [PMID: 19959447 ] [18] Grewal R, Suh N, Macdermid JC.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1016/j.jhsa.2013.01.032 ] [PMID: 23531510 ] [19] Bain GI, Bennett JD, Richards RS, Slethaug GP, Roth JH.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1007/BF00198413 ] [PMID: 7644940 ] [20] Singh HP, Forward D, Davis TR, Dawson JS, Oni JA, Downing ND.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1016/j.jhsb.2005.05.007 ] [PMID: 16006021 ] [21] Adolfsson L, Lindau T, Arner M. Acutrak screw fixation versus  cast immobilisation for undisplaced scaphoid waist fractures.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1054/jhsb.2001.0558 ] [PMID: 11386765 ] [22] Vinnars B, Pietreanu M, Bodestedt A, Ekenstam Fa, Gerdin B. Nonoperative compared with operative treatment of acute scaphoid fractures.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.2106/JBJS.G.00673 ] [PMID: 18519309 ] [23] Saedén B, Törnkvist H, Ponzer S, Höglund M. Fracture of the carpal scaphoid.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1016/S0363-5023(98)80093-2 ] [PMID: 9523959 ] [25] Grewal R, Frakash U, Osman S, McMurtry RY.",OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.1186/1749-799X-8-28 ] [PMID: 23961919 ] [26] Bhandari M, Fong K, Sprague S, Williams D, Petrisor B.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
[http://dx.doi.org/10.2106/JBJS.K.01344 ] [PMID: 22854998 ],Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
[http://dx.doi.org/10.1016/0266-7681(88)90058-7 ] [PMID: 3361213 ] © Grewal et al.,OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/34/TOORTHJ-10-431.PMC5034027.pdf
"[http://dx.doi.org/10.17372/OTSHD.2015412555 ] [2] Guler O, Mutlu S, Isyar M, Seker A, Kayaalp ME, Mahirogullari M. Comparison of short-term results of intraarticular platelet-rich plasma (PRP) and hyaluronic acid treatments in early-stage gonarthrosis patients.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1007/s00590-014-1517-x ] [PMID: 25085316 ] [3] Gökçe A, Yılmaz I, Gökay NS, Can L, Gökçe C. Does insulin, transferrin and selenous acid preparation effect chondrocyte proliferation?",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.3944/AOTT.2014.2635 ] [PMID: 24901923 ] [4] Kerimoğlu G, Yuluğ E, Kerimoğlu S, Çıtlak A.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.5606/ehc.2013.23 ] [PMID: 23692198 ] [5] Di Matteo B, Perdisa F, Gostynska N, Kon E, Filardo G, Marcacci M. Meniscal scaffolds - preclinical evidence to support their use: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.2174/1874325001509010143 ] [PMID: 26157531 ] [6] Brady RT, O’Brien FJ, Hoey DA.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
[http://dx.doi.org/10.1016/j.bbrc.2015.02.080 ] [PMID: 25721667 ] [7] Park JB.,OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1007/s10616-014-9778-0 ] [PMID: 25149286 ] [10] Pyar H, Peh KK.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.3923/pjbs.2014.462.471 ] [PMID: 25911832 ] [11] Isyar M, Bilir B, Yilmaz I, et al.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1186/s13018-015-0264-y ] [PMID: 26223355 ] [12] Kellgren JH, Lawrence JS.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
[http://dx.doi.org/10.1136/ard.16.4.494 ] [PMID: 13498604 ],OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.6026/97320630011096 ] [PMID: 25848170 ] [14] Dogan M, Isyar M, Yilmaz I, et al.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1186/s12893-015-0111-4 ] [PMID: 26652613 ] [16] Kim SM, Kim YG, Park JW, Lee JM, Suh JY.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.5051/jpis.2013.43.4.168 ] [PMID: 24040569 ] [17] Gokce  A,  Yilmaz  I,  Bircan  R,  Tonbul  M,  Gokay  NS,  Gokce  C.  Synergistic  Effect  of  TGF-β  1  And  BMP-7  on  chondrogenesis  and extracellular matrix synthesis: an in vitro  study.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.2174/1874325001206010406 ] [PMID: 23002411 ] [18] Ciftci  Z,  Deniz  M,  Yilmaz  I,  Ciftci  HG,  Sirin  DY,  Gultekin  E.  In  vitro  analysis  of  a  novel  controlled  release  system  designed  for intratympanic administration of N-acetylcysteine: a preliminary report.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1016/j.amjoto.2015.08.004 ] [PMID: 26545472 ] [19] Yilmaz I, Gokay NS, Bircan R, Saracoglu GV, Dervisoglu S, Gokce A.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1155/2013/631959 ] [20] Lynn  AK,  Brooks  RA,  Bonfield  W,  Rushton  N.  Repair  of  defects  in  articular  joints.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1302/0301-620X.86B8.15609 ] [PMID: 15568518 ] [21] Griffith LG, Naughton G. Tissue engineering-current challenges and expanding opportunities.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1126/science.1069210 ] [PMID: 11834815 ] [22] Köse GT, Korkusuz F, Korkusuz P, Hasirci V. In vivo  tissue engineering of bone using poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) and collagen scaffolds.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1089/ten.2004.10.1234 ] [PMID: 15363179 ] [23] Jäger M, Fischer J, Dohrn W, et al.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1002/jor.20565 ] [PMID: 18404732 ] [24] Peter SJ, Liang CR, Kim DJ, Widmer MS, Mikos AG.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0 ] [PMID: 9736454 ] [25] Chang PL, Blair HC, Zhao X, et al.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1080/03008200600584074 ] [PMID: 16754512 ] [26] Shima WN, Ali AM, Subramani T, et al.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1007/s10616-015-9844-2 ] [PMID: 25634598 ] [28] Cenni E, Ciapetti G, Pagani S, Perut F, Giunti A, Baldini N. Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.1902/jop.2005.76.3.323 ] [PMID: 15857063 ] [29] Beyzadeoğlu T, Torun Köse G, Ekinci ID, Bekler H, Yilmaz C. Cytotoxicity of local anesthetics to rats’ articular cartilage: an experimental study.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"[http://dx.doi.org/10.3944/AOTT.2012.2606 ] [PMID: 22659637 ] [30] Fickert S, Schröter-Bobsin U, Gross AF, et al.",OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
[http://dx.doi.org/10.1007/s00774-010-0215-y ] [PMID: 20811759 ] © Isyar et al.,Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/TOORTHJ-10-420.PMC5034028.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 (Supplementary information is linked to the online version of  the paper on the Cell Research website.)",Non-OADS,/arxiv_data1/oa_pdf/5b/97/cr2016100a.PMC5034106.pdf
The PyMOL Molecular Graphics System on World Wide Web http://www.pymol.org 2002 (Supplementary information is linked to the online version of  the paper on the Cell Research website.),OADS,/arxiv_data1/oa_pdf/6e/f7/cr201689a.PMC5034110.pdf
Please read the full license for further details at - http://creativecommons.org/ licenses/by- nc-sa/4.0/ © The Author(s) 2016,Non-OADS,/arxiv_data1/oa_pdf/6e/f7/cr201689a.PMC5034110.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016",Non-OADS,/arxiv_data1/oa_pdf/b3/bd/cr201693a.PMC5034111.pdf
"Please read the full license for further details at - http://creativecommons.org/ licenses/by-nc-sa/4.0/ © The Author(s) 2016 Centre of Plant Gene Research, Huazhong Agricultural University, Wuhan  430070, China; 2Center for Structural Biology, School of Life Science,  Tsinghua University, Beijing 100084, China; 3College of Life Sciences and  Technology, Huazhong Agricultural University, Wuhan 430070, China*These two authors contributed equally to this work.Correspondence: Ping YinE-mail: yinping@mail.hzau.edu.cn References 1 Coller J, Parker R. Annu Rev Biochem  2004; 73:861-890.",Non-OADS,/arxiv_data1/oa_pdf/43/e4/cr201698a.PMC5034116.pdf
"All the cryo-EM work and all the intensive computations were performed at Centre for Biological Imaging, Institute of Bio- physics, Chinese Academy of Sciences (CBI, http://cbi.ibp.ac.cn),  with the help from Drs Xiaojun Huang and Lunjiang Lin.",OADS,/arxiv_data1/oa_pdf/a4/1f/cr201699a.PMC5034117.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 61  Scheres SH, Chen S. Prevention of overfitting in cryo-EM  structure determination.",Non-OADS,/arxiv_data1/oa_pdf/a4/1f/cr201699a.PMC5034117.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/17/kew229.PMC5034218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dc/34/kew261.PMC5034219.pdf
"National Institute of Health and Clinical Excellence, London, 2009. http://www.nice.org.uk/CG79 (date last accessed 18 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/dc/34/kew261.PMC5034219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/2b/kew262.PMC5034220.pdf
The nuclear localization signal was predicted using the cNLS Mapper (http://nls-mapper.iab.,OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
A hydrophobicity plot was generated by ProtScale (http://web.expasy.,OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
The genome browser and the relevant databases are available at http://kumamushi.org/.,OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: T. Kunieda and T.H.,Non-OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hashimoto, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12808 14 NATURE COMMUNICATIONS | 7,12808 | DOI: 10.1038/ncomms12808 | www.nature.com/naturecommunications",Non-OADS,/arxiv_data1/oa_pdf/bd/eb/ncomms12808.PMC5034306.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/8d/4f/10.1177_2058460116668216.PMC5034335.pdf
"Biophysical Journal 111, 1223–1234, September 20, 2016 1223http://dx.doi.org/10.1016/j.bpj.2016.08.007 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/5e/51/main.PMC5034351.pdf
http://ipython.org .,Non-OADS,/arxiv_data1/oa_pdf/5e/51/main.PMC5034351.pdf
http://www.blender.org .,Non-OADS,/arxiv_data1/oa_pdf/5e/51/main.PMC5034351.pdf
<http://www.ccsa.ca/ Resource%20Library/CCSA-Substance-Use-Hospital-Impact-Report-2014-en.pdf >.,Non-OADS,/arxiv_data1/oa_pdf/13/56/CPT-97-551.PMC5034357.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4e/main.PMC5034358.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.12.002 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/af/4e/main.PMC5034358.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/71/main.PMC5034360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/71/main.PMC5034360.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2016.02.001 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/71/71/main.PMC5034360.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org /licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/main.PMC5034362.pdf
This is an open access article under the CC BY- NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/main.PMC5034362.pdf
URL: www.ksu.edu.sahttp://dx.doi.org/10.1016/j.jsha.2015.12.005 Production and hosting by Elsevier,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/main.PMC5034362.pdf
"Biophysical Journal 111, 1295–1303, September 20, 2016 1295http://dx.doi.org/10.1016/j.bpj.2016.08.013 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/46/74/main.PMC5034364.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/4f/e0/lsv018.PMC5034368.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/ed/61/lsv031.PMC5034369.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"264 rOrphandrugincentivesinthepharmacogenomiccontext INTRODUCTION Duringthelate1970sandearly1980s,thelackofcommercialdevelopmentfordrugs thattreatrarediseasesbecameanimportantpoliticalissueintheUS.1Theseso-called ‘orphandrugs’werelargelyneglectedbythepharmaceuticalindustrybecausetheyrep- resented small markets that were unlikely to be profitable.2The lobbying and public awarenesseffortsofanumberofrarediseasepatientorganizationsintheUSeventu- ally culminated in the passage of the Orphan Drug Act of 19833(ODA), which pro- videsindustrywithsupportandincentivestodeveloporphandrugs,definedasdrugs intended for use in treating a condition that affects less than 200,000 persons in the US.Thesubstantialincreaseinthedevelopmentofdrugsforrarediseasesoverthepast three decades is often directly attributed to the passage of the ODA4,a n dt h eA c ti s widelyconsideredtobeasuccess.5SincetheODAwaspassedin1983,morethan400 orphandrugshavebeendevelopedandmarketedintheUS,6whichsuggeststhatthe incentives are having an effect.7Moreover, the last 10–15 years have been the most successfulperiodofdevelopmentfororphandrugs.8AccordingtotheFDA,nearly200 orphandrugsenterdevelopmenteachyearandapproximatelyonethirdofnewdrugs approvedbytheFDAareforthetreatmentofrarediseases.9ODAincentivesarealso creditedwithcontributingto‘breakthroughinnovation’thatprovidesadvantagesover previouslyavailabletherapies.10 A concurrent trend that is contributing to the shift toward niche market develop- ment is recent advances in new genomic technologies that are now making ‘person- alizedmedicine’areality.In2003,thecompletionoftheHumanGenomeProject— theinternationalefforttomaptheentirehumangenome—‘laidthefoundationforthe developmentofnewhealthcaretechnologiesandtherapies,includinggeneticteststo assist in the diagnosis and prevention of disease and drug therapies that are tailored tothegeneticcharacteristicsofindividualpatients’.11Pharmacogenomics,thestudyof 1AbbeyS.Meyers, HistoryoftheAmericanOrphanDrugAct, NATIONALORGANIZATION FOR RAREDISORDERS, Feb. 18, 2000, at 1, https://www.rarediseases.org/docs/policy/HistoryoftheAmericanOrphanDrugAct.pdf (accessedDec.10,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"6USFoodandDrugAdministration, DevelopingProductsforRareDiseases&Conditions ,http://www.fda.gov/ forindustry/DevelopingProductsforrareDiseasesConditions/default.htm (accessedDec.10,2014).Incon- trast,between1973and1983,only10orphandrugsmadeittomarket.",OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"8Reuters,The Economic Power of Orphan Drugs , 2012, at 4, http://thomsonreuters.com/business-unit/ science/subsector/pdf/the-economic-power-of-orphan-drugs.pdf (accessedDec.10,2014) 9Jonathan D. Rockoff, Drug Makers See Profit Potential in Rare Diseases, WALLSTREETJOURNAL, Jan. 30, 2013,http://www.wsj.com/articles/SB10001424127887323926104578273900197322758 (accessed Apr.2,2015).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"12National Human Genome Research Institute, Frequently Asked Questions About Pharmacogenomics , http://www.genome.gov/27530645 (accessedDec.10,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"20HealthCanada,OfficeofLegislativeandRegulatoryModernization, InitialDraft Discussion Documentfora Canadian Orphan Drug Regulatory Framework , Dec. 13, 2012, at 4, http://www.orpha.net/national/data/ CA-EN/www/uploads/Initial-Draft-Discussion-Document-for-A-Canadian-Orphan-Drug–Regulatory- Framework.doc (accessedDec.11,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"Indeed, several pharmacogenomic products— imatinib,nilotinibanddasatinib—havebeengrantedorphandesignationsforthisparticulardisease.SeeUS FoodandDrugAdministration, OrphanDrugProductDesignationDatabase ,http://www.accessdata.fda.gov/ scripts/opdlisting/oopd/index.cfm (accessedDec.11,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"66US Food and Drug Administration, Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products (Draft Guidance) , 2012,http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM332181.pdf (accessedMay6,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"71American Lung Association, Lung Cancer Fact Sheet, http://www.lung.org/lung-disease/lung-cancer/ resources/facts-figures/lung-cancer-fact-sheet.html (accessedDec.11,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"Inclarifyingtheirlongstandingapproachtoeligibilityfororphansubsets,theguid- ance provided by the FDA in the 2013 amendments may help to decipher the rea- sons behind their decisions to deny orphan drug designations to some pharmacoge- nomicdrugsinthepast.Forexample,beforereceivingapprovalforthebreastcancer (specifically,HER2-positivemetastaticbreastcancer)drugHerceptin(trastuzumab) inSeptember1998,itsmanufacturer,Genentech,appliedfororphandrugstatuswith theFDA,butthedesignationwasdenied.Atthetime,therewasanestimated165,000 metastatic breastcancerpatientintheUS,ofwhomapproximately30%,or49,500peo- ple, had HER2 overexpressing tumors76—well below the 200,000 cut-off for orphan drugdesignation.However,theFDAdeniedHerceptinorphandrugstatus.77Whilethe exactreasonforthe denialwasunclear, the OOPDindicatedthatthemost common reasonsforrefusalisdisagreementbetweendrugsponsorsandregulatoryauthorities overhowthetargetpopulationisdefined.78In2002,ShahsuggestedthatHerceptin wasmostlikelynotapprovedfororphandesignation‘becausethesizeofthepopula- tionofHER2overexpresserswasunderestimated,asitisoverexpressedincancersother thanthatofthebreast’.79Inparticular,itwasclearfromthesuccessofclinicaltrialsthat Herceptincouldpotentiallyalsobeusedinthetreatmentofarangeofotherpossible cancersincludingbladder,pancreatic,ovarian,colorectal,andprostate.80However,it seemsunlikelythatthepossibilityoftreatingmultipletypesofcancerwithHerceptin was in fact the reason for the denial since in the 2013 Final Rule, the FDA explicitly states that ‘[a] drug that shows promise in multiple, different rare diseases or condi- tionsmaybeeligibleformultipledesignations,oneforeach diseaseorcondition,be- cause FDA considers the prevalence within each disease or condition’.81Rather, it is orphansubset.SeeJamesH.Reese, FDAOrphanDrugDesignation101 ,at23,http://www.ema.europa.eu/ docs/enGB/document library/Presentation/2014/03/WC500164160.pdf (accessedJan.13,2015).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"74National Cancer Institute, SEER Stat Fact Sheets: Melanoma of the Skin ,http://seer.cancer.gov/ statfacts/html/melan.html (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"83National Cancer Institute , SEER Stat Fact Sheets: Breast Cancer ,http://seer.cancer.gov/statfacts/html/ breast.html (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See Leukemia and Lymphoma Society, Facts, 2014, at 8, https://www.lls.org/content/nationalcontent/resourcecenter/ freeeducationmaterials/generalcancer/pdf/facts.pdf (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"86In2011,therewereanestimated43,538casesofpancreaticcancerintheUS.SeeNationalCancerInstitute, SEERStatFactSheets:PancreasCancer ,http://seer.cancer.gov/statfacts/html/pancreas.html (accessedDec.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See Kurt R. Karst & Michelle L. Butler, FDA Issues Post-Depomed Pol- icy Statement; Agency Doubles Down on Clinical Superiority Requirement ,F D AL AWBLOG, Dec. 22, 2014,http://www.fdalawblog.net/fda lawbloghymanphelps/2014/12/fda-issues-post-depomed-policy- statement-agency-doubles-down-on-clinical-superiority-requirement.html (accessedDec.23,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"109Grossman,forexample,suggeststhatitispossiblethatFDA‘calculatedhowrarelythiscaseislikelytocome upanddecidedthatforanotherplaintifftoemergewithasimilarsituationandadeepenoughsetofpockets towanttosue[isunlikely]’.StevenGrossman,PresidentofhealthpolicyconsultancyHPSGroup,quoted in Fiona Barry, FDA Defiant on Orphan Exclusivity Rules after Court Judgement ,IN-PHARMA, Jan. 7, 2015, http://www.in-pharmatechnologist.com/Regulatory-Safety/FDA-defiant-on-orphan-exclusivity-rules- even-after-court-judgement (accessedApr.2,2015).Alternatively,KarstandButlersuggestthat‘[p]erhaps this out-of-left-field-strategy is FDA’s way of drawing out another lawsuit from an affected sponsor so that theAgencycanhaveanothercracktorelitigatetheissueincourt’.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"According to the Cystic Fibrosis Foundation, approximately 30,000 people in the US have cystic fibrosis—well below the 200,000 person threshold required to qualify for orphan designation under the ODA—CysticFibrosisFoundation, FrequentlyAskedQuestions ,http://www.cff.org/aboutcf/faqs (accessed Dec. 18, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"Subsequently, in Feb. 2014, Kalydecowasapprovedforthetreatmentofpatientswitheightadditionalcysticfibrosismutations(G551D, G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P, and G1349D)—Cystic Fibrosis Foundation, FDA Approves Expanded Use of KalydecoTMfor Eight Additional Mutations that Cause CF , Feb. 21, 2014, http://www.cff.org/aboutCFFoundation/NewsEvents/2–21-FDA-Approves-Expanded-Use-of-Kalydeco- for-CF.cfm (accessedDec.18,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"131US Food and Drug Administration, The Future of Drug Safety — Promoting and Protecting the Health of the Public (FDA’s Response to the Institute of Medicine’s 2006 Report) , Jan. 2007, at 3, http://www.fda.gov/ downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM171627.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"US Food and Drug Administration, A Valuable Resource for Drug Devel- opers: The Rare Disease Repurposing Database (RDRD) ,http://www.fda.gov/ForIndustry/Developing ProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/ucm216147.htm (ac- cessedDec.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See M. Angeles Villarreal, Orphan Drug Act: Background and Proposed Legislation in the 107th Congress (CRS Report for Congress) , July 25, 2001, at 2,http://www.law.umaryland.edu/marshall/crsreports/crsdocuments/RS20971.pdf (accessed Dec. 19, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"‘Genericdrugapplicationsaretermed“abbreviated”becausetheyaregenerallynotrequiredtoincludepre- clinical(animal)andclinical(human)datatoestablishsafetyandeffectiveness.Instead,genericapplicants mustscientificallydemonstratethattheirproductisbioequivalent(i.e.,performsinthesamemannerasthe innovator drug).’ See Food and Drug Administration, Abbreviated New Drug Application (ANDA): Gener- ics, updated Sept. 18, 2014, http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsare DevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ (accessedMar.9,2015).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"2009, http://www.fr.com/files/Uploads/bios/Mahn Terry/Protecting NewInvestments.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"153Health Canada, Orphan Drug Policy (letter sent to associations, file no: 96–037419), Jan. 16, 1997, https://web.archive.org/web/20130722055233/ ,http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic- demande/pol/orph˙pol-eng.php (accessedJuly2013)[hereinafterHealthCanada1997PolicyStatement].",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"156Canadian Organization for Rare Disorders, Canada’s Orphan Drug Policy, July 6, 2005, at 4, http://paperzz.com/download/1749313#pdf (accessedDec.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"157BIOTECanada, Helping Canadians with Rare Diseases: Government of Canada Rare Disease Strategy Offers Hope and Solutions for Patients ,http://www.biotech.ca/en/policy-matters/health-bio/rare.aspx (accessed Dec.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"158External Advisory Committee on Smart Regulation, Smart Regulation: A Regulatory Strategy for Canada (Report to the Government of Canada) , Sep. 2004, at 93, http://publications.gc.ca/collections/Collection/ CP22-78-2004E.pdf (accessedDec.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"159CanadianOrganizationforRareDisorders, CurrentIssues ,http://www.raredisorders.ca/currentIssues.html (accessedDec.19,2014).",OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See US Food and Drug Administration, User Fee Waivers, Reductions, and Refunds for Drug and Biological Products (Guidance for Industry) , Sep., 2011, at 11,http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm079298.pdf (accessedDec.19,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"Success- ful applicants can have their drug review fees ‘capped at 10% of the drug’s anticipated sales revenue in Canada for its first three years on the market’: Health Canada, Health Canada’s Proposal to Parliament for User Fees and Service Standards for Human Drugs and Medical Devices Programs , Apr., 2010, at Table 1A,http://www.hc-sc.gc.ca/dhp-mps/finance/costs-couts/fee-propo-frais-eng.php pdf (accessed Dec. 19, 2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See US Food and Drug Administration, Postmarketing Requirements and Commitments: Intro- duction,http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Post-marketingPhaseIV Commitments/default.htm (accessedDec.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"173European Commission, Orphan Refusals ,http://ec.europa.eu/health/documents/community-register/ html/orh others.htm (accessedDec.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"See Health Canada, GuidanceDocument:DataProtectionunderC.08.004.1oftheFoodandDrugRegulations(Guidancedocument), http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/data donneesprotection-eng.",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"189Kurt R. Karst, Exclusivity Creep: OPEN ACT Would Open Up Hatch-Waxman and the BPCIA to Add a 6-Month Extension to Existing Exclusivities ,F D AL AWBLOG, Dec. 4, 2014, http://www.fdalawblog.net/ fdalawbloghymanphelps/2014/12/exclusivity-creep-open-act-would-open-up-hatch-waxman-and-the- bpcia-to-add-a-6-month-extension-to-ex.html (accessedDec.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"190Health Canada, An Orphan Drug Framework for Canada ,http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/ 2012/2012-147a-eng.php (accessedDec.20,2014).",Non-OADS,/arxiv_data1/oa_pdf/d6/14/lsv013.PMC5034370.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/0e/74/lsv028.PMC5034372.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/d8/9e/lsv016.PMC5034373.pdf
"2008, at 76 https://www.fas.org/irp/agency/ dod/jason/human.pdf(accessedMay2,2014).",OADS,/arxiv_data1/oa_pdf/d8/9e/lsv016.PMC5034373.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/ab/48/lsv033.PMC5034374.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"3SeeFDA, WhatWeDo ,http://www.fda.gov/aboutfda/whatwedo/ (accessedApr.10,2015).",OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"8E.g., FDA, Informed Consent Information Sheet: Guidance for IRBs, Clinical Investigators, and Sponsors ,J u l y 2014, at 9, http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM405006.pdf ; FDA, Guidance for Industry: Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medi- cal Devices Jan. 2009, http://www.fda.gov/regulatoryinformation/guidances/ucm125126.htm (hereinafter ‘2009ReprintsGuidance’).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"See Citizen Petition from MIWG, DocketNo.FDA-2013-P-1079 ,Sept.3,2013, http://www.regulations.gov/#!documentDetail;D=FDA-2013- P-1079-0001 (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"FDA-2011-P-0512 ,J u l y 5, 2011,http://www.regulations.gov/#!documentDetail;D=FDA-2011-P-0512-0001 (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"See Warning Letter to Duane Burnham, Abbott Labs., from Minnie Baylor-Henry, FDA (June 26, 1998), http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/ WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/UCM168187.pdf (accessed Apr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"), http://www.regulations.gov/ #!documentDetail;D=FDA-2011-P-0512-0008 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"Asanadditionalmethodforrestrictingoff-labelpromotionundertheFDCA,adrug is‘misbranded’ifitslabelingfailstoinclude‘adequatedirectionsforuse’.105FDAregu- lationsdefine‘adequatedirectionsforuse’asthosethatallowalaypersonto‘useadrug http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM401087.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"99See, e.g., FDA, Draft Guidance for Industry: Presenting Risk Information in Prescription Drug and Medical Device Promotion , May 2009, at 3 n.9, http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM155480.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"109See,e.g.,CriminalInformationat4,UnitedStatesv.ParPharm.Cos.,No.13-MJ-8080(D.N.J.Mar.5,2013), http://www.justice.gov/usao/nj/Press/files/pdffiles/2013/Par%20Pharmaceutical%20Information.pdf (accessedApr.10,2015)(‘AnFDA-approvedprescriptiondrug,bearingtheFDA-approvedlabeling,could beexemptfromtheadequate-directions-for-userequirementifitwasmarketedforanFDA-approveduse.... Aprescriptiondrugthatwasmarketedfornon-approved,off-labeluseswouldnotqualifyforthisexemption andthereforewouldbemisbranded’.).",OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"124SeeFDA,GuidanceforIndustry:ProvidingClinicalEvidenceofEffectivenessforHumanDrugandBiologicalProd- ucts,May 1998, http://www.fda.gov/downloads/Drugs/.../Guidances/ucm078749.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"131See Robert Temple, Communication of CER Findings , Feb. 9, 2012, at 14 (presentation at ‘Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making’ confer- encehostedbytheNationalPharmaceuticalCouncil), http://www.npcnow.org/system/files/conferences/ download/rtemple asym12.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"FDA-2011-P-0512 , July 5, 2011, at 9, http://www.regulations.gov/#!documentDetail;D=FDA-2011-P-0512-0001 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"135See Michael Loucks, Trends in Prosecutions and So-Called Off-Label Promotion Issues , Nov. 26, 2007, http://www.ehcca.com/presentations/pharmaaudio20071126/loucks.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"137FDA,Revised Draft Guidance for Industry: Distributing Scientific and Medical Publications on Un- approved New Uses—Recommended Practice , Feb. 2014, http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM387652.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"140FDA,Draft Guidance for Industry: Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices , Dec. 2011, http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM285145.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"188 rBacktofirstprinciples rAdraftguidancein2014addressingthecircumstanceswhenamanufacturer may disseminate scientific publications discussing risk information that is inconsistentwiththeFDA-approvedlabelingforthedrug.144UnderthisRisk Information Draft Guidance, drug manufacturers are permitted to commu- nicate new risk information about a drug based on, among other things, a pharmacoepidemiologicstudyorarigorousmeta-analysis,thatmayrebutor mitigateriskinformationintheapprovedlabeling.145Thisguidanceappearsto establishanexceptiontotheAgency’ssubstantialevidencerule,146butFDA doesnotexplicitlyacknowledgethatitsnon-bindingguidanceissomehowin- tendedtooverruleabindingregulation.147 Importantly,noneoftheguidancedocumentsprovideanydiscussionofhowFDA’s regulatoryframeworkandpoliciescomportwiththeFirstAmendment.Theyalsodo notaddressanumberofothersignificantareasofambiguity,suchascommunications withpayorsandformularycommitteesorthescopeofpermissiblescientificexchange morebroadly.Therecentguidancesalsodonotalterexistingstatutoryandregulatory requirements and, at least according to their express terms, do not ‘bind FDA or the public’.148Rather,ifamanufacturerfollowstherecommendationsprovidedbythese guidancedocuments,‘FDAdoesnotintendtoobject’tothemanufacturer’sactionsand ‘doesnotintend’tousethemanufacturer’sactionsasevidenceofanew,unapprovedin- tendeduseforaproduct.149SuchlanguageindicatesthatFDAbelievesthesepractices donottechnicallycomplywiththeFDCAandFDAregulationsbutmaybepermissible 144FDA,DraftGuidanceforIndustry:DistributingScientificandMedicalPublicationsonRiskInformationforAp- provedPrescriptionDrugsandBiologicalProducts—RecommendedPractices ,June2014, http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM400104.pdf (accessed Apr.10,2015)(hereinafter‘RiskInformationDraftGuidance’).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"See FDA, Revised Draft Guidance for Industry: Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs , Feb. 2015, http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm069984.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"FDA-2011-P-0512 July 5, 2011, http://www.regulations.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"27, 2012, at 2, http://www.regulations.gov/#!documentDetail;D=FDA-2011-N-0912-0015 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"FDA-2013-P-1079 , Sept. 3, 2013, http://www.regulations.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"158CitizenPetitionResponsetoMIWG,DocketNos.FDA-2013-P-1079andFDA-2011-P-0512 ,June6,2014,at8, http://www.regulations.gov/#!documentDetail;D=FDA-2013-P-1079-0004 (accessedApr.10,2015).",OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"159RachelKornfieldetal., PromotionofPrescriptionDrugstoConsumersandProviders,2001–2010 ,PLOSO NE, Mar.2013,at2, http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0055504#pone -0055504-t005 (accessedApr.10,2015).Inaddition,manufacturersalsoengageindirect-to-consumerad- vertisingintelevision,print,Internet,andothermedia.",OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"176GlennC.Smith, AvoidingAwkwardAlchemy–IntheOff-LabelDrugContextandBeyond:Fully-ProtectedIn- dependentResearchShouldNotTransmogrifyIntoMereCommercialSpeechJustBecauseProductManufacturers DistributeIt ,34WAKEFORESTL.REV.963,971(1999)(‘Manufacturercirculationofoff-labelresearchcould resultinsuchinformationcomingintophysicianhandsinamoretimelyandaccessibleway.’); CitizenPetition fromMIWG, DocketNo.FDA-2011-P-0512 ,July5,2011,at5and6(quotingMoreInformationforBetterPa- tientCare:HearingoftheSenateComm.onLaborandHumanResources,104thCong.81(1996)(statement ofDrGregoryH.Reaman,Director,MedicalSpecialtyServices,Children‘sNationalMedicalCenter)(‘Phar- maceuticalandbiotechnologycompanies...happentobeinthebestpositiontoshareinformationwiththe physiciancommunityattheearliestpossibletime,whenitmayreallymakeadifferenceintreatmentoptions.’), http://www.regulations.gov/#!documentDetail;D=FDA-2011-P-0512-0001 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
": ‘Academic Detailing ’on Medical Treatments and the Over- sightImperative ,TheWashingtonLegalFoundationBackgrounder,Apr.22,2011, http://www.cohealthcom.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"(noting that the several organizations receive millions of dollars from the Agency for Health- care Research and Quality (‘AHRQ’) to conduct academic detailing, with little oversight over such activities); National Resource Center for Academic Detailing, About Academic Detailing, http://www.narcad.org/about/aboutad/ (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"186Seeid.at 2 (describing federal funding of CERand other academic detailing initiatives through AHRQ, as well as the Patient-Centered Outcomes and Research Institute established under the Patient Protection andAffordableCareAct);CoryL.Andrews, TheRiseofthePharmaceuticalUn-SalesForce ,FORBESApr.25, 2011,http://www.forbes.com/sites/docket/2011/04/25/the-rise-of-the-pharmaceutical-un-sales-force/ (accessedApr.10,2015)(notingfundingofacademicdetailingbyPennsylvaniaandSouthCarolina).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"27, 2012 (describing this as an ‘asymmetrical scheme’ and noting that the ‘uncertainty in the regulatory scheme prevents [manufacturers]’ from rebutting CER), http://www.regulations.gov/#!documentDetail;D=FDA-2011-N-0912-0015 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"216See,e.g.,FDA, FY2012InnovativeDrugApprovals:BringingLifeSavingDrugstoPatientsQuicklyandEfficiently , Dec.2012,at21, http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/ucm330859.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"and Feb. 2006, http://www.fda.gov/AboutFDA/WhatWeDo/History/ ProductRegulation/PromotingSafeandEffectiveDrugsfor100Years/ (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"2001, at 9, http://www.business.ftc.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"27, 2012 at 13, http://www.regulations.gov/ #!documentDetail;D=FDA-2011-N-0912-0018 (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"239See International Committee of Medical Journal Editors, Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals , Dec. 2014, at 2–4, http://www.icmje.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"241Seeid.at14–17; PhRMA,Commentsre:CommunicationsandActivitiesRelatedtoOff-LabelUsesofMarketed ProductsandUseofProductsNotYetLegallyMarketed,DocketNo.FDA-2011-N-0912 ,Mar.27,2012,at14–15, http://www.regulations.gov/#!documentDetail;D=FDA-2011-N-0912-0018 (accessedApr.10,2015).",OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"27, 2012, at 7,http://www.regulations.gov/#!documentDetail;D=FDA-2011-N-0912-0014 (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"253See PhRMA, Code on Interactions With Healthcare Professionals , 2008, at 9 (‘PhRMA Code’), http://www.phrma.org/sites/default/files/pdf/phrma marketing code2008.pdf (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"3, 2014, http://www.propublica.org/article/as-full-disclosure-nears-doctors-pay- for-drug-talks-plummets (accessed Apr.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"See Sarah K. diFrancesca, GSK Announcement May Change Industry Speaker Programs ,LAW360, Feb. 14, 2014, http://www.law360.com/articles/505701/gsk-announcement-may-change-industry-speaker-programs (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"rDisseminationofHCEIandpipelineinformationtopayors,formularycommittees, andsimilarentities.259PayorsandformularycommitteesevaluateHCEI,even whereadrugisnotyetapprovedforaparticularindication,inmakingcoverage andreimbursementdecisions.AlthoughtheFDCAcurrentlyallowsmanufac- turerstoprovideto‘aformularycommittee,orothersimilarentity’HCEIthat ‘directlyrelates’toan approvedindicationiftheinformationisbasedon‘com- petentandreliablescientificevidence’,thisprovisiondoesnotpermitthecom- munication of HCEI about off-label uses nor does it permit communication 255See PhRMA Code, at 9, http://www.phrma.org/sites/default/files/pdf/phrma marketing code2008.pdf (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
",http://www.themsls.org/ what-is-an-msl/ (accessedApr.10,2015).",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"2001, at 9, http://www.business.",Non-OADS,/arxiv_data1/oa_pdf/94/a1/lsv014.PMC5034376.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"6National Federation of State High School Associations, High School Sport Participation Increases for 25th Consecutive Year, Oct. 30, 2014, http://www.nfhs.org/articles/high-school-participation-increases- for-25th-consecutive-year (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"7ErinIrick,NationalCollegiateAthleticAssn,NCAASportsSponsorshipAndParticipationRates:1981–82To 2012–13,2013,at74, http://www.ncaapublications.com/productdownloads/PR2014.pdf (accessedMay15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"18SeeegIvyLeagueAdHocConcussionCommittee,ReportRegardingtheIvyLeagueReviewofConcussions inFootball,3,2011, http://www.ivyleaguesports.com/sports/fball/2011-12/releases/Football Concussion Report-July 2011.pdf(accessed May 15, 2015); Pac-12 Conference, Pac-12 Conference Establishes New Football Contact Policy as Part of Student-Athlete Health Initiative ,July 26, 2013, http://pac-12.com/ article/2013/07/26/pac-12-conference-establishes-new-football-contact-policy-part-student-athlete-0 (acc- essedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"19See eg Vic Carucci, No Wedge Means Adjustment for Kickoff Units, N AT’LFOOTBALL LEAGUE, July 26, 2009,http://www.nfl.com/news/story/09000d5d8104d93c/article/no-wedge-means-major-adjustment-for -kickoff-units (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"20See eg National Football League, Rule 12: Player Conduct, O FFICIALNFL P LAYINGRULES68, 68, http://www.nfl.com/static/content/public/image/rulebook/pdfs/15 Rule12PlayerConduct.pdf (acc- essedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"at 64; Pop Warner National Office, Rules Changes Regarding Practice & Concussion Prevention, P OPWARNER, June 13, 2012, http://www.popwarner.com/About Us/PopWarnerNews/ RuleChangesRegarding Practice Concussion Prevention s1p3977.htm (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"27Alan Schwarz, Despite Law, Town Finds Concussion Dangers Lurk, N EWYORKTIMES, Sep. 22, 2010, http://www.nytimes.com/2010/09/23/sports/23concussion.html (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"38Steve Alic, Datalys Center Study Finds USA Football’s Heads Up Football Program reduces Injuries by 76 Percent,USAF OOTBALL,Feb.16,2015, http://usafootball.com/blogs/heads-up-football/post/9900/datalys -center-study-finds-usa-football%E2%80%99s-heads-up-football-program-reduces-injuries-by-76-percent (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"30, 2015, http://www.ninesigma.",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"com/ge-nfl-head-health-challenge (accessedMay15,2015);NCAA,DOD,launchMindMattersChallenge, NCAA.COM(accessed Nov. 6, 2014); http://www.ncaa.org/about/resources/media-center/news/ncaa-dod- launch-mind-matters-challenge (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"62SeeegJakeNew,CombatingConcussions,I NSIDEHIGHERED ,Oct.2,2014, https://www.insidehighered.com/ news/2014/10/02/u-michigans-response-athletes-concussion-renews-regulation-debate (accessed May 15, 2015);PatrickHruby,TheCaseAgainsttheNFL,T HEPOSTGAME ,Feb.29,2012, http://www.thepostgame.",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"63SeeNFLCommissionerRodgerGoodellurgesgovernorstoadoptyouthconcussionlaw, NFL.COM,May23, 2010,http://nflcommunications.com/2010/05/23/nfl-commissioner-roger-goodell-urges-governors-to- adopt-youth-concussion-law (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"13, 2014, http://espn.go.com/espn/otl/story/ /id/10276129/popular-nfl-backed-heads-tackling-method- questioned-former-players (accessedMay15,2015).",Non-OADS,/arxiv_data1/oa_pdf/df/08/lsv023.PMC5034378.pdf
"This is an Open Access arti- cle distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ),whichpermitsnon-commercialreproductionanddistri- butionofthework,inanymedium,providedtheoriginalworkisnotalteredortransformedinanyway,andthat theworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
",CEREBRUM, July 14, 2010, http://dana.org/news/cerebrum/detail.aspx?id=28786 (accessedMar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
",SINGULARITY HUB,Jan.14,2013, http://singularityhub.com/2013/01/14/does-passing-a-small-current-through-your-brain-really-make-you -smarter/ (accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"24, 2014); Greg Miller, The Unfinished Science Behind the New Waive of Electrical Brain Stimulation ,WIRED, May 5, 2014, http://www.wired.com/2014/05/brain-stimulation-science/ (accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"24, 2014); Greg Miller, Inside the Strange New World of Brain Stimulation ,WIRED,M a y5 , 2014,http://www.wired.com/2014/05/diy-brain-stimulation/ (accessedMar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"18CLINICALTRIALS.GOV TDCS,http://clinicaltrials.gov/ct2/results/map?term=tdcs (accessed Jan. 17, 2014).",OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
",http://www.fda.gov/ medicaldevices/deviceregulationandguidance/overview/classifyyourdevice/ucm051512.htm (accessed Mar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"28Judith A. Johnson, C ONG.RESEARCHSERV., R42130, FDA R EGULATION OF MEDICALDEVICES(2012) https://www.fas.org/sgp/crs/misc/R42130.pdf (accessedMar.24,2014);21C.F.R.parts862,892(2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"38US Food and Drug Administration, P ETITIONS TO REQUEST CHANGE IN CLASSIFICATION FOR CRANIAL ELECTROTHERAPY STIMULATORS , (FDA executive summary, prepared for the Feb. 10, 2012 meet- ing of the Neurologic Devices Panel), 2012, http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevices Panel/UCM290787.pdf (accessedMar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"39Beth Israel Deaconess Medical Center, TMS and tDCS Treatments, http://www.bidmc.org/ Centers-and-Departments/Departments/Neurology/Noninvasive-Brain-Stimulation/Patient-Care/TMS- and-tDCS-Treatments.aspx (accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"24, 2014); The Brain Stimulation Clinic, Medical Doctor of the Brain Stimulation Clinic ,http://www.transcranialbrainstimulation.com/doctor-fugedy (accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"46CaliforniaDepartmentofPublicHealth, CDPHWarnsConsumersNottoUseTDCSHomeDeviceKit ,June 28,2013,http://www.cdph.ca.gov/Pages/NR13-029.aspx (accessedMar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"27, 2012, http://www.reddit.com/r/ tDCS/comments/rgzv6/opensource tdcsproject/(accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"24, 2014); NathanWW, OpenStim, SOURCEFORGE ,http://sourceforge.net/projects/openbrainstim/ (accessedJan.29,2013).",OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"66Shawn Nock, Two New Open tDCS Designs ,NOCKO.SE, Aug. 8, 2012, https://nocko.se/2012/07/30/ brain-zapping-is-fun/ (accessedMar.24,2014); https://nocko.se/2012/08/08/opentdcs/ (accessedMar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"70eg 55tfg7879fe42e345, DIY tDCS Howto, R EDDIT TDCS, Mar.3, 2012, http://www.reddit.com/r/ tDCS/comments/qn6s5/diy tdcshowto/(accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
"On the other hand, the moderator said we cannot assume that these end users are knowledgeable enough to make informed decisions about their REDDITTDCS,June27,2012, http://www.reddit.com/r/tDCS/comments/vpob3/simple diytdcsdevice/ (accessedMar.24,2014).",Non-OADS,/arxiv_data1/oa_pdf/5e/0f/lsv017.PMC5034380.pdf
